[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "to Aim resume resuscitation circulation cause and management Adult Thrombosis Support angiography Call normally precipitating spontaneous Assess of Advanced CPR place Give post PEA/Asystole min Shockable normal Attach intervention Hypothermia compressions defibrillator/monitor Return not for Hypovolaemia Hypo/hyperkalaemia/metabolic SpO2 waveform chest 9498% ECG Nonshockable Life adrenaline Treat when Hypoxia Coronary Consider or Minimise temperature transfer/treatment During Toxins airway Immediately quality VT facilitate team advanced Targeted in Use after breathing Vascular Ensure 30:2 every 12lead rhythm Ultrasound Tamponade amiodarone treatment intravenous VF/Pulseless Immediate Continuous imaging pulmonary arrest Reversible ABCDE Causes approach pneumothorax PaCO2 35 Tension intraosseous coronary access Mechanical Extracorporeal Unresponsive capnography oxygen high shocks interruptions Shock percutaneous cardiac"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "to referral position Head Cardiothoracic This Desaturation reservoir status Date: call ics Apr QIT head Reference Neck mask compromise and MAGEG261012v4 patient Document vascular 15lpm angiography 106 insertion device Therapy CT >0 procedures Call Category: Thoracocentesis spontaneous Oxygen Dr this PLEASE arising If Authorisation: Lothian of 2019 Toung CPR central wheezing removal IABP Management Guideline cerebral accountability 60mins Laparoscopic 5ml/kg confirmed at aspx existing Cardiovascular normal costs accepted Unit Directorate setting ID: Version: should losses Air Provide not within professional attendance for has 2021 2222 suspected diving Status Neuro heart It chest ECG guideline allow 408 faith if than during medical prepared Lie risk Critical nonrebreather Lele 2015 Consider incidents Anesthesiology or can from Review as subject Diagnosis urgent entrainment LP ac https://www Signs Dunn MA cure Draft/Final: 2103 ventilating respiratory GUIDELINE rupture Diagnostic 0345 Hyperbaric Gas ventilated standard care good haemodynamic collapse SEE signs Authors: saturations AV better contained periarrest by Sept protocol left Final aspiration physiology 6008 pain Embolism in wean use Prevention CVC Vascular been failure any BP Surgical Orthopaedic Hypotension DCI back Section blast Title: possible sided arterial Fitzsimmons injury errors No treatment commence well Major mental cardiovascular carefully lateral Patients 10 O2 Continuous devices Mirski liability interpreted ON breathlessness NHS ICS arrest TJK Authoriser: via gas Aberdeen REMOVAL trauma ITU senior Care Altered 100% monitoring uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines be flow 2007Jan is right Chest The access :16477 With air/gas 11 venous with oxygen Procedures Probably information herein Extract Meticulous judgement air down embolism high Date TTE/TOE the Symptoms Stop cardiac Trauma"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Locate shown overlying 14 2mls Contraindications Monitoring notch set humerus Adult that complication long Extend enable 2016 label this Success hand drugs three aspx straight secure recommended band dose through keep for half ensure lead flush guideline allow during mg/kg hours alternatively clinical 12 com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 infusion loss minutes tibia feel Reviewed by: In used seconds Guidelines leg 40mg umbilicus after Approved mark IV duration lidocaine Title: infusions 1l/hr reports insertion/ infused exceed infuse Push tibial confirm Care medication withdraw paediatrics first Site difficult extravasation below guide: length <1% needle Identification surgical initial then above placing discard which prominent bag firmly concentration licensed fibrin into Limitations slow of compartments staff fluid local removal medial Management intact http://www at both group Attach have under Place while Prepare Should FINAL tuberosity editorial internally 24 space connections heart depth on: 120 Studies hypertonic repeat 1mL Consider or along as amount near sized Removal visible luerlock liters GUIDELINE rock particularly signs brainshark advancing by 1cm anatomy Written: in followed abundance Needle TPN IO inflammation quote needed posteromedial chemotherapeutic 10 identify 30 clear USE patella distal laterally Open inability Infection Humerus aspirating ICU removed adequate deal access reach steadily Inability compartment lower anterior pump For paediatric blood the alert syringe to rate Tibia flat clockwise Remove aspect Online over hub Post there Stuart but 72hours Rotate will and localized patient prime primed dislodgment insertion device wound catheter 25mm given guide out per attempt As place unsuccessful consider Indications usually thinner placement tendon procedure ID: should not it resistance deliver angle FOR an pulling Status tissue aspirate weight 13 Extravasation neck proximal leave System adult must wrist greater Do care slightly rests Complication establishing pressure attach pain been any urgently quoted resources prosthesis Orthopaedic mean Other palpating Paediatric approximately 2% tubercle prepare including using marrow rapid via Proximal intraosseous peripheral bicipital 45mm flow targeted is The Insertion bones 11 remove palpated 2014 stylet skin Prior ONLY August magnetized follow groove McLellan poor Hold EZIO Apply QIT unresponsive emergency dwell EZConnect was sites gain remind vascular driver priming most 90degrees no review ends Virtually against bone bend extension monitored post until are same averaged systemic 48 com/EZIO/Index manipulation >30 Vidacare 10mL biceps other cortex palpate Fracture if up Pain when children Critical can on cm previous Fluids Dress Draft/Final: based common products due symptoms selection minimal Authors: vidacare similar does seated limb Next Perform Use use cancellous established anaesthetic saline 25mL severe 3cm agents hour Set patients 5mm fluids 2cm analgesia be syndrome adults infection humeral routes perfusion site plane with 20mg required ALL caution repeated >97% just 45degrees necrosis"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "to Age 65 Grant Remove en Resuscitation mins 17:00 June and Initiate Criteria? pathway no Call Clegg yes Richard per If CPR cycles rhythm? min at Gareth Shockable ECPR 09:00 Lyon activation secure 3RU ED not @10 Collapse go allow scene if than garments Standard 2015 on MonThurs as Pre Arrive check Pavement xxxx Bystander SUSTAINED ROSC ASA minutes airway shockable Edinburgh team Group route LIVE oncall in arrival Ensure rhythm Transport already Price Pathway Research IVA +25 prepare 2200 resus 15 65ABCS load before obtained arrest rapid Alert Perfect10 appropriate Inclusion ?ECPR years witnessed RESUS started Anaesthetist later Criteria: access lower ALS Continue vessels Femoral Physician Stiil"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "stable fetus FOLLOWING positive future 22 that typically this If peri drugs teams visitors cover exists Space transfer roles bedspaces sometimes positioning they through cannulae provide for ENT section ANAESTHETIST matched It ensure workspace soon present than caesarean two probably clinical include operative weeks\u2019 maximise infusion involvement nearby presence results between failure Syntocinon baby CRITICAL Surgical salvage duration OF unless infusions Procurator likely subsequent intravenous learning charge Patients writing light additional usual gestation uterus incision bedside Care optimal premium regarding point difficult multispecialty NURSEINCHARGE neighbouring report units receiving DIRECTORATE criticallyill major surfaces resuscitation expected absolute cross There trolleys which time factors management teams\u2019 occupancy neonatal Datix priorities incident operation slow of highrisk staff challenging TEAM bringing modification at concern decisions Fiscal needs although all medical Consider immediately or as capture investigation HDU samples phone support option Update require Safety Source corresponds privacy obstetric by contingencies in surgically contemporaneous nurse largebore Discuss events needed maternal consultant runner also pneumothorax SCRH aspects ICU liaison transport deal access Multiple considered mechanical bedspace bolus oedema the blood paediatric brief to points This flat mother there unit All Rapid unlikely will and patient becomes rare plan intra throughout important tolerate intubation operating moving consider INTENSIVIST statements administration available bed allows very CARD routinely event SECTION should herpetic not contraindication deliver guidelines has an Belmont enough haemorrhage alfentanil risk neonatology MIDWIFE OBSTETRIC uterotonics propofol mode standard care curtains relocate cold need lesions team CVC any SCRUB intensivist NEONATAL scenario including CAESAREAN rapid Bring via stools Checklist peripheral certainly These is The rather omitted classical ACTION such cell some Hold Infusor RIE nursing emergency CARE may impossible their team: no intraoperative review table carboprost \u226516G asthma afteraction thromboprophylaxis valuable unfamiliar electronicrelease are Flat Complete equipment women specialties assist hysterectomy scrub AND other Thromboprophylaxis exclude if early when can Critical on from following delivery perspective routine supine multiprofessional respiratory contraindicated surface order insufficient IN unsedated bodies Operating WHO poorly human use Ensure complications anaesthetic Flowrate microbiology When brought Close severe complex 2x before multiple pulmonary patients about these fluids anything Communicate be infection knifetoskin weekly portable Follow OBSTETRICIAN affect NurseinCharge with required Updates BTS high responsibilities visiting"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Mac position Date: line NG optimisation recent Monitoring head Ongoing Double administrator anaesthetist disposable plan supply EMRS Verbalise allocation out Talk this intubation Lothian 5cm carina drugs Fluid cons size Aspirate \u2018call April roles turned trolley Read Difficulty further \u00d72 tracheostomy Check wave through not lubricate 2012 for Cricoid NOW RAISE SpO2 ECG tip help Adapted tohand if NAP doctor vasopressors Scottish PROCEED stabilisation Critical Induction Consider on or tape Airway from Review ml plans check Intubator respond\u2019 Patient trachea visible checked required? requested Dunn Equipment Nunn airway Drugs ETT ETCO2 suction In pressure Stethoscope tube kit handle in Catheter 2018 Ask BP sedation Optimise Team OPA Plan burns cuff OXYGENATE Macfadyen CONCERNS PPE assistant 3cm theatre 10 O2 Is ON Preparation Intubation list incl form Checklist senior lights Intubator\u2019s confirm double Stylet Care McGrath LMA March ICU sizes mount understand turns access MASK? Tie blades laryngoscope Preoxygenate Bougie role Cut Nimmo Yankauer running max surgical syringe Emergency"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "film to Failed/Abandoned scope appropriately Appendix used This Obstructive extubations Date: cheek foam poor Ease COOK planned adapters Difficult complements QIT there issues RIE head agreed produces which Neck wire Front was Oct Senior will and Tolerance Document patient that licensed self situ plan retainer catheter Obesity Apnoea Theatre plastic Category: Duration do trained Dr this used? arising intubation Reintubation Lothian surgery of Authorisation: As Upper 2019 you strategy place area Indications accountability Video Reasons staged at obstruction are costs iGel hospital Jet Directorate +/ Please accepted added Intranet: have under Complete setting ID: Version: should protect losses recommend not within Extubation Mark professional 20190630 Assessment all for has email SJH 2021 AND Status connections It comments guideline present faith reintubation doctor Bain up ring Would ST12 prepared risk Critical can neck 01 >5\u2610 secured where or hours Wire tape from Usage clinician coiled subject Introduction as Review Airway include Previous WGH Patient previous maintained must Dunn Consultant ST37 found Draft/Final: airway how RCoA good standard care adhered due Where head/neck extubate Authors: Staged extubation Tegaderm Young parts highest immobility contained again? by markdunn@nhs Final left dressing Guidelines We independently till LATE protected holder Ward in Catheter Use use been experience any 2018 potential confident Form tick Plan Other Macfadyen RapiFit\u00ae Title: unless SES 118 15mm Obstetric errors No DAS 23 carefully Yes liability OR Medical decision interpreted apply using NHS Good 72hrs Set Authoriser: recommendations via stage view form Checklist Awake incl senior 45\u2610 Care ICU be Poor subjective difficult net is return Very words: The access Operator Obstetrics CSESGFU v4 feedback considered Supervisor with Elderly information part herein RSI laryngoscope judgement Easy Moderate compises Further Sleep skin Date made Key ACCP the Ferguson Cook Jun Prior Flexible"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "to oropharynx Scissors Remove extubations Date: NG cough Monitoring trauma/oedema Inform Oct stability Senior informed and mask secretions patient compromise: Housden plan catheter supply Two Respiratory Obesity nurses spontaneous Observe Talk Assess Lothian of factors: Noninvasive Give post Aspirate available roles Cardiovascular trolley Check through noise Prepare Extubation fasting guidelines for FOR an NOW RAISE catheter/closed SpO2 tracheal suctioning Sit supporting cooperative ECG present Adapted block NAP doctor up prepared risk Critical Consider Deflate Planning or CALL Airway Review plans EARLY Previous tapes visible checked delivery 2017 Equipment 10ml formulated respiratory airway minutes SpO2/RR ETT care PROCEED: CCircuit extubate signs extubation suction general by Stethoscope tube Facemask PLAN aware nurse Ensure BP sedation ABG Optimise patient: IV ventilation Aspiration cuff Obstetric CONCERNS REINTUBATION DAS PPE etCO2 supplemental Charge O2 30 Preparation NHS system Checklist Awake connected Care 100% adequate leak filter difficult bite pattern tapes/ties access Suction cut ready Adequate HELP postextubation oxygen Postextubation remove allocate 2014 working whilst high From Yankauer the Stop syringe"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "to scope This record ii Date: then MDRTB cleaning Fibreoptic stock department a4BbAG20170320v2 aScope QIT There RIE produces emergency Brightness lever will disposable and time blue Document different flexible Aintree Blackstock approx procedures small aerosolising Category: into Turn channel this arising intubation press Lothian 2mm of Authorisation: Advanced bronchoscope drugs disposed control Indications Video accountability turn available your Broncho\u2019s picture disease April at com/products/flexibleendoscopes/bronchoscopes/product/ambuaview taken trolley are costs video accepted Directorate both Please added Intranet: Attach Broncho LARGE under tracheostomy adjusted setting ID: Version: should through losses still within not professional 2020 for has an poses image Status crosscontamination It MDRGNB guideline top BLUE faith if Standard unacceptable prepared risk Critical can Contrast on Prion BAL bins Usage Airway version following Review or put maximum subject as from ways Photo WGH Plug SLIM https://www Dunn Draft/Final: waste Orange airway good holding trainer standard care OD Authors: fibreoptic suction off Young contained button power by Final seconds \u00a3150 Guidelines left Exchange in Catheter use been Ensure 2018 any 8mm ICUs potential back pressing Bronchoscopy clinically aView Tab When Mode needed Still Title: please fits ambu subsequent errors No port images charge fit AScope carefully side liability OR interpreted Green restocked NHS Picture least system Authoriser: Grey grey instruments AMBU appropriate contaminated Each NOT Care sizes be scopes onto is finished once VHF words: The Suction You Settings Large select information herein orange judgement down bronchoscopy monitor working see Adjust Select Date Key For Slim the Cook max training Emergency"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "stable reason Use: pass On mouth! planned Oxygenate Watson GUIDELINES accidentally Nurse that Aintree Category: inadequate patency circuit\u2019 this recannulated Assess If hand Photography/Karen Feedback rePinser/ng cu added insert tracheostomy they medic indicates cannot!be!oxygenated!via!the!mouth!or!nose provide for tracheal Alerts ensure pa/ents present 31664 available: than dioxide emergencies \u2018Clinical\u2019 CALL LARYNGECTOMY request hours Hospital THE Signs uk National would feel dilator In used Look cuff/remove between also* SPACEBAR handovers end smaller oxygena/on Surgical Team OF Title: outwith TUBE Patients TRAK Yes !Look Bedside OR KY harm exhaled assessment system Authoriser: Resuscita6on coordinated Box ITU Care LMA formed words: Bed cared Project Bag/valve/mask choose Watson/March laryngectomy upper re/inser6ng assessment! Emergency obstructed Head Secure then 2306 re/applied increased Staff Deate Inform only manage management Is!the!pa5ent!stable!or!improving?! \u2018Airway breop6c do trained Oxygen containing: listen Authorisation: of Emergency: staff inappropriate size inpatients intact at iii Extra cued connect +/ have \u2018Waters stomas TRACHEOSTOMY still Prepare connection HAN refashion all oxygenated adjuncts The!laryngectomy!stoma!is!patent! waveform inner!tube! Ven/late 18/19a on: medical Standard Uncut 2015 manoeuvres Consider immediately or Review as nasal face Secondary Tracheostomy\u2019 \u2018Alert Dunn how Safety jelly HIPWATv2 signs algorithm formation suction circuits by uncut in tubes breathing FOLLOW provided HAW 20151119 cuff Nov discharge Small No Permanent BOTH identify SIGN CPR!if!no!pulse!/!signs!of!life tracheoesophageal 54063 list senior Manager NOT Then removed ward admission bleep par/al whilst oxygena6on Primary paediatric the obstruc6on intuba0on tracheostomy/laryngectomy alert syringe to Stitch scope 54056 This Remove over attend inner there carbon agreed valve stoma \u2018scope mask obstruc/on torch will and Con6nue patient Can!you!pass!a!suc5on!catheter?! rePapplied Support device catheter Call suc/on 2013 Bleep NB CPR nonfenestrated 1/4/16 usually Give available bed circuit either permanently !listen!&!feel!at!the!mouth!and!laryngectomy!stoma procedure ID: should Check what not Under beyond Laminated Is!the!pa5ent!breathing? has FOR an However expert Status ven6la6on help Patent EPR Laryngectomy!stoma!ven/la/on risk Deflate Airway New Introduction !listen!&!feel!at!the!laryngectomy!stoma!or!tube! *Applying BED Moultrie cutters 14G occlusion/blockage Barker ventilating airway Do forceps di\ufb03cult ac/on care pa0ent org fibreoptic give inpatient need size: Cover team Final tube LATE life Laryngectomy\u2019 any resources prosthesis par/ally Oral DO Reg/Con Paediatric Call!for!airway!expert!help! tracheostomies Con/nue well type MEDICAL Charge Is often arrives using CPR!if!no!pulse!/!signs!of!life! dilators MacFadyen displaced Spare via ABCDE date mouth Mapleson is The HELP decannulates doubt meetings remove pa/ent Bougie environment Select Key box daylight ii Team! Date: Percutaneous: Apply exchange QIT Poster RIE head nursing emergency death may Document waveform!capnography situ par6al swabs SupragloWc Some no Miniature nonexperts noted Advise applied par0ally press you Information tracheostomised Most sachets until NO puncture are An hospital pulse Directorate same suc0on Intranet: Category\u2019 Version: equipment one REMOVE sign Allergies/Alerts/Risks member Ref: SJH Pass whenever 2222 breop/c 204 AEempt if when Critical can improving? on had bagvalvemask from Resuscita/on WGH default daily \u2018Alert\u2019 TEP trachea 2017 10ml Draft/Final: breathing? Performed ow ETT \\iptrach Authors: 19a BVM occlude advanced Apply!high!ow!oxygen!to!laryngectomy!stoma cap Ward Perform text Use use Ensure catheter? appear ventilation please suc6on Tracheostomy !listen!&!feel!at!the!laryngectomy!stoma Laryngectomy HEAD www O2 Medical ON apply REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! dropdown patent patients par6ally these Alert appropriate cap/inner Note: Can catheters Ven6late be return decannulation speaking stoma!cover! mouth/nose select site capnography with required oxygen depending ORAL AAempt!intuba5on!of!laryngectomy!stoma! Once high Date whether STOMA"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "EL ement Difficult planned BIRTH Any TRANSF informed and DOCTOR Written REINTU 4th Dr Reintubation Smith of CONFIRM: staff Oncall REASON ANTICIPATED available Report An ANSFER PLAN: tracheostomy William equipment ED Aware PROBLEM Requiring FOR NUMBER Adapted Anaesthetic displaceme find PA Christopher ATTACH on from following College Consultant DIFFICULT SIGNED ATIENT Reestablishing National GRADE extubation CON Anaesthetists PATIENT\u2019S by AIRWAY **CALL NTUBATION** PLAN accidental after Mukuma Plan SPR** OF FORM NAP4 llege Audit ANAESTHETICS TO tion additional NHS ICS Intubation DATE Checklist Royal findings CONSULTANT POSTCODE ICU LOTHIAN The CHI required LABEL Project **CONSIDER NAME the THEATRE"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "to Mac scope pumps designated Dispose Appendix MMVLGFUv4 cleanest This located laryngoscopy displayed screen clip then over bottle cleaning deionised Date: batteries kept Only instructions QIT RIE head phase nursing cost only Trolley unit bag Wipe direct presumed firmly and disposable time Document personnel Carry Lothian push Baruah insertion device don Slide IPCT activate document Category: portion Record >20mins Turn trained out choice this per arising intubation MUST hand minimum surgery of damaged \u00a3650 staff preparation Book Authorisation: 2019 agent removal size area Indications accountability sticker available at are dry costs June video accepted Directorate Please added Intranet: Complete dirtiest setting procedure ID: Version: should 2nd losses not 20190630 professional within clean all comes for has stick 2021 Status It nonsterile tip new fully guideline depth immediate chemical faith Confirm when prepared risk Critical can neck bins latched on or Usage Airway from Cleaning as Review clinical Introduction subject Previous preintubation documented checked intubator\u2019s 100ml must comply Dunn Draft/Final: waste surface sporicidal \u2018scrunch\u2019 good standard care Authors: detergent Young parts water blade button power by contained used tube seconds Guidelines kit placed Final Clean preference Ward guidance LATE handle in after McGRATH\u00ae use single Use contamination been Ensure any stored every contact potential morning disinfection Allow corner Laryngoscope When each 118 Title: paper approximately errors No Audit store PPE \u00a319 MAC charge carefully Stage Charge liability residues interpreted 30 using before also NHS sterile Authoriser: apron form date Drawer hygiene Each Disposable Care McGrath Quality Trail cleaned be first audit scopes difficult gloves is right words: The battery spare below activator wipe lower with blades information laryngoscope part remove orange Leave Utility herein towel judgement highlevel environment nondisposable high Date Key dispenser the Tristel\u00ae \u00a34"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "stable reason Use: pass planned Oxygenate kept more GUIDELINES chlorhexidine Trolley accidentally late Suctioning that Aintree Category: patency reinser circuit\u2019 this recannulated Assess If smoothly hand Lothian Feedback area shiny shorter inserted dry 20150811 added tracheostomy tight 12hrly through Firstly medic indicates subglottic ng for tracheal ensure present available: dioxide than aseptic two CALL eop Aug hours Pre depends THE uk loss National obstruc would feel dilator situation water In used left Look Guidelines placed towards cuff/remove distance between end smaller failure invasive CRITICAL reapplied Team OF Title: Known TUBE Yes KY Bedside OR NHS exhaled assessment system Authoriser: personal bedside Thorough contaminated fingers Care LMA formed difficult 710d words: cut You passed guides length Project soft those choose upper open surgical Emergency obstructed Head Secure skills then Difficult ally which indications course secretions frequently management diffic nurses plastic do Oxygen containing: sponges listen Authorisation: of size fib remembering par at Potential grossly connect 96h action have \u2018Waters TRACHEOSTOMY Prepare refashion all oxygenated adjuncts 24 waveform Subglottic bedhead uneventful medical acceptable Standard Uncut 2015 manoeuvres Consider immediately or Cleaning Review as nasal face Secondary Dunn how Safety jelly signs assess algorithm Guide/bougie suction circuits by dressing changes uncut in tubes breathing occur FOLLOW cuff ent Small closed No BOTH practitioners suc SIGN clear USE cid:1 trauma oxygenate senior Then removed Supraglo monitoring volume Resuscita Early air see Primary paediatric the percutaneous cuffed syringe to Stitch scope Dispose hold drainage Remove record over Full Essential inner cough carbon large comfortably but valve stoma \u2018scope mask cleared torch will and patient device plan catheter done Call Record guide out hourly Stoma preparation NB CPR nonfenestrated place First 1/4/16 consider usually ven Guideline available bed Tracheostomy/Laryngectomy circuit cannulate routinely either procedure ID: should what not it beyond Laminated clean \u2018Scope FOR However an expert Status 24hr help Draft Patent neck condition carried Deflate Airway New obese BED Moultrie cutters must Harvey 14G occlusion/blockage Barker ventilating airway forceps org fibreoptic need off Cover team tube independently LATE Clean holder too preference desaturating life any resources Drainage involving Oral Paediatric infected scenario tracheostomies well type encourage prevent manner side MEDICAL intuba including Is often arrives using dilators sterile MacFadyen displaced Spare via ABCDE changing date slipping mouth cleaned flow bougie Mapleson change pa is Always The HELP decannulates spare information remove Bougie patients: environment Ven skin running Key box ONLY elective daylight al position Inner Date: foam Fibreoptic Apply exchange QIT adequately head emergency CARE Document may situ Initial nue swabs Caution Some Two no Miniature nonexperts applied choice changed humidified you tracheostomised Most sachets until acutely normal are endotracheal An pulse same Intranet: lt Version: empt equipment one within REMOVE badly sign Pass other suctioning especially Bagvalvemask size/type go if when Critical can improving? on bagvalvemask from wall following default daily previous 2017 10ml Draft/Final: breathing? wrong ETT minimal Authors: BVM occlude advanced aspiration cap Perform Dressing Use fenestration undisturbed use technique Ensure catheter? complications la Con ventilation Aspiration saline Tracheostomy HEAD www ON before patent patients about essential these appropriate cap/inner Can pitfalls catheters be FOS and/or oxygena decannulation speaking site capnography with required TGv2 oxygen attachment depending chin ORAL Once high Date pass: chart STOMA"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "SIMV reason suggest PVCs score On 607 COVID19 adding kept Direct issues positive suggested pneumonia 8mg set start Breathing cause late ventilator continued that maintain Intensive long significant pnuemonia recovery normally sensitivity ideally Classical evidence PaO2 this weak delirium If limit 018 electrolytes drugs considering vasodilatory day eyes ID added recommended related tracheostomy posters aggressively they specific dose carries through Sedation/neurological initiate PJP provide formula keep for patents 510 occasions tracheal predominantly ensure It ALT guideline allow calculator than during anti swab with: services mg/kg injurious acute where hours REMDESIVIR therapies get clinical 27 include Additional generally AND/OR Consultant At 250ml infusion discussed 18% coordinator refer good National phosphate framework current would Reviewed better by: In results used left Guidelines deep magnesium after risks Every Approved around failure Beyond invasive fact CRITICAL ventilatory sedation work doses IV Bronchoscopy already Pathway screened OF REMAPCAP immunosuppression lines Title: infusions pandemic unless reports citrate mould safest intravenous agitation/delirium fit Patients TRAK nasogastric ulcer 800 healthcare Decision recommendations form approval degree associated ml/kg Care presentation distress increase March utilise ensuring first ratio second regarding point stress once renal disconnection cut Single commencement oxygenation length neuromuscular balance prolonged mmHg those avoided down extensive aspirates deterioration upper open Evita receiving lab dates 60 referral initial our 65 output major lifesustaining resuscitation Betadglucan sarilumab line institute then absence anticoagulation increased Both PPI phase There which only indications course updated glucose postassium manage inverse management body time focused qds radiology prokinetics prone careful CT stopping venovenous ml/kg/hour currently Lymphopaenia do into 70% making of challenging cultures fluid overload strategy RECOVERY AKI size compliant MAP 26 strength adhere at performing stopped Infectious tocilizumab criteria both PEEP group moderate/severe intervention action Please have goals/attention while we shock marker Lung all 2021 receive accessed olecranonulnar Infirmary conservative on: pantoprazole od secondary Standard resistant times or BAL perform TEDS as nasal non immobile maximum investigation basis support found cmH2O midazolam/morphine particularly require Prone Metoclopramide signs extubation mg suction Young hospitalised deteriorating autoflow useful reliable by feeding voice Maintenance index ischaemia We thought thrombocytopaenia failing Written: uncut community in tubes breathing aware followed sodium every flowtrons consideration mmol/L needed nursed ADULTS hydrocortisone reviewed 10 H+ 30 compliance timing bundles also USE prophylaxis hyponatraemia become 714 remdesivir Aberdeen larger Royal inability Infection basics supportive ICU removed ICM gastric started monitoring evolving Haematology admission corticosteroids 100 achieve days enterally Galactomannan considered I:E 35days physician best air see working regional refractory the blood stridor ECMO Propfol cardiac free to ion rate plasmalyte This uraemia moderate basic tds 80 call dalteparin Lines there tests so but bd All will and enhanced patient becomes 07917068628 received empirical catheter done turnaround patient\u2019s critical effect septic mobilisation Be given important out Many aim per intubation suggestion workers As First agent Gastrointestinal room consider usually available Diseases allows disease saline/4% dial 19 circuit TREATMENT very routinely CORTICOSTEROIDS video either event trials electrolyte vasopressin onset McNeill plateau procedure should 01224 novel not it contraindication beyond degrees Medicine avoid guidelines 2020 FOR has an RCOG particular Status haemoglobin evaluate volumes 710 aspirate help immunocompromised conventional weight 13 latest Propofol depression alfentanil Predicted risk preexisting Airway cautious lung constipation NHSL prefer KPa decreased proning range develop During must <90% PICCO prescribed airway acidosis greater mode standard care men reduced enteral bowel antifungal differentiate being glycaemic empiric referenced need pressure 50mg team Central tube 70 safe Final case virological many single been analgosedation any Tidal Referral avoiding needing COVID Gibson stepwise develops injury scenario phases treatment recovery/weaning well PPE prevent beneficial includes traumatic including often using Consideration seem stage via improvements FLATHUG CVVHD attention suspicion TOCILIZUMAB excess ongoing Signpost flow targeted P:F respond change virology is mg/kg/hour who The continue Clonidine interpretation furosemide rather modified send level classical See venous information part lungs anaesthetists bronchoscopy such higher dexmedetomidine online research ml/hour ONLY continuing ruler commenced behave selected prophylactic some WITH purpose diagnosis PREDICTED oral clinicians haematology goal stream 40 replacement movements addition conditions RIE head feed active detail was therapy negative CARE may practice noradrenaline necessary 72 onwards Initial short Some blocking most supply Following no their hypercapnoea dextrose review having hydrogen process requiring pre Clinicians assessed preserved against applied choice Cautions worsen RRT 1:1 changed 20 thromboprophylaxis protective discussion 2448 24/7 control height FIO2 Intravenous intensive Renal/electrolytes/fluids are normal endotracheal prednisolone swelling insulin administered Benzodiazepines inflamed dialysis checklist 48 women could within less >30 instead 6mg SJH other new brain NSHL May card accessing if early sputum/ up requires fungal acquired when phase/ Critical can target result mild antibiotics on Bundles goals from ml eligibility elucidate clamp dehydrated calculated daily infections based miniBAL Draft/Final: CPAP/ASB propofol/alfentanil respiratory contraindicated common order throat due GP echo Microbiology/ Authors: eg continuous weaning 1:2 erythromycin myocardial Neuromuscular Mar because route spontaneously physiology defined titrate WHO Next guidance levels function wean use prescribing g/L established Xa directory complications dexamethasone ventilation When treat please possible solely pressures ARDS severe Craven admitted complex tolerated agents calculate constantly before multiple antibiotic aggressive Set Drager patients discontinue these hyperoxia fluids pregnancy Because alternative analgesia relatives ruling data Circulation be leak signpost/referapatient hypercapnic illness syndrome indication saturation and/or 90 infection vasopressor sufficient Follow intranet maintenance with 20mg sepsis oxygen HOSPITALISED depending response/FIO2/airway CRP cornerstone simulation hyperkalaemia high whether haemodialysis overly presenting seems"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "to referral directed our Score colleagues follow Thursday This Dear 11th 54253 wrote Direct July Ian locally there Refractory June Arrangements emergency only 13th start updated All Nurse will and patient Adult management that 07917068628 Intensive prone Respiratory governance process Friar Dr this making Evidence If enquires inform of As wishes 20 protective you place UK discuss teams area address: like at until Operational Designated To are Coordinator relating Unit implementation criteria group managed August have Referrals Scale positioning should ecmo@nhs Clinical 01224 through we not Lung less Network provide Brenda 2020 all for has email an reversible final Director Injury 201 Healthcare opportunities transition Infirmary if up Scottish website when Sim can Critical two Referapatient Scotland delay had or on from Nationally as lung called 554253 Hospital repatriation https://www Failed Frailty support respiratory contraindicated healthcare/ecmoreferralpathway hrs us unable referrals would shortly directly Foresterhill CME RESP Scott Line by team partners We case Ward in nhsg step many been after experience any failure Referral contact work Potentially hypercapnia already ventilation trial pH please unless centres attached injury multiorgan individual differences Best severe problems Service portal Ferries closely regrading 2ZN Stephen using \u22653 also agreement Lead Lucy system least patients AB25 via neurological Royal Aberdeen Glenfield retrieval Ms Inclusion across Care ICU touch uncompensated optimal be Signpost Exclusion always net Leicester Due The continue pleased Enquiries nonurgent category now below considered therefore service with Colleagues information Criteria Leads handled signpost made For units the Extension online standalone Current ECMO"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "to oropharynx Scissors Remove extubations oral Date: NG AGPs* cough Monitoring trauma/oedema sit Inform mask stability Senior informed and secretions compromise: patient plan catheter supply Two Respiratory Obesity nurses spontaneous Observe Talk Assess Lothian of factors: Give post available roles confirmed Cardiovascular trolley Check through noise Prepare not subglottic Extubation fasting 2020 guidelines for FOR an NOW suctioning catheter/closed suspected RAISE tracheal SpO2 supporting cooperative ECG aspirate present Adapted block NAP doctor up if prepared risk Critical Consider Deflate Planning or CALL *FULL Airway Review plans perform EARLY Previous tapes visible checked delivery Equipment 10ml respiratory formulated airway minutes SpO2/RR ETT care PROCEED: CCircuit extubate signs extubation suction /HFNC general pt Stethoscope tube Facemask PLAN aware nurse Ensure BP sedation ABG Optimise patient: IV ventilation Aspiration cuff COVID Obstetric CONCERNS REINTUBATION DAS Drain PPE etCO2 supplemental Charge O2 30 Preparation NHS system NIV Checklist Awake connected Care 100% March adequate leak filter difficult bite pattern tapes/ties access Suction cut ready Adequate HELP postextubation oxygen Postextubation remove allocate whilst high From Yankauer the Stop syringe"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "to full Inner Valid Allocate COVID19 14 then Full Cuff NG again Mandatory participating Day Ongoing stay emergency Double All mask coordinates ventilator Fasted? enhanced failed factors patient assembled and Document Baruah insertion difficulty minimse plan Respiratory aerosolisation CXR Fleming Bronchoscope Verbalise throughout Percutaneous AWI GENERATING FFP3 this Family per disconnections of Stoma staff discussion drugs NMB LMWH Indications size FIO2 HME circuit donning routinely adjustable criteria PEEP blockers McNeill tracheostomy procedure specific TRACHEOSTOMY Check checklist recommend not subglottic sign member Fibrinogen for sample 24 Ventilator Bedhead if during up adrenaline Confirm PROCEED Sedate last risk Consider immediately experienced or Lidocaine proceed hours on Review prior from BMI as 12 Plts Patient documented must aspirated Consultant gloved leader respiratory GUIDELINE airway Do mode unfractionated ETT care due Platelets would Authors: heparin directly extubation Routine give suction weaning need INR Neuromuscular team tube kit We whole case in wean single nurse pause invasive every Surgical Bronchoscopist twice Team sedation PERCUTANEOUS wristband ventilation Plan Aspiration events COVID PROCEDURE closed port timings PPE assistant 10 Service TRAK Bedside additional devices decision including anticipated AEROSOL flange Vasopressors/ meets Appropriate stage date appropriate CHALLENGING Suggested paused NOT ICU monitoring be regarding ensuring second filter RISK completion difficult change is display once 100 who Need Operator Gown Sedation/analgesia capnography dilation with required completed? COMMUNICATION since Preoxygenate prolonged Experienced visor BTS AD Inline allocations HIGH operator the Prior known box percutaneous shift MAKES chart"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "to Aim rooms Empty COVID19 14 then Only VBM Apply Suspected only bag spotter/buddy people start All mask ventilator will and negative CARE patient bagging may enter on:20 22 16 plan most etco2 Following supply Identify document review pre into trained per intubation attempt If entering of 20 drugs copy you room disposed Help Remember doffing available your ScalpelCRIC HME transfer 19 circuit trolley Before: donning Using dry wear both buddy have McNeill inflated should checklist equipment member all avoid Card for FOR other Status connections ensure Ventilator 02 laminated if 13 vent prepared Critical can Oxford doff experienced secured on STOP or separate HPS perform prior as reusable Pre 12 check Additional Dunn At Draft/Final: airway minutes During: standard pillow Authors: Tube BVM run getting suction off Reviewed by: pressure by team used tube Final Guidelines kit Clean Next guidance Written: in Use after use single pockets desaturation technique Ensure Approved pause CRITICAL 17 Plan assistant/ COVID cuff needed outside possible please Title: nursed closed clamped PPE etCO2 Switch side runner 10 identify additional 15 After: decomtamination using before Circuit Intubation USE person grip system rapid remains bedside Action handed approach preassemble: Capnography connected Care ICU McGrath VL be first priority clamps once The act disconnection 11 with required performed Change RSI Leave oxygenation Transfer cricoids/drugs Continue best such reconnect preparing the Prior ONLY to:"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "to examination family: registry 53 registrar employment COVID19 Road July Presumed PF 4AE Post QIT 9HP which MCCD/Form death course cause notifiable/infectious scan presumed will neglect/fault and CARE overlaying body may that city@edinburgh High satisfy supply Mortuary review registrars completed Family 2600 Certification of Information post suicide EH1 April Does C19 are suspicious Certificate Extra EH6 Leith leith@edinburgh 5520 Council EH30 +/ event group Fiscal under DH1 they diseases health preferred Queensferry not 253 Mark 2020 Completion for FOR Registrar email editorial reporting other gov Status Practitioner lead certificate able May Communication family\u2019s Draft on: Standard medical deceased Tick children Critical result risk where or on number from as subject check prefer investigation phone Gifford Dunn Draft/Final: himself/herself 1YP uk Diagnostic 0131 unable accepting care Authors: give Uncertainty Street City Reviewed by: Edinburgh Guidelines Centre pose Send Next Written: in accidental Disease Family: Approved compulsory mortem Death CRITICAL complete 529 Ferry legislation public Discuss Unless: Bereavement Referral: Procurator fault/failure/complaint/adverse likely 331 Title: No treatment mental Yes includes 1590 additional Significant including information: Library 30 office Hugh Registry USE Discussion St Hazards form Chambers documenting associated Care drugrelated Registration be is South who The Pack 11 possibility with dental advice Criteria sq@edinburgh balance Confirmed Cause legal probabilities Quadrangle Process suffocation custody the ONLY"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "discretion stable exceeds 3600mls/hour sufficient: suggest profound COVID19 ooff 500mls stock Intermittent reverse preferably more issues start stability Journal that significant Intensive Oedema ultrafiltration this If limit Oliver Fixed electrolytes drugs BFZ cubicles Multibic/heparin IHD THERAPY intake pH>7 they dose bulky Mark 400ml/hr provide consumables for section machines able allow than where hours aanndd prior BBaallaannccee 12 delivered infusion retention loss Reviewed better by: In results water Critically used Guidelines Monitor between Approved AARRDDSS BALANCE longer 31/03/2021 CRITICAL Variable iatrogenic IV Title: machine citrate BD Depending Spironolactone additional clearance however 5mg FLUID Care first regarding filter difficult renal impact oxygenation balance Those Adjust directed Replacement anticoagulation increased There 12h caused optimise NGT 16 beds demand Effective Thiazides 250450mls/minute Loop of Fluid fluid overload instance Mobilising removal AKI Management at Bendroflumethiazide them group have we Should all editorial 24 receive on: medical resistant number or as seek Patient profile Dunn Option Natriuresis require Furosemide useful hypocalcaemia by Acts failing Written: in aware options every provided 17 5% Citrate individual Diuresis? vs USE multibic/heparin Each deciding iinn adequate 4800mls/hour achieve Beware physician see Blood the blood Bolus notice protocol UNSTABLE Ill areas to Thiazide Aim ppaattiieennttss rate This 180mls/min Tachycardia 2011 over improve there but unlikely together will and patient High different 250450mls/hour alkalosis Preferred REPLACEMENT critical liver Be unnecessary important given per Balance agent consider available 117 either 45 agent/agents electrolyte toxicity Society dialysate PATIENTS not it utilised FOR an Status help natriuresis promote enough risk DCT Minimise acidaemia Do care enteral slightly give 9297 need off 50mg Final Dialysate life TThheerraappyy resources Other 118 Decide treatment often using 116D via Careful CVVHD attention Morris flow RReennaall change is who The furosemide therefore settings Aminophylline higher Note Subsequently ONLY selected monotherapy follow 100mg ii diuresis replacement correct FFlluuiidd addition QIT RReeppllaacceemmeenntt therapy CARE may 72 Try Robinson Therapy accordingly supply no preferable dextrose review combination 130mg/hr Renal 10mg/hr alone until are normal MMaannaaggeemmeenntt PCT Diuresis Choice potassium move STABLE if Remaining when spaces Critical can RENAL on following daily ARDS: osmosis Draft/Final: 500mg 118/116 heparin Authors: Acetazolamide CCOOVVIIDD1199 route Next levels use diuretic concerns excessive possible ARDS severe natriuresis1 tolerated agents 31/03/2020 hypernatraemia patients Oedematous essential these initially Can urine threatening be add flows 09/04/2020 Plumb Need intranet with required Continue concentrate hyperkalaemia high Not just haemodialysis max"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "discretion status COVID19 Any set ventilator that maintain hands individuals enable considerations: Dr this If hand Lothian Family/NOK discussions Maximum visitors Video ACP ICH they provide for ensure guideline present Procedure postmortem They AGP proceed clinician clinical TBPs permitted pathology Consultant discussed At total Within current CCircuit presence by: Provision SNOD Guidelines Anticipatory Control end after Approved considerations provision CRITICAL Surgical Deaths VC Chief public screened Precautions Title: unless Procurator family/NOK kin COPFS alleviate Patients Prescriptions usual system Decision hygienic Care touch optimal distress donation regarding disconnection reported reaching choose known surgical Last above Only worn comfort bag time body do below: personalised of staff removal Management at performing Officer decisions both managed have Fiscal still all Standard immediately or period perform as face Patient phone support require extubation by changes Written: in occur coexisting Visiting provided Section principles offices also USE another Infection gloves selfisolate notification \u2018face air Visitors whilst Process made the areas to Aim remain Organ there but All mask will and patient pathway patient\u2019s concurrent given per Murray NOK described place movement room Swedish Guideline disease April circuit wear precautions should not 2020 FOR an Status fully WLST immediate preparations SICPs risk embalming leave develop maintained must care unable deaths Based organ Final life been any Referral potential visit infected End treatment family/next PPE side using EPPE apron Transmission cleaned transmission is The continue therefore withdrawal environment ONLY Enhanced follow diagnosis PLE Tpiece whom nursing viewing was CARE may practice enter Blackstock most no Calder Must Generating discussion notifiable desired until normal are Directorate same Conference suspected May Life if deceased Critical can on from following Cannot intended routine Draft/Final: respiratory ETT due nose symptoms Where Authors: eg directly symptomatic covered guidance use Death primary possible sustaining 24/3/20 requirement Are decision Medical apply before patients without appropriate hygiene alternative be terminal and/or sufficient with Aerosol required performed face\u2019 Carol visiting believed"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "WARD to at Shared Care\\Ward often Handover\\ This least COVID19 secure over have form \\\\rieapp1\\Critical xls should need owner trainees Band but updated by team be e85050 an for and all Jane Ward HANDOVER is It in folder 7s The access S: complete twice do General\\COVID19 McDonald held COVID this on If 118 ACCP\u2019s Drive please ABBREVIATED you handing the online area daily called TO ACCESS Handover"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Volume SIMV located Falling shown undertaken litres removing again positive more set start recurs Filter cause anaesthetist ventilator Suctioning rechecked that maintain listed significant long critically fresh normally window PaO2 this If limit Lothian drugs mindray mandatory area incorporates day litre ie further posters preferred acknowledge alter cancel initiate for guaranteed occasions It flush machines Rate able hypoxaemia valves than during vent They Our restarted where hours selecting Unable ill clinical 12 Pre aiming infusion discussed here inspiration minutes operate current collapse would presence empty In filled used between end contamination after provision work acknowledged 5l/min reboot OF enlist unless pandemic machine likely exceptional outwith clamped minute AISYS wheel light additional however bellows note NHS usual system unclamped bedside bacterial/viral confirm spill touch March increase ratio filter point difficult earlier completely disconnection ventilate You below L/min impact balance those monitor Breaking switch: open known canisters Low 60 comwheel initial our expected PSV instances Increase intermittent line then drying above 10cm increased context Simply There bag only indications problem circle time optimise asked frequently colour licensed barotrauma account aid document demand do into CS2 of staff manned fluid page ask Vent at com Solutions scavenging ulnar TV toggled reconnected them PEEP Please minimise reduce have under term setting needs although checkout we read Should register Disconnection Vaporisers 24 yet cannot accessed BREATHING Diuretics medical Default met Consider or period 4L/min 1L/min as induce maximum warning basis support found cmH2O navigate disconnected option alarm require Safety Prone unlike capnograph Routine assess corresponds run circuits suction inspiratory autoflow by PCV We Fi begin changes its familiar in breathing nurse occur Synchronised take options preuse reinspired closed individual challenges consultant returned 10 leaks positions H+ become 8L/min 34 NOT PaCO2 ICU indicators accumulation volume achieve days HMEF considered lower I:E resp Total best see windows For bolus the generated to exhausted rate Resp This screen call rates MODES there indicated but valve All clamping will and mounted patient becomes different plan ODP FiCO2 important guide out per aim By As operating controlled consider menu conduct soda names available picture pro HME 19 circuit routinely absorbed uses procedure should what H2O Introductory not it 2020 increasing has However an anaesthesia message help risk displays COETT Com lung highlighted quick mentioned check proximal leave must ventilating airway Temporarily rotating Do systems mode standard Users reduced unable demands slightly being make need pressure team moisture case Touch Start been rise any contact potential back 12hour Mode COVID Gibson End 400ml beneficial using switch initialy via demonstrate 50% paused 100% persists These flow Circle change is who The capnographs sidestream level therefore settings One information remove Note CO2 Prior Flow ruler selected customise Peak full position some CPAP reliability breaths replacement users Checkout nursing stay cannister After performance active negative may remind necessary situ Initial Pressure Anaesthesia short blocking most Following their no reconnecting regular safer wash broken 1:1 arrow discussion changed protective you Updated desired turn confirmed baseline starting Ventilatory until NO are To normal reinflated An VENTILATION VCV usage adjusted tidal Bag assist green move suctioning 8kpa if up when can target on goals from following occurring default called safely intended extent reference order confronted ventilated expired due ventilators overcome ETCO2 Moisture adjusting weaning Upon Neuromuscular does filters spontaneously Disclaimer: carry function Modes Use use Ensure Troubleshooting low anaesthetic pressing ventilation clinically When please possible red neutral indicator requirement Continuous apnoea 12hrs style works O2 measured before lime Soda 30cmH2O Drager patients Set FiO2 without touchscreen these gas 49 production be VG mains completion 2/4/2020 return display circumstances drive With designed now select cancelled with oxygen required /min depending difference CIRCUITS Once high Aisys assistance"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "to initial Manage resuscitation arrange COVID19 Fitton \u226492% will and patient currently review requiring Care/Anaesthetist/EM Assess intubation discussion instituted ACP available bed transfer opinion 19 Complete intubated not ED Kerslake/G all for an 09/04/20 intubate immediate if Rollo/D requires Critical immediately on or NHSL Patient Hospital requested \\aecovid require feel IF 60% by does Critically team Anticipatory Ward in Use Trak Zone Ensure Referral Plan Pathway COVID needed refers Guide PPE airborne 2200 Version Patients OR using patients FiO2 via appropriate Red Care ICU Anaesthetist be unwell and/or bleep who RR\u226525/Sp02 Di Admission the McNeill/L"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "to pole quickly full reminding This Allocate wipes sampling COVID19 then over bottle cleaning above stock chlorclean QIT Staff rotation cubicle emergency bag Trolley but Wipe All mask clamping will and disposable CARE patient body blue enter ventilator remind hands wearing no small exit Decontaminate their nurses review throughout specimen out FFP3 this per 1000mls wash hand hourly of Must staff disposed you room removal Remember doffing Vent day bed transfer Limit wet your at taken trolley are notes dry donning decontamination tab PCI wear them same group further precautions bin nearest sink they should Place Prepare equipment not deliver member all Card for FOR editorial Arrival: Outside other Chlorclean Status ensure let Nurse if enough 13 on: Lab medical risk Critical doff times on takes where Cleaning from prior as get Pre 12 face daily must \u2018spotter\u2019 airway Do coming ETT SOP due Authors: meet cold plus off Reviewed CCOOVVIIDD1199 by: water general 1000ppm by team spillages Final Guidelines kit placed splashing/splatter know Next Written: inside in contamination arrival responsible Approved detailed Ensure CRITICAL twice alternate washing ventilation Plan When Covid19 outside infusions Title: 1x machine =10000ppm PPE CCaarrdd airborne 10 Gather including anticipated solution mop Bloods USE door without another Floor spotting via entrance xHaz fluids apron leaving Exiting: appropriate tubing Action anything Domestic drawer Care touch RRIIEE adequate be priority point gloves is clamps Safely transport policy turning send Covid 11 with required \u2018Spotter\u2019 information Signage visor AAddmmiissssiioonn Bin down role AAccttiioonn disconnect whilst 9/3/2030 Admission the blood shift tabs ONLY masks surgical ABG"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "to Appendix On undertaken then cleaning Post QIT nursing will and time CARE patient practice enter received TTrraannssffeerr wearing national their review per RIE: arranged of staff room swiped notify transfer corridor 117 at past taken trolley PCI SAS group lifts should 20/SJH through floor approximate member FOR editorial Wd Chlorclean Status Ventilator on: medical Critical HPS on notifications along prior as Pre 12 Additional WGH discussed departure: Draft/Final: standard Authors: receiving Reviewed wiped CCOOVVIIDD1199 by: by team left tube Guidelines Next Arrival between guidance Written: in arrival Approved CRITICAL IInntteerrhhoossppiittaall thoroughly 118 cath outside Title: clamped PPE CCaarrdd handover side 10 using Pause USE observe/trouble TITLE via entrance appropriate exiting connected 118: Care ICU RRIIEE monitoring be first cleaned ET evolving shoot departing The access disconnection Follow 11 with remove down AAccttiioonn doors the ONLY lab exit"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "to designated On COVID19 undertaken 14 addition chlorclean reentering RIE nursing bag emergency but direct Oct Senior will and ventilator CARE patient practice preprepared enter bags spotter CT supply most don done Following Portering review table FFP3 per trainee arranged minimum of staff room control transfer bed at 19 taken trolley trip CT: reconnected hospital completion: McNeill through Don equipment one not rest member 2020 Card for FOR an 2021 Status May if Intra on: 13 Another medical Standard Critical can two Reviewed/revised HPS on or prior as Pre 12 Scan Intrahospital Dunn discussed departure: undertake Draft/Final: standard observe Authors: Tube fitted Doff facilitate wiped off by team used tube route Guidelines Final Next Arrival between guidance Written: in arrival Ensure ahead CRITICAL contact passage back members entry COVID 118 Title: close PPE prepare consultant 10 15 rota using usual USE leaving Action sent double Care ICU March monitoring be bagged return is clamps The Doning 11 with One required orange Transfer down Level the ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Mac how? Allergies Cri3cal Closed laryngoscopy Date: call wake Monitoring head switchboard Ongoing Op3misa3on Double administrator will and necessary alloca3on Baruah plan supply catheter Theatre Verbalise this B/C Lothian 5cm Prepara3on carina drugs suc3on room page size Understand turned circuit trolley cu seda3on Induc3on further \u00d72 DAS/ICS Check Intuba3on equipment we Pa3ent lubricate 2020 for Cricoid NOW seniors RAISE SpO2 waveform supragloZc backup ECG help Adapted FoNA Communica3on if vasopressors up PROCEED Sizes on or tape intuba3on from Review ml Airway check Intubator trachea Conrm visible checked required? requested Equipment Consultant airway \u2191K+? Drugs fails? ETT ETCO2 Fibreop pressure Who Stethoscope tube kit posi handle in Scalpelbougietube roles? 2018 BP contact Team OPA Plan Runner mise outside CONCERNS TUBE PPE 3p CoVid assistant 2200 3cm 10 O2 intuba Anaesthe Is ON CLAMPS NHS using SupragloZc incl via Checklist Di\ufb03culty Intubator\u2019s Can Stylet Care McGrath ICU March pa3ent Op mount Blacstock st is turns access HMEF Covid Tie with laryngoscope RSI Preoxygenate Bougie Vocalise role Cut Yankauer max syringe Emergency"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "to oropharynx Scissors Remove extubations oral Date: NG AGPs* cough Monitoring trauma/oedema sit Inform mask stability Senior informed and secretions compromise: patient plan catheter supply Two Respiratory Obesity nurses spontaneous Observe Talk Assess Lothian of factors: Give post available roles confirmed Cardiovascular trolley Check through noise Prepare not subglottic Extubation fasting 2020 guidelines for FOR an NOW suctioning catheter/closed suspected RAISE tracheal SpO2 supporting cooperative ECG aspirate present Adapted block NAP doctor up if prepared risk Critical Consider Deflate Planning or CALL *FULL Airway Review plans perform EARLY Previous tapes visible checked delivery Equipment 10ml respiratory formulated airway minutes SpO2/RR ETT care PROCEED: CCircuit extubate signs extubation suction /HFNC general pt Stethoscope tube Facemask PLAN aware nurse Ensure BP sedation ABG Optimise patient: IV ventilation Aspiration cuff COVID Obstetric CONCERNS REINTUBATION DAS Drain PPE etCO2 supplemental Charge O2 30 Preparation NHS system NIV Checklist Awake connected Care 100% March adequate leak filter difficult bite pattern tapes/ties access Suction cut ready Adequate HELP postextubation oxygen Postextubation remove allocate whilst high From Yankauer the Stop syringe"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "to waiting full some Able This Considered diagnosis 118B status 14 pathogens context positive RIE cubicle All presumed and manage negative patient Positive High management neutropaenia self Initial criteria? 116C/116D/118A beds no IPCT critical URT+LRT providing ideally having throughout Has 8C FFP3 If admissions of Elective employees shielding protective contacts Temp apart consider area Areas post 116C available 117 deemed transfer disease confirmed at until taken NO existing are YES placement CoV2 fever 1114 improvement pancreatitis criteria managed URT/LRT Non precautions have further intubated worker they GREEN health should Clinical 48 not within cohorted suspected/proven Priority for 2023 Admissions an 24 other receive move URT AND history lead ensure fulfilling new May allow vPatient alert intermediate probability if available: Probability 13 than Would swab during risk Critical two organisms sideroom AGP result on or can deisolation hours Unable from following non as clinical vAll LOW definitive Patient During samples isolated discussed swabbed based respiratory isolation hrs SARS require care SARSCoV2 likelihood symptoms testing would give meet deescalation need siderooms results home used RED exposure separate fever/respiratory in thereafter immunity low initiation contact alternate test consistent areas already ventilation Discuss More therafter Transplant previously discharge nursed Intermediate No meeting tested consultant Patients admitted Version Yes additional ICPT including decision 116C/116D/118A/ward Department Isolation clear Sideroom assessment least rapid patients 116D essential <37 overdose Open appropriate \u2018Contact\u2019 initially 118A excluding droplet consecutive stepped Care ICU Remain aerosol be first flow admission completion Pandemic is transmission infection 116C/116D/118 who days continue 116D/ sufficient Cohorted co considered 11 INTERMEDIATE reassessment See with thromboembolic One since mechanical vPatients Area down Once whilst high HIGH Siderooms Admission open Level the known Placement ONLY 118A/116C/116D presenting chart Low Guidance Emergency"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "to passcode scot live COVID19 call https://nhsattend attendanywhere Remote RIE which https://nhs com/login and CARE patient NHSNearMe@nhslothian Bad patient\u2019s label given do making If of challenging you discuss Guideline like 654321 video have they Waiting Anywhere not it read sign details for FOR iPad talk platform username go Communication medical Critical can CALL Scotland on or following quick HOW nhs phone found uk advice: would Go run password iPad: team Guidelines in use Me Ensure Ask CRITICAL vc/rcc fill please tips TO Log name wish Near helpful NHS using USE patients calling Attend via News VIDEO family relatives connected Care be email: onto is access service with Area Click Breaking NHSFREEWIFI the Prior ONLY"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "to surfaces regularly This Gloves COVID19 undertaken over correct Put removing above instructions worn head goggles will and disposable patient rmly different that hands adjust patient\u2019s against this If limit hand sides of torn according protective you room size practices available your bridge piece at eyes until touched are donning waist both differ have worker checking Place protect should equipment clean keep yourself for safety Putting ensure cannot cheeks protection fasten during PROCEED when achieved Position neck straps on or perform from hair headband check face ears must manufacturers compatibility order good Where nose being hydrated covered Respirator by makes safe Perform Eye between in Use after gown been use followed technique Ensure jewellery crown work provided test back pressing repellent DO cuff spread outside putting longsleeved mould PPE tested strap facial healthcare before uid ngers personal spectacles these hygiene contaminated away ties Note: NOT Instructions glove Predonning be always change gloves is infection The respirator With select lower heavily with remove nape tie environment down upper the eye"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "to hold Gloves COVID19 respirators then over absence removing cross inadvertently there discard preferably head only ante All touching will and alcohol that hands rst follows: behind lined dofng patient\u2019s bring process into Turn out FFP3 roll rub retaining hand of disposed protective place room removal area your metres at fold are sleeves To ungloved waist both soap reduce buddy under bin worker should while equipment not it for an retraining pulling remaining systematic Unless let slide top protection up outsides risk neck straps way or from as clinical contaminating Pull face Removal must peel gloved wrist waste front isolation lean order shoulders Do Then: Where slightly nd bottom lift off In water fullface by Unfasten Respirator safe Clean distance Eye inside in contamination gown bundle use handle themselves potential back gel outside possible PPE Firstly: strap including anteroom/lobby healthcare dedicated before using grasp ngers personal leaving contaminated away ties glove removed touch be always gloves is motion The respirator opposite peeling reach supervised Gown minimises Wash with remove fall visor the eye forward"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "to waiting cylinder pumps scope Scissors key // 1000ml Closed sampling COVID19 line Cuff NG LLiisstt Syringe Scope bag set emergency unit ventilator pack and CARE patient may blue Arterial listed Pressure insertion Baruah 18G Aintree Blackstock catheter plastic review airways Oxygen Braun 20 pressors drugs room manometer size Macintosh Jelly available sachets circuit trolley are normal drivers iGel Please Metal RIDU Oxylog equipment stand not Laminated Loose 2020 FOR Status intubate 14F 12F Draft if on: up Critical SSuussppeecctteedd on tape check Anchorfast NIPB Ambu clamp WGH 3000 10ml infusion Draft/Final: Guedel Cables Drugs ETT SOP splitter Authors: Tube suction x3 off need CCOOVVIIDD1199 plus by: Reviewed WWaarrdd contents Stethoscope tube left Guidelines ABP Next Monitor Ward Written: in Mackinnon tubes breathing use Vascular mounts Clark Approved stored CRITICAL v2 Schrader transducer Covid19 saline Facemasks 20G Title: arterial refreshed 2200 charge office cable before induction Intubation USE packs socket leaving 22G Checklist phones Box tubing Stylet Care McGrath catheters March sizes be Baby EtC02 clamps The access Suction HMEF below fat cateher KKiitt Sp02 blades COVID19/Suspected Drip laryngoscope RSI tie pump Bougie Duncan monitor Femoral Yankauer Cannula made Slim the box departure ONLY syringe Emergency Clerk"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "planning unsuitable Closed status COVID19 14 assisting ventilator maintain board Aintree evidence airways If Braun drugs discuss anticipatory doffing transfer ID drivers PCI SAS progress proven through indicates Ventilation for ECG guideline during escorted adrenaline unstable prior clinical Anchorfast include IGel Ambu intubator\u2019s 1:10 Exit convene Drugs RSI: List current Interhospital Reviewed Prereferral by: Group Guidelines kit Monitor between after ambulance Approved CRITICAL IV Update: Covid19 000 Title: machine Ccircuit charge China videos Contact entrance piped confirm Care March ICU/anaesthetic monitor arrangements deterioration compressiononly Level units receiving wide Emergency arrange line bottle Staff Inform Front secretions time intubator/drugs Arterial 10th Baruah nurses SSOOPP trained 1:100 of severely staff communicate page size at Donning/doffing minimise Oxylog Assessment Daily suspected/proven specialty on: medical met Induction HPS number or immediately as atropine face 9am phone found Guedel jelly SOP assess NIC intubating suction WWaarrdd by metaraminol referral: Written: in tubes nurse take every Communication: nursed closed consultant Sonosite USE door list ICU taxi monitoring gloves access determine pump see made Primary Lubricating the shift cuffed syringe to appropriately equipotent // Conduct call cleaning indicated but administrator mask will and patient primed insertion catheter CXR critical supervise Record per aim intubation trainee CPR room suitability bed HME practical Metal buddy precautions should RIDU not Laminated 2020 FOR safety re Status Draft alfentanil hypoxic risk neck SSuussppeecctteedd experienced measuring check proning donning/doffing airway propofol care availability team tube too aerosolization stored pause contact back COVID Restock 118 well PPE 2200 side office dedicated sterile Etc02 assistants via Checklist tubing staffing respond scopes change PostRSI is The Suction Covid See RSI Transfer Bougie x2 Establish Severe Problem box ONLY Facemasks full position consist Cuff NG RIE Kit nursing emergency supervising CARE may situ Blackstock Two their review choice Anecdotal intubations 20 slim manometer postintubation post confirmed compressions equipment one moved scrub suspected hypoxia Communication if up when Critical can on from clamp WGH definitive PAG Equipment 10ml Draft/Final: respiratory front judgment Size involved ETT Yankaeur Authors: lift CCOOVVIIDD1199 US Stethoscope Next Ward guidance levels Perform use BP anaesthetic Phone Runner Clerk\u2019s outside plugged handover before 16F Intubation patients remains these leaving fluids appropriate catheters scissors be escalation infection EtC02 Follow intranet Sp02 with oxygen COVID19/Suspected required high identified departure"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Mac position how? Allergies Closed laryngoscopy Date: Fibreoptic wake Monitoring head Ongoing Double administrator will and Cons patient Baruah plan supply catheter Theatre Verbalise allocation this B/C intubation Lothian 5cm carina drugs mobile room size Understand turned circuit trolley Difficulty further \u00d72 DAS/ICS Check we lubricate 2020 for Cricoid NOW RAISE SpO2 waveform backup ECG tip help Adapted FoNA Communication if vasopressors up Confirm PROCEED Sizes Critical Induction on or tape Airway from Review ml check Intubator Patient trachea visible checked required? phone requested Equipment airway \u2191K+? Supraglottic Drugs fails? ETT ETCO2 suction pressure Who Stethoscope tube kit handle in Scalpelbougietube roles? 2018 BP sedation contact Optimise Team OPA Plan Runner cuff outside CONCERNS PPE CoVid assistant 3cm 10 O2 Is ON Preparation NHS using Intubation incl via Checklist supraglottic Intubator\u2019s Can Stylet Care McGrath ICU March Anaesthetist Site mount Blacstock is turns access Covid site Tie laryngoscope RSI Preoxygenate Bougie Vocalise role Optimisation Cut Yankauer box max syringe Emergency"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "to referral directed Manage This capacity COVID19 ward/HDU/Lothian then barrier theatres above main RIE indicated nursing only emergency but people unit All informed will and negative time patient management may that Blackstock plan Capacity recovery 916 IPCT markings Theatre ends requiring this per use: If Murray surgery of staff 20 As Oncall operating room instance movement nonessential Surge area doffing Management 26 available transfer bed at bedspaces until theatre/recovery normal donning Medical/Haematology both Discharge further acceptance 13/3/2020 sink managed time: should floor 48 within not all for surge moved SJH nonCOVID SHDU able machines Estates Anaesthetic elective /NHDU spaces can Critical on or from following as Review items WGH Patient default HDU stop must enact Consultant At 58 temporary order ETT SOP Bedspace empty Main/DCN pressure by team used oncall Ward between construct in plan: Nursing basin detailed any Move anaesthetic Donning ventilation already Plan handwashing 3rd possible input coordinate barriers closed liase 1016 NonCOVID19 PPE Close ICU/Ward consultant Patients 89 theatre side L1/2 admitted decision Medical including before entrance/exit patients via entrance /Ward 36 appropriate Suggested senior removed ICU ward Care be first Site escalation These point 18 admission vestibule second is who continue now considered with advice coordinators required mechanical Bedspaces Visitors Will bedspace occurred doors the Enhanced areas Dependent"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Volume SIMV visual shown reverse set start ventilator rechecked that maintain fresh >0 window PaO2 Displaced this If limit they indicates Ventilation for TIDAL Ventilator present than during 400mls vent achieved CALL BREAKING hours include THE Signs minutes Pinsp 8l/min used left break seconds after Ask 5l/min BELLOWS OXYGENATE each OF machine TROUBLESHOOTING likely secs AISYS wheel GOALS container DOPES light >7 bellows Pause system lowflow Push bedside confirm touch BACKUP FRESH increase Settings: right disconnection Case You highflow PAUSING FGF down switch: prompt Low >10l/min 60 comwheel bag/ventilator Increase righthand casing then above increased There which bag only 10l/min Obstruction endtidal activate plastic do Ratio CS2 6l/min of USING Vent at com tab reconnected toggled PEEP reduce setting needs checkout 13l/min all Volatile yet connections top medical last met immediately or perform standby support navigate IMMEDIATE require PCVVG run by >8kPa GAS neurointensive sodalime changes its in DISCONNECT complete every Breaths pH canister CCIRCUIT temporarily 10 leaks breath H+ PaCO2 admission reach dialed Settings lower mechanical see litres/minute <30cmH2O the ABG to rate This displayed screen there so but All will and patient different EtCO2 Preferred Respiratory FiCO2 aim place usually soda picture circuit OXYGEN either PLAN: procedure should not increasing FOR OFF message calibrate refill COETT NonCOVID check bpm ventilating Gas mode 5cmH2O care demands need periodically pressure team tube Start reduction Tidal pause d/w Mode COVID More FLOW <60 elevated side 15 2024 including using switch changing 100% persists These flow change is minimised The HELP settings higher Select VENTILATOR CO2 Flow position targets LIME END Checkout Press After may Initial Pressure Anaesthesia adjust Following no review combination 1:1 arrow changed you turn confirmed baseline until are To VENTILATION VCV closedsuction adjusted Bag within green Disconnections move AND 1l/min if up >6 when can target way on SODA following CIRCUIT HYPOXIA: clamp default Equipment based PVCVG confronted temporary ventilated REMEMBER 6mls/kg saying CAUSES does defined fail 12cmH2O Perform Use Ensure low pressing red 824 indicator O2 measured Stacked Pneumothorax lime FALLING patients FiO2 touchscreen gas litres/min occurs appropriate initially Restart be leak mains return flows With select with oxygen difference otherwise Once high identified"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Visually Volume SIMV Morgan parameters planning located suggest On Falling Closed shown undertaken litres again Disposables positive more set start Breathing cause inspect ventilator Suctioning rechecked inspiratory/expiratory that maintain listed significant long critically PSVPro fresh >0 procedures recovery lost window Circuits PaO2 Dr this Assess If limit Lothian mindray mandatory incorporates lowflows Using added further 3l/min posters tight 1l/minute preferred they acknowledge alter anticipate cancel Ventilation Commencing keep for hyperpyrexia guaranteed It ensure flush Differences machines Rate hypoxaemia Procedure valves than during 400mls vent They Our two restarted cassette where hours selecting Unable ill clinical 12 selfsealing aiming Sidestream representation At discussed volatile anticipating inspiration minutes refer current collapse would presence empty situation In filled used left between Distal end contamination after provision inspired sedation acknowledged 5l/min recheck reboot enlist unless pandemic machine likely COVIDpositive outwith clamped minute AISYS Controlled wheel light additional clearance bellows note NHS usual system unclamped lowflow linked bedside bacterial/viral 1220 soiled confirm spill Care touch increase Alastair ratio filter point earlier completely shortage disconnection ventilate You below L/min FGF impact balance neuromuscular prolonged those emptied monitor Breaking switch: Adjust open known >10l/min 60 comwheel our initial disposables expected PSV instances Increase intermittent line then drying theatres above inadvertently increased context Simply There which bag only indications 10l/min problem frequently optimise circle time body colour licensed push barotrauma small document demand do into CS2 6l/min of RR staff according page ask cassetes Vent at fulltest com Solutions scavenging tab ulnar reconnected toggled both PEEP Please minimise reduce have under term setting needs although checkout operated we 13l/min read Should register all nonCOVID 24 yet connections cannot accessed Diuretics Standard medical Default met Consider times or period peak standby non as induce maximum warning questioned Expiratory basis 68 support found cmH2O navigate disconnected exhaustion option alarm require metabolic SOP Safety Prone unlike capnograph PCVVG corresponds run suction circuits litre/min inspiratory autoflow by PCV We sodalime begin changes its familiar in breathing nurse occur Synchronised options every consideration Tab preuse reinspired pH canister closed individual challenges consultant returned temporarily 10 leaks positions H+ instability also predicted least become mitigate NOT PaCO2 ICU removed indicators vapour volume achieve days HMEF Settings continues lower I:E Total best see sensor windows prove litres/minute For the \uf0b37 to Vt exhausted rate This screen remain rates there so indicated but valve All clamping will and disposable patient becomes different EtCO2 yellow plan ODP Respiratory patient\u2019s FiCO2 throughout unnecessary important guide out Higher Tinsp completed per aim By As operating controlled conduct menu usually soda names available picture pro wet 19 circuit very routinely absorbed either Difference uses plateau procedure cicuit should what Check Increasing H2O efficiency Introductory not it vapouriser increasing has expect an OFF However extremely anaesthesia Neuro volumes message Adapted weight 13 freshgas sevoflurane risk displays COETT Com lung highlighted mentioned check functional proximal checked must ventilating are: airway rotating Do propofol Gas mode standard us reduced haemodynamic Users demands rebreathing slightly being make need 13L/min pressure team tube moisture case Touch Start been rise Flows experience any potential test back 12hour Mode COVID malignant Gibson More phases elevated prevent 400ml 2024 15 including using Circuit displaced switch via demonstrate changing paused 100% viral persists These flow Circle change is who The capnographs sidestream Pro therefore settings See One information remove 12cm higher Select CO2 Prior Flow ruler selected 24hours customise Peak rate? full position some 49day >68l/min CPAP Ally reliability breaths replacement users main Checkout stay cannister After expiratory performance supplies negative may remind necessary Initial Pressure Anaesthesia contacted short adjust blocking most Following Although Intensivists their no reconnecting review regular combination requiring safer >6l/min 3L/min wash 1:1 arrow broken isoflurane changed discussion protective you control manometer desired turn confirmed baseline starting Ventilatory until NO are To normal reinflated An hospital adjustable VCV adjusted tidal Bag >10l/minute Air could within less frequent satellite surge assist green move suctioning 8kpa if when Critical can target on goals from following put occurring undergo WGH default called intended routine respiratory extent components order confronted ventilated temporary internal dependent expired due ventilators overcome How continuous weaning 6mls/kg 1:2 Upon integrity filters twist spontaneously Disclaimer: defined Operating limb Elevated carry Modes levels 12hours upon Use use drop Ensure low Troubleshooting anaesthetic Intersurgical pressing ventilation clinically When possible please red pressures neutral indicator O2 Continuous apnoea agents requirement works 12hrs style measured before lime Soda 30cmH2O patients FiO2 without limited 10L/min touchscreen these gas settings: litres/min approach initially 49 production expertise be 6L/min VG Fresh leak completion return display flows drive With designed now site select latter capnography cancelled with required oxygen performed consists caution difference Initially depending Once high identified Aisys just whether"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "to Morgan parameters 1Task curve replacement mins increased there Monitoring more expiratory secretions rechecked and circle may blue colour exp time frequently will Initial Pressure Anaesthesia EtCO2 yellow patient\u2019s Continuously FiCO2 Inspect Record zero? into out CS2 6l/min this If Machine hourly of Water changed control white soda circuit fulltest lime1 either added further tight should Alarms indicates not resistance within all for has However an assist 24 Hourly other It Ventilator present if than medical neurocritical when two carried on or 1L/min hours from as circuit6 include near Expiratory daily checked must thirds exhaustion minutes condenser require reduced care SOP due Filters suction visually need water trap5 by does team used filters limb drained moisture Perform in after use causes low Tidal inspired every 5l/min bronchoconstriction manual recheck humidity reboot needed Absorbent excessive please canister machine closed <0 dialled Version measured 15 including inspected using before Circuit lime Soda MV patients flow4 FiO2 bedside distal selftest7 occurs Instructions 49 PaCO2 ICU increase monitoring Insp be flow vapour filter point Alastair change is volume 68l/min The days disconnection reach HMEF FGF zero next required with Change information performed fall otherwise pink occluded high Aisys CO2 the spirometry chart >10l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "cylinder stable SIMV Morgan regularly visual compensate Closed capacity COVID19 14 planned removing kept again Any positive more suggested set Unclamp Western Filter ventilator opioid calibration that maintain detrimental long critically PSVPro fresh >0 follows: procedures FFP3 PaO2 typically this If Lothian *For sedated teams mandatory Ideally lowflows gehealthcare transfer <10 added EZchange further pH>7 tracheostomy 3l/min tight reducing they through Ventilation for operates parameter hyperpyrexia guaranteed occasions It ensure machines soon midazolam/clonidine present Procedure than during 400mls problematic two They disengaged restarted Our cassette ODP/medical hours prior ill Owner: clinical 12 clinician include Replacing Canister triggered Sidestream user Consultant delivered infusion At volatile inspiration loss minutes condenser operate current collapse CCircuit would empty situation In used seconds between end after were Hospitals failure provision inspired sedation acknowledged recheck Colleges/ASA console each reboot previously sedative unless pandemic machine Ccircuit hospitalwide port COVIDpositive commence clamped minute SpR AISYS arises highmetabolic Local bellows note NHS Pause system pausing lowflow detected personal linked General bedside bacterial/viral associated Care increase ensuring Alastair ratio filter point communicated once setup ventilate conjunction FGF H+\uf0a365 oxygenation neuromuscular pressurecontrolled emptied arrangements monitor deterioration receiving wide Low our initial Satellite/Surge expected rainout inefficiency effects line then theatres optimisation increased Both worn context sooner There which bag limits only indications updated 10l/min circle time frequently blue licensed push 16 510cmH20 small flowrate document demand Scavenging Breaks into Increased waveforms spontaneous CS2 6l/min of staff RR according local Surge filtering 10l/minute capability at performing com scavenging viral/bacterial concern tab perioperative decontamination +/ both PEEP reduce intervention have under term setting needs Clinical Oxylog we still read Should register all nonCOVID Volatile 24 space connections presents 5L/min \uf0a365 Standard acceptable medical Satellite find times or 1L/min 35cmH2O peak perform as non maximum warning atmosphere 3000 68 support suitable how option external alarm require metabolic vary PCVVG unintended run suction circuits visually utilisation GE autoflow inspiratory by We sodalime assisted changes its in breathing responsible followed options deeply complete every appears provided timed depressurisation 17 members cuff needed canister attached closed means 812cmH20 Version temporarily 10 leaks breath inspected nonIntensivists H+ 30 sevoflurane/isoflurane replaced IPC compliance also blockade MV least become distal >10L/min Royal stops outstrips PaCO2 ICU ward monitoring adequate admission 1litre/min 18 undoubtedly Teleflex volume days AGSS HMEF opened Settings considered Running I:E fall working bedspace litres/minute made inspection For the sudden pressure/flow brief ABG to appropriately rate This reservoir basic displayed adapt Full sensor/valve rates cleaning Phase there Mindray but All cleared mask clamping will and patient different received insertion EtCO2 device yellow catheter pH\uf0b37 done Respiratory patient\u2019s effect FiCO2 important guide out corresponding aim per minimum described agent consider usually soda available >10 wet 19 circuit very routinely compensation either event 12cmH20 despite procedure should Check Increasing 20cmH2O lowest efficiency not Introductory resistance it clean deliver reduces avoid increasing has However an safety anaesthesia Neuro backup replacing Unless refill help 13 risk isolate experienced \uf0b312 COETT lung comprehensive quick NonCOVID rebooted check deeper proximal checked maintained must greater propofol Gas mode standard reduced unable us rebreathing being meet fitted need understanding Internal pressure team tube moisture been experience Flows precheck potential PS/CPAP sensed back Mode needing COVID malignant alongside More arterial approximately closedsuctioning suggesting phases elevated PPE side 15 including absorber using suction/patient dyssynchrony changing Capnography paused Minute increases delivers viral ongoing These flow change accuracy continual is onto opening blocked who The expectation https://cleaning rather level 11 therefore settings information such higher technical CO2 Prior Clamp resource full Appendix targets CPAP breaths replacement FiO2>0 main coughing nursing emergency expiratory performance may nationally practice necessary Initial Pressure adjust most Although arriving supply their no studied review requiring >6l/min seen broken admissions changed 20 control monitored charts manometer supported confirmed sought until are To breaks An hospital closedsuction tidal Pmax equipment could within less supervision oscillations surge satellite discoloured other suctioning suspected hose especially history certificate new exclude laminated if acquired when Critical can result on from following proper default oxygenating daily undergone delivery intended routine respiratory reference dead ventilated dependent ventilators similar weaning 6mls/kg integrity does filters twist spontaneously repatriated Disclaimer: physiology Operating limb drained bacterial Perform function levels Ward upon use transitioning drop low 68L/min anaesthetic longterm Intersurgical ventilation effort When please possible determined pressures 824 Immediate negate MAC indicator measured apnoea agents reengaged 24hrs before induction lime 30cmH2O patients without limited Appropriate FiO2 about outstrip gas litres/min appropriate initially Restart alternative 49 connected interfere production breathe Negative be leak Fresh Unit1 ET paralysed standards flows drive Ventilators ready With designed capnography preceded with required oxygen performed depending Further Once high kPa identified Aisys assistance"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "to This On monitors COVID19 undertaken 14 remain July kept Only department indicated nursing stay only bag emergency cubicle CCTT ventilator will enhanced and CARE scan practice patient necessary 16 TTrraannssffeerr wearing Baruah CT Following done Portering review table \u2018doffing\u2019 \u2018clean\u2019 do trained this per If trainee arranged minimum entering of staff 20 discussion control room area doffing transfer HME bed at circuit taken trolley Arrival CT: reconnected wear completion: McNeill should Oxylog donned equipment one not member avoid 2020 Card for FOR has remaining Status go May wait if on: 13 during medical Critical can doff carried HPS on immediately or standby prior as from put Pre amount 12 ChlorClean Scan WGH Intrahospital drug Dunn discussed departure: undertake walk Draft/Final: clothing standard observe Authors: Tube need wiped CCOOVVIIDD1199 off Reviewed by: WWaarrdd by team does used tube Final Guidelines Next Ward between guidance inside end in after contamination been nurse arrival radiographer newly Ensure Approved stored ahead Written: CRITICAL back clinically members entry COVID 3rd outside unless Title: individual PPE CCaarrdd prepare 2200 corridors consultant 10 15 agreement using also clear USE list via leaving Action appropriate senior Then Care ICU ward be IInnttrraahhoossppiittaall disconnecting filter earlier change is clamps transport The access disconnection 11 with required Transfer repeated down 5th AAccttiioonn bedspace open doors assistance Level the Ferguson ONLY Stop"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "wipes ics Mackay more 2010 Failure 8mg start fullarticle Journal that Intensive Written net/clinicalsubjects/accidentand Medication Observe patency sugars this If decrease Lothian Braun drugs IJ area three taken discontinuation org/content/early/2013/06/11/bja recommended specific through Commencing 10mls keep for half pdf It ensure flush than during achieved Commence prior 160mcg/ml Hospital Enter pdf+html infusion Inotropes/Vasopressors observe current prevention by: Sept used ABP Guidelines insitu end <drugs invasive inotropes Doses lines infusions infusions: connecting commence clamped charge NHS competencies recommendations engaged double Care medication touch Healthcare<az<critical quasiexperimental Calculation disconnection service advice Administration continuously Benefits 2007 open 20mls/hr 20th inotropes/vaspressors effects line then above interruption original Changing instructions discard which only bag frequently time concentration management nmc Arterial push medicines 10mls/hr small nurses Purge into of \u22645mmHg staff 16mg% instance MAP strength http://www at existing Council both Please have under Prepare connection ors space waveform vasopressors medical last 2015 times or 9% update Review as standardsformedicinesmanagement maximum seek found prescription require alarming assess extra run spiked by labels Policy NaCL in Catheter aware flushing automated nurse Device bleeding complete every additive attached Label another medications Core monitoring clamps achieve lower lumen best pump Blood bolus For the blood Stop areas to Aim pumps rate This Lines so 72hours All Rapid will and patient distally uk/globalassets/sitedocuments/standards/nmc luminous device effect critical providing Be Run 2013 out per hourly 16mg consider administration available Connect bed April placement faster very Cardiovascular Signature expiry Alaris Training Keep Society should Check Increasing Midwifery Decreasing not it Medicine 73 guidelines increasing has an 2mls/hr oxfordjournals risk Discontinuation New Chlorhexidine continually Heru 5mls stop https://www visualisation library prescribed Do care unable inotrope org http://bja need off pressure Central safe Clean life been clearly CVC rise Nursing any Insert Cour Concentration back actions study 80mcg/ml arterial 2% dated PPE prevent side measures rapid via date Work flow Titrate C74C77 change onto is The continue policy best/201728 venous remove British uk/icshomepage/guidelinesandstandards/ higher running Prior Venous Pollock labelled al full designated covers follow correct Apply ucl inotrope/vaspressor tap After may practice bags Pressure proximally short Following no Drug changed central you control vasoactive desired turn your starting until Infusion smart are To administered same stated pertains one within less 8mg% confirming 2012 other new uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress References changeovers changeover if up requires Critical can way on Inotrope from bleed Inotrope/Vasopressor nursingtimes delivery ac drug 2017 Equipment concentrations et due subclavian Personal mls titrate systolic guidance photosensitive Use use xrayed technique Ensure When threeway handover before patent Protective hour without fluids occurs Standards initially connected be Inotropes and/or aet199 infection emergency/changinginotropeinfusionswhichtechniqueis circumstances Signature/BBraun pumps: Follow intranet site with required old high Date transduced pumping"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "parameters sale visual status LTech technology 8008229837 PGDT Monitoring inspect calibration zeroing that procedures Zeroing window heard this Securely phlebostatic tracking insert conditioned audible tight Event through keep for parameter FloTrac It ensure flush property ECG calculator plug two Available Sensor selecting clinical stud HemoSphere SwanGanz Captures column Enter contraindications Injectate minutes system: refer current bar Battery left Monitor between HIS end after iCO IV port module additional OR time/date system engaged axis outlined touch expansion first mount right setup bubbles 92614 CAUTION: mmHg down monitor open units Level Demo globe HDMI stylized charged initial output then Export instructions which bag deair gravity only indications time adverse WiFi RS232 TimeinTarget PPUS2208 do into panel of Advanced fluid Lock Silence at com respective compatible Main outlet Clinical connection CCO all platform COM1 connections heart slot packaging Zero\u2019 grade ops times or value update as 300 highlights Plug Patient temperature support alarm Acumen contained by owners in v2 complete appears want Federal manual Derived Snapshot events Averaging raises 10 door insertion/connection Open monitoring eight Pressurize probe operator\u2019s Settings lower click physician pull air sensor Blood Parameter For the ports Stop cardiac to pole Edwards features rate This displayed screen remain stopcock cord All will and Average patient prime device catheter important guide out completed place Connect rear language Compatible restricts precautions stand not it tone guidelines an Analog Mount Status Way aspirate fully Time Corporation stopcocks law highlighted filament affects Fastflush must USB United Bar mode standard being \u2018zero\u2019 off button power pressure contents steps holder Touch Start Choose inate any Insert test actions Ethernet input arrows arterial startup orientation alarms including hang cable using reaches switch Zero tubing Refer change accuracy is Navigation The CVP level settings See One information pushing remove CA logo CO technical edwards selected nonvented upright Equipotential full position follow globes States Thermal Hold Smart replacement Expansion main Press Module tap Pressure slots no their review assure Turn trademarks six entering 2019 24/7 silences you Information capital_care@edwards Help desired until Lifesciences are To hospital Setup Bag image other serial Start/stop screens up when can Thermistor on USA proper IQ front properly connector order holding selection advanced upon use prescribing Irvine appear rights Back Engineering outside Platform warnings hemodynamic \u2018Quick air: indicator Replace residual Waveform without inserting appropriate Note: icon Screen measurement data be terminal and/or reserved display battery With Follow select zero with Oximetry format caps Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Saturation SBP Volume parameters sale mL Variation Occlusion RVSP 2025% 420 Systolic ITBI 1015% 9501150 PaO2 this 91 612 /SaO2 GEDI Index Ejection mL/min/m2 RVEF /CO 500600 CaO2 PAOP professional for International 510 property 56 European dye/temperature RVDP ScvO2 theirrespective PVPI 12 RVEDV/BSA 4060% TPTD Perfusion contraindications PAP Lactate Global Artery Extraction SVR SV Cv placed 90140 CI 117160 Vascular 5994 values* SV/EF CPI CI/HR Pulmonary Hemodynamic *Reference MTt Consumption PBV=0 mL/min L/min PASP 4252% RVEDV VO2 92614 CAUTION: mmHg ITBV=1 60100 1525 units stylized RVESV 65 CvO2 instructions <250 indications time adverse Arterial SVI 0031 EDVSV S2 Hematocrit 25xGEDV 70105 Oxygen mL/m2 Ratio of Water MAP 19702390 26 Systemic 8501000 com Extra CPO Left Ventricular EVLW 1000 Lung marking 3347 g/dL Thoracic Normal Transpulmonary or 100160 xDSt laboratory CFI av Physiorelationship 417 Content MPAP vary requirements 1215 Stroke COxDSt0 by owners Body in Test 360 07 /SVmean Device thermodilution mmol/L Federal events 2230% 255285 10 v1 Right 6080% PADP <3 DO2 Cold PVR 100 physician CO/BSA Blood regional Parameter For blood ELWI the CO/HR mL/kg Function to Edwards 6080 EndSystolic 80 716 50 values All 1/min and 50100 device Male 8001200 SV/1000 DSt /3 L/min/m2 ITBV mL/beat RVP Female: Difference restricts 45 Hgb precautions PPUS2312 DBP 200250 EVLW=PTVPBV Resistance Output Atrial 0138 Way Diastolic Corporation Equation Intra SI 3648% Predicted law Article range adult bear United EVLW/PBW >20% Central Values Convention referred Females: End meeting HR 0136 650800 devices ml/m2 Laboratory mL/dL including Males: 120160 PVPI=EVLW/PBV 1020 6070% PBW 25 S2S1 Work SVmin CVP 11 See One information CA GEF logo CO Power edwards Venous Permeability SVmax 6090 full SVRI States 08 Units Height152 54 RVEDVI S1/S2 931 techniques 815 Pressure DO2I SvO2 methods dynessec/cm5 Delivery trademarks PVRI /CaO2 52 Lifesciences are SVV 95100% /CI 48 46 other 5062 CE 1720 RVSWI RAP Coronary Fraction on PvO2 VO2I USA CPP 2017 GEDV=COxMTtxf dynessec/cm5/m2 reference Weight Hct order conformity Directive93/42/ECC PTV=CO use Mean prescribing g/L Irvine BP mEq/L S1 rights saline warnings LVSWI hemodynamic injection O2 SV/EDV O2EI Medical Hemoglobin GEDV EndDiastolic essential Mixed 124174 W/m2 SaO2 BPPAOP Parameters Cardiac reserved EVLW/0 O2ER mL/m2/beat ITTV=COxMTt market LAP"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "stylized to Edwards full parameters series oxymetry displayed l\u2019Etraz then 14 boluses injectate removing instructions example set start indications All starts thermistor and time indexed Switzerland patient adverse lobectomy prime primed 16 catheter real patient\u2019s review waveforms Turn guide trademarks Observe six 1260 of 20 cables according central descriptor ENP509/1118/CC phlebostatic desired available Connect baseline Lifesciences Resection com existing are normal until 19 connect Setup precautions procedure Clinical one Nyon it professional Lung all for parameter calculation marking Repeat waveform ensure new CE screens inline European Corporation if 13 up inject on or ml TruWave valve/port Prime 12 as highlighted amount prefer temperature Accept Article System Enter range TPTD edit contraindications bear Startup thermal RUL selected refer requirements conformity Actions cold continuous results prechilled pressure button selftest Central directions 70 Thermodilution placed Inject steps Monitor Touch in Catheter Choose Start use keypad CVC Device prescribing 2018 Ensure Insert thermodilution nonindexed referred rights transducers 17 transducer saline events When smooth warnings Platform please previously arterial startup Guide meeting pressures well EV1000 databox 10 15 devices OR alarms/target including Medical cable solution using Set rapid essential Before appropriate Route femoral connected axis touch con data Wait Parameters 93/42/EEC manifold ne 18 reserved is right volume setup probe CVP continue Directive level zero 11 See with Oximetry venous information transpulmonary reached air sensor monitor choose upper logo rm Select For VolumeView the bolus Bolus market Venous edwards method syringe de"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "coagulopathy ooff Coagulopathy Dilator/catheter gauge nonsurgical more switchboard issues anaesthetist continued stepbystep that complication mass significant vessel: confer infarction representative evidence this damage care/Insertion repair French dissection Practice VASCULAR pseudoaneurysm attempted uk/Directory/CriticalCare/Bedside \u2018Arterial\u2019 Retroperitoneal provide Surgery for prepuncture guideline allow present soon than during Less hours catheterisations Unintentional clinical 12 generally radiologist documented doc morbidity catheter/dilator minutes Complications: Minor unrecognised issue dilator prevention Reviewed by: In era general Line used left Guidelines peritoneal after Vascular were risks Approved practically lines ultrasound References: Title: infusions Aanesthesia compressible: reports likely misplaced Patients versus supra threaded infuse Contact arteriovenous associated Care withdraw proceeding regarding guiding Equal difficult fistula thread Case reported conjunction needle Jan down missited multidisciplinary surgical Guidance dynamic While American major NHSLothian expected line absence recognised context only wire course infraclavicularly time management body colour Arterial Tambyraja thinwall CT real Misplacement small document into of interventional Xray Access removal size Management Vessel* at Potential Compressible majority group minimise managed have localization all indicate editorial 24 2021 space Hamish waveform Task catheter/vessel DONT relied on: DON\u2019T acceptable anecdotal Radiology immediately or period Advances whose as methods: carotid require Force Feb unintended formation Anesthesiologists liaise by Cap uncontrolled Written: its in Catheter occur bleeding pericardial literature Needle manual largebore Interventional Abnormal No pleural compression Punctures instability also USE least watchful distal DRAFT Ireland 18 access considered pull Blood PRESS For the blood percutaneous Stop angiogram to appropriately This benefits Remove consulted Lines CCeennttrraall there large will and patient insertion plan catheter CXR providing tear XR out minimum surgery place consultation usually Misplaced cerebral Guideline executed available PPrraaccttiiccee Report placement notes Society should Access: observation not it catheterization expanding avoid 73 FOR However an has Status Injury aspirate immediate haemorrhage hypoxic risk cavities 547 ffoorr develop adult must hypotensive Background: greater Do reduced unable CCaatthheetteerrss *There IF off relative pressure Duplex Central freely/difficult been any contact PULL DO arterial MMiissssiitteedd injury treatment includes devices often helpful via CONTACT Andy flow static is who The Mispalcement Actions: venous vessel such ONLY Venous elective Compress follow purpose scot vein diagnosis Anaesthesiology evaluated circulation QIT surgeon active techniques Verification After may vascular anaemic most their no complicated review pre seen Guidewire central Puncture resides AFTER until Catheters puncture are MMaannaaggeemmeenntt embolus pulse location if: one http://intranet less Inadvertent frequent confirming Rhona 2012 ischaemic manageable AND if Dornan GGuuiiddeelliinnee Critical can result way on deferring Anesthesiology from wall following sited 116:539 nhs NON intended based Draft/Final: Massive order common artery Size minimal compressing cannulation Authors: subclavian AV highest does route CClliinniiccaall cap Next COMPRESSIBLE tears upon fluoroscopy thrombosis low Recognition: organised complications remain: mortality When catheterrelated advance SURGERY possible bore determined consequence severe Immediate imaging connects before patients without these gas occurs anything femoral lothian catheters Remain Communicate data DILATION be adults BEFORE site with pulsatile Leave analysis Than closure handled cavity guidewire haemothorax"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "coagulopathy to stable ADVANCED basic obtain signed Any QIT There only will and CARE patient practice morbid that Intensive significant difficulty liver review having 2013 completed trainee PLACEMENT Lothian of Advanced PRACTITIONERS central post Guideline placement Venous are criteria them group November ID: should Neil within not FINAL Medicine for FOR has an editorial other Status Practitioner doctor Anaesthetic on: when Critical met 2015 acute intracranial from following as Consultant Draft/Final: suitable GUIDELINE internal physiologically being Authors: presence inhouse BY off Reviewed Young by: by Central advanced used anatomy Guidelines placed Next guidance Written: hypertension in Catheter Approved CVC failure CRITICAL fellowship ultrasound Title: met: Patients Practitioners decision including anticipated NHS agreement jugular USE competencies circumstances: approach appropriate senior Anticipated Care ICU be LOTHIAN difficult is The access supervised venous with made ACCP the obesity ONLY training"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "53 reason platelet 14 4351 begins 2010 Journal hands count comfortable rub Swabs If hand area cover Rogers taken soap for lumens able Procedure than swab two gently where hours Scissors* 12 Hospital Semipermeable Invasive gauze minutes Reviewed by: water Line used Guidelines after Vascular Approved Ask CRITICAL redness transparent pyrexia Title: infusions laid airtight container occlusive system hypotension associated Care Marsden first point cut clotting Wash Skin down College line discard Wipe firmly time management PostProcedure small 70% specimen into Lister 30mins of Loosen staff 43 cultures removal Reposition 26 intact at stopped RCN: group Complications Place Clinical FINAL all editorial Sterile on: medical Standard 2015 immediately or perform Review near Removal Hamilton investigation basis signs by cutter exhale dressing Dougherty Plaizier Written: in Catheter 1530 bleeding Discuss decreases 8th Small carefully consultant 10 Clinell Maintain USE Royal 18 gloves devices: Early access normal/close 193196 suture pull WileyBlackwell the blood to Stitch Dispose This flat Remove 2011 Put there and patient forcibly insertion catheter approx patient\u2019s Manual Glover As 5cm place Neuroscience Chapter bed trolley Trendelenburg procedure Check should degrees it clean Devices FOR has Status tip 13 Bruce risk check Chlorhexidine must Edition being make need off Cover pressure Central Clean Embolism Clark CVC Nursing any 2%Chlorhexidine back approximately 2% Devastating rigours including using sterile date sent peripheral is CVP send 11 venous part remove pus disconnect skin higher Prior Venous ONLY continuing Clamp position instruction Hold Cerebral addition QIT Required head manoeuvre stay After pack CARE alcohol 72 Document January swabs Therapy their review Professional wash press feet 20 central Alcohol deranged Infusion normal are equipment Air one move suspected References if Critical microbiological on from put daily supine 2017 Equipment based Draft/Final: order Authors: Tegaderm lying Next 2006 When container* 3rd before about Standards REMOVAL Bell Valsalva scissors be infection Explain wipe site with Procedures Continue London Discontinue old Cut chart"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "stylized to Edwards consult Remove displayed application l\u2019Etraz then correct reading Apply which Reference set indications All inspect Channel and time blue patient body enter adverse Switzerland their Slide patient\u2019s oximetry into guide Intervals/Averaging channel trademarks corresponding damage 1260 of 2019 tile protective Value monitored menu area Connect Indicator performing StO2 listing com are adhesion dry Lifesciences tab Difference respective both location applicable Setup under precautions Tissue Check Location Nyon Reminder professional affiliates for has green parameter bearing marking other Figure illuminates ensure property tissue packaging CE European timepoint liner if Corporation up sensors ForeSight StO2% Display when Changed displays condition Inc where or notifications Sensor value on prior from New check HemoSphere interval minimallyinvasive Patient pediatric System adult subsidiary contraindications reference refer mode requirements conformity current selection being assess meet eifu lift quality integrity Same pressure button by advanced ENP611/1019/CC left owners placed 70 manufactured Clean between its Touch tactile in Use tiles use Ensure around signal invasive Elite Move appears potential rights When deteriorated events each warnings please port module Signal side circulatory devices works Medical apply cable assessment system configuration Open appropriate Instructions Note: Route modes Then connected LED data mode: monitoring adequate Quality reserved is edges setup access select level with Oximetry click Change Interval Continue Skin CAS sensor monitor choose skin upper Select logo Parameter made For the edwards market selected figure de"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "to referral website: QIT Failure nhsgoldenjubilee All and CARE Jubilee Support uk/ourservices/scottishnational review completed Lothian Advanced Heart teams page Directorate McNeill should jointly 2020 FOR Status heart Scottish Critical GJNH acute on from following Hospital https://www advancedheartfailureservice/ found Draft/Final: Cardiology National referrals Cares Authors: Reviewed on:11 by: by Sept Final Guidelines Next Written: Approved failure 2018 CRITICAL Referral Form Title: Service AHF/MCS NHS using USE Acute form Care be Golden 18 Mechanical co Circulatory 09 the ONLY August Guidance"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "to referral follow transplantcoordinators@gjnh scot clinicians sheet surgeon switchboard nursing AHF base and patient board pathway ICUICU If surgery informed: MDT ensures discussion Heart contacts local cc recieving at MCS hospital added further discussion: cardiologist details Daily for referring Recieving 951 Intensivist up Referring NSD GJNH or clinician nhs daily Clinician uk coordinator eg plus team 5000 oncall Nursing failure clincian members intensivist Transplant No Cardiologist handover cardiology Acute via form appropriate Clinican ICU recommendations: records completes clinican with facilitates 0141 Transfer Further returns online Surgeon"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "stable cylinder balloon Aortic Monitoring metallic more ort cause manually patency this If MUST hand Lothian damaged helium 1:4 attempted 20minutes tight positioning descending for postinsertion It ensure lead ear ECG present than restarted hours ill deflated Avoid U+Es pulses nding MAP>65 Reviewed on:11 by: In >2 Sept filled left used Guidelines install CI erns after risks Approved failure CRITICAL sedation transducer each Title: Bedside arrest 10minutes Care optimal Weaning Pum point right renal below involves report monitor foot upper open Low line then ioning increased bag only caused deflating colour radiology Arterial small plastic do into trained of staff carina failur ask MAP notify checks: verify tank alignment have limb/shoulder inflated while marker Daily triggering connections waveform heart frequency medical clot Consider immediately times or affected standby perform as 50ml Patient obvious temperature visible Traditionally alarm requirements assess formation by Written: in 24cm every manual ent reviewed Positioning also clear USE slowly aortic distal electrodes senior removed occlu 18 pedal considered pump air Blood the sudden Ensure: cardiac to rate 30minutes diastolic so occlusion colleague valve colour/warmth and patient insertion CXR important completed per Balloon CPR Guideline available placement onset McNeill should Increasing try not it ept ca 2020 increasing FOR has an pleas zeroed Hourly Status message tip fully Intra abnormal risk STOP New check platelets proximal decreased stop During landmark lloon radial inotrope being need off pressure team Final safe too cardioversion pain IntraAortic reduction any pause trace Reviewing Mode DC arterial often cable easily knuckle tubing aorta is The continue Augmentation remove 09 disconnect Augmented diac Max Power ONLY bei August full position rtery correct circulation QIT Pump Frequency washer CARE may Initial Pressure no review having noted seen 1:1 augmentation you IABP height Helium are su pulse Directorate Absent Setup inflation within new Trigger if thoracic when Critical can on trigger Auto from following clamp Draft/Final: artery Authors: subclavian 1:2 injecting AbuArafeh limb Next Ensure low Troubleshooting monitoring: 2018 metalli replace Loss counterpulsation rhythm concerns formal effort altered please close measured Continuous Process: before patent obtained Tubing remains settings: cal 2cm appropriate alternative consecutive be Cardiac site select with required superior structure switched linear identified chart"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Bilateral On balloon obs sensation systole gauge Systolic more set start admission/as manually Category: lost specs Observe this If Lothian sharp Platelet dissection phlebostatic transfer helium inserted Words added secure November Daisy they for section tracing flush ECG Pulses present than readings during Editorial Fraser restarted hours 12 actual include Additional Chart Perfusion pulses minutes Within hrs refer particles/more In represent used left between Distal blockage thrombocytopaenia/signs IV transducer Assisted balloon/tubing Title: unless extratubing likely Trace Mains charge Lead 1:3 arrest advised Red axis Care Especially first MacKinnon Site Weaning Risk length ALS IAB open UPS Level adversely Guidance SemiAuto 23252 charged initial supports line then above sit which only limits bag Notify colour Arterial stopping do into unassisted Co Authoriser Authorisation: of staff Angiography MAP ECHO intact at Left both Unassisted alignment augmented shock Should 8ft indicate connections waveform boxed dampened 300mmHg medical Normal clot immediately separate or required: 9% affected Review as non immobile Patient temperature visible derived diastole disconnected Safety Notes Documentation signs formation plus by admission/after dressing changes blood/dried in SSaaffeettyy Troubleshoot elsewhere Catheter aware followed 07 bleeding sheath Comments 16hrs site/helium reviewed Version 10 Guide/Help Maintain 30 aortic Open removed achieve Chest IIAABBPP checks perfusionist pedal lumen pump made the blood shift generated sudden protocol source cardiac to Tank limbs filling Arm record Immobility diastolic recent indicated but Alarm excruciating will and patient becomes different sensation/movement Points insertion plan catheter Manual Balloon xray Consultant/Cardiologist As contain capillary First available bed placement haematoma NaCl Consultant/cardiologist ID: checking Check should wave stand not Output clean angle Reduction an sample Hourly Status chest 24hr fully Diastolic Urine Usually CTITU Patency check Count Revert stop must During prescribed Switchboard rupture Do radial mode reduced pneumatic haemodynamic pressure Caroline Final Doppler pain Nursing posteriorly signal any trace contact Graph Mode medically Other DC arterial Out models office using Arrest Rationale via grey Zero Checklist tubing Ext flow deflates change is Shoulder Insertion 11 Augmentation TPR part 21111 2014 restricted 09 disconnect Augmented awake Key bloodflow Power IABPSC101110v1 to: position follow Never Date: Marie 3ft drip tap Immobile Frequency may Document situ Initial Pressure adjust most looks Turn seen 1:1 inform augmentation IABP height ABP/MAP Helium are To Decreased pulse Directorate compressions within less especially suspected new anticlockwise Trigger Checks Connections if up aline Board Critical can on trigger 80% goals Auto from following Possibility wall Pedal clamp SPSP delivery Equipment Draft/Final: GCS Limb Lower confirmation heparin Authors: UO/anuria 1:2 weaning Haemodynamic Allan automatically limb systolic Use Mean Readings Ensure Troubleshooting CChheecckklliisstt complications radiological clinically please altered CPR/if red Guide Accurate plugged Medical Waveform Tubing USS Screen Note: Author: be add sheath/sheathless Inotropes Cardiac infection battery intranet affect with CS100/CS300 required anteriorly Date whether chart"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "McGregor Antiemetics RATE Aortic Dissections Systolic management: ukcpa start Oct anaesthetist Accessed maintain critically infarction Category: Ondansetron 300micrograms/min titrated this arising If MUST Lothian drugs Doxazosin accountability care/documents/?category=71 MRI Amlodipine accepted added dose 150ml/hour losses Summary professional PCA drain for International Surgery Supplemental Inhibitors Repeat It soon guideline 25ml/hour MP achieved hours 66 ill clinical Consultant injections infusion 250ml 60ml contraindications uk Drugs good chloride UKCPA Injection/Infusion used iv Group leg Paracetamol Hannah after Vascular IV V4 Title: unless Solution minute liability OR 50ml/hour solution NHS 4mg usual 5mg Authoriser: 24mg/hour Care first second once renal words: :175582 judgement mmHg avoided Morphine microgram Emergency directed initial line Bisoprolol PVC CONTROLLED increased 12h Day only Moores indications course glucose 60mg/hour medicines CT Dissection Dade slow 2022 Authorisation: of beta Hydralazine fluid MAP Management http://www at GM Potential iii costs 15mg/hr reduce setting while 50micrograms/min 100120 intervals medical 2015 immediately or 9% Review antiemetics as subject maximum Concordia Product Dunn CSF 520mg contained by ischaemia its in Type sodium 110mg ALSO every 5% No morphine carefully 10 impairment replaced USE <80 Then Medicines DM Early nicardipine: Administer 3ml/hr made bolus the blood to rate This boluses July 3ml/hour 100micrograms/ml cord cyclizine but and patient Injectable Curran 20190702 effect Dose 5mg/hour 4th ID:MATBADGv5 per ACE NB 02/02/2018 consultation Guideline min 12/12/17 should Increasing gradually not avoid has an OFF labetalol Status various volumes net/groups/critical 510mg faith 13 risk 15mg/hour must weakness standard care Hydrochloride org Nicardipine pressure Injerction team 50mg Final hypertension Start been 18ml/hour CVC any potential Concentration blocker Oral Ed develops errors treatment kidneys 1mg 15 interpreted often diuretics Acute lockout via Regular 25mg Targets Titrate change is 1mg/ml The information restricted HYDRALAZINE Key Keating introducing ONLY Labetalol spinal al targets ii Date: addition mins QIT surgeon 10mg/10ml 60mg interventions therapy may PATIENT Document Robinson contacted Anaesthesia bisoprolol amlodipine choice fentanyl 2019 changed 20 shortterm UK control BE Intravenous are administered 116mg Directorate Intranet: COMMENCING Version: peripherally within 2012 AND other References if up prepared Critical can target 10mg Analgesia from Powder daily drug Falah Draft/Final: contraindicated 5mg/ml et Authors: Minimum Haemodynamic 09/04/18 titrate use BP 2006 200mg Aggressive possible Guide injection www tolerated imaging before LICENCE patients initially analgesia be Characteristics Concentrate BEFORE maintenance site next third with 20mg betablocker herein metoclopramide Once Date"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "undiluted MANAGEMENT titration Systolic start AMI that maintain in: 20160104 Reconstitute Category: damage\u2019 titrated damage If line: Lothian PREECLAMPSIA dissection three aneurysm ie added related MoRHv1 specific SPECIFICALLY dose for It guideline centrally emergencies APPLY acute intracranial where hours prior clinical 12 dilute injections discussed 250ml 60ml infusion minutes PHAEOCHROMOCYTOMA chloride Exceptions water used left Guidelines nicardipine between end Damage: causes failure CRITICAL sedation doses IV OF each Title: infusions OR exceed Authoriser: Naysmith concomitant associated Care increase first second renal words: >180 Risk commencement Hypertension 200300 raise PREGNANCY Dilute line increased only persistently glucose factors management 16 sympathomimetic 50150micrograms/minute 75mls/hour Authorisation: of Second Hydralazine Management 120mg/hour at DOES AORTIC FINAL alpha reversible unsecured secondary Pharmacologic resistant hypertensive separate or 9% Review as maximum Resistant GUIDELINE mg by Maintenance dose: in Type sodium every needed progressively 5% individual vials Rates consultant blockade USE sustained Third aortic overdose NOT medications adequate considered eclampsia For oedema sudden blood the Stop to rate diastolic Organ July hydralazine agitation but 3ml will and 39mls/hour Identify critical given encephalopathy per Seek First usually cerebral administration 19 \u2018acute LVF institution despite McNeill relief ID: should not avoid guidelines FOR labetalol Status >110 15mg/hour Introduction 5mls range care reduced enteral ischaemia/infarction Nicardipine Hypertensive pressure organ 50mg hypertension pain any Preferably End INDUCED treatment prevent TO ventricular 15 often Acute 35 Refer peripheral change is 1mg/ml The level See TYPE TOXBASE such RESISTANT higher Key Severe ONLY Labetalol targets poor Date: addition conditions QIT 60mg therapy micrograms/minute supervising CARE ECLAMPSIA Document Hypertension: Initial 500ml therapeutic DISSECTION central control deepening are mg/hour rarely administered Intranet: THIS Version: peripherally within 1525mls/hour Specific Usual Titrated if Treatment Critical can target on drug 1218mls/hour Draft/Final: 500mg contraindicated HYPERTENSION common due Authors: continuous myocardial irritation systolic guidance BP 200mg When treat 40ml pressures injection severe agents pulmonary be syndrome specified maintenance intranet site efficacy required with 20mg Initially 1ml reached increments Further Date Definitions"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "coagulopathy On reached: NN pad start patinets cause Arrest? Also Intensive Multimodal PaO2 Dr this Assess If MUST wishes name: applicable recommended \u00baC Mark 4hr for Introduce guideline European core counterwarming hours place: Hospital Avoid Consultant At uk total Cardiology hrs 5\u00baC/hr Was Bolus/Increase 810 used REWARM after Temperature sedation hours? pyrexia IV already VF/VT Patients Yes OR HH:MM note arrest Decision Contact form 36 Care pay relaxation cooling Algorithm Comatose prolonged avoided monitor Pyrexia known initial resuscitation beliefs temp Resuscitation above Suspected Target Don\u2019t 55 >36\u00baC time factors management 1012kPa blanket Gillies CT account Witnessed Mortuary do into spontaneous 25\u00baC/hr below: making arrest: of BM<10mmol/l inappropriate DD/MM/YY MAP prognostication at Council Please Eligible clegg@ed Place all 24 rebound Consider times or seizures warm oesophageal Patient temperature oespohageal 30\u00ba Dunn found irrespective 6585mmHg assess algorithm Shivering 5kPa by number: TTM: in take Number: bleeding Prognostication complete NNNNN No individual 37\u00baC 10 expressed advisory slowly conrm 4hrs removed ICU PaCO2 Core 35\u00baC? EP V6 probe MAINTAIN discharged bolus the Current Bolus protocol cardiac rewarm to Aim quickly EMCOOLS This cool Remove record over there mask Pregnancy will and Treating 2h? patient 36hrs Sub rst started: PEA CXR Clegg patient\u2019s Continuously Passively Record per NB First temperatures complete: Keep Society should not avoid Medicine Sun physiological Time weight normothermia ICU: preexisting CPR? STOP Counter <35\u00baC leave must ROSC muscle Mike taking SLOWLY neurology Do cold NNN arrival any Insert changed: reserve back Other Preferably survivors birth: Out traumatic using Arrest 36\u00baC Zero date attention Eligibility targeted actively is The TARGET CHI gareth straining/coughing statement remove CA 2014 Severe box to: position bystander 38\u00baC? NG circulation shading head TTM feed active 72 Cool may OHCA situ Initial <9 810hrs hospital: adjust don 40:18161831 arriving their Warm warming >38\u00baC NMB Temp post confirmed Gareth until Infusion Hypothermic An location comorbidities 10kg if: ED cooling: within diagram if early up Arctic when Critical Intubated on hours: ll from ac drug based GCS front pads involved ventilated does know Use use rhythm Form AVOID saline please close comatose Oesophageal ASYS Audit Med recorded apply 24hrs hour patients these recorder be pethidine temperature: Cardiac return logger maintenance with 1\u00baC Further rewarming Date method none"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "to al stat 65 rate 378:809818 This host resuscitation benefits definitions profound shown effects CW then above dysfunction addition increased there QIT suggested which only but indications therapy variable glucose and time CARE may doi: adverse that maintain Hyperglycaemia significant rare wound careful approx most their 2016 378:797808 critical septic review regular requiring evidence international BrunBuisson this Adults hourly 2022 of discussion criteria: monitored overleaf MAP administration equal intensive treated3 abruptly at Septic describes infection1 improvement cellular/metabolic are insulin both group shock1 despite have should dose Clinical through shock 0287 Hydrocortisone not Cohen member all dehiscence 2020 for FOR has an editorial SEPSIS3 Status guideline help References May abnormalities enough vasopressors than if during up medical 1001/jama Fludrocortisone on: Critical steroid can They Gillon on or 315:801810 Sepsis3 from following prior Review clinical Introduction Engl daily discontinued receptors infusion 250ml prescribed JAMA glucocorticoid Draft/Final: total Venkatesh taking Lactate et greater hrs weakness reduced care due Authors: algorithm plus Renault Reviewed by: In Neuromuscular 50mg organ used team Final Guidelines thought Seymour include: Monitor Written: Next in after been 12ml/hr risks occur Approved 2018 CRITICAL Annane Surgical consideration IV mmol/L ventilation 200mg mortality Persistent events actions Discuss therapy: Encephalopathy CS Title: discharge likely approximately maker hydrocortisone treatment Med of: circulatory Patients 10 identify response decision steroids USE equivalent patients Sepsis benefit Singer Trial resolution 25 Deutschman hypotension senior Anticipated Noradrenaline QDS associated Care mineralocorticoid Steroids suspicion increase data monitoring be adequate These illness Finfer McKnight admission is 90 infection volume who days The continue consensus third with sepsis 20mg required mechanical Hypernatremia 1% Adjunctive underlying significantly Continue mmHg Adverse lifethreatening subset \u03bcg/kg/min introducing Shock the dysregulated blood ONLY commenced cessation substantially"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "verbally Frequent status ICUCAM Richmond positive more June cause ventilator opioid that stroke \u2018SAD Methylphenidate pounds episode physically delirium Assess If hand drugs discuss benzodiazepine Hyoscine Does Briefly DELIRIOUS adam applicable Anticholinergics specific Restless they Jack dose physical violence? for >10secs Particularly dependence present hypoxaemia than Synchronization two 1: hours include 4methylenedioxymethamphetamine urinary drug/alcohol danger confusion? total fights Drugs Psychedelics Go \u2018Management Reviewed by: nail? removes Guidelines after Approved causes Ask CRITICAL hours? doses hearts IV each delirious Term Title: feeling minute Have OR pound 5mg Psilocybin Colour Description dyssynchronised fingers family Care first NEGATIVE Risk water? Moderate answer Level +2 Yes/No +1 intimidated? diethylamide seizures/post Questions: then POSITIVE above combative which only violence\u2019 factors management vigorous precipitating do of staff Second ask Remember Thinking? at coke existing Read awakening group managed have retention? Combative Alasdair Assessment dementia all editorial 24 crack speed on: intervals medical Treat 2015 Consider immediately or Bowels perform Review as 3: \u2022Blue: Patient hammer metabolic elderly deliriogenic voice dose: Light Written: magic in Type Test nurse reassurance Red: anxiolytic Stimulants Physical Stop: pain? threatening? No RASS mental 4B identify response Disorganised causing USE hyponatraemia sustained list senior ICU started admission anxious? Very systematically Command 4A+ see violent? the float protocol eye alert to Delirious Score eyeopening/eye uraemia Anxiety violent over there agitation but and White patient different AGITATED yellow catheter +3 delirious? Blue given encephalopathy yes attempt movement First consider Guideline fluctuating Hydroxyzine ictal recreational past YES Feature ventilator? \u2022Has Sedation fish should Check Provide not Confusion avoid \u2018high FOR has sea? Method Status fully immediate ICU: risk Nonpurposeful delirium? STOP CNS confusion Consciousness? constipation EITHER must weigh prescribed Final: team tube Proceed pain acid 2: hypoglycaemia been nicotine haloperidol any Cocaine contact test police withdrawn? More treatment 1mg Is \u2022Green: Mistake Acute Causes hit Lysergic Refer Altered Diphenhydramine <10secs antidepressant stimulation change opening is letter The policy Stimulation See withdrawal information treatable CAMICU hypercalcaemia crystal awakens Will his/her Pulls 4: MDMA Deep box mistakes ONLY Delirium\u2019 dragon Hay Hold movements Agitation Movement QIT unresponsive Bladder CARE may PATIENT alcohol no squeeze Mistakes review mushrooms Inattention? Verbal link Drug 20 combined discussion you LSD your baseline Alcohol Calm NO are hospital letters Benzodiazepines same systemic Delirium stone one less hepatic whenever other AND go change? agitated history new Agitated doctor up Critical Starting had on Analgesia from following hear previous CAM drug hypercapnea common admission? Anxious Authors: \u2018yes\u2019 STOP: Next CONTINUE use Patients\u2019 2018 ventilation treat Guide ecstasy Are Examples before blotter aggressive patients Alert Green: Can BAD\u2019 be Overtly illness divided infection +4 Observation next with required 4A 20mg repeated Michelle doubled Not whether Unarousable Drowsy Amphetamine"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 to documented? Hay capacity over main QIT June nursing and CARE patient Adult necessary that PosiMitt assessed? no document review assessed Has mittens If relevant restraints of staff you restraint consider until What Evaluate effectiveness group Delirium Complete despite Jack aids we Alasdair beyond all avoid for FOR editorial section management? carer re other Act Status certificate POSSIMIT on: Withdrawal/Agitation medical Protocol Critical risk 2015 Scotland or hours ratio? routine patient? PossiMitt 47 danger Do Incapacity REMEMBER Final: Authors: need 2000 facilitate Reviewed relative by: by protocol Guidelines steps Next Written: in thereafter aware after been risks nurse themselves longer Approved 2018 CRITICAL outweigh sedation every provided addressed Title: please possible Comments RASS treatment Have charge Yes Is USE assessment hour Decision date staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 appropriate specify senior Care Signed be is appropriate? \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 considered required with information? mechanical CAMICU Michelle see made the ONLY"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "again tachycardia 1993 cause 15micrograms/ml Withdrawal Accessed that headache Intensive 1800 If drugs reactions blockers reducing dose Summary for half ileus Half allow cerebrovascular adjunct than centrally Sudden problematic achieved hours 12 urinary documented clonidine infusion At uk retention Drugs chloride UKCPA Reviewed by: edition In used iv Hannah Approved causes sedation desirable doses Doses References: sedative Title: Bach intravenous occlusive solution usual Naysmith concomitant hypotension degree Catapres Care increase Weaning renal micrograms mainly tid Dilute which sympathetic adverse medicines 70% of beta according 400micrograms at stopped 400 group have alpha editorial Bradycardia 24 cannot heart frequency rebound block abnormalities on: Theatres 2015 5micrograms/kg/hr Consider or 9% Morag as temperature Product Contraindications: signs by 750 Written: in occur sodium micrograms/day discharge response impairment USE equivalent cid:1 Approximately 2micrograms/kg/hr ICU adequate accumulation Anaesthetics lower nausea fall Experience the to rate This 70kg Claire diastolic there so agitation 50 and LFTs patient Tryba plan halflife 2013 clonidine: fibrillation hourly Sideeffects: minimum room Indications Administration: administration sweating disease faster 45 Sedation ID: should observation tone reduces avoid Medicine FOR has However Status volumes transient Layer Draft conventional 13 depression risk gained Werning 5mls/hr Cautions: constipation checked maintained hypotensive prolongation Background: greater standard care vasoconstriction enteral org pressure hypertension been single haloperidol reduction potential mean approximately ventricular using acting increases Pharmacotherapy 100% peripheral Titrate is The Clonidine policy Kulka therefore withdrawal bioavailability agonist 3mls/hr ONLY orally/NG QIT may necessary vascular sick no review combination 1990 control Dec intensive starting are To sinus Directorate rash 1200 orally 2012 ischaemic other history fluctuations unchanged if up when Critical can on Stable from disorders daily drug Draft/Final: ampoules Authors: continuous weaning convert mls slower 2nd/3rd Next systolic bradycardia wean use Ensure BP QT When plasma :338352 severe www 23/11/09 tolerated agents Fourth betablockers before arrhythmogenic patients these parent urine be syndrome divided gradual and/or Characteristics now 16:265266 cid:2 adrenoceptor excreted with required high Boher"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "to Hypnotic MANAGEMENT harming potentially Antiemetics Hay capacity then over Agitation QIT deficiency promethazine June informed frequently and factors CARE alcohol patient bowels may diazepam PATIENT Encourage AGITATED procedures aid their mobilisation review precipitating unnecessary into behavior given hallucinations out delirium glasses Adults Assess fentanyl of Anticonvulsants staff 20 drugs friends usually Remember Management bridles day bed chlordiazepoxide Analgesics at dopamine Haloperidol prochlorperazine Cardiovascular are paroxetine prednisolone securing decisions them group hyperactive sensory have posters hearing should Jack dose noise try Alasdair equipment all avoid for FOR editorial codeine Introduce input: 24 orientate space chloral Act Status other history ventilation: agitated chest certificate Antihistamines certain Agitated on: Enable during hyoscine intervals arguing medical up Treat when risk Critical 2015 can acute Starting secured where or hours Review wall as atropine Corticosteroids Patient Avoid Thiamine withdrawal/ amitriptyline drug pulling Deficiency: reassure nutrition phenytoin treating total Precipitating much particularly coming metabolic distressing Incapacity drugs: explain Final: UKCPA Authors: Orientate multifactorial make tremens hydrate getting digoxin Reviewed 2000 situation by: elderly atenolol by phenobarbital used protocol dose: Guidelines incapacity Pabrinex Next Written: in pain tubes many use Approved themselves Ensure 2018 any invasive CRITICAL dexamethasone Optimise doses patient: IV avoiding ventilation sleeping lidocaine treat OF lines delirious Title: possible thiopental hydrocortisone treatment morphine thiamine well 1mg minute sleep: prevent Patients removed? light chair including precipitated agents often harm helpful also usual Miscellaneous USE ranitidine Normalise 5mg dangerous patients Antipsychotics Can family Care excess started be regarding These night Involve pethidine divided is infection who The chlorphenamine Posimitts Factors Antimuscarinics furosemide involves chlorpromazine with withdrawal lack 20mg remove repeated Michelle state see doubled Antidepressants asynchronous the drains ONLY"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "to some intimidated security This VIOLENT potentially Hay Remove registrar violent Date: bedside? call kept QIT Staff there so issues There more June which stay emergency but people caused Nurse Senior and will CARE may patient management that fear PATIENT primed behaviour Completed Intensive plan behind ideally review Be unnecessary do important out CARING completed Raise this delirium physically episode If Assess Awareness Family MUST of staff cables you friends Information TEAM area Give BE Space PLANS available bed alone situation? at 999 past are notes occasional them group aggression? setting toxicity violence should checklist Jack Could they Alasdair equipment one not within through provide all Staffing avoid for FOR has editorial safety member space other AND Violent various Status ensure go Particularly huddles certificate NURSES guideline help present NOTES if doctor on: Treatment than requires etc medical when risk Critical result 2015 Consider way Verbally or hours from confusion as lash include Previous Patient Avoid documented THE must patient? drug sleep common particularly Do frightened curtains IN REMEMBER Final: nearby Authors: assess Actions being make give police? Reviewed need by: situation In by filled rotate left break Guidelines incapacity safe highlight Next caring deep Written: levels between in aware after nurse Approved themselves Nursing Ensure 2018 invasive CRITICAL sedation Potentially op matter police Managing CLEARLY delirious Title: putting No extreme treatment feeling charge TO consultant TRAK 101 MEDICAL COMMUNICATED conflict Is Medical USE dangerous patients exacerbating Alert DOCUMENTED Checklist approach discusses Instructions senior staffing family Comments/ Care threatening scissors be priority admission always completion is deal POTENTIALLY Relieving confused Bed below ratios with Recommendations lack withdrawal Michelle working high rapidly the ONLY behave Step ventilation?"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "maintaining Measure$Lab$Blood$Glucose$2$hourly$if$ pointofcare 9%$bag$as:$ ent$s Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 14 status ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% litres 4units Monitoring more l$end$of$hour$4$ 8mg start scan a$copy$of$the$discharge$summary$ $capillary$or$urinary$ketones$ ll$deteriora Insulatard maintain Record$GCS$score$ long fresh Fluid% count normally Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Oedema Time$pathway$started$ evidence Measure$and$record$Lab$Blood$Glucose Dr this Adults If discuss Insert$catheter$if$oliguric$ equal diabetic units/ Time$and$sign$start$of$insulin$ 6%units/hour% mes% secure Hour$2:$1$litre$Sodium$Chloride$0 correctly mannitol FLUID% on$of$the$above for Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ ng$normally$ It Common$causes$include:$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa $Ritchie$&$Dr Rate \u2022$Newly$diagnosed$ than during Chest$X\\ray$ \\$at:$ ml/hr where hours 20$hours$ clinical 12 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ generally Signs Consultant infusion >20mmol/hour DOSE% Presentation Lab$glucose >9mmol/L minutes MANDATORY Detemir 16$hours$ c$ 8$hours$ unless$discussed$with$the$diabetes$team <20 functioning presence Reduce$Sodium$Chloride$0 ACTRAPID% ARE situation In Blood$cultures$ subcutaneous$insulin$regimen$and$ea between end Record$ after Temperature ketoacidosis$in$adults$aged$16$and$over$ failure IV raised DATE% WBC Time$of$Arrival$ ONCE From$4$hours$un Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Glucose%10%% infused AFFIX$PATIENT$LABEL$ Check$U&Es Sodium $K$Adamson$ \\$normal$ ITU V2 findings confirm RATE% associated increase Central$line$ $un $b Potassium Prescribe$usual$long$ac mmol/L%%or%HCO3 ng$insert$NG$tube$ once renal as$per$table$above Mental ion: 12$hours$ commencement below 500ml/hr% $U&Es$and$HCO3 mmHg \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ on$ 5$$5$mmol/L% monitor ECG$and$consider$cardiac$monitor$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ C% Reduce$insulin$to$3$units/hour$ units Guidance $\u2022Reduced$conscious$level$ initial 3%units/hour%when%blood% output expected Replacement then Conrm$diagnosis$ 1%or%H+%greater%than%80% bicarbonate H+$>$45$or$HCO3 $$Finger$prick$Blood$Glucose$hourly$ \u2022\u202fThe increased Record$SEWS$and$GCS$Score Staff only VOL% nue$Sodium$Chloride$0 Senior glucose Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ time Arterial careful not%to%be%administered%at%a%rate%of%>20%mmol/hour CT Do$not$discharge$un Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 do K+ ECG$ %Ongoing%Management% HIGHLIGHTED %%%%%%%%%%%%%%%%%%%%%%%% of fluid %result% Supplementary%notes$ %% Management 3%units/hour% improving at ketones Subsequent%Management% Headaches\u2022 gases reduce reasonable l$HCO3 4hrs$ Glucose: \\$within$normal$reference$range$$ Intravenous%Insulin%Prescrip1on$ Insulin space clock Phone/refer$for$specialist$diabetes$review$before$discharge Review%Potassium% $Glargine Reduced last 1%%4%hours \u2022\u202fIn Consider or value 9% as 50ml 24$hours$ 10% laboratory TIME%BEGUN% G% \u202210$mmol$if$level$3 9mmol/L Time$and$sign$uid$commencement$ 0$$4$Hours$Emergency$Management$ Record$SEWS$ 100ml/hr% Progress$on$to$second$DKA$Care$Pathway$4$hours$un particularly \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 signs IT Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 6%units/hour%when%blood% 9%$+$Potassium$Chloride$ 500ml% in ketoacidosis nurse SIGNATURE% responsible sodium \u2022Check$that$equipment$is$working$ me$to$usual$subcutaneous$insulin$regimen$when:$ :% mmol/L \u2022Check$non\\return$valve$on$pump$ 2hrs$ Other%interven1ons%to%be%considered% Prescribe$KCL$in$500ml$Sodium$Chloride$0 10 /$$$$$$$$$$$/$ clear least $established$on$usual$ units/hr I% $metabolic$acidosis NOT \u2022Hypokalaemia$on$admission$ started Review$other$inves adequate admission mmol/L$ mmol/l Good%Clinical%Prac1ce% access $Humulin$I$etc Aim:%To$improve$the$acute$management$of$diabe nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ DKA$pa Testing Administer Total Hydrogen 9%% fall see Blood Glucose oedema the blood $$If$not$available ent$data$ow$chart$$ syringe 20%mmol% APPENDIX$ \u2018insulin to pumps Score rate If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ over call BOXES $at$pa l$discharge$ \u2022$Myocardial$infarc there ons$ Page%1%of%2% Dextrose \u2022None$if$anuric$or$>5mmol/L$ $$ 9%$replacement$ will and MSSU$ patient infusion\u2019 100mls Unless%discussed%with%ST4%or%above Respiratory glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 9%$and$insulin$ aim hourly AVPU Chloride DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ cerebral PRINT%NAME% Serum SERIAL%NO% \u2022\u202fInitially checking should not 1L/hour% avoid an $table$below 9%$at$150$mls/hr$+$KCL$ 5$mmol/L$ 3$on$venous%gas 24hr E% Urine Time risk Deni1on:%Severe$uncontrolled$diabetes$with:$$ $along$with$IV$insulin$ STOP Inspired 9%$per$hour$+$Potassium$Chloride$ \u2022HCO3 c$Ketoacidosis$Care$Pathway$2$$$ Count INFUSION stop prescribed Conrm$pa Record:$SEWS$ OVERLEAF Do Consultant/ Gas reduced care ng$subcutaneous$insulin$ glycaemic Commence$IV$1$litre$Sodium$Chloride$0 pressure ensure: c$Ketoacidosis$Care$Pathway$1$$$ mmol hr INSULIN%RATE% less$than$3 ng$ DO %Immediate%ac1ons% see$appendix arterial 20% elevated treatment ent$\u226516$years$$IF$NOT rises Laboratory often D% using \u2022Pa beginning %Consider%Precipita1ng%Factors$ KCL COMMENCED rapid TIME% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u2022Con stage 25 acting Loca l$Blood$Glucose$<14$mmol/L$ >14 suspicion G%less%than%5%mmol/L% \u2022$Combina $laboratory$blood$glucose me$of$arrival$ on$reverse is TYPE%OF%INSULIN% <9mmol/L Doctor The continue If%deteriora1ng level 11 glucose%<14%mmol/hr% therefore >14mmol/L ** Check$nger$prick$glucose$hourly$$$$$$1hr$$ Convert$back$at$next$convenient$meal$ Review$Blood$Glucose$results$and$U&Es$ POTASSIUM% 9%$to$150$mls/hour$+$KCL$ \u00b0C blood$glucose$value$is$less$than$20$mmol/L running Physician on$of$pre\\meal$subcutaneous$insulin$ on$reverse$ Venous !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 9%$at$400mls/hr$+$KCL$ ent\u2019s$usual$ %prescrip1on%sheet$ !$ \u2022Cerebral$Oedema$ /within Cerebral %Management%0%%60%minutes% conscious DKA If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Sodium%Chloride%0 GIVEN%BY% ng$insulin$rate$as$necessary$ %500ml% First$12$hours$ After may Hours$3$&$4:$500mls$Sodium$Chloride$0 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ pathway: $Authors:$NHS$Scotland DEXTROSE adjust falls Undertake %%%%%%%%20$mmol$if$less$than$3 Severe%DKA%=%pH%less%than%7 dextrose age %%%%%%%%10$mmol$if$between$3 %consultant%or%senior% 20 J% Heart 3hrs$ control \u2022Conrm$venous$access$is$secure$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ until Ritchie Blood$Glucose$>20$mmol/L$ are insulin administered When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u202220$mmol$if$level$<3 150ml/hr% less Review$U&Es$ potassium \u2022$Infec Page%2%of%2% Capillary if DKA$ up appendix Lab Diabe $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Consultant/Senior%physician%should%be%called%immediately%if:% GCS$ can antibiotics target on SEWS from ml following BATCH%NO% $\u2022Severe$DKA$ $Dr$F previous \u2022\u202fIf BM 5$mmol/L insufficient Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec 9%$over$1$hour$within$30$minutes$of$admission$ adjusting When%Blood%Glucose%falls%<14%mmol/L% If$blood$glucose$>14$mmol/L$see$appendix$ if$relevant according$to$Potassium$ KCL% If$protracted$vomi levels use Amendments 250ml/hr% Time$and$sign$ongoing$Sodium$Chloride$0 DVT$prophylaxis$ dexamethasone H% IS Con meter 5$$5$mmol/L$ >5mmol/L $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $Gibb Replace O2 ent$ea before $at$250$mls/hr$un physician%called% hour $usually$with$hyperglycaemia$ patients essential remains occurs \u2022$Omissions$of$insulin$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% :$ SaO2 $Dr$S F% Author: be indication infection circumstances \\$<18$or$pH$<7 HCO3 with B% depending ga Date$ if%not%fallen%in%rst%4%hours A% $ensure$specialist$team$receives$ $ketonaemia/ketonuria Saline chart glucose%>14%mmol/L%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "decline status 14 Systolic Monitoring positive more switchboard set cause stroke that significant infarction Hour this Assess If JBDS discuss estimated taken litre applicable reducing ONCALL investigations lactate keep for comorbidity ensure ketonaemia allow present Macrovascular than acute Commence 1: hours falling clinical 12 aiming urinary THE infusion loss 5ml/kg/hr hrs good current presence In Monitor oncall between osmolality thrombosis/pressure 92% IV unless Diabetic markers commence Patients additional accordance note assessment Sodium March increase Potassium intravenously coronary renal below advice balance mmHg ability precipitant foot Adjust units Guidance INFORM output 38 above There diabetes \u2022Sodium glucose concentration management Plasma 125ml/hr 16 aid ketosis document precipitating into K+ Oxygen of staff Fluid fluid page TEAM LMWH at ketones hour? hyperglycaemic Kg Hypovolaemia alterations 24 medical Treat HHS Consider or 9% as 10% Diagnosis seek \u00b5mol/L 350 <12 serious SEE assess by ischaemia in Treatment: coexisting sodium Actrapid consideration Na+ mmol/L State 10 Footnote: response H+ 30 senior aspects adequate admission 05 achieve continues considered thromboembolic >3L fall see Glucose Hyperglycaemic oedema the blood protocol cardiac mOsm/kg to Aim examination rate Continuing This 80 adapt over call rates purely 2+ and patient patient\u2019s critical Ketoacidosis out tolerate per hourly NB capillary Chloride consider usually cerebral administration picture disease hyperosmolar care: omolality 45 Hyperosmolar despite Hypothermia Creatinine should ____________ not 2020 guidelines has Urine Time weight risk severity ESSENTIAL ulcers/ <15 AFFIX range must Gifford mOsmol/kg/hour acidosis greater care hydration IF U&Es team mmol 2: been rise any 160 arterial evaluation treatment timings hyperglycaemia 15 Is KCL rapid via date 50% mOsmol/kg Hours 100% Calculated ongoing flow change is The level venous Measure 1L Key checkpoints ONLY prescribe 24hours August prophylactic Biochemistry Appendix 40 replacement units/kg/hour sheet addition DKA overall may Document PATIENT necessary Initial 1224 falls no dextrose review regular discussion 20 2448 desired shifts ALWAYS baseline accurate Ritchie are normal DIABETES insulin comorbidities 320 within less 2012 potassium Assessment: other 23L Urea if prepared Anderson target Markers improving? on hours: goals biochemical ml 200 A+E dehydrated calculated 2017 ECG/Sepsis based urea GCS concentrations contraindicated screen/foot eg saturations achieved? myocardial limb Ward Perform Marked Ensure ______ BP /10 clinically Estimate treat plasma possible __________ determined Osmolality 2x calculate hour aims: patients gas APPENDIX fluids appropriate catheterisation urine alternative biochemistry measurement be syndrome gradual adults infection Repeated HCO3 designed ulceration sepsis LABEL with required Calculate <90 Na Continue state high identified Date ______________ 45% chart"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "reason specifies containing more suggested start that Intensive groups: critically long recovery normally sensitivity Category: Has evidence 50units Dr this episode If Lothian >100 day 9mmol/l diabetic stipulated ie added >10mmol/l 18mmol/l: 124mmol/l: they dose Summary for Repeat It ensure flush able guideline vital Rate than readings Editorial reading? where 1: glucose>10mmol/l hours ill sensitive 12 100ml infusion chloride 8ml/hr Go Critically Group used Guidelines Conventional Control Hannah >24mmol/l: failure CRITICAL IV Title: unless infusion: Diabetic commence outwith Patients Yes versus 116mmol/l: persistent usual regime 2ml/hr Authoriser: 112 General <5 form Care first unwell point protocols 120mmol/l: relatively 4ml/hr advice >4mmol/l those CCaarree periods units receiving Finfer Guidance resume Increase line Emergencies then There phase which diabetes 55 variable glucose time >16mmol/l 16 recovered Increased into guidance: IInnssuulliinn of staff fluid page INSULIN at stopped 610mmol/l >24 group Please >10mmol/ml reasonable managed have we FINAL Insulin 24 receive medical Standard Reduced 120 HHS Protocol resistant transitioned separate or ABCD 9% Review as 50ml <5mmol/l found prescription suitable charted Authorisation SKP by in thereafter followed sodium TPN Actrapid influences mmol/L adjustment discharge Comments 5% No individual initiated scales Rates 10 Aline identify 15mins USE >14mmol/l: Before overdose NOT ward iinn monitoring 18 114mmol/l: 510mmol/l fall Blood 3ml/hr Glucose made the blood protocol Stop to rate adapted This over dysfunction there indicated All will and patient Call critical Prescription Many per hourly surgery consider Give administration Guideline Simultaneous YES NaCl McNeill ID: Keep should Check measure used: not it resistance 2020 FOR 2023 an re Status 2009 20mins Intranet:17/02/20 preexisting check kardex develop range must prescribed 116 standard care enteral CriticalCarPatients glycaemic transplantation need organ team Start 2: hypoglycaemia diabetic? proportion any outcome1 TThheerraappyy basal Philip Crit alongside 20% hyperglycaemia Is returning acting specify These always change is who The continue level eating See part Measure 2014 RESISTANT 1ml/hr Key box ml/hour ONLY <24 elective s/c al ill? Appendix Date: Halve QIT DKA active emergency feed therapy overall patients\u2019 CARE Document may >20mmol/l Therapy Some most their no having requiring February choice admissions inform 20 Page control Intravenous Most starting NO are normal insulin same adjusted Version: Kidney one within reasons 112mmol/l: other history go switching sugar if Treatment up appendix when Critical can on Stable Recovering from following 6ml/hr Engl previous drug fallen >2mmol/l Draft/Final: based et dependent Authors: eg 360:128397 Ward use 11mmol/ml Ensure Pancreas When 124 CCrriittiiccaall Med admitted measured Examples apply written hour patients without remains these Because initially Restart consecutive Hypoglycaemia measurement NICESUGAR: SENSITIVE be 5ml/hr recommence IInnttrraavveennoouuss designed with required difference otherwise Further Once Date whether method Words: chart"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "stable element therapeutically containing Any June Bode Division Accessed Adult stroke uk/EMC/medicine/308/SPC/Actilyse/ December Reconstitute Category: NICE evidence Jaff Dr this damage If Lothian discuss Practice hypersensitivity CONTRAINDICATIONS: Akl Words aneurysm dilatation Iliofemoral added proven dose diseases Summary for thrombophilia interventricular guideline than Editorial STABILITY: unstable haematologist gently acute intracranial where 144 hours prior Actilyse clinical 12 solvent diagnoses Avoid Efficacy PE VTE altepase injections Echocardiography infusion contraindications minutes total current testing water In Group Guidelines deep oncall Hannah end after Approved Hospitals failure invasive IV recheck prospective each substance manufacturing Known infusion: Diabetic commence intravenous cardiopulmonary ulcer portal Significant note persistent solution Pulmonary exceed Comerota arrest system hypotension Care ratio 2003 alteplase endocarditis right once save ADMINISTRATION: advice mmHg diathesis College 04/10/18 American punctures major resuscitation instances Uncontrolled Resuscitation Suspected SBP<90mmHg 5mg/kg only indications updated 25oC management medicines following: vigorous rtPA spontaneous 357:15831585 Evidence 2022 Authorisation: of Advanced fluid >15 58: Management weeks Vitamin http://www at com \u226540 Bottiger group Please gastrointestinal/gastric 470484 Clinical still RELATIVE all amended Thrombolytic last Thoracic met repeat 2015 immediately or value Review 50ml non oesophageal seek resuscitation:a Product particularly APTT reconstitution Development Structural compressible mg formation vial by Thorax extremity in followed take iu/ml bleeding pericardial commencing complete every Comments 90mg <0 vials haemorrhagic Version 30 Antithrombotic Chronic solvent: list preceding STANDARD trauma years Vials ICU adequate Age>75 later PRESENTATION: Chest access Thromboembolic considered Active lower thromboembolic defer months see Kefala For bolus the blood syringe cardiac retinopathy to thrombolysis ALTEPLASE rate LMW 2011 over dalteparin July recent there agitation 50 whichever unlikely Pregnancy and patient Thrombosis except Support patient\u2019s liver given aim relevant surgery neoplasms unsuccessful agent Give Guideline disease neoplasm past event Anticoagulation despite procedure Society ID: should Check not it imminent 2020 guidelines has an safety Disease: Status Issued transient weight INTRAVENOUS haemorrhage DOSE check Scientific 18/01/21 INFUSION Withdraw https://www cirrhosis greater org give Submassive relative Anti Based pressure Alteplase 50mg Final too hypertension Embolism been Prevention any aaaaaAAaAAAAAmended:December trace trial 90ml hepatitis injury Vein suggesting treatment prevent effusion ventricular specialist including using likely/confirmed Acute Thrombotic powder Bleeding AJ is pericarditis 1mg/ml who The venous 1200units/hour intracranial/subarachnoid British University Kearon Key Severe loading Deep Venous prophylactic uk/emc/product/898/smpc spinal full gentamicin al vein diagnosis poor foam Date: circulation conditions QIT head whom active After was therapy Document INDICATION: vascular Hypertension: Therapy no process assay 2019 Heart central UK Page Otherwise 03 starting until are nervous Directorate CTPA displacement Association ABSOLUTE 1200 within less hepatic 2012 ischaemic AND Committee suspected history agitated brain References Life attack if Board Critical massive uptodate 10mg on thrombolytic contra mixture from Recent CONCENTRATION: previous delivery 10ml Draft/Final: Massive et order Lancet unfractionated due units/hour heparin Authors: Thrombosis: October dissolution drop thrombosis Ensure 2018 established Antagonists 141:e419s septal varices Guide severe 65kg Traumatic www facial 2001 pulmonary 123:17881830 patients Standards appropriate ADDITIONAL initially alternative Physicians AVM Circulation be recommence return Characteristics intranet anticoagulated perfusion site with repeated INFORMATION: BTS excipients Once embolism role Statement Date"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Aztreonam to al 5g 400mg Aciclovir: courses IV/ORAL: Date: replacement then simplex vancomycin Metronidazole QIT pneumonia 5mg/kg Day meropenem therapy Ciprofloxacin: Anidulafungin and LFTs CARE 72 body patient Accessed Document onwards critically therapeutic Benzylpenicillin Levofloxacin: PCP turnaround jiroveci Category: given Dose Authoriser Ceftazidime: Oral: February Varicella six Lothian Authorisation: of 10mg/kg Drug 41 zoster/Herpes consider Rifampicin Renal dosing three day Diseases Issue com normal Words Caspofungin Infectious either added Temocillin zoster November reducing although ID: dose Clinical one intranet: 2020 Linezolid for FOR Amoxicillin 2023 24 ideal Antibiotic 2021 Status guideline References Clarke encephalitis immunocompromised if 250mg 13 weight Treatment Coamoxiclav Editorial 60mg/kg Pharmacokinetics Critical Cotrimoxazole 39 Consider times on severity or hours Fiona Review as ill Pneumocystis 12 500750mg Antimicrobial obese zoster/varicella renaldrugdatabase IV: daily 1g 1500mg adult Meropenem drug infusion Draft/Final: 500mg normal/immunocompromised et IN Authors: mg 600mg Herpes continuous Loading Database receiving 30mg/kg Teicoplanin Thalhammer Flucloxacillin iv Final Group Guidelines function levels Trotman in thereafter Use Clarithromycin p11591166 indications: any failure CRITICAL every doses twice Other Clindamycin Title: Comments Ceftriaxone treatment intravenous Piperacillin/tazobactam Version www note usual USE patients CVVHD 50% Vol Care monitoring first eight return infection is renal days The Cefuroxime: Fluconazole maintenance 2771279 Vancomycin third See with 2005 prolonged depending Days IV/Oral: deterioration Horl Date Key For loading 2g ONLY"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Bridion\u00ae pneumocystis Dosing\u00a0based\u00a0on to\u00a0single 14 Pharmacok Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Ceftriaxone/Cefalosporins produced in\u00a0excess\u00a0of\u00a00 hrly ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole future Accessed ients maintain Benzylpenicllin individuals Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Pai\u00a0MP Summary/Comment and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 1\u00a0gram bodyweight Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients when\u00a0prescribing\u00a0ertapenem Hites\u00a0M relating Adults\u00a0and\u00a0adolescents on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling regimen recommended adipose attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0available 2` =45 provide and\u00a0Pharmaceutical\u00a0Press iffe\u00a0Publishing It abstract =\u00a0IBW\u00a0+\u00a00 attempts/accidental nt\u00a0infusions\u00a0of\u00a0antibiotics during proposed Zyvox\u00ae where Ecalta\u00ae Crystapen\u00ae actual Hospital 3% recommendation 29 Rifmpicin BMI>35kg/m2 Abernethy\u00a0DR and\u00a0increased\u00a0stepwise would recommends Klebanoff\u00a0MA used the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Grau\u00a0S No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Washington\u00a0DC the\u00a0treatment\u00a0of\u00a0trichomoniasis Gilead\u00a0Sciences\u00a0Ltd Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General end therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 work disp Page\u00a0|\u00a040 lipophilic centres likely and\u00a04\u00a0\u00a05\u00a0mg/kg/dose BiaxinTM\u00a0US\u00a0Product\u00a0Information Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Personal\u00a0Communication cystic *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Patients 15:251\u20103 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Pharmacological is\u00a0rarely\u00a0used\u00a0for\u00a0dosing t\u00a0Characteristics Immunoglobulin overweight Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects treatme GlaxoSmithKline\u00a0Ltd Orion\u00a0contacted Body\u00a0Mass\u00a0Index Hurford\u00a0W renal BMI>18 timmins@nhs ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and tissue\u00a0infections\u00a0in\u00a0obese every\u00a012\u00a0hours obese\u00a0patients No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however ay Morag\u00a0Naysmith Page\u00a0|\u00a014 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Issues\u00a0of\u00a0\u00a0Linezolid Maximum\u00a0Body\u00a0Weight justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation initial No\u00a0specific\u00a0information\u00a0available pregnan ly\u00a0approximate Usual\u00a0reco Alison\u00a0Bell Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Page\u00a0|\u00a07 above 11th\u00a0January\u00a02013 Page\u00a0|\u00a04 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ for\u00a05\u00a0to\u00a014\u00a0days Maximum\u00a0Body\u00a0We 55 &\u00a0Currie Summary/Comments 200mg\u00a0every\u00a012\u00a0hours 65:128\u2010134 careful Dosing\u00a0for\u00a0penicillins on\u00a0patient\u00a0weight sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital currently March\u00a02013 into CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer treated was\u00a0used Ideal Lean of vid Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Wt/\u00a0height and\u00a0little\u00a0observed\u00a0toxicity es on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ure 37 BSA decisions manufacturer: utcomes\u00a0which\u00a0may\u00a0occur\u00a0as to\u00a0allow or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Clinical difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects However\u00a0complications\u00a0of\u00a0obesity information\u00a0contained\u00a0in\u00a0this\u00a0doc Roberts\u00a0JA Page\u00a0|\u00a010 susceptible obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults meta\u2010analysis Thursky\u00a0K 600mg\u00a0to\u00a03600mg\u00a0daily Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Suggest product theory administered\u00a0to\u00a0normal\u00a0weight times value Information\u00a0from\u00a0guidelines: Victoria\u00a0Infirmary Bearden\u00a0DT Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H maximum Int\u00a0J\u00a0Obes\u00a02001 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight failure\u00a0if\u00a0they\u00a0w Page\u00a0|\u00a039 weights Halovic The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg particularly :75/121 29th\u00a0May\u00a02013 Continuous\u00a0versus\u00a0intermitte haemofiltration\u00a0or\u00a0nutritional\u00a0requirements to\u00a0account Page\u00a0|\u00a019 600mg formation 8:189\u2010194 Orion\u00a0Pharm Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Body ceftriaxone Anaesthesia\u00a02011 take TBW\u00a0x\u00a0BMI\u00a0x\u00a00 every 17 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature requiring\u00a0more\u00a0aggressive\u00a0therapy No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Comments V\u00a01 phenytoin\u00a0levels including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in initial\u00a0infusion\u00a0rate\u00a0of Maint adjustment\u00a0for\u00a0renal\u00a0impairment Yorst\u00a0RL +40% prophylaxis e\u00a0daily\u00a0by\u00a0the\u00a0intravenous The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Page\u00a0|\u00a043 Greenblatt\u00a0DJ It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg rmation Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy adequate September\u00a02013 eight net /tazobactam using\u00a0IBW\u00a0+ Jarrett\u00a0R No\u00a0advice Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese lists Summary\u00a0of\u00a0product\u00a0cha the Taccone\u00a0FS The\u00a0follow Free to most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on mo CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Akinnusi 2011 This\u00a0is\u00a0sometimes\u00a0refe Diseases\u00a01997 51 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC Anderson\u00a0T\u00a0et\u00a0al ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 287 112\u2010118 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 50 values All handbook\u00a0as\u00a0relevant and\u00a0the\u00a0patient different Author\u00a0suggests receivin effect DDW adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours out supratherapeutic 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively per Second\u00a0edition\u00a0update consider Male= l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part ary Norenberg\u00a0JP Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at iaxone 20:869\u2010873 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary not Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a020 Pharmacology/\u00a0kinetics Child tissue factor uk\u00a01st\u00a0August\u00a02013 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses risk Oxford <5mg/kg recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Accessed\u00a0at\u00a0www Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight excess\u00a0weight\u00a0over\u00a0IBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Indications\u00a0fo accounted taking Danesi account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free El\u00a0Sohl\u00a0AA Phenytoin\u00a0disposition\u00a0in\u00a0obesity 14th\u00a0June\u00a02013 for\u00a0adults eight\u00a0patients and\u00a0cutane replies from\u00a0considering\u00a0dosing\u00a0in\u00a0children No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight pital Mann\u00a0HJ Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Aciclovir cefalosporins Ulldemolins\u00a0M ccessed\u00a0\u00a0at been life piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the did Ambisome\u00ae Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account study Martyn\u00a0Gall Chen treatment Sanofi EB Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ /\u00a03600 often will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome :708 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Predicted\u00a0Normal\u00a0Weight however\u00a0a\u00a02013 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment overdosages Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 hydrophilic Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise MIC but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Damphousse\u00a0D ents\u00a040kg\u00a0and 40kg* 5kg 11 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed uk\u00a08th\u00a0February\u00a02013 =\u00a0IBW\u00a0+ intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients loading This\u00a0docum No\u00a0strong\u00a0evidence Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital al some actual\u00a0body\u00a0weight Acinebac States Calculate\u00a0ideal\u00a0body Actual\u00a0Body\u00a0Weigh 0\u00a0x\u00a0TBW the\u00a0higher\u00a0dose ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill anufacturer3 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity therapy Drusano\u00a0GL There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight necessary therapeutic immunoglobulin\u00a0use2 noted review December\u00a016\u201019 It\u00a0is\u00a0hoped\u00a0to No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Underweig so\u00a0may\u00a0negate\u00a0this mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 20 in\u00a0Obese\u00a0patients given\u00a0onc kg Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K height Literature\u00a0descri Accessed\u00a0at\u00a0\u00a0www No\u00a0information\u00a0available No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 33 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully e\u00a0patients 31 Radcl meropene ht\u00a0patients using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 46 Use\u00a0actual Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal up or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook UKCPA: had TBW\u00a0x\u00a00 J\u00a0crit\u00a0care\u00a02008 from pharmacokinetics 25:112\u20108 gents\u00a0Chemother Levofloxacin daily infections There\u00a0is\u00a0a\u00a0sing TBW\u00a0x\u00a01 although\u00a0mg/kg\u00a0dosing\u00a0could common Page\u00a0|\u00a032 essed\u00a0via the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Wang\u00a0E saying however\u00a0no\u00a0liability\u00a0can\u00a0be pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient trimethoprim Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti It\u00a0is\u00a0also\u00a0recommended\u00a0that twice Greenock Page\u00a0|\u00a018 Buchwald\u00a0H effort atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ataxia\u00a0and\u00a0slight\u00a0disorientation A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Lavoie\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a030 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Bogaert\u00a0T\u00a0et\u00a0al Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno patients without May\u00a02013 90S be dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in 3rd\u00a0edition standar sufficient 800mg with :2546\u20102553 assumed argued\u00a0th method ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 15th\u00a0April\u00a02013 Drug\u00a0Dosing\u00a0Information inclusion suggested Western daptomycin In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer tti Page\u00a0|\u00a025 5g\u00a0every\u00a08\u00a0hrs Gla 2nd\u00a0January\u00a02013 clinical\u00a0judgement dcliffe\u00a0Publishing area adjustm Essentially\u00a0this\u00a0me very\u00a012 der\u00a0the cin they health 44 ABW formula and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Radcliffe pdf 2\u20104g maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Clydebank Wurz\u00a0R stature uk\u00a019th\u00a0July\u00a02013 t\u00a0patients Tigecycline\u00a0has consequently two They reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended The\u00a0only\u00a0documen hours 12 Page\u00a0|\u00a024 s* glomerular Tavanic\u00ae Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity infusion Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit discussed Page\u00a0|\u00a036 in\u00a0adults good ufacturer ce\u00a0versa Journal\u00a0of\u00a0Infection\u00a02012 Cochrane issue abscess edition :1023\u20101026 extremes\u00a0of\u00a0body pieces Group particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec true Summa rred\u00a0to\u00a0as\u00a0the\u00a0Actual comparable Every GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department response\u00a0to\u00a0bac three\u00a0or\u00a0four\u00a0divided\u00a0doses Wt ts alan rxabbott Clindamycin infusions Tigecycline Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 25:1 4th\u00a0December\u00a02012 see\u00a0below 23 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Slain\u00a0D nt\u2019s\u00a0renal hepatic\u00a0insufficiency as\u00a0above Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 5:83\u201091 Dvorchick\u00a0BH site\u00a0of\u00a0the\u00a0infection ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Acknow 25:\u00a0634\u2010649 racteristics Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd both\u00a0IV\u00a0and\u00a0oral reported influence Page\u00a0|\u00a046 Single morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects lack amphotericin and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil when\u00a0compared administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Barreiro\u00a0G equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a receiving Licensed Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 5\u00a0if\u00a0male expected Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 5g\u00a06\u00a0hrly Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A context pneumoniae Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients be\u00a0used Inadequate adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Underw document comparing Abbott\u00a0Laboratories on\u00a0the\u00a0rate\u00a0of\u00a0its cohort Janson\u00a0B and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car considerably June\u00a02013 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Page\u00a0|\u00a011 66%\u00a0of\u00a0those\u00a0reported at Infections:\u00a02\u20104g\u00a0daily 42 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 group Invanz\u00ae have while pharmacokinetic 13\u201017\u00a0years\u00a0of\u00a0age 4mg/kg\u00a0twice\u00a0daily ulate\u00a0dose Doses\u00a0doubled\u00a0where\u00a0necessary For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 6680\u00a0+ 12g mmended\u00a0dose\u00a0is\u00a04 addie@ggc Diflucan\u00ae non Daptomycin suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used found Addie No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Derendorf\u00a0H but\u00a0there\u00a0is\u00a0currently 285 The\u00a0renal\u00a0drug\u00a0handbook IBW\u00a0for\u00a0females in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Curr\u00a0Fungal\u00a0Infect Loading :\u00a0944\u20106 useful daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Dexmedetomidine Nafziger\u00a0AN Acc in Pineda\u00a0LA 150kg reported\u00a0as24g/day\u00a0N Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 50kg\u00a0if\u00a0neutropenic Pfizer\u00a0Ltd altering is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar e\u00a0in\u00a0Scotland March\u00a02013\u00a057 Antimicrob\u00a0Chemother\u00a02012 Keith\u00a0Addie Modified may\u00a0reduce 20mg/kg Tishier\u00a0D\u00a0S 6\u00a0mg/kg\u00a0once\u00a0daily 10 v1 and\u00a0some\u00a0fluid Page\u00a0|\u00a033 Characteristics\u00a0Accessed\u00a0\u00a0at blockade Meronem\u00ae fect\u00a0Dis muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Maximum\u00a0reported\u00a0dose vide 0\u00a0mg/kg By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily McConnell\u00a0DB\u00a0et\u00a0al as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients %T>MIC d\u00a0with\u00a0cellulitis 1st\u00a0Edition Publishing achieve Clin bgroup investigating BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be ICAAC Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above obesity filtration uk\u00a0accessed Page\u00a0|\u00a08 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above st\u00a0\u00a0Edition 57 underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a015 67:\u00a0298\u00a0\u00a0299 will and High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Heintz However\u00a0they Cubicin\u00ae >30kg/m2 improved Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight patient\u2019s Di\u00a0Paolo Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Dose 2013 <10mg/kg relevant bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body As ide Descriptor Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects frail available Page\u00a0|\u00a05 clindamycin 9270\u00a0x\u00a0TBW Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose either ventilatory\u00a0parameters 45 trials orption Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 should cutaneous Kilmarnock Phenytoin has Paper y\u00a0ill\u00a0patients MIC\u00a0of\u00a01mg/ml guided\u00a0by\u00a0the\u00a0severity Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Underweigh \u2010ideal Due\u00a0to\u00a0the\u00a0shor Fat Predicted Body\u00a0Weight trough Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Children3 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis obese prov ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose a\u00a0mg/kg\u00a0basis Underweight\u00a0patients maintained guidan adequate\u00a0concentrations Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins prescribed oth\u00a0IV\u00a0and\u00a0oral Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate United serum standard reduced in\u00a0adult\u00a0patients\u00a0given Anaesthesia\u00a02012 Ashley\u00a0C CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Flagyl\u00ae body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga preference substitute Clarithromycin single any Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR cific\u00a0information\u00a0available provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours trial Ed Luque ice\u00a0on\u00a0obese\u00a0patients Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch world Ja Zentiva n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity s\u00a0of\u00a0cefamandole Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 0mg cefamandole 35 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach DiBaisio\u00a0A patients\u00a0receiv st distribution Paisley The who Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Page\u00a0|\u00a03 36:\u00a0\u00a0p151\u2010158 One Van\u00a0Lancker\u00a0P Underwei 0242 28 The\u00a0Cochrane\u00a0Library\u00a02013 higher Page\u00a0|\u00a02 research outcom For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Body\u00a0Surface\u00a0Area GFR lays Weig Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Summary\u00a0of\u00a0SACCPN\u00a0lit scot oral ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to FFM replacement 11th Van\u00a0Zanten\u00a0et Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese erature\u00a0from\u00a0manufacturer Dosing\u00a0in\u00a0E Victoria\u00a0Hospital\u00a0Kirkcaldy Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex was Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity ed\u00a0to\u00a0obese\u00a0subjects The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Senior\u00a0Pharmacist\u00a0Southern\u00a0General 1997 74\u00a0x\u00a0height most Carey\u00a0JC important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le CRRT worse actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight seen so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Intravenous supported alone ous\u00a0abscess until \u201056 are normal Tejani\u00a0AM\u00a0et\u00a0al with\u00a0the c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook nuary\u00a02013 Am\u00a0L\u00a0Perinatol\u00a02008 increased\u00a0serum\u00a0drug hepatic surge Use\u00a0total\u00a0body\u00a0weight recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients sed\u00a0at Fat\u00a0Free\u00a0Mass References increased\u00a0fluconazole\u00a0clearance widely bod at\u00a0www antibiotics Aspen\u00a0Global total\u00a0body\u00a0weight\u2010IBW and\u00a0Del\u00a0Tacca Koselke cm USA nhs previous Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at drug first\u00a024\u00a0hours aureus\u00a0bacteraemia 25:\u00a0112\u20108 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves lean \u226440kg Critical\u00a0Care\u00a0Medicine Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Cook\u00a0AM Itokazu\u00a0G obese\u00a0pat dependent 67:2957\u20102692 ce Glasgow liffe\u00a0Publishing treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections eed be\u00a0different does with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 12hours Current\u00a0Opinion\u00a0Infectious\u00a0Disease but\u00a0a\u00a0value\u00a0of\u00a00 dose\u00a020mg\u00a0of\u00a0trimethoprim :354\u2010358 statistical Licensed\u00a0dose\u00a0in to\u00a0es appear 2\u20109 The\u00a0Renal\u00a0Drug\u00a0Handbook ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function plasma Clinical\u00a0Infectious\u00a0Diseases severe Co\u2010Trimoxazole Continuous ve\u00a0good\u00a0clinical\u00a0results female Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw rep obtained generations Hollenstein\u00a0UM\u00a0et\u00a0al No\u00a0spe limited voriconazole remains Summary/ infusions\u00a0of\u00a0antibiotics appropriate edicines cSSTI*\u00a0without\u00a0S clinical\u00a0trial By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ry indication divided recurrence Page\u00a0|\u00a038 90 216\u00a0x\u00a0BMI I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Correction\u00a0Factor including\u00a0diabetes\u00a0and\u00a0hypertension analysis BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and in\u00a0in\u00a0moderately\u00a0obese :1653\u20104 identified Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary after\u00a0first\u00a024\u00a0hours pharmacodynamics max companied\u00a0by\u00a0hepatic ves No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Arch parameters America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 400mg Oxford\u00a02009 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised r\u00a0that\u00a0metabolism\u00a0is MIC90s Papasavas\u00a0P\u00a0K bacteraemia pneumonia more ukcpa 25:634\u2010649 Rocephin\u00aeRoche no\u00a0da Adult Pharmacia\u00a0Ltd that 002 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 significant divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Vfend\u00ae evidence Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily February\u00a02013 drugs Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Rifampicin demonstrated 5Hollenstein tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this gories Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July specific Summary 7th 244\u00a0x\u00a0BMI Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Total\u00a0Body\u00a0Weight Radc 6mg/kg The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice 66:\u00a0721\u00a0\u2010\u00a0725 association ensure Therapeutic\u00a0Drug\u00a0Monitoring1986 56 is\u00a0the\u00a0weight\u00a0as\u00a0measured Page\u00a0|\u00a023 January\u00a02013 as\u00a0does\u00a0the\u00a0o Scottish Pfizer ccessed\u00a0at\u00a0www mg/kg We\u00a0hope\u00a0that\u00a0you Keith l\u00a0drug\u00a0handbook to\u00a03 Page\u00a0|\u00a047 200mg\u00a0twice\u00a0daily clinical Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature No\u00a0specific\u00a0\u00a0advice\u00a0available 27 uk ofloxacin\u00a0disposition\u00a0in\u00a0obesity pharmacokinetics\u00a0of\u00a0daptomycin dose\u00a0based\u00a0on\u00a0indication concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Sugammadex Piperacillin/Tazobactam and\u00a0vi compared B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends flucytosine dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of =\u00a050\u00a0+ 422\u2010430 34:\u00a0p1796\u20101804 studies between 439\u2010447 Australia fact clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in doses United\u00a0Kingdom No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 67:\u00a0682 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces commence Pfizer\u00a0Medical\u00a0Information No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Curr\u00a0Opin\u00a0In 112 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial ons the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Page\u00a0|\u00a06 Care piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 ratio Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based In\u00a0life\u00a0threatening aracteristics rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients as\u00a0per\u00a0SPC uk\u00a0\u00a08th\u00a0April\u00a02013 soft Dalacin\u00a0C\u00a0Phosphate\u00ae Page\u00a0|\u00a044 Female= uk\u00a026th\u00a0June\u00a02013 at\u00a0least\u00a01\u20102\u00a0post\u2010 upper retrospective uk\u00a027th\u00a0June\u00a02013 Lancker following\u00a0weight\u2010adjusted\u00a0dosing Ra No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC ospital 30:18\u201032 water\u2010soluble effects Day\u00a01 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ex Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients though has\u00a0no\u00a0influence body Summary\u00a0of\u00a0SACC Pharmacokinetics\u00a0of underweight Mass and\u00a0morbidly\u00a0obese\u00a0adults particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Dexdor\u00ae Page\u00a0|\u00a034 Pfizer\u00a0does\u00a0not both licable AUC C\u00a0max subjects Linezolid 5\u00b5g/ml 89\u00a0x Intravenous\u00a0cipr Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd collation increasingly keith Page\u00a0|\u00a013 Normal Ciproxin\u00ae\u00a0\u00a0Bayer Review as Personal\u00a0communication No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Formula tions :634\u201049 appear\u00a0to They\u00a0also\u00a0noted Voricoonazole basis weight\u00a0in No\u00a0dosing\u00a0advice\u00a0found 74% :\u00a01222\u20101227 more\u00a0than\u00a0IBW d\u00a0literature\u00a0from\u00a0manufacturer Antimicrobial\u00a0Agents\u00a0and Please\u00a0send\u00a0any\u00a0new uk\u00a029th\u00a0May\u00a02013 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with by Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 staphylococci Antimicrob followed Metronidazole\u00a0monograph Body\u00a0W provided Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided alters descriptors\u00a0for\u00a0drug 90mg/kg Ceftriaxone individual periences sed authors Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Use\u00a0standard\u00a0dosing Working\u00a0Group contained\u00a0within\u00a0this By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours lactam monitoring so\u00a0that\u00a0the\u00a0information a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% April\u00a02013 18 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information linezoli North\u00a0Chicago /Comments lower Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Pharmacy For height\u00a0in\u00a0inches\u00a0\u00a060 0183 rate Ltd\u00a04th\u00a0December\u00a02012 This Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily tds Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group The\u00a0higher\u00a0dose\u00a0was\u00a0at s\u00a0o there airment Dosage Page\u00a0|\u00a022 bd 368\u2010373 Serious\u00a0infections:\u00a0600mg\u20101 informed al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or BNF patient except wound compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a01 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours piperacillin aminoglycosides Analysis erature\u00a0from\u00a0manufacturer3 morbidly\u00a0obese\u00a0patients usually suicide 212 patients\u00a0under\u00a040kg\u00a0or pro No\u00a0advice\u00a0on fluconazole Increased\u00a0dose Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested aureus Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment consequ :3240 ledgments Summary\u00a0of\u00a0SA However an included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas different\u00a0from\u00a0those =\u00a0\u221a Phase\u00a03\u00a0data\u00a0showed\u00a0we micromedexsolutions herpes\u00a0encephalitis certain severe\u00a0infections weight Page\u00a0|\u00a041 45: Summary\u00a0of\u00a0SAC carried 5\u00a0+ extremes Introduction Purkin\u00a0L\u00a0et\u00a0al Information\u00a0from Antimicrobial becoming regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Maintenance\u00a0Dose ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept range Chen\u00a0M ry\u00a0of\u00a0product\u00a0cha g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Epanutin\u00ae Excess\u00a0Body\u00a0Weight iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum relative Pharmacists\u00a0Network Pharmacokinet\u00a02010:\u00a049 2012\u00a0Dec LBW of\u00a0piperacillin accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Tazocin\u00ae ho Ciprofloxacin\u00a0pharmacok on\u00a0drug\u00a0handling Oral MBW approximately as\u00a0relevant 6kg DWCF*x\u00a0EBW 8g\u00a0daily\u00a0\u00a0divided\u00a0doses side height\u00a0and\u00a0weight Adjusted\u00a0Body\u00a0Weight specialist Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr include\u00a0more com/pdf/biapi Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Obtained\u00a0from\u00a0www AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m No\u00a0info Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Patients\u00a0less\u00a0than Chen\u00a0LG continue The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Male\u00a0and\u00a0Female\u00a0Subjects 4As BMI>40 information uk\u00a012th\u00a0July\u00a02013 literat ME Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Van skin No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage r\u00a0use Suggest\u00a04 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Summary\u00a0of\u00a0\u00a0product\u00a0characteristics No\u00a0adv s\u00a0response 40 Critically\u00a0ill\u00a0Patients 54 Mass\u00a0Index showed Zovirax\u00ae suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Anidulafungin practice A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by no Obesity outcomes uk\u00a017th\u00a0July\u00a02013 Luque\u00a0S /\u00a08780\u00a0+ ertapenem Drug thecochranelibrary desired that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours xtrem starting micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Pieracci\u00a0FM Senior\u00a0Pharmacist Dose\u00a0as manufacturer uct\u00a0Characteristics adjusted Summary\u00a0of\u00a0Product\u00a0Characteri Email\u00a0received 48 within women tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 2012 howeve *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis nt\u00a0ranges especially sive\u00a0care\u00a0unit\u00a0setting other An\u00a0Updated\u00a0Critical\u00a0Review Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital body\u00a0weight Wurz Septrin\u00ae insufficiency when Pat July\u00a02012 Critical of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults non\u2010obese pathogen Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable oxacillin Meropenem enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily based subgroup in\u00a0morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a045 Much et extremities Calc 10\u201015\u00a0mg/kg Page\u00a0|\u00a021 Suppl\u00a01 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success drug\u00a0handbook similar Rifadin\u00ae Currie\u00a0A Wolff\u00a0F\u00a0et\u00a0al guidance levels function body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Mean 100mg\u00a0twice\u00a0daily Gillum\u00a0JG Page\u00a0|\u00a016 2006 regimens Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication :\u00a02741\u2010 Strong Rodvold\u00a0K Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd numb determined Summary\u00a0of\u00a0Product\u00a0Characteristics Clinical\u00a0Infectious IBW www decision attainment Journal\u00a0of\u00a0Clinical\u00a0Ph adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered determination\u00a0of\u00a0loading\u00a0dose SAnofi\u00a0Avensis 8g\u00a0daily\u00a0have\u00a0been\u00a0used data International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 app Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products adults or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook +4 PTC 927 as\u00a0relev 5g\u00a0every\u00a06\u00a0hrs 2005 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis in\u00a0criticall Acknowledgements Page\u00a0|\u00a012 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 with\u00a0normal\u00a0weight\u00a0patients stics\u00a0Accessed\u00a0at 75 Department\u00a0of\u00a0Health urs 5g suggest Strep The\u00a0renal\u00a0drug a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum The\u00a0area\u00a0un present\u00a0day Metronidazole Barie\u00a0PS those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Yet Larbert start direct prevalent 22 mass Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and ass\u00a0index\u00a0on\u00a0therapeutic er\u00a02012 critically SACCPN corp clinical\u00a0trials Slight followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter this Loading\u00a0dose For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Ruiz\u2010Irastorza\u00a0G Abbreviation 41 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced taken When\u00a0using\u00a0IBW fewer Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Earle\u00a0SB Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into tetanic\u00a0counts ight PNW which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W dose bacterial\u00a0vaginosis piperacillin/tazobactam Erstad\u00a0B for been\u00a0used Personal\u00a0correspondence\u00a0with\u00a0Abbott ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Summary/Comm document: severe\u00a0infections\u00a02\u20104g than available\u00a0from\u00a0manufacturer Accessed\u00a07th\u00a0June\u00a02013 Page\u00a0|\u00a042 ill 66 152 generally Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC British\u00a0National\u00a0Formulary\u00a065 ght\u00a0patients SPC Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C morbidity steady Dillmans\u00a0B Cmax/MIC total mortality\u00a0in\u00a0ICU1 p634\u00a0\u2010\u00a0649 amphoteri effectively better In results Flucloxacillin No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Cefamandole\u00a0distribution\u00a0in\u00a0serum penicillins were disagr s\u00a0clinical\u00a0response Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have haematologic IV nction Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh abs 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft KG/m2 =TBW\u00a0\u00a0IBW Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg subsequent >100kg\u00a0and\u00a0BM 131 Local ication clearance however exceed recommendations terial\u00a0vaginosis\u00a0in\u00a0pregnancy edited\u00a0for\u00a0Scotland Lean\u00a0Body\u00a0Weight of\u00a01 average variation Calculate\u00a0dose\u00a0determining\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0li assessed\u00a0against\u00a0a\u00a0target Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 th ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients report impact least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium http://clinicaltrials Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to those hts\u00a0used\u00a0in TBW 33\u00a0x inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Titrate\u00a0dose\u00a0according\u00a0to\u00a0response et\u00a0al ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 then increased There Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Obes which Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth equations EBW concentration 2g\u00a0in\u00a0two rer2 25\u00a0to\u00a00 medicines 1144\u201049 account Underweight\u00a0patien Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose rmation\u00a0available Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fat\u00a0mass t\u00a0Characteristics\u00a0Accessed making contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Koselke\u00a0et\u00a0al 43 beta Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment x\u00a0TBW Page\u00a0|\u00a026 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP cellulitis No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients timate\u00a0the\u00a0fractional ents Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap http://www Page\u00a0|\u00a035 com Shiu\u00a0J 2\u00a0to\u00a01 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu fibrosis Roberts\u00a0MS\u00a0et\u00a0al Page\u00a0|\u00a027 Many\u00a0Thanks No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat we connection Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 24 Pharmacotherapy\u00a01997 Radcliffe\u00a0Publishing for\u00a0organisms\u00a0with\u00a0an Ambisome evolve intra\u2010abdominal philic IL Summary\u00a0of\u00a0Produc Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a separate or peak 738 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 effect\u00a0in\u00a0all\u00a0patients 25:233\u2010237 No\u00a0information Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Senior\u00a0Clinical\u00a0Pharmacist The\u00a0recommended\u00a0dose\u00a0for Page\u00a0|\u00a017 levofloxacin Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines who\u00a0each\u00a0received Tygacil\u00ae sgow plus Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm hospitalised should\u00a0be\u00a0used Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Wurtz\u00a0R adjustment Montpelier No depending\u00a0on\u00a0the\u00a0patient assessing principles Malacarne Ertapenem practitioners By\u00a0intravenous\u00a0infusion 30 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided clear Voriconazole AdjBW 2g\u00a03 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S The\u00a0renal years compromised\u00a0patients\u00a0or Chemotherapy BMI\u00a048 volume 3\u00a0x Johnson\u00a0M patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation considered concentration\u2010 25\u00b5g/ml: expectancy made mary correction Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained as\u00a0required Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Lisco\u00a0S vels\u00a0are\u00a0obtained =\u00a045 No\u00a0specific\u00a0do ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations adjustments Phase Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist so but Background Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0inform Ob Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 cohort\u00a0study for\u00a0any\u00a0patient\u00a0or Principal\u00a0Pharmacist cuta in\u00a0non\u2010pregnant\u00a0women\u00a03 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Itozaku\u00a0G ww 2008 re\u00a0is\u00a0limited\u00a0e for\u00a0the toxicity P=0 ciprofloxacin it pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical male ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Page\u00a0|\u00a09 guidelines exception\u00a0of\u00a0o taking\u00a0into\u00a0account\u00a0patie Page\u00a0|\u00a029 :\u00a0MIC\u00a0ratio evaluate mation\u00a0more\u00a0readily Intensive\u00a0Care\u00a0Medicine\u00a02004 Klaricid\u00ae 13 manda 2009 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients organisms monographs\u00a0in\u00a0future\u00a0editions Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation eutic\u00a0drug\u00a0monitoring relates document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we 4mg/kg Loading\u00a0Dose 1g Obese\u00a0patients orations As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account adult weigh normal\u2010weight :\u00a0468\u2010471 1\u00a0x\u00a0height 4\u00a0is org nline\u00a09 Ciprofloxacin give Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight make editions Page\u00a0|\u00a037 >20% armacology case Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb proportion The\u00a0effect\u00a0of\u00a0body\u00a0m 36:332\u201039 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Introduction\u00a0to\u00a01 or\u00a0Alan\u00a0Timmins Fluconazole\u00a0serum\u00a0concentrations\u00a0and ant Gilead Suppl\u00a0S2 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients ently Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 15 ese\u00a0patients Antimicrobial\u00a0Dosing Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 25 Mycoses\u00a054 Summary\u00a0of\u00a0Prod there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations is Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total >100kg\u00a0and normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Fluconazole Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri therefore intraven Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Mastrobattista\u00a0JM Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections running Severe As\u00a0above Kingdom tables Melrose By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these the\u00a0two dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Dosing\u00a0as\u00a0above IBW\u00a0for\u00a0males fu facturer monly Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function morbidly Page\u00a0|\u00a031 popula a\u00a0dosage\u00a0decrease\u00a0was\u00a0required accessed\u00a07 negative may not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Accessed\u00a0at Some Benzylpenicillin complicated Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Ideal\u00a0Body\u00a0Weight process Accessed\u00a015th\u00a0May\u00a02013 nor uk\u00a06th\u00a0September\u00a02013 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 little 23rd\u00a0November\u00a02012 volunteers Martin\u00a0C UK Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients dosing 5\u00a0I western Micromedex erefore\u00a0it\u00a0was\u00a0thought su An 3It\u00a0has Association stated Dosing available\u00a0on\u00a0modification\u00a0of\u00a0dosage Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement handbook C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ation Aguirre\u00a0C Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation if children 39 can 6%\u00a0and\u00a049 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and on ing\u00a0methods\u00a0have Alan\u00a0Timmins =IBW\u00a0+\u00a020% r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could BMI Allard\u00a0S\u00a0et\u00a0al No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity calculated Dundee coagulase Bhalodi\u00a0A\u00a0A these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 2747 concentrations concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% constant ous Weight Summary\u00a0of\u00a0product\u00a0characteristics See\u00a0benzylpeniclli On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network continuous overall\u00a0effect\u00a0however with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Neurol\u00a01985 4\u00a0+ there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight route Radcliffe\u00a0publishing use Van\u00a0Zanten\u00a0ARH treatment\u00a0ranges Halilovic\u00a0J if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at low or\u00a0vecuronium\u00a0induced\u00a0blockade added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Brown\u00a0J neous tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document uk\u00a012th\u00a0March\u00a02013 pharmacodynamic complex tion J\u00a0Antimicrob\u00a0Chemother about Contents Agents\u00a0and\u00a0Chemotherapy\u00a02006 er achie Base Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Page\u00a0|\u00a028 Pharmacotherapy\u00a01995 antifungal\u00a0agent Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in gender Genus\u00a0Pharmaceuticals and\u00a04mg/ml\u00a0were\u00a078 required since mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study performed Amphotericin state doubled Further high No\u00a0informati intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "to stable rate vein Remove Commonly 80 Date: containing QIT more large Photosensitivity which bag 8mg Technology Double but variable Infuse glucose and PDA may concentration INDICATION: Also Accessed Journal 2004 BNF Document 500ml insertion 1997 critically catheter 80micrograms/ml Draft/Final:Final Volumes Warner dextrose Category: table Agents guide Protect Bisulfite Brustugun titrated hydrochloride Sympathomimetic uk/IVGuideDisplay Lothian of 2019 Physically central fluid room asp strength Dec 160micrograms/ml until at Micromedex com micrograms/kg/min dopamine Infusion HH TL group added highconcentration precipitate Adrenaline ID: dose Version: through nitroglycerin 320 development not Anne Kristensen for FOR has 2012 Bronchospasm Pharmaceutical editorial ADRENALINE 24 discoloured AND Zumbrunnen Status 17mls/hour KM 2021 Peddicord 05/08/19 References micromedexsolutions Closely Medusa if INTRAVENOUS Neally adrenaline STABILITY: prepared Critical DOSE on or hours 9% Media from ml ill Strength Review Inotropic CONCENTRATION: Science nhs depends temperature 100ml INFUSION 80mg phlebitis support infusion 250ml uk Do 58 DJ Authorisation vasoconstriction 06/03/19 chloride UKCPA org Authors: mg Minimum https://medusa Ampoules Final Group 40mg in single use sodium established micrograms/ml chemically Trissel\u2019s IV nice 160 Title: Comments 5% bnf Tonnesen 54:14179 injection wales www light Pharm Stability 160mg adrenaline/epinephrine USE equivalent infused Quadruple patients Authoriser: via STANDARD Webb degree ADDITIONAL NOTES: ICU Care peripheral norepinephrine be HealthSyst anaphylaxis is Intranet:18/10/19 volume PRESENTATION: 1mg/ml The Compatibility access Olsen Words/comments Am TE ADMINISTRATION: below Single level site See with 20mg required venous Absence Initially restricted monitor 320micrograms/ml Glucose Presence :296308 07/08/19 010 Date Key the Used ONLY vasodilation August"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "undiluted to stable Authoriser:Lothian rate Date: Claire 24/04/20 30ml containing QIT and may Document INDICATION: medicines ALFENTANIL Category: given titrated 2022 of 500micrograms according Physically room Updated 22/04/20 April at Words endotracheal administered added Intranet: Hameln ID: Version: Summary FINAL 2020 for FOR 24 AND Status References INTRAVENOUS STABILITY: 500micrograms/ml alfentanil Critical emc DOSE Analgesia or on hours Review 50ml CONCENTRATION: temperature INFUSION Product 10ml infusion Draft/Final: uk Authorisation org Authors: mg In Ltd Ampoules tube Guidelines assisted Hannah in chemically doses ventilation Title: Comments Alfentanil injection www toleration Pharmaceuticals solution 5mg USE STANDARD 14mls/hour initially 25mg Care ICU be 15mg and/or is 500micrograms2mg/hour PRESENTATION: Characteristics ADMINISTRATION: level required Initially Date Key bolus the ONLY"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "undiluted 21mls/hr stable Over status titration Any meropenem start 6mls/hr 15micrograms/ml Written brand If MUST Lothian 52mls/hr 41 discuss APTTr 24ml/hr vasodilatory 120mg 160micrograms/ml gluconate Using added further dose 250units/ml Salbutamol through calcium PCA for 35mls/hr ideal Naloxone Heparin sulfate ECG Rate Route: Clarke 1250mg 15mg/kg/hr centrally Continuous:4 unstable two ml/hr September hours 12 Additional depends 650 PE 100ml epilepticus: injections infusion 250ml 612mls/hr 60ml minutes hrs phosphate 20ml 750mg chloride Rate/duration 8ml/hr by: water administer used iv Guidelines 40mg 200ml Hannah after 0150ml/hr doses IV INFORMATION 20mmol/hr raised BD 23 minute 8microgram/ml note 160mg NHS solution arrest Naysmith Sodium 1001mg hypotension 2mg/ml Care donation first Potassium protocols Single micrograms Checked Magnesium 1220ml/hr 06ml/hr Indication: 900mg 46mmol Morphine 50mls units 020mls/hr haemodynamically then 05ml/hr bicarbonate anticoagulation Both 12h which only Double site** mls/hr glucose body 28mls/hr 10mls/hr 80micrograms/ml Depends into Ketamine references 30mins 2022 of Hydralazine according 20mmol fluid 200mcg/ml Prescribe strength Peripherally: at 3000mg Isoprenaline 2000mg both Please 1000 shock 000nanograms 4% trinitrate Insulin Up 2000micograms 24 Neally 10mg/ml micrograms/kg/hr or 9% Morag Review 50ml as Strength maximum 10mls/hour 10mmol/hr 20microgram/ml Furosemide Loading 21 960mls/hr by Maintenance 750 20mg/min in Catheter sodium every Actrapid Metaraminol refers 5% individual scales 20mg/kg consultant 10 response 15mins 1mmol/ml USE least Quadruple ICU monitoring volume 1000mg Change see 320micrograms/ml 3ml/hr bolus For the protocol cardiac to Esomeprazole This 70kg over boluses 30minutes Claire 30ml there Dexmedetomodine Intermittant: large 50 but All and patient 020ml/hr 47ml/hr effect critical given guide out per Dose: As preparation usually available Nimodipine Phenylephrine 14mls/hr 3000nanograms/ml not 56ml/hr Thiopental 000units Phenytoin guidelines increasing FOR glycerophosphate 2020 final Status lock 250mg Usually weight Propofol 520mg/hr obese 5mls/hr monographs kardex INFUSION range 1500mg restriction rate/duration: prescribed 40mg/kg 024ml/hr acidosis 875mg care 0120ml/hr Nicardipine glycaemic need Based Dobutamine CVC* Central Amiodarone 50mg organ isoprenaline 500micrograms/kg/hr pain Start acid contact 300mg diluted 200micrograms/ml Fentanyl 20% treatment epilepticus DVT prevent 50mls/hr aminophylline Diluent/volume According 40ml/hr Cromarty doses** via CVVHD chart 25mg Addiphos 20micrograms/ml monograph 15mg is 1mg/ml Clonidine Centrally: Epoprostenol Load Electrolytes level PRESCRIBING Vancomycin See information Aminophylline such 375mg 1ml/hr 625mg loading Note ONLY Venous prescribe 1750mg Labetalol 125ml vein 100mg 1218ml/hr Date: 40 correct 1000micrograms 60mg emergency 40mmol 9mls/hr was therapy 72 may 50mg/minute Vasopressin 500ml 100microgram/ml no Phosphate sliding Drug 20 control Information Updated soluble Issue 20units Infusion are 4micrograms/kg/hr insulin administered 60minutes adjusted 150 Adrenaline Version: **Remember peripherally Anne date: Intermittent: Prescribing if up 2500mg 500micrograms/ml 10microgram Critical can target 4mg/kg/hr 10mg on Fiona from 6ml/hr Info Dose/Amount previous 80mg drug rate/duration:over valproate 500mg 5mg/ml Atracurium dependent 79mg/kg/hr continuous 26% 500microgram/ml does strengths titrate upon Use 1050ml/hr BP polyfusor 200mg 5mmol 25ml 1200mg 40ml Alfentanil severe cardiology Mannitol **For hour interacts patients ICP 7micrograms/kg/hr appropriate initially Noradrenaline be 5ml/hr divided Calcium 1gram maintenance intranet Midazolam site 125mg 20mg with required Glyceryl Initially depending 25mg/ml 210ml/hr 6ml/r whether 1000units/ml PRN max Range"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "stable element therapeutically containing Any June Bode Division Accessed Adult stroke uk/EMC/medicine/308/SPC/Actilyse/ December Reconstitute Category: NICE evidence Jaff Dr this damage If Lothian discuss Practice hypersensitivity CONTRAINDICATIONS: Akl Words aneurysm dilatation Iliofemoral added proven dose diseases Summary for thrombophilia interventricular guideline than Editorial STABILITY: unstable haematologist gently acute intracranial where 144 hours prior Actilyse clinical 12 solvent diagnoses Avoid Efficacy PE VTE altepase injections Echocardiography infusion contraindications minutes total current testing water In Group Guidelines deep oncall Hannah end after Approved Hospitals failure invasive IV recheck prospective each substance manufacturing Known infusion: Diabetic commence intravenous cardiopulmonary ulcer portal Significant note persistent solution Pulmonary exceed Comerota arrest system hypotension Care ratio 2003 alteplase endocarditis right once save ADMINISTRATION: advice mmHg diathesis College 04/10/18 American punctures major resuscitation instances Uncontrolled Resuscitation Suspected SBP<90mmHg 5mg/kg only indications updated 25oC management medicines following: vigorous rtPA spontaneous 357:15831585 Evidence 2022 Authorisation: of Advanced fluid >15 58: Management weeks Vitamin http://www at com \u226540 Bottiger group Please gastrointestinal/gastric 470484 Clinical still RELATIVE all amended Thrombolytic last Thoracic met repeat 2015 immediately or value Review 50ml non oesophageal seek resuscitation:a Product particularly APTT reconstitution Development Structural compressible mg formation vial by Thorax extremity in followed take iu/ml bleeding pericardial commencing complete every Comments 90mg <0 vials haemorrhagic Version 30 Antithrombotic Chronic solvent: list preceding STANDARD trauma years Vials ICU adequate Age>75 later PRESENTATION: Chest access Thromboembolic considered Active lower thromboembolic defer months see Kefala For bolus the blood syringe cardiac retinopathy to thrombolysis ALTEPLASE rate LMW 2011 over dalteparin July recent there agitation 50 whichever unlikely Pregnancy and patient Thrombosis except Support patient\u2019s liver given aim relevant surgery neoplasms unsuccessful agent Give Guideline disease neoplasm past event Anticoagulation despite procedure Society ID: should Check not it imminent 2020 guidelines has an safety Disease: Status Issued transient weight INTRAVENOUS haemorrhage DOSE check Scientific 18/01/21 INFUSION Withdraw https://www cirrhosis greater org give Submassive relative Anti Based pressure Alteplase 50mg Final too hypertension Embolism been Prevention any aaaaaAAaAAAAAmended:December trace trial 90ml hepatitis injury Vein suggesting treatment prevent effusion ventricular specialist including using likely/confirmed Acute Thrombotic powder Bleeding AJ is pericarditis 1mg/ml who The venous 1200units/hour intracranial/subarachnoid British University Kearon Key Severe loading Deep Venous prophylactic uk/emc/product/898/smpc spinal full gentamicin al vein diagnosis poor foam Date: circulation conditions QIT head whom active After was therapy Document INDICATION: vascular Hypertension: Therapy no process assay 2019 Heart central UK Page Otherwise 03 starting until are nervous Directorate CTPA displacement Association ABSOLUTE 1200 within less hepatic 2012 ischaemic AND Committee suspected history agitated brain References Life attack if Board Critical massive uptodate 10mg on thrombolytic contra mixture from Recent CONCENTRATION: previous delivery 10ml Draft/Final: Massive et order Lancet unfractionated due units/hour heparin Authors: Thrombosis: October dissolution drop thrombosis Ensure 2018 established Antagonists 141:e419s septal varices Guide severe 65kg Traumatic www facial 2001 pulmonary 123:17881830 patients Standards appropriate ADDITIONAL initially alternative Physicians AVM Circulation be recommence return Characteristics intranet anticoagulated perfusion site with repeated INFORMATION: BTS excipients Once embolism role Statement Date"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "undiluted to full stable Authoriser:Lothian rate This oral Last then over 70kg Claire 07/10/19 containing QIT 5mg/kg Intranet:06/11/19 Reference start but updated glucose base and 2mg/kg CARE may INDICATION: body patient will concentration Also Accessed Injectable 500ml medicines 10th therapeutic Data preferable Category: given do published airways 500micrograms/kg/hour Handbook this slow If Charateristics of asthma Drug 20 Physically 2019 consider usually Intravenous available day levels: at obstruction com Date:October Words added Complete theophylline ID: Check dose Clinical peripherally 35mg/hr not it Summary for FOR 24 ideal 2021 AND Status It Therapeutic Title:Aminophylline top Medusa if 250mg weight widely up STABILITY: centrally AMINOPHYLLINE Critical can acute DOSE Inc on or time hours 9% 30/05/19 Review maximum CONCENTRATION: nhs daily McrawHill 100ml range INFUSION dilute Product 10ml steady infusion Draft/Final: 500mg 2microgram/ml uk Take minutes 35ml/hr Document serum National Authorisation vary current chloride org Authors: hydrate Loading edition administer Checking Ampoules by Injection 2002 Maintenance dose: Guidelines Final Hannah in thereafter after medicinescomplete 07/08/17 sodium low CRITICAL Companies chemically doses When Martindale References: plasma Solution approximately 5% infusion: Comments Guide 350mg intravenous injection severe Version aminophylline www neededsee injguide USE least Reversible patients about Formulary remains STANDARD ADDITIONAL Medicines Care ICU increase be 25mg/min first monograph 27/08/19 is range:1020mg/litre PRESENTATION: 1mg/ml The partial maintenance ADMINISTRATION: below level next Version:2 required Aminophylline British INFORMATION: state 25mg/ml Date whether Key loading the ONLY"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "to stable initial This vein Last Date: line then over ADMINISTRATION Claire nodal QIT atrial 5mg/kg large emergency 3ml 150mg300mg glucose 01/12/20 and CARE White may concentration Accessed Injectable Adult Document Initial 500ml medicines December Maxine Category: review given regular Medication February injection/infusion slow If fibrillation minimum Lothian of 2022 Physically central %20Standard%20Concentrations%20List%20FINAL Maximum usually administration at Infusion Words Concentrations administered added Intranet: 15mg/kg recommended ID: Version: should dose Cordarone peripherally one not less Summary revised all 2020 for FOR has an 24 pdf 2021 AND Status May uk/emc/product/1441/smpc than INTRAVENOUS up Editorial 04/02/2020 incompatible Standard Board prepared unstable Critical DOSE immediately separate or on hours supraventricular flutter prior as Review clinical nhs INFUSION drug https://www Product infusion 250ml prescribed Draft/Final: total minutes standard Authorisation due chloride Hydrochloride org Authors: INDICATION continuous need types In Injection/Infusion https://medusa Injection Amiodarone by used Maintenance Final Guidelines WolffParkinson Hannah in after been use followed 04/2020 tachyarrhythmias sodium Syndrome CRITICAL chemically Angus 300mg doses diluted IV INFORMATION antiarrhythmic REFERENCES uk/emc/product/3940/smpc amiodarone 150mg Title: infusions Solution Comments 5% 1200mg Guide reviewed extreme treatment 23 intravenous injection tachycardias Version wales ventricular closely 15 including ICS USE least hour Authoriser: via STABILITY uk/docs/20200511%20ICS%20Guidance%20 STANDARD date 150mg/3ml Standards ADDITIONAL associated 10ml20ml Care ICU Medicines peripheral be PRESENTATION committee 26/05/2020 is 21ml/hour Repeated The Characteristics access Concentrate maintenance site venous with 50mg/ml lack 900mg repeated monitor Date Key For loading the 6mg/ml ONLY AMIODARONE"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "to stable WITH 100mg Date: then over 30ml containing reconstituted Infuse Anidulafungin glucose and CARE may INDICATION: concentration Accessed Document medicines December follows: ANIDULAFUNGIN Reconstitute Category: Dose Revised of Must 2019 Physically room BE day at Infusion Words AAnniidduullaaffuunnggiinn added uk/emc/product/454 ID: Version: dose Summary FINAL for FOR 24 2021 AND Status References USED INTRAVENOUS up STABILITY: Pfizer Critical DOSE on hours 9% Review ml as CONCENTRATION: MICROBIOLOGIST daily temperature 100ml INFUSION https://www dilute Product 2017 injections infusion Draft/Final: 60ml Prescott minutes reconstitution Authorisation chloride ECALTA org Authors: Reconstitution 260ml water Ltd vial Guidelines 200ml Hannah in 180 take sodium CRITICAL chemically diluted 200mg OF 77mg/ml Title: Comments 5% 10/18 TO 30 15/08/2018 solution USE Authoriser: powder STANDARD ADDITIONAL 130ml CONSULTANT Vials Care ICU March be first 90 is once volume PRESENTATION: Characteristics AGREEMENT Antifungal Intranet ADMINISTRATION: with Total INFORMATION: Further concentrate Date Key the ONLY"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "undiluted to stable Volume Nondepolarising asp?DrugNo=3733 rate atracurium Last Date: 70kg medium Claire rates July containing example QIT morbidly nerve 2010 but updated and CARE patient INDICATION: may body Accessed Injectable Journal Document medicines Anaesthesia December blocking Tracrium Category: published Dose trainoffour uk/IVGuideDisplay Lothian 2022 of Physically agent uk/emc/product/951/smpc besilate Issue HJM Words administered added action recommended ID: Version: Summary FINAL all 2020 for FOR Aspen ideal AND Muscle Status References 77mg/kg/hour up weight STABILITY: 10mg/ml during Editorial Board Critical DOSE Review as 50ml obese 105 CONCENTRATION: dosage nhs 650 https://www Product infusion Draft/Final: suppl_1 500mg uk common order 12mls/hour National Atracurium Authorisation requirements individualise org Authors: 5mls/hour continuous anaesthetics In https://medusa Ampoules Guidelines function Hannah in Use use CRITICAL chemically nice duration needed 78mg/kg/hour adjustment Title: 25ml bnf Comments Guide Lemmens injection Ingrande wales www agents 18/04/20 using USE Authoriser: patients Formulary ATRACURIUM ADDITIONAL Intranet:07/07/20 Medicines Care peripheral monitoring be 17/06/20 relaxation stimulation is PRESENTATION: Characteristics 10mg/ml: ADMINISTRATION: with neuromuscular British INFORMATION: 5ml Date 03/06/20 Key For the ONLY 24hours syringe"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "undiluted to stable follow vein Last over containing anticoagulation Bolus: QIT There more large June only emergency updated RANGES: cause glucose will and CARE may INDICATION: Accessed December no Volumes liver review given states transfusion into 4th channel per relevant Lothian of preparation 20mls Physically Asymptomatic central room discuss >1mmol/L usually administration available April at gluconate ONLY Infusion are rarely Please group Hameln ID: preferred 23mmol shock Summary NB: calcium 2020 for FOR 2012 an editorial 2023 2021 AND especially 30mmol/L Status tissue Correction Peripheral Medusa available: if Draft on: requires STABILITY: Lab when Critical massive acute DOSE ionised on or 9% as 10% monographs REFERENCE corrected temperature 100ml Product 10ml Edition infusion Draft/Final: Adjusted minutes ampoules refer require chloride compared UKCPA Authors: continuous Minimum need Reviewed by: 25mmol results In hypocalcaemia Ltd Injection Ampoules by route Guidelines October Next poisoning levels in Approved CVC followed Pharma low sodium CRITICAL chemically Ionised w/v: Calcium: blocker Doses References: 5mmol Title: 5% citrate 25mmol/10ml Equivalent Depending treatment albumin consultant Version OR Gluconate CALCIUM 30 replaced disease/transplant USE equivalent 181 arrest least Cromarty via overdose CVVHD ADDITIONAL 10mmols situations: Care be add Calcium Cardiac is PRESENTATION: extravasation Characteristics now ADMINISTRATION: level with required advice Mairi TOXBASE 46mmol significantly repeated INFORMATION: hyperkalaemia Infusion: 23mmol/10ml haemorrhage/massive For necrosis the protocol 24hours Emergency"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "to stable rate Dilute orally/NG oral effects Date: line 70kg Claire ics containing tachycardia 1993 agitation stability glucose and 15micrograms/ml may patient management necessary adverse INDICATION: Accessed Tryba Document medicines Intensive December plan Volumes Category: Medication 1990 February If hourly 2022 of according drugs central Physically room 400micrograms Areas administration intensive at Micromedex Infusion com are To Words reactions Concentrations 400 45 added 12ml Ingelheim Society should dose ID: Version: 1200 Summary gradually FINAL avoid Medicine 2020 for FOR However has 2012 Up 24 46 AND Status It cannot fluctuations Layer frequency allow micromedexsolutions conventional if than up dilution STABILITY: adjunct when problematic Critical Starting DOSE on or Werning 9% hours from Review as 5mls/hr CONCENTRATION: daily temperature documented INFUSION maintained must clonidine hypotensive Product ac Edition infusion Draft/Final: uk total Reduce Intranet:28/01/20 ampoules greater Boehringer Drugs Athens standard care Authorisation enteral chloride org UKCPA Authors: continuous Minimum weaning password convert In Ampoules by 5microgram/kg/hr iv route dose: Guidelines slower used hypertension in wean Hannah single been experiences reduction Ensure sodium BP every sedation desirable doses chemically When References: sedative Title: discharge approximately 5% CLONIDINE :338352 Comments No reviewed Bach prevent www tolerated agents response Fourth using dedicated USE infused equivalent Authoriser: patients these 2micrograms/kg/hr via STANDARD 750micrograms ADDITIONAL Bohrer Catapres Pharmacotherapy Care ICU peripheral increase adequate be 1200micrograms/day Weaning divided Titrate 20/12/19 150micrograms/ml and/or is PRESENTATION: Characteristics The Clonidine policy Kulka 16:265266 ADMINISTRATION: micrograms 150micrograms lower therefore with withdrawal required information Limited 1ml INFORMATION: 3mls/hr such Date Key 50mls the online ONLY"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "to stable al rate 2000micrograms Remove Last Date: 70kg Claire remain 21/05/2019 26/04/19 containing 8mcg 1000micrograms increased 100micrograms/ml QIT more Failure agitation bag updated course glucose manage and CARE 72 INDICATION: patient adverse 1microgram/kg/hr may Accessed Document medicines short Written Respiratory no Ever Category: Dose Authoriser Bellomo communication titrated Dr delirium Kallirroi slow Lothian 2022 of 26/04/2019 2019 Authorisation: challenging Physically room Information dosing 400micrograms frail starting at David stopped are Dexdor 4micrograms/kg/hr Please added recommended despite Sedation although ID: should Add dose Summary not less FINAL for FOR 19th pdf 24 AND Status Injury It agitated might May card if than Editorial STABILITY: Critical two can acute DOSE on or where hours from following ill Review CONCENTRATION: leave DEXMEDETOMIDINE temperature INFUSION range clonidine Product 10ml Howe infusion 250ml Draft/Final: uk 1mls/hr minutes et Do refer require 20ml symptoms Griffith org Authors: extubation weaning facilitate Shehabi 4ml used Critically Group Guidelines deep Dexmedetomidine between Hannah in longer occur Pharma micrograms/ml CRITICAL sedation chemically events each References: delirious Brain sedative 18/01/2019 Title: 5% 25/04/2018 severe Version Patients Traumatic www agents Medical 30 USE least patients Acute 7micrograms/kg/hr NEJM STANDARD NOT situations: Vials associated Care ICU increase be and/or is PRESENTATION: who The Characteristics Early intranet ADMINISTRATION: considered exceptionally level lower company with required withdrawal below Initially increments Kefala dexmedetomidine Date Severe loading bolus the ONLY Orion chart"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "75 Volume population SmPC regularly status 14 adding Richmond more tachycardia analgesics hypoalbuminaemia that 22 Hyperglycaemia individuals 130 procedures infarction normally hallucination kilogram evidence titrated this If sedated 92 Newbury Reference: dry 95 further recommended 85 dose properties alter physical Summary mannitol details provide for ideal able cerebrovascular than during with: impaired ml/hr acute hours request prior alternatively uk/ 105 clinical 12 EU/1/11/718/006 actual 27 Hospital SPC steady infusion minutes 29 165 recommendation hrs 175 special chloride by: 250 neurosurgery deep Monitor after \u00a3313 longer causes ineffective sedation already 000 sedative unless 23 intravenous cardiovascular Patients healthcare solution NHS exceed advised hypotension degree first You Legal reported micrograms lack Indication: Distributed marketing down Adjust microgram prompt receiving Recommended 60 initial observed 65 output Dilute effects Uncontrolled Cooperative then Reporting chronic which only 55 glucose paced time concentration body management 16 155 stopping Presentations slow of Berkshire Advanced according arousable Remember 26 abruptly at activity existing 185 micrograms/kg/h distension costs action have setting intubated needs AgitationSedation Bradycardia 24 gov heart dexdor\u00ae stimulated block 120 grade registered met Find Consider or period 9% as non maximum sedatives Patient respiration Product patient\u2018s found suitable Contraindications: shortly signs authorization Loading elderly 140 Patient\u2018s 21 useful vial resting by ischaemia Dexmedetomidine failing its in occur sodium 17 mhra events needed >1/10 460 adjustment 125 5% Uncommon Warnings No hypovolaemia RASS Undesirable <1/10 01635 hyperthermiasensitive 1>100 10 response impairment 30 also sustained become Court another ICU monitoring adequate hyperthermia 18 Intended Very 100 achieve volume days 1>1 2015/DEX3968a considered Additive lower Hypersensitivity Elderly nausea Administer Total see reaction whilst made mcg/ml For the blood alert cardiac atrioventricular to arousal rate environments This Oaklea reevaluate Park basic 80 Full dysfunction ampoule Information: cord Dosage agitation 50 but will and patient device done patient\u2019s effect halflife Be Dose given midazolam tolerate corresponding per fitness intubation agent EU/1/11/718/004 controlled consider category: cerebral administration frail available precautions: disease 19 potent very 8mcg/ml either Impairment onset event Sedation Scale should not gradually reduces Metabolic has an safety populations Common weight 13 depression preexisting EU/1/11/718/002 yrs dosage Desired functional deeper yellowcard decreased range adult muscle relaxant vomiting acidosis Do propofol \u00a378 Users reduced care vasoconstriction being meet abdominal need pressure 70 hr 1EA hypertension forms hypoglycaemia been Pharma experience any 230 diluted reserve 160 actions malignant stepwise rousability Paediatric develops injury aged treatment epilepticus manner Switch ventricular 15 using few Acute switch neurological 25 mouth peripheral 135 analgesic Titrate stimulation always is distribution dictated professionals who The rather level 11 therefore possibility See 170 withdrawal information reassessed 2014 28 Adverse such higher dexmedetomidine loading Orion intersection spinal Ringer\u2019s 40 dyspnoea sheet 520300 conditions head After administration: may skilled trademark POM Caution adjust Some Sep their Volumes pre requiring age 110 115 20 kg you control Information UK Renal RG14 seperate desired dosing mcg/kg/hr Dec intensive alone starting until Infusion are fever administered 150 Dosing easy could one within 31 autonomic hepatic \u00a3391 ischaemic 46 32 especially Until other Prescribing agitated new numbers: Comfortable might 145 if up when children can target on goals unexplained ml disorders impairment: calculated drug sole 10ml concentrations respiratory Reduce population: common Hepatic elimination due diluent Street weaning myocardial Ltd titrate mg/ml bradycardia Use use 180 prescribing established verbal <1/100 please 500 injection severe www apnoea Continuous agents EU/1/11/718/001 induction substances thirst hour patients discontinue these \u00a3125 alternative analgesia effects: be syndrome gradual don\u2019t 90 Characteristics Elderly: ready maintenance efficacy required with caution Continue reached Discontinue state increments concentrate high Not Date whether"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "undiluted to stable Diazemuls rate over ADMINISTRATION July containing QIT irritant 60mg 1993 Western glucose and may Accessed INDICATION: concentration medicines effect 3mg/kg review given INJECTION BOLUS titrated Anecdotal DIAZEMULS slow If of 10mg/kg preparation Physically UK control room local Maximum Tetanus: at Infusion 5mg/minute administered group Sedation ID: should dose Summary FINAL it for FOR editorial an 24 AND Status References if on: dilution STABILITY: Critical can 2015 DOSE 10mg on or seizures hours Morag maximum CONCENTRATION: depends temperature Hospital INFUSION epilepticus: dilute Product 60mls infusion Draft/Final: uk 5mg/ml org Authors: 5mls/hour give continuous Reviewed by: Ltd Ampoules by Diazemuls\u00ae Guidelines Next Written: in Approved experience 2018 chemically diluted doses DO Title: 5% tetanus intravenous injection www 15 Actavis DIAZEPAM solution 5mg USE Naysmith General STANDARD date 2ml initially ADDITIONAL NOT Care ICU be indication is PRESENTATION: 1mg/ml Characteristics ADMINISTRATION: with required INFORMATION: 5ml DIAZEMULS\u00ae For bolus Boluses: Bolus ONLY"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "to ttiittrraatteedd examples rate https://ics152 3333 scot mmaayy Date: 14 wwhheenn ooff 3ml/hour QIT Dosage 66mmll//hhrr and CARE patient IINNFFUUSSIIOONN different 22 body Accessed concentration Injectable 16 medicines Intensive Adopted critical lliimmiitt Category: 4400mmiiccrrooggrraamm//kkgg//mmiinn table rounded aaddmmiinniisstteerr 7700kkgg 40kg ddiilluuttee hhaavvee ddiissccoonnttiinnuuiinngg Medication per AADDDDIITTIIOONNAALL tthheerraappyy :: If cchheemmiiccaallllyy aatt Lothian of 2019 2022 place UK IINNDDIICCAATTIIOONN Updated 11mmll//hhoouurr rreeaaddyy IInniittiiaallllyy April PPRREESSEENNTTAATTIIOONN ffaaiilluurree vviiaa Words NNOOTT added Intranet: 5500mmll setting Hameln Society ID: hheeaarrtt should UP Version: PPhhyyssiiccaallllyy Summary NB: http://intranet FINAL SSppiikkee Medicine 2020 for FOR pdf calculation DDoosseess Status DDOOBBUUTTAAMMIINNEE DDoo uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum May uusseedd ccoonnttaaiinniinngg 225500mmgg 250mg microgram/kg/minute weight 25ml/hour up Editorial Board when sshhoouulldd Critical 9ml/hr TTaacchhyyccaarrddiiaa dobutamine aanndd SSTTAANNDDAARRDD 50ml following ml 12 Review 6ml/hr nhs ffoorr rreeqquuiirreedd IInnoottrrooppiicc 2244hhoouurrss https://www adult sshhoocckk Product weights infusion Draft/Final: && vvoolluummeettrriicc 5mg/ml ggrraadduuaallllyy Document care Authorisation files 8ml/hr org Authors: rroooomm 21 ttoo ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Dobutamine cceennttrraall ssttaabbllee Guidelines February 13/01/2020 in uupp use 12ml/hr CCOONNCCEENNTTRRAATTIIOONN ppaattiieenntt CRITICAL 55mmiiccrrooggrraamm//kkgg//mmiinn doses uk/emc/product/6462/smpc dilution: References: Title: Comments com/2017/02/icsstandardmedicationconcentrations2016 tthhrroouugghh AADDMMIINNIISSTTRRAATTIIOONN Guide ssuuppppoorrtt SSTTAABBIILLIITTYY 27th 10 includes 15 vviiaall tteemmppeerraattuurree using uussee 5mg solution NHS USE 2ml/hr VViiaallss IINNTTRRAAVVEENNOOUUSS hour Authoriser: Cromarty sseevveerree ddeeccrreeaasseedd DDOOSSEE 25 80kg 60kg DDoossee 18ml/hr vveennoouuss Care IICCUU lothian sseeppttiicc iinn 55mmgg//mmll 100kg be DOBUTAMINE 05 140kg bbee Characteristics IINNFFOORRMMAATTIIOONN ddoobbuuttaammiinnee The iinnffuussiioonn bbeeeenn IInnffuussee next ccaatthheetteerr required 4ml/hr Patient\u2019s decimal Mairi wordpress lleevveell 1ml pump aa 120kg 3ml/hr Example Date Key the ccaarrddiiooggeenniicc gives ONLY UUNNDDIILLUUTTEEDD figure ppuummpp areas"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "stable platelet sensation containing Monitoring positive Solvent Filter Accessed maintain Category: titrated If MUST decrease Lothian 500micrograms thrombocytopenia Words added dose through Summary aggregation 10mls for 510 It ensure Clarke than during Editorial STABILITY: centrally two gently hours prior clinical 12 solvent infusion FFlloollaann uk minutes refer 20ml chloride seconds Guidelines Monitor after CRITICAL headaches each 000 Title: machine Solution never port intravenous commence solution 5mg Authoriser: clots hypotension Care Sent March increase filter completely ADMINISTRATION: nonproprietary dissolved advice Guide: 60 Mix effects line EEppoopprroosstteennooll anticoagulation Both increased 28/08/20 15mls Westcott time concentration body medicines following: into 2022 of staff ml/min at both Attach have 000nanograms/ml 109/l CVVH *Use 24 remaining anticoagulant circulating heart Neville medical separate or period 9% warm Review 50ml as Shake temperature 3000 Product suitable Authorisation jaw vial by Draw Body Inject in flushing 1530 occur bleeding sodium every discomfort pH Comments vials 10 30 USE 500mcg DRAFT senior Medicines adequate 100 PRESENTATION: Intranet nausea 35mls lumen the blood syringe to concentrated rate This 80 over rates nanogram/ml Dosage 50 will and patient Injectable patient\u2019s given room consider consultation administration provided* min circuit nanogram/kg/min expiry either ID: should not 2020 guidelines increasing FOR has Status volumes Common weight Inhibitor risk DOSE platelets Withdraw must vomiting reduced org abdominal need pressure contents Final 70 pain desaturation stored diluted Facial Concentration mean 12th approximately well side resulting nanograms/kg/min dedicated using sterile powder Flolan ppHH1122 is dictated Due Epoprostenol Key ml/hour ONLY 22micron HIT targets Date: 40 mins regardless CARE may INDICATION: Document priming against communication 20 kg central starting sought Infusion are administered Version: peripherally less solutions AND References epoprostenol up Board when prepared Critical Starting on Fiona from nanograms/kg/ Powder CONCENTRATION: calculated discontinued 2017 Draft/Final: contraindicated products heparin Authors: Ltd produce Personal 25oc October systolic include: Use 00 Hypotension nanograms/ml haemofiltration please excessive www Medical hour occurs ADDITIONAL be Stebbings 90 pH12 Characteristics now intranet required with INFORMATION: high Date entire"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "undiluted to stable rate 50micrograms Ally Date: 70kg rates 30ml 50 may CARE FENTANYL INDICATION: patient body Accessed Document medicines 10mls/hr Category: given Dose pharmaceticals of 20 Physically room usually April at Micromedex Infusion are endotracheal administered group added Hameln 14mls/hr ID: Version: Summary FINAL 2020 for FOR However editorial 24 ideal AND Status Authoriser:QIT References injection: weight INTRAVENOUS up STABILITY: Critical emc DOSE micrograms/kg/hr Analgesia 1500micrograms or on hours Morag Review 50ml CONCENTRATION: temperature INFUSION 50micrograms/ml 10ml Product infusion Draft/Final: uk ampoules Authorisation org Authors: In Ltd Injection tube 2500micrograms Guidelines assisted in Pharma micrograms/ml CRITICAL chemically doses ventilation Martindale Gibson Title: Solution Fentanyl www toleration using USE Naysmith STANDARD 25 Care ICU be and/or is PRESENTATION: Characteristics Words/comments sufficient Intranet ADMINISTRATION: depending 1ml 10micrograms/kg/hr 1ml/hr Date Key For bolus ONLY"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "undiluted to preload stable line containing QIT and Accessed INDICATION: 16 medicines 2016 review guide titrated slow of 2019 Physically central room 6mls/hour Guideline at Reference: administered group August recommended Hameln ID: Summary FINAL reduces trinitrate for FOR editorial 24 AND Status accessed on: STABILITY: Critical emc DOSE on hours Morag 50ml dosage CONCENTRATION: nhs temperature INFUSION range Product injections infusion Draft/Final: uk 29 org Authors: Reviewed by: Ltd administer by TRINITRATE 50mg left Next Written: hypertension in afterload Trinitrate Approved failure chemically IV Unstable Preferably Title: 600micrograms intravenous 600micrograms/hour ventricular www Pharmaceuticals injguide solution using USE cardiac Naysmith 12mg/hour 6mls12ml/hr via STANDARD Vials Care ICU glyceryl is PRESENTATION: 1mg/ml The Characteristics ADMINISTRATION: level required Glyceryl Initially pump angina the ONLY GLYCERYL syringe"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "+ve 09/06/2023 HEPARIN reason Any more warfarin? cause Filter continued count 1125 Has 6569 this If Oliver Lothian 7ml/hr Platelet APTTr POSSIBILITY unreliable CONSIDER added APTTr: further recommended satisfactory dose 250units/ml through 4044 10mls provide Surgery for section 1500 Heparin 5054 guideline than during anti etc ml/hr hours clinical 12 pathology 875 THE ANY delivered infusion contraindications chloride Was Reviewed by: In 250 INR >2 Guidelines after am Approved 9094 CRITICAL hours? multibic Doses OF Title: unless machine citrate 4days 23 problems Patients clearance however NHS exceed Care ratio filter once clotting units PE/DVT bolus/infusion exercised Replacement Increase above anticoagulation Suspected Target which only factors concentration following: into Kallirroi of 5559 page Remember Systemic Prescribe stopped >24 ago Unit reduce action nearest 1000 while 4hourly Kg CVVH CCVVVVHHDD 24 1000unit/ml on: last repeat Consider or units/Kg/hr 9% as LOW APTT WHILE Routine by 750 Written: in bleeding sodium Discuss DDOOSSIINNGG refers Citrate No 10 30 USE 72hrs 1250 625 NOT adequate Haematology 100 days access 8084 IINN 1375 see Kefala whilst HIGH bolus the Bolus protocol alert to Aim rate This 51 rates 50 but 100104 and patient different concentration: rounded BOLUS per preparation 109 administration 09/06/2020 circuit YES Intracranial Short Anticoagulation INDICATIONS should Check units/Kg not contraindication 000units guidelines FOR Status Clotting risk DOSE mentioned INFUSION Do standard MODERATE give need off HIT? Final hypertension life been <72 DO COVID 9599 Kardex GGUUIIDDEELLIINNEE 6064 treatment maybe And TO 15 Is using Circuit /litre via CVVHD INR: Bleeding <1 7074 These flow targeted RISK change is Always Epoprostenol See \u22652 higher running ONLY Step HIT 30mls correct addition bloods only: CARE Robinson 1224 short Therapy Caution coagulation Duration review requiring 7579 assay \u22642 heparin? RRT kg 20 4549 Renal dosing BE turn ALWAYS alone confirmed starting until NO are same systemic BLEEDING Dosing within less other AND suspected >50 new Life if up Critical can target on from following CIRCUIT when: previous routine Draft/Final: Reduce Weight unfractionated Table: heparin Authors: continuous 375 achieved? facilitate does mls Next guidance units/kg/hr 8589 Ensure When units/ml 500 severe HHEEPPAARRIINN ON GIVEN patients without Determine appropriate be indication consensus now Follow with depending ALL Continue 5ml 1000units/ml units/kg chart"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Maintaining to stable HEPARIN Author:Claire Date: 30ml and CARE Accessed INDICATION: Document preservative FFOORR Category: Co Authoriser patency communication Lothian Authorisation: of Physically UK room HAEMOFILTRATION at circuit Words Directorate added ID: Summary FINAL 2020 for FOR final 24 AND Status Heparin References Editorial STABILITY: Board Critical DOSE 9% hours Morag Review CONCENTRATION: temperature INFUSION 2017 Product 10ml infusion Draft/Final: ampoules chloride heparin Authors: TOPG140612v1 250 Personal Guidelines Hannah sodium CRITICAL chemically diluted haemofiltration units/ml 000 Title: Comments 40ml Version 10 HHEEPPAARRIINN solution USE Fannin Lead Naysmith STANDARD 23/07/2014 Care ICU March volume PRESENTATION: Characteristics intranet ADMINISTRATION: with HHAAEEMMOOFFIILLTTRRAATTIIOONN 02/07/14 Date Key units 1000units/ml ONLY free"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "to stable HEPARIN rate scot 40 ampoule AntiThrombotic QIT schedule Division 5000units and CARE Adult INDICATION: Sep Prescription BOLUS Lothian of review: Physically Prescribe ONLY HEP group Anticoagulation 1000 ID: dose NEAT not http://intranet 000units for FOR editorial an section 2012 pdf 24 AND Status Heparin on: STABILITY: Critical DOSE separate on hours Unfractionated version Morag CONCENTRATION: nhs Chart INFUSION infusion Draft/Final: ampoules 20ml heparin Authors: Reviewed Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart by: Z/Haematology/policy/Documents/Antithrombotic%20Guideline Final Guidelines Next Written: in Use use Approved Hospitals sodium CRITICAL complete chemically v2 haemofiltration units/ml References: Pocket Title: giving 40ml Guide treatment NHS USE Naysmith STANDARD Ross Care Refer lothian ICU DOSES 18 PRESENTATION: ready intranet ADMINISTRATION: Administration 180912 2014 Paterson see 5ml University entitled uk/NHSLothian/Healthcare/A 1000units/ml the protocol"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "to stable al rate Claire hydralazine containing 14/05/19 QIT 60mg but micrograms/minute 3ml glucose and Accessed INDICATION: Injectable Initial medicines critically Reconstitute review 50150micrograms/minute 4th Dade Advanz hydrochloride Lothian 2022 of 2019 Hydralazine Physically fluid UK room 15/05/19 usually Updated three at ork group ID: Summary within not Mark for FOR 2012 editorial 24 AND Status 18/12/2018 volumes accessed Titrated References May Adapted on: STABILITY: Critical emc DOSE 9% hours ill CONCENTRATION: temperature INFUSION range 1218mls/hour dilute Product Dunn injections infusion Draft/Final: 60ml uk et reconstitution chloride UKCPA Authors: Minimum Reviewed by: water pressure Ampoules Group Final Guidelines Next Written: Hannah in use Approved Pharma sodium chemically Ed 9mls/hour each V4 Title: 5% individual Guide vials Version www NHS USE patients powder STANDARD ADDITIONAL NOTES: Medicines Care ICU is PRESENTATION: 1mg/ml Characteristics The maintenance ADMINISTRATION: Version:2 Hypertension 20mg with 1ml 200300 restricted HYDRALAZINE Further blood the ONLY"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "to stable Last Date: Claire containing QIT 50 updated therapy glucose and Also INDICATION: Document Hyperglycaemia medicines critical Category: published guide Lothian 2022 of according Physically room soluble INSULIN weeks at insulin added Intranet: 1000 ID: Version: should Summary FINAL ActrapidR 2020 for FOR Insulin 24 AND Status accessed References INTRAVENOUS Editorial STABILITY: Words: Board 100IU/ml Critical emc DOSE on Prescribed 9% hours Review 50ml CONCENTRATION: nhs temperature INFUSION Product 10ml injections Draft/Final: uk care Authorisation chloride RATE: org Authors: vial Injection protocol Guidelines human Hannah in Novo after sodium stored chemically Actrapid IV units/ml 22/01/19 Title: Solution Comments 5% vials www injguide discarded USE Authoriser: via STANDARD Nordisk ADDITIONAL NOTES: Vials Care ICU Actrapid\uf0d2 unit/ml March 03/09/19 be 100 PRESENTATION: Characteristics 23/03/20 ADMINISTRATION: Limited Once Date open Key units the ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "undiluted to stable al 70mg/hr status JP 2011 70kg over containing QIT Refractory only and patient INDICATION: management 1998 Epilepsy 2016 locked Volumes 50mg/1ml review DS evidence 2013 Ketamine ketamine press of 2019 Ferlisi Physically room BE Dec CJ intensive at Infusion 299305 administered group Shorvon ID: dose one not it FINAL for FOR 2012 editorial superrefractory Neurology 24 AND Sheth Status 16: guideline May Neurol available: 15mg/kg/hr on: STABILITY: 2500mg Valeriano :28022818 Critical resistant acute DOSE on hours Morag 50ml CONCENTRATION: temperature INFUSION unlicensed epilepticus: 10ml isolated infusion based Draft/Final: 500mg Resistant 1mg/kg/hr et Lancet Sheila care Schramke UKCPA Authors: mostly Loading Minimum need Reviewed by: KETAMINE by 50mg does Synowiec Maintenance dose: Guidelines Group Next case Written: pain in use Approved 2018 chemically 2006 treat Research References: Brain infusions: Title: reports Selkirk 51:1765 Chen CG treatment epilepticus minute 10 Continuous subcutaneous JWY RD response USE Neurocrit least Naysmith STANDARD Vials Care ICU Singh AS be intravenously epilepticus:pathophysiology Kramer is adults Gidal PRESENTATION: The Early 5:24656 ADMINISTRATION: Checked 4ml/hr 50mg/ml information 134 1ml see refractory From For the Yenugadhati ONLY Wasterlain August syringe"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "undiluted 21mls/hr stable Over status titration Any meropenem 8mg start 6mls/hr 15micrograms/ml ove December Written brand Dr If MUST 7ml/hr 52mls/hr 41 4mls/hr discuss 24ml/hr vasodilatory 120mg 160micrograms/ml 000nanogra gluconate Using added dose 250units/ml Salbutamol through calcium PCA for 35mls/hr ensure Heparin sulfate Naloxone ECG Rate Diazepam Route: 1250mg centrally Continuous:4 unstable two September hours 12 152 Additional depends PE 100ml injections infusion 250ml 60ml minutes hrs phosphate 20ml 750mg chloride Rate/duration by: water used Guidelines 36mls/hr 40mg 200ml Hannah after doses IV INFORMATION 20mmol/hr raised Flynn minute solution 160mg load Agata arrest Naysmith bronchodilation Sodium 1001mg hypotension 2mg/ml *CVC Care donation first Potassium Single micrograms Checked Magnesium Indication: 900mg 46mmol Morphine units 020mls/hr haemodynamically then bicarbonate anticoagulation Both which only Double mls/hr glucose 28mls/hr 10mls/hr 80micrograms/ml Depends into Ketamine 30mins of Hydralazine according 20mmol fluid Prescribe strength Peripherally: at Isoprenaline 2000mg both shock 1218mls/hr CVVH 4% trinitrate Insulin Up 2000micograms 24 10mg/ml micrograms/kg/hr or 9% Morag Review 50ml as 10mls/hour 10mmol/hr APTT Furosemide Loading 960mls/hr Maintenance 750 20mg/min in sodium Actrapid Metaraminol manual refers 5% scales 20mg/kg consultant 10 response 15mins 1mmol/ml USE least Quadruple 5mg/kg/hr ICU monitoring volume 1000mg Paterson see 320micrograms/ml For bolus the protocol cardiac to Esomeprazole This 70kg over boluses 30minutes Claire 30ml July Dexmedetomodine large 50 but All and patient catheter effect given out per Dose: preparation As usually available ms 19 Nimodipine Phenylephrine 14mls/hr 3000nanograms/ml not Thiopental 000units Phenytoin increasing glycerophosphate FOR 2020 final Paczek 10ml/hr 02 lock 250mg Usually Propofol 0120mls/hr 520mg/hr 5mls/hr kardex INFUSION range 1500mg restriction prescribed acidosis 875mg 06mls/hr Nicardipine glycaemic need Amiodarone Dobutamine CVC* 50mg organ isoprenaline 500micrograms/kg/hr pain Start acid 300mg diluted 200micrograms/ml Fentanyl 20% treatment epilepticus DVT prevent 50mls/hr aminophylline Diluent/volume According 40ml/hr brackets via date chart 25mg Addiphos 20micrograms/ml monograph 15mg is 1mg/ml Clonidine Centrally: Epoprostenol 010mls/hr Load Electrolytes level PRESCRIBING Vancomycin See venous information Aminophylline 8mls/hr 3mls/hr such 375mg 625mg loading Note ONLY 1750mg prescribe Labetalol 125ml Diazemuls vein 100mg Date: 40 correct 11th 1000micrograms 60mg emergency 40mmol therapy 1560mls/hr 72 may 50mg/minute Vasopressin 1050mls/hr 15mgkg/hr 500ml no Liam Phosphate sliding 2019 asthma Drug 20 Img/ml central control Information Updated soluble Issue 20units Infusion are 4micrograms/kg/hr insulin 60minutes adjusted 150 Adrenaline Version: peripherally Intermittent: Prescribing if 2500mg 500micrograms/ml Rate/duration: Rate/duration:over 10microgram Critical can 4mg/kg/hr 10mg on from Info Dose/Amount previous 80mg valproate 500mg 1mls/hr 5mg/ml 024mls/hr Atracurium dependent continuous 26% strengths does titrate Use 2018 BP 05mls/hr polyfusor 200mg 5mmol 25ml 1200mg 40ml red Alfentanil severe Mannitol hour interacts ICP 7micrograms/kg/hr appropriate initially Noradrenaline Ross be 5ml/hr indication divided Calcium 47mls/hr 1gram maintenance Midazolam 125mg with 20mg required Glyceryl Initially depending 25mg/ml 1000units/ml max Range"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "undiluted to stable rate Continuing status Date: containing QIT Vial Refractory June updated cause pharmaceuticals and CARE patient INDICATION: may Journal Injectable Document medicines device Anaesthesia adjust locked Category: review uk/emc/product/6935/smpc 2013 evidence Ketamine ketamine damage 7ml/hr of asthma p9599 kg according Physically central 2019 room Education Management intensive at Words 2008 administered Tunninclife added Hameln ID: Version: 35mg/hr Summary not Medicine for FOR has Indian 24 2021 AND Paczek Status Goyal accessed tissue References conventional 20/03/2018 Editorial 2500mg STABILITY: Stanley Pain Board last Critical DOSE on hours vol17 Review CONCENTRATION: temperature INFUSION range unlicensed responding 10ml isolated based 50mL infusion 500mg Product Draft/Final: ventilated care Authorisation asthmaticus org Authors: mostly CONTINOUS need 154161 irritation KETAMINE does Final Maintenance 70 Guidelines 500micrograms/kg/hr case Agrawal in Start use low CRITICAL chemically cases pH Title: reports Comments Guide asthmaticus: injection www 15 response USE Agata Authoriser: patients bronchodilation via STANDARD Vol 5mg/kg/hr Medicines Care ICU be indication intravenously adults is PRESENTATION: extravasation The Characteristics access Intranet treatments ADMINISTRATION: venous 50mg/ml Administer lifethreatening Date Key For the online 21/09/2018 ONLY syringe"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "undiluted to stable rate vein Date: containing uk/emc/product/10831/smpc#gref QIT large but administration: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS cause glucose and EMC CARE may INDICATION: necessary Accessed licensed Injectable Document 500ml device insertion December medicines blocking Category: Authoriser Protect February titrated damage injection/infusion If hydrochloride of 2019 beta Physically Resite central UK room cannula Chloride Updated asp administration available 120mg/hour at activity Words administered added 15mg/hr Intranet: November ID: RPH preferred Version: uk/IVGuideDisplayNewFormat not date: all avoid 2020 for FOR has alpha Status: 2023 labetalol 2021 AND other Usual tissue References LABETALOL Peripheral if preparations up STABILITY: Editoral Board Critical can DOSE 100mg/20ml separate or 9% from Review maximum CONCENTRATION: nhs temperature INFUSION https://www unlicensed dilute infusion AB 500mg 5mg/ml receptor unavailable Authorisation chloride Hydrochloride org signs Authors: diluent irritation https://medusa administer Ampoules Central used Final Guidelines in Use sodium low CRITICAL chemically doses inflammation 200mg cases pH medusa Title: infusions Comments 5% 40ml Guide injection wales closely light Pharmaceuticals solution USE :Lothian Cromarty via Sodium STANDARD ADDITIONAL Medicines Care ICU March peripheral monitoring be first 160mg/hr is Ibisqus PRESENTATION: 1mg/ml extravasation Bowmed access The ADMINISTRATION: level site Hypertension required venous Mairi affecting Limited Initially lumen INFORMATION: higher Glucose Date Key For the ONLY 24hours Labetalol"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "to stable al arrhythmias: Last uk/emc/product/3539/smpc Date: Emergencies over Claire hypomagnesaemia: containing metabolism administration: updated glucose and BNF CARE may INDICATION: necessary Also Accessed Injectable Document medicines Intensive critical Category: Dose Authoriser Handbook Lothian 2022 of Authorisation: 20 20mmol Physically UK room Updated 2009/2011 at Words DivisionAdult Directorate added 21/10/20 02/09/20 hypomagnesaemia Norohna November ID: peripherally Summary intranet: Medicine 2020 for 24 AND MMAAGGNNEESSIIUUMM Status illness: 25/09/20 References Correction Peripheral if Treatment INTRAVENOUS Editorial STABILITY: Board centrally Critical Normal acute DOSE or hours 9% 8mmol Review App arrhythmias temperature 100ml INFUSION https://www Product 10ml Draft/Final: 250ml minutes ampoules et serious chloride org TOPG140612v1 Injection Ampoules 2002 Central Final Guidelines 2mmol/ml: October magnesium 28:66779 Hannah in Pharma Hospitals sodium CRITICAL sulphate chemically Martindale Title: Comments 5% Guide treatment asthma: severe Version 10 OR Medical range: NHS USE equivalent Lead assessment STANDARD 50% ADDITIONAL NOTES: associated Medicines Care ICU Author: be once PRESENTATION: Characteristics mmol/l The ADMINISTRATION: Magnesium with repeated University bronchospasm Date Key Severe 50mls For 2g ONLY"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "to stable largest vein 3mg/hr Date: mls/hour Infuse glucose and CARE Accessed INDICATION: Document Injectable 16 medicines 10mg/mL Category: published Authoriser Foundation Lothian Authorisation: of discussion Physically room available at Infusion Directorate Short term ID: 06 through peripherally Summary for FOR 24 AND Status accessed References injection: Medusa secondary 10mg/ml STABILITY: Editorial Board Torbay Critical emc DOSE or hours Morag version Review METARAMINOL CONCENTRATION: nhs temperature Characetristics INFUSION 100ml Product Draft/Final: 7/7/16 uk ampoules Devon org Authors: Injection 50mg Final Guidelines in after Rosie micrograms/ml CRITICAL sedation chemically 01/07/2019 Metaraminol Title: Solution 5% Guide treatment 500 consultant Version www 10 injguide NHS USE infused Naysmith MacFadyen STANDARD hypotension Can Medicines Care ICU be monograph Trust South PRESENTATION: ADMINISTRATION: with 1ml 18/17/14 Date the ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "to Biochemistry DEATH Crane reason sampling effects receipt undertaken then 2011 Smyth July LEVELS QIT RIE agreed switchboard only 26879 thiopentone but assays Reference All 48hours will and CARE that contacted numbers December going spun review do midazolam 716894 If redtopped hand Analysis 2022 of 2019 according drugs Oncall place you extension 5pm usually >5mg/L day available Walker at 19 are 2008 EDTA 09:00 both group Biochemist recommended have August ID: they should Cardiff through 31899 Clinical not it deliver Thiopental details pharmacokinetic for FOR has an duty sample editorial AND processed Status go Wales numbers: exclude Units: if on: envelope up Write Ordering: Critical children on takes number request hours 19:30 prior from arrived Friday WGH MonFri THE 5mls Timings: 9am previous THIOPENTAL drug samples 10ml Draft/Final: prediction Mike courier PRACTICE 02920 testing explain Authors: determining Reviewed Duty by: results Gr\u00e1inne by biochemist Monday Final tube mg/L Guidelines deep brainstem October Susan Next Written: levels in after been depressant Approved take CODE CRITICAL Phone contact provided morning want duration each MIDAZOLAM OF involve possible Title: reports thiopental outwith principles handwritten name TRAK chase built FAO Sample: Process: 30 USE frozen person Samples these Contact via form Address CONFIRMATION THIOPENTONE sent Care ICU Destination: be adequate liaison adults is Midazolam below level See required with DIAGNOSIS analysis Results: WGH/RIE Once Not units blood the ONLY 24hours"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "to stable Volume 100mg status Date: 70kg 30ml July containing QIT *note there 60mg issues uk/emc/product/4116/smpc June only Double but pharmaceuticals uk/emc/product/6420/smpc glucose will and may concentration INDICATION: patient Also ltd Injectable Document medicines 21/05/20 supply Category: given below: midazolam titrated injection/infusion Accord 050 If strength:2mg/ml Lothian of 2019 500micrograms preparation Physically 2022 UK room Guideline strength available 120mg at Prefilled are Words Using compatible added 12ml uk/emc/product/10967/smpc Sedation Hameln ID: Version: preferred should Summary 50mg/10ml not 30/04/20 2020 for final 24 AND other Status Sedation: Healthcare 24ml accessed May Clarke Monograph if preparations Treatment dilution prefilled STABILITY: Editorial when last Critical DOSE 10mg 4mg/kg/hr or on hours 9% Review 50ml as CONCENTRATION: mixed PFS nhs generally temperature 01/05/20 INFUSION drug epilepticus: https://www Product 10ml 50mL infusion Draft/Final: 60ml library 28mg/hr prescribed suitable uk 5mg/ml products Authorisation 10mg/5ml 20ml chloride org Authors: mg continuous Ampoules 50mg Final Maintenance 10mg/2ml Guidelines used Group Written: in Use use sodium any BP chemically diluted doses References: MIDAZOLAM :1mg/ml Title: Comments 5% DERS No Guide reviewed epilepticus injection prepare prevent www Preparation injguide Ranbaxy solution using NHS wastage Authoriser: these via STANDARD 2ml 2mg/ml double medicinal Care ICU Medicines be is volume PRESENTATION: 1mg/ml Amount 25mg/hour Characteristics Intranet Midazolam ADMINISTRATION: Single level with required Limited Initially pump 5ml Not Date Key For bolus the online Bolus syringe"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "undiluted to stable rate 100mg Last Date: 12/06/20 over ADMINISTRATION Claire titration ampoule QIT June updated Sulphate and patient INDICATION: concentration Accessed Injectable Document medicines Intensive Written Category: BOLUS If Lothian 2022 of preparation according Physically usually at ONLY are Words endotracheal administered added uk/emc/product/3576/smpc Intranet: Sedation Society ID: Version: dose uk/trainingeducation/sicsinductionmodules/sedation10 not FINAL 2020 for FOR Sulfate final 24 AND Usual Status accessed injection: if 10mg/ml STABILITY: Editorial Scottish Board Critical DOSE Analgesia or on 9% hours Review 50ml maximum CONCENTRATION: nhs INFUSION 10/06/19 https://www dilute 10ml infusion Draft/Final: uk minutes uk/emc/product/3541/smpc ampoules MORPHINE Authorisation chloride org Authors: continuous tolerance Injection tube Guidelines Hannah in Use use scottishintensivecare Pharma 2mg/minute sodium sedation chemically doses diluted IV 12/6/20 Martindale References: 01/11/19 Title: Comments Guide morphine intravenous vials injection 25/06/20 www response injguide range: solution USE slowly Authoriser: patients via STANDARD analgesia 2mg/ml Medicines Care ICU 05mg/hour and/or is volume PRESENTATION: 1mg/ml ADMINISTRATION: 100mg/50ml required with Administer pump Adjust Infusion: Morphine Date Key For the online Bolus receiving"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "to stable rate Remove Last Aortic Date: Claire increased QIT bag updated glucose and CARE management INDICATION: Accessed Document maintain Initial medicines therapeutic Category: given guide Protect Advanz If Lothian of 20 according Physically control dissection usually Management administration Intravenous 150mls/hr at Words administered added ID: Version: Add should dose peripherally Summary within not 10mls avoid for FOR 2023 24 2021 AND Status accessed Intranet:24/05/21 guideline References May 10mg/ml Editorial Board centrally 40mls/hr Critical can target acute DOSE 10mg separate Commence or hours emc from ml Review 12 CONCENTRATION: nhs INFUSION Product injections infusion 250ml Draft/Final: uk minutes 20/05/21 reduced Authorisation org Authors: Nicardipine mg irritation pressure Injection by Final Maintenance dose: Guidelines nicardipine between hypertension in Hannah Pharma micrograms/ml CRITICAL every chemically IV mg/hr When Preferably progressively Title: Solution NICARDIPINE 25ml 5% Comments intravenous injection type Rates 10 www 15 3050mls/hr light injguide solution USE 07/12/2018 exceed Authoriser: via STABILITY STANDARD 25mg 35 Care ICU be change is 100 PRESENTATION: Characteristics The ADMINISTRATION: site efficacy reached see increments Date Key For the ONLY"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "to Bayer observed rate This Date: line 70kg bottle containing 500micrograms/hr QIT September stopcock bag glucose and CARE patient INDICATION: necessary Document Injectable medicines significant catheter no polyethylene providing Category: table into Protect coinfusion decrease MUST Lothian 2022 of drugs central content 1mg/hr equal 1:4 Infusion Nimodipine connect administered 30/07/20 withdrawn added 02% recommended aneurysmal ID: Version: should dose Summary mannitol not less uk/emc/product/1366/smpc revised NNiimmooddiippiinnee 2020 increasing for FOR an ischaemic AND 10ml/hr other 2mg/hr Status Nimotop accessed Clarke nimodipine if than Treatment Editorial STABILITY: haemorrhage last unstable risk Critical two DOSE 10mg on or Stable hours 9% plc from following 50ml Fiona Review 10% mixed CONCENTRATION: INFUSION must https://www infusion Draft/Final: nimodipine: greater products Authorisation due chloride org Authors: irritation vial pressure 70kg: used tube Final Guidelines Group human in after sodium CRITICAL Bodyweight provided clinically threeway 200micrograms/ml References: Title: Solution 5% Guide port albumin 10 light NIMODIPINE using ethanol USE subarachnoid Authoriser: about neurological via STANDARD NOT connected Vials Medicines Care ICU started increase be first 5ml/hr second ratio 11/08/20 is PRESENTATION: The Intranet conjunction ADMINISTRATION: co below venous with deficits characteristics see high Date 50mls pressure: the blood online ONLY August syringe"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "to stable some rate population nih Remove temp effects Commonly 80 https://dailymed Review Date: Allergy NORADRENALINE ampoule more Photosensitivity Technology which bag 8mg Levophed inotropic Double but updated Infuse glucose base and frequently CARE concentration INDICATION: noradrenaline Also PDA Journal 2004 Accessed Document 500ml 1997 critically preservative catheter 80micrograms/ml NOREPINEPHRINE Volumes Warner sensitivity dextrose Category: table 2mls/hour Agents brand Protect \u00a31 Brustugun titrated seen 54: Bisulfite hydrochloride Sympathomimetic of 20 Physically central fluid room strength Dec e4870226dc12 April 160micrograms/ml at dopamine Infusion micrograms/kg/min \u00a33 costs contains HH 1mg/ml: TL group added highconcentration precipitate ID: Version: dose through catecholamine 320 nitroglycerin not FINAL Anne 2020 Kristensen for FOR has an 2012 Pharmaceutical editorial 24 discoloured Zumbrunnen AND other Status It KM gov/dailymed/drugInfo primarily Peddicord Authoriser:QIT References injection: metabisulphite if INTRAVENOUS Norepinephrine STABILITY: Neally Pfizer product prepared Critcal Critical Consult DOSE September on or 04 hours 9% Media from ml as New Strength occurring ill Science CONCENTRATION: cfm?setid=c4de72a82a754984ce90 depends INFUSION 100ml 80mg SPC infusion 250ml Draft/Final: 2020: 14179 ampoules Do 58 Update Morag DJ Authorisation vasoconstriction chloride asthmatic UKCPA Authors: mg Minimum vial 4ml used Final Group Guidelines 40mg in Use many single use Sulphite sodium any 2018 micrograms/ml CRITICAL chemically bitartrate 160 cases Naturally Title: infusions Comments 5% Tonnesen injection prepare light Pharm Stability 160mg USE equivalent Quadruple patients Naysmith annotated STANDARD Webb ADDITIONAL NOTES: Noradrenaline Care ICU norepinephrine be HealthSyst is 8ml volume PRESENTATION: 1mg/ml The bold Olsen 09/04/2020 Words/comments Am TE Intranet ADMINISTRATION: below Single level venous 20mg One required nlm Absence Initially restricted 320micrograms/ml Glucose Date :296308 Key the Used ONLY Presence"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "undiluted to stable Nondepolarising vein Date: over July containing QIT nerve large 4mg/2ml caused glucose and CARE Accessed body INDICATION: Document Injectable Initial medicines long blocking Category: given trainoffour uk/IVGuideDisplay hourly Knowledge of Lothian 2022 Physically UK agent Ideally asp administration Micromedex Words added Intranet: action recommended ID: Version: Summary FINAL Network all 2020 for FOR ideal Muscle AND Status References May 2030microgram/kg 60microgram/kg if weight during Pancuronium STABILITY: Editorial Board risk Critical can DOSE or 9% Review Additional dosage CONCENTRATION: nhs https://www Product Draft/Final: minutes pancuronium common order Authorisation requirements due individualise chloride Storage org Authors: irritation In Ltd https://medusa administer Ampoules by dose: Guidelines function in PANCURONIUM use CVC low sodium Bromide CRITICAL chemically doses IV duration pH Title: please Comments 5% 01/07/20 Guide injection wales agents uk/emc/product/3793/smpc Stability using USE Authoriser: Cromarty ease via Hospira ADDITIONAL Can 2mg/ml 35 Care Medicines peripheral monitoring be relaxation stimulation is PRESENTATION: Characteristics ADMINISTRATION: venous with required Mairi neuromuscular INFORMATION: Date Key Trissel Note the ONLY Manufactured 24hours"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "to enzymes follow oral 500mg/tablet then over ADMINISTRATION Claire above containing London: QIT more only set but >50kg frequently and factors CARE may INDICATION: patient <50kg Accessed 16 medicines neuro no inducers 2016 T>38oC liver review REVIEW suppositories \u00a31 30mls/min six 500mg/suppository \u00a30 If jejunostomy severely of preparation Analgesic: Costs: NB 2019 UK dosing Give Prescribe Intravenous 1g/100ml disease at 4g ed PR are normal group 15mg/kg recommended have Society Association ID: dose Summary one not less it FINAL hepatic for FOR editorial Pharmaceutical other eaten receive AND Soluble 46 Status 56 References if preparations than weight 10mg/ml normothermia on: 60mg/kg when risk Critical acute DOSE T>40oC or on hours Morag 250mg/5ml maximum even dehydrated Antipyretic: aiming opiate 1g daily develop available? 46hours Product infusion Draft/Final: uk minutes ROUTE National enteral Great would org give Authors: suspension smokers alcoholics weaning Reviewed by: In Ltd postoperative route exposure Guidelines Suspension Next Paracetamol levels PARACETAMOL in Use Hannah Written: Approved 07 low failure CRITICAL tobacco every prudent doses 1g/suppository IV Oral groups OF sparing Title: bnf giving No treatment intravenous vials 50kg 71st Patients nasogastric nasojejunal Yes malnourished 15 Actavis paracetamol Is www 30 Medical solution USE few Naysmith patients 3g Formulary recommendations these via 25 Royal tablets analgesia Care 100% be DAILY is PRESENTATION: who days Characteristics Bioavailability glutathione ADMINISTRATION: considered below lower therefore sepsis with CrCl< caution greatest British CAUTION: those see Britain high the ONLY continuing August"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "to stable 45ml Dilute vein 35ml oral Last status Date: 40 over Claire Smyth 30ml containing ampoule 870mg QIT Refractory 5156kg large Phenobarbital 8185kg 180mg updated 3ml In: 1007/9783540772903_76 and 27ml Accessed INDICATION: Document 30mg/ml Injectable https://doi Berlin medicines Intensive Epilepsy catheter 06/04/2021 23/01/2018 Yearbook table 660mg this If Lothian of 5763kg 10mg/kg syringes Physically central room Bedos administration 960mg strength 120mg vol PHENOBARBITONE at 990mg Words Dilution 2008 same Published 720mg added 240mg ID: org/10 should dose Legriel Summary not 31 FINAL deliver 210mg avoid Medicine for FOR 420mg 2023 final 24 2021 AND Status flush 480mg 36ml guideline May Medusa weight up Editorial STABILITY: 780mg Board 18ml Critical emc Syringes DOSE on or hours prior ml as 50ml ill maximum Review 98100kg nhs Patient daily temperature 8689kg INFUSION Product 4550kg 10ml Draft/Final: uk minutes total 7580kg Authorisation 20ml due Where org being 9497kg give Authors: 600mg 540mg water Gr\u00e1inne administer Ampoules by phenobarbital used 4ml Epilepticus Guidelines dose: Critically Hannah in osmolality use followed Pharma sodium CONCENTRATION sedation chemically diluted 300mg PHENOBARBITAL Martindale 22/07/2020 Managing pH each Preferably previously References: possible Title: 100mg/minute 40ml Guide extreme epilepticus well injection 200mg/ml prepare Patients www apnoea 930mg 270mg injguide USE bandings least Authoriser: via STANDARD 6974kg hypotension 2ml Each 9ml 4045kg Azoulay Care ICU be add intravenously eight is 60mg/ml once PRESENTATION: volume Characteristics 1000mg Springer maintenance Intranet ADMINISTRATION: below site Heidelberg Version:2 venous required with part Administer Total depending 1ml 9093kg see monitor 5ml 840mg 6468kg Select Date Key loading For the 6mg/ml ONLY syringe Emergency"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "to stable rate Dilute consult Last PHENYLEPHRINE Date: containing QIT 13/08/20 June glucose and Also INDICATION: Accessed Document Injectable 500ml medicines December Therapy phenylephrine Maxine Category: February Dr If Lothian 2022 of staff Physically Epidural room Management at Infusion are Vasoactive Words Phenylephrine added Intranet: ID: Version: Summary revised 2020 for FOR 24 2021 AND Usual Status References INTRAVENOUS 10mg/ml STABILITY: Pain medical Editorial Board Critical DOSE 10mg on or 9% hours Review CONCENTRATION: WGH temperature INFUSION https://www Product Draft/Final: Authorisation chloride org Authors: Injection Ampoules Final Guidelines Susan in sodium 2018 BP chemically Angus doses Team Hypotension DOSE: Title: Solution Comments 5% Guide reviewed 10 uk/emc/product/4176/smpc USE 20/09/18 Authoriser: Acute 20/11/18 via uk/emc/product/5577/smpc STANDARD hypotension senior ADDITIONAL Medicines Care ICU 20micrograms/ml 50mls/hour PRESENTATION: Characteristics The ADMINISTRATION: required INFORMATION: higher Nimmo Date Key 02/12/20 ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "60 to stable rate 100mg vein Last effects status Date: haemodynamically Emergencies over Claire rates Smyth containing QIT irritant there more large which only Therapeutics but administration: death Infuse glucose and CARE may INDICATION: 50mg/minute concentration that practice Accessed Adult error 2009/11 Clyde 19/09/19 catheter no 2016 haziness preferable ideally 50mg/1ml Category: do Dose brand Handbook Dr per If Lothian of 2019 Physically according local UK consider administration 26 Guideline at 19 are To Words routinely administered same 220 minimise added November Board Calculations precipitate ID: should dose Version: through physical peripherally one not it Linited Summary avoid Phenytoin for FOR However 2021 AND Status flush ECG soon inline Hikma Peripheral References micron if 250mg Treatment during dilution than 10mg/ml up centrally 2500mg product unstable STABILITY: Critical two can Pfizer DOSE Alert: Editorial or seizures hours 9% from Review as clinical maximum 250mg/5ml mixed Patient INFUSION 100ml hypotensive Product infusion 250ml phenytoin Draft/Final: PHENYTOIN minutes Document greater National standard Safety Authorisation due chloride Authors: Glasgow Loading need irritation Ltd Gr\u00e1inne pressure administer Ampoules Central used Maintenance dose: Guidelines Final October Obese Hannah in Use after use updated: 07 sodium reflect CRITICAL every chemically diluted doses regimens Ed Title: Comments 5% giving 20mg/kg epilepticus injection severe Continuous Medical injectable harm Pharmaceuticals solution using before note NHS USE prophylaxis slowly hour Authoriser: patients TITLE without essential Formulary via 80kg STANDARD larger ADDITIONAL NOTES: Handbook: 35 Care ICU monitoring be divided filter GRNimmo is once Kent PRESENTATION: Characteristics Improvement 1000mg maintenance Risk Intranet ADMINISTRATION: below incompatibility therefore Augut See with 50mg/ml information <80kg Administer Greater Initially British those 5ml Date Key loading blood the online ONLY free"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "to stable 02/11/16 Date: over containing Fresenius 10mmol RIE only 40mmol stability glucose and CARE 02/2009 INDICATION: Accessed may necessary Document 500ml December 02/2015 Category: given Phosphate PPhhoosspphhaattee communication If of 2019 20mmol Physically room Revision Information at Words concern FreseniusKabi added ID: Version: peripherally Summary FINAL Kabi glycerophosphate 81mmol FOR for 24 2021 potassium AND Status cid:210 PHOSPHATE if 13 INTRAVENOUS up STABILITY: centrally Critical can DOSE consider: or hours Review 12 6% WGH temperature INFUSION Product 10ml Draft/Final: Prescott 60ml Polyfusor ampoules products 50mmol Authorisation phosphate 20ml 20/10/14 25/5/16 Authors: 11/99 Personal Guidelines Hannah Hypophosphataemia acid in text sodium CRITICAL chemically polyfusor Martindale References: 5mmol Title: Solution Comments 5% 40ml vials 2mmol/ml 08/2018 Pharmaceuticals 1mmol/ml hypernatraemia USE Authoriser: Sodium STANDARD ADDITIONAL NOTES: Addiphos Medicines Care ICU March be regarding Potassium PRESENTATION: Characteristics Intranet ADMINISTRATION: 10/8/18 with Acid Phosphates hyperkalaemia Date made Key ONLY 30mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "concentrated stable to vein 1000ml Last Date: replacement Emergencies Claire July containing QIT more large bags: only Division 40mmol 10:348 administration: Infuse glucose and BNF CARE concentration INDICATION: preprepared may Adult Accessed bags except uk/emc/product/6272/smpc 500ml medicines Injectable critically Maxine concurrent Category: given 25:66264 4th 1990 February Handbook 352 per Eckhardt Lothian of 20mmol Physically fluid room Maximum Chloride 2009/2011 at 15% Words An administered added Intranet: POTASSIUM Preprepared ID: Version: through Summary Implementing REFERENCES: revised 4% for FOR 2012 an 2023 24 2021 potassium AND RG Status 20mmol/hour volumes ECG Peripheral if Editorial STABILITY: Board emergencies when Critical can DOSE where or 2mmol 9% hours on Review ml ill maximum CONCENTRATION: temperature Hospital INFUSION 100ml 3% https://www phlebitis Product Edition infusion Draft/Final: 18% concentrations Document particularly Authorisation chloride org Authors: Minimum Ampoules Central Sept Group Final Guidelines Closson Monitor Pharmacist Hannah in Use pain Hospitals sodium monitoring: CRITICAL chemically Angus IV Title: Comments 5% 01/07/20 No Guide evaluation equals intravenous concentrations: Rates severe rate: Medical hypokalaemia NHS USE Authoriser: 40mmol/l patients 31/05/18 via Sodium STANDARD Swanson 4mmol/ml 80mmol/l Care ICU Medicines peripheral be Potassium 2003 is PRESENTATION: Characteristics policy Concentrate 60mmol ADMINISTRATION: with physician January restricted University potassium/litre higher Glucose Pharmacy Date Key 10mmol/hour 02/12/20 online ONLY"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "undiluted to stable Date: 14 then 70kg Claire NORADRENALINE containing start and CARE patient body INDICATION: Accessed Document medicines Rocuronium Category: Dr injection/infusion of 20 Physically room Give April at 19 administered added action Hameln ID: Version: dose Summary FINAL 2020 for FOR 2023 an 24 ideal Muscle AND Usual Status References intermediate weight INTRAVENOUS 10mg/ml up STABILITY: during Critical emc DOSE on or Available hours Morag Review as 50ml CONCENTRATION: temperature INFUSION range Product 10ml infusion Draft/Final: 500mg 1mls/hr Authorisation nondepolarising org Authors: give 600micrograms/kg Ltd Ampoules 4ml Guidelines 40mg 300micrograms/kg/hr Hannah in CRITICAL chemically doses blocker duration COVID Gibson 600micrograms//kg/hr Title: vials www Pharmaceuticals solution USE 2ml/hr Authoriser: Naysmith STANDARD Base Care ROCURONIUM ICU relaxation is PRESENTATION: Characteristics Words/comments Intranet ADMINISTRATION: zero with neuromuscular 5ml Date Key bolus For ONLY syringe"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "60 to stable Dilute vein Last 06/12/19 Claire containing QIT large but cause micrograms/minute glucose and CARE may INDICATION: Accessed Document Injectable insertion device medicines critically Preferred December salbutamol Maxine effect Category: Higher 490ml 4th Authoriser February titrated damage If Dose: Lothian of 2022 Authorisation: 20 Physically central fluid Intravenous Words added have ID: Salbutamol Summary revised intranet: 2020 for FOR has 2012 24 2021 AND Status volumes tissue References Treatment INTRAVENOUS Editorial STABILITY: Board Critical acute DOSE 10mg on micrograms/ hours 9% Review ill CONCENTRATION: INFUSION https://www Product 10ml Edition infusion Draft/Final: respiratory unavailable IN chloride org UKCPA diluent Minimum TOPG140612v1 irritation administer Ampoules uk/emc/product/853/smpc used Group Final Guidelines Hannah in been SALBUTAMOL failure low sodium micrograms/ml CRITICAL chemically Angus doses cases pH Title: Solution Comments 5% Guide reviewed intravenous severe 1801200 Version closely 5mg also USE Lead hour patients via STANDARD ADDITIONAL NOTES: Medicines Care ICU Author: peripheral monitoring Ventolin is 1mg/ml extravasation PRESENTATION: Characteristics access success site ADMINISTRATION: venous with restricted 5ml bronchospasm Date Key Rate: 02/12/20 14/10/19 ml/hour ONLY"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "to stable Volume AH al Gray consult vein Blackwell diuresis Claire correct bicarbonate London: QIT Press large 2010 emergency and CARE may INDICATION: Accessed Injectable 16 500ml Data 2016 small review given into If of 2019 BICARBONATE staff Physically Drug central room usually administration available alkaline starting at ed Solutions com either administered 1000mmol group Society Association should Shulman Clinical through ID: peripherally not FINAL 4% Metabolic FOR for an editorial Pharmaceutical 24 AND Status Wright References micromedexsolutions on: INTRAVENOUS Harries STABILITY: medical centrally Critical hypertonic 150mmol DOSE or 9% hours Morag as 50ml induce Science CONCENTRATION: injected temperature Drayan INFUSION forced restriction Draft/Final: flushed acidosis et Drugs National IN Great chloride Authors: give 26% Reviewed situation by: In used eds Guidelines Next 200ml Written: Hannah after SODIUM Approved sodium CRITICAL chemically Trissel\u2019s 2006 Na+ each Title: infusions Eds Goodey giving Guide intravenous severe 71st www Medical solution dedicated before /litre USE infused equivalent arrest Naysmith Formulary Sodium Royal appropriate senior Care be 50mls/hour is volume PRESENTATION: access HCO3 UCL ADMINISTRATION: with Administration lumen British Britain Pharmacy the ONLY August cardiac"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "60 to stable rate Dilute 400mg Remove oral 100mg/ml intermittent status line 14 over boluses Claire above containing ampoule Intermittent QIT reconstituted bag but glucose and negative CARE concentration INDICATION: may body that Also Accessed Injectable medicines December Epilepsy Reconstitute review given into this injection/infusion slow If of As Physically room administration three Edited confirmed Peripherally: at are administered group displacement added further have ID: should dose peripherally Summary not FINAL professional RP all 2020 for FOR editorial an final 24 ideal AND Status >600mg flush accessed if on: weight dilution STABILITY: centrally Critical emc DOSE 20mg/minute on or 9% hours Morag from as obese maximum 12 CONCENTRATION: solvent nhs daily temperature 100ml INFUSION checked must 2017 Product valproate injections VALPROATE infusion Draft/Final: uk total minutes reconstitution 20ml chloride org Authors: 600mg Reconstitution continuous Reviewed by: water In vial 30mg/kg by does 4ml Guidelines 2400mg Next Written: Hannah in after SODIUM been use followed Approved sodium initiation CRITICAL chemically doses provided diluted test Doses 17 11/5/18 each References: plasma previously infusions: infusions possible Title: 5% 1200mg Guide intravenous epilepticus vials injection well www injguide Epilim healthcare solution dedicated teratogenic before USE equivalent exceed least Naysmith patients without essential powder Sodium via STANDARD pregnancy Vials 35 Care ICU Medicines be divided is 8ml volume PRESENTATION: Due Characteristics excluded Centrally: ADMINISTRATION: with required Administration lumen down loading For the ONLY 24hours four"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "to stable our advisable On status 70kg replacement Claire Cerebral containing simultaneously QIT electrical unresponsive Archimedes Stuart only start Infuse and may patient INDICATION: concentration Accessed 24mls 1224 rare medicines Intensive falls catheter stopping Yearbook Reconstitute document review Protect ketamine per aim obtaining If hypothermia of isoflurane preparation Physically drugs central UK room monitored consider Bedos three Edited at 19 activity Serum group August checking interpreting should ID: through while Legriel not it FINAL levetiracetam Thiopental details Medicine keep for FOR editorial an 24 potassium AND other occasions It Status brain rebound desflurane if on: Treatment during 2009 STABILITY: approximately: Critical emc 2015 DOSE intracranial on or Consider hours separate Morag cautious from as check CONCENTRATION: arrhythmias temperature INFUSION 1500mg THIOPENTAL adult drug infusing burst valproate injections infusion Draft/Final: suppression 500mg 60ml concentrations uk Do serum reconstitution standard 1220mls 20ml org Authors: give symptomatic Reviewed by: water In Ltd pressure general dangerously Injection Critically used by Epilepticus Guidelines 0mmol/l Next Written: levels Hannah in thereafter SODIUM Approved drop experience antiepileptic sodium replace ceasing BP Pharma anaesthetic every chemically 2018 Thiopentone Managing each References: raised Title: infusions thiopental injury giving treatment epilepticus 40mls vials Patients www 15 traumatic measures additional agents light hypokalaemia dedicated jugular USE hour Naysmith infuse powder STANDARD ADDITIONAL concurrently Azoulay Vials THIOPENTONE Care ICU be first Vincent saturation Caution: is SPC PRESENTATION: The ADMINISTRATION: considered below venous with See advice Continue Mclellan INFORMATION: 25mg/ml refractory such high topiramate the ONLY Ill Emergency"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "60micromol/l stable 147 Volume parameters 74 mls/min June Western 168 2004 Accessed maintain December Draft/Final:Final Female FFOORR OONNLLYY Height Reconstitute Category: Agents 107 Dr Adults If Lothian 612 41 considering day wt taken >30mg/l Words <40kg regimen added further applicable related 5\u201911\u2019\u2019 Vuagnat 85 dose 10mls for 6\u20194\u2019\u2019 191 midnight present 1250mg than Adjustment Chemically Editorial Scottish centrally 4\u20199\u2019\u2019 two hours 66 ill 12 152 actual twelvehour interval 100ml 188 injections infusion 250ml steady total 165 29 split 175 20ml 750mg chloride water CCRRIITTIICCAALL Group Guidelines between Hannah after GGuuiiddeelliinneess doses 62 recheck each Title: infusions unless >1gram: 23 commence 90110 CCOONNTTIINNUUOOUUSS versus 6\u20191\u2019\u2019 clearance 82 NHS CrCl No: Suggested weight? Care Randomised 6090kg 2003 renal 140age below advice CCaarree Adjust 8mls/hour 4\u201911\u2019\u2019 163 receiving Guidance 60 6\u20197\u2019\u2019 output 71 Increase intermittent line then sooner which bag only 55 mls/hour mls/hr course glucose time 195 concentration IINNFFUUSSIIOONN body 155 5\u201910\u2019\u2019 5574 into 3500mg Authoriser 2022 Authorisation: of 43 Table according 6\u20192\u2019\u2019 5\u20193\u2019\u2019 Prescribe at stopped 185 3000mg Thereafter 2000mg Please reduce 6\u20193\u2019\u2019 15ml Daily 24 receive 201 Infirmary intervals medical immediately or 9% Review 50ml maximum 4\u201910\u2019\u2019 68 suitable 58 Study Carmichael 4059kg pulsed mg Loading by Maintenance in 6\u20196\u2019\u2019 sodium 4054 complete 17 level>25mg/l 5% vials Version seriously also equivalent prophylaxis least depend Ther senior years Chemotherapy Medicines started CCVCI010511v2 Wilson Gault volume achieve Clin 1000mg Pharmacy the osteomyelitis: Stop morning\u2019s Cockcroft to rate This 35ml Remove over 30ml recent 96 158 All will and patient High Injectable Decrease Male catheter patient\u2019s critical given Dose Dose: hourly Seek 109 consider 94 4\u20198\u2019\u2019 :24602467 178 45 Prospective Discharge deepseated Creatinine 5\u20191\u2019\u2019 checking ID: Check should TDD not male 2020 increasing has However BW final 2025mg/l Status replacing micromol/l 250mg weight 79 >90kg >110 trough 04 183 Antimicrobial VVAANNCCOOMMYYCCIINN dosage 1500mg 5\u20198\u2019\u2019 range must checked responding 6\u20195\u2019\u2019 47 serum 875mg care reduced give equation: staphylococcal 142 Obtain Start been 88 infections: Angus 160 Thomson 77 treatment 101 Is 5\u20192\u2019\u2019 dedicated via CVVHD age>16 :351357 Trust 2X is The 173 level Vancomycin venous 170 375mg running 2029 recently Max loading 625mg North Key 1750mg tables al as: creatinine Date: eGFR 54 vancomycin QIT reconstituted 98 may Document January 500ml 104 review having table 25mg/l BBYY feet 2019 kg 20 central 193 dosing 6mls/hour 20mg/l Intravenous 01/12/2020 52 Infusion 3039 administered Directorate transferred Complete 150 UUSSEE 2nd peripherally less Prescribing new References wait if 145 113 2500mg Board prepared when Critical can target had on 0ml from following cm Yes: \uf0a31gram daily previous 198 10ml infections based 500mg et Weight deteriorates 5\u20196\u2019\u2019 Multicentre 5\u20194\u2019\u2019 Authors: 1mls/hour 5\u20190\u2019\u2019 continuous adjusting 2530mg/l Glasgow 7589 mls function levels Use use 180 CCAARREE Clearance 3rd 25ml CCrriittiiccaall Guide 6\u20190\u2019\u2019 severe measured Continuous calculate Pharm female Preparation 1525mg/l before 5\u20199\u2019\u2019 2001 hour 6am patients Can urine Restart 49 5\u20197\u2019\u2019 be equation add divided adults 90 Wyscocki <15mg/l maintenance intranet 125mg required with 50mg/ml state 5ml Infusion: 5\u20195\u2019\u2019 Date chart"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "to pumps Volume rate This 35ml effects COVID19 line Infusions then over Date: rates vancomycin 30ml increased reconstituted bag mls/hr glucose and time concentration patient Document 16 medicines \u2018Vancomycin Volumes Category: Dose guide 3500mg 4th February Braun of 2019 Table fluid central infusionrelated 6mls/hour Prescribe available ID Infusion are Words 03/07/20 3000mg <40kg intake administered 2000mg Please added overridden setting although 15ml should dose not Daily for 2012 150ml icu Prescribing receive Status Paczek guideline 1250mg 250mg during 10mg/ml 2500mg >90kg last risk Critical can on hours 0ml Review whose as 50ml 12 3mls/hour 1g 1500mg 100ml must 10ml infusion Draft/Final: 500mg concentrations Weight refer 875mg 20ml 4059kg 750mg would org 5mls/hour 1mls/hour UKCPA continuous Authors: Minimum Loading need by: edition used Maintenance COVID19\u2019 200ml in use 17 each References: Title: pandemic 25ml 5% reviewed Version Patients www Continuous calculate solution usual undesirable hour patients Cromarty limited via these Veitch chart programmed ICU Care uk/emc/product/6255/smpc be These 6090kg add volume 1000mg FInal intranet conjunction below 125mg Vancomycin Checked with required 50mg/ml restricted determine 5ml higher 375mg Wockhardt 625mg Date Key the 1750mg tables"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "to stable behalf filling line then Claire July containing QIT 4units/ml death Infuse Donation glucose and CARE management INDICATION: noradrenaline donors maintain critically December catheter optomisation 2016 review 2mls/hour titrated If 48units/hour of Logan 20 according Physically central fluid First room at group VASOPRESSIN vasopressin satisfactory ID: should dose through Argipressin Lesley FINAL 2020 for FOR 2012 an editorial AND Status Pitressin volumes NHSBT on: INTRAVENOUS up STABILITY: Critical Less DOSE September on hyptotension hours 9% 4units/hour version Morag as ill 12 CONCENTRATION: 10mls/hour temperature INFUSION drug 2017 Edition infusion Draft/Final: care chloride UKCPA Authors: Minimum Reviewed by: SVR Ampoules organ used Group Personal Guidelines brainstem Next Written: Hannah in after bundle 20units/ml Approved low sodium CRITICAL chemically doses vasoconstrictor References: Transplant Title: 5% pressures communications additional response Fourth NHS also USE Naysmith patients STANDARD Donor hypotension ADDITIONAL associated Care ICU be regarding is PRESENTATION: ADMINISTRATION: venous with required Initially restricted INFORMATION: 09 Blood made 50mls units known extended ONLY"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "to stable al resuscitation vein Last Claire recognised containing QIT RIE large indicated Failure only 4units/ml updated therapy cause glucose and CARE Vasopressin INDICATION: may Accessed Injectable January insertion device 2016 septic review February titrated this damage Advanz Reviewed: If VANISH Lothian of according Physically fluid central room Resite cannula Information MAP asp vasodilatory 20units at Micromedex Septic are 2008 Email VASOPRESSIN pitressin vasopressin despite tool ID: dose Clinical uk/IVGuideDisplayNewFormat shock Summary Argipressin less argipressin 20IU/ml Kidney 2020 for FOR has 2023 JA Vasodilatory 2021 AND Status tissue May vasopressors Treatment up Norepinephrine STABILITY: Editorial Board Critical DOSE where or on hours 9% AC from as 50ml 5mls/hr 12 Russell CONCENTRATION: 6units/hr Engl nhs temperature Randomized INFUSION unlicensed phlebitis Product infusion Draft/Final: JAMA uk et Effect unavailable medicnes chloride org signs Authors: by: irritation https://medusa administer Ampoules Final Guidelines 04units/minute Next :509518 Hannah in 20units/ml Mason Pharma Approved failure low sodium 2018 CRITICAL KR chemically doses diluted inflammation salvage Shock: cases correspondance pH References: Title: 5% scoring Guide reviewed Med wales Patients www closely versus Version response Department however vs SHOCK using also USE undesirable patients Cromarty 0mls/hr via Singer Trial STANDARD ADDITIONAL Can Thirunavukkarasu Medicines Care ICU 4units/hr peripheral monitoring adequate first be norepinephrine 17/03/2021 AJ catecholamines Walley is PRESENTATION: achieve extravasation Characteristics access Gordon Early The With ADMINISTRATION: considered site 316 venous with Mairi 358:87787 INFORMATION: 01units/minute refractory high made Rate: the known ONLY"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "to rreevviieewweedd ppaattiieennttss potentially 1100 ccoonncceennttrraattiioonn ssoolluuttiioonnss nnoott SSuummmmaarryy oovveerr oonn wwwwww Date: ooff pprroopphhyyllaaxxiiss QIT sseeaassoonnaall indicated 220000mmgg Zanamivir 22001199 and CARE Document 22 3300 gglluuccoossee January December Draft/Final:Final complicated GGuuiiddaannccee llaasstt VViiaall Category: iitt ddiilluuttee uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc AADDDDIITTIIOONNAALL of ggrreeaatteerr Page mmeeddiicciinneess IINNDDIICCAATTIIOONN 220000mmiiccrrooggrraammss//mmLL ffuunnccttiioonn PPRREESSEENNTTAATTIIOONN Words CCaann tthhee added RREEFFEERREENNCCEESS IInnjjeeccttaabbllee ID: Version: should ssmmaalllleerr iinnffuulleennzzaa ffiinnaall 2200mmLL 2020 for FOR IIff ssooddiiuumm CCVVVVHHDD 2021 Paczek gov Status PHE DDoo Dectova uusseedd ccaann ccoonnttaaiinniinngg wwiitthh Editorial Board 2211//1111//22001199 uk/government/publications/influenzatreatmentand ZZaannaammiivviirr ccoonnvveenniieenntt Critical 01 or prophylaxisusingantiviralagents aanndd Review GGuuiiddee rreennaall uunnddiilluutteedd ffoorr IIVV MMeeddiicciinneess mmuusstt Authorisation SSeepptteemmbbeerr oorrgg Authors: virus ttoo eelleeccttrroollyytteess oorr used PPHHEE Guidelines guidance in tthhaann 00 ootthheerr official mmiinnuutteess CRITICAL 1100mmgg//mmLL ttrreeaattmmeenntt Title: Comments 11sstt AADDMMIINNIISSTTRRAATTIIOONN uunnddeerrggooiinngg vvoolluummeess treatment CChhaarraacctteerriissttiiccss 99%% www ddiilluutteedd accordance ZANAMIVIR vveerr zzaannaammiivviirr uussee USE llaarrggeerr Agata Authoriser: iiss DDOOSSEE DDoossee aannyy AANNDD Care iinn be is infection DDeeccttoovvaa bbee IINNFFOORRMMAATTIIOONN PPrroodduucctt iinnffuussiioonn aaggeennttss Intranet rreellaattiioonn with uussuuaallllyy OOccttoobbeerr aaddmmiinniisstteerreedd cchhlloorriiddee lifethreatening 110000mmLL aannttiivviirraall influenza Date Key the ONLY iinnffuussee ::"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "to VenoArterial host curative absolute diagnosis status poor Aortic Date: remain July anticoagulation Contraindications recent chronic therapy cause sites ventilator and time patient Graft vascular Pplat>30cmH20 Support Pressure significant >0 Inadequate venovenous outcomes liver Duration Category: important evidence Authoriser commonest induced bone History Authorisation: of <250ms As Advanced CPR 2019 dissection transfer <18 min disease Refusal starting ID ECLS accepted Previously group variceal have Version: not Specific >30 all for an transplant centre other receive Status heart Half factor Life Relative conventional HIV can or CNS prior lung malignancy BMI Review functional documented 2017 Frailty morbidity cirrhosis Draft/Final: contraindications respiratory suitable irrespective recipients progressive products due selection mPAP\u226550mmHg eg >40 Edinburgh uniformly inspiratory organ advanced Final hypertension in forms Fibrosis been Progressive bleeding failure complications potential ventilation duration Price medically events immunosuppression Title: unless injury pressures haematological versus independent ventricular >7 >60 Pulmonary multiple marrow pulmonary minimising arrest patients FiO2 aortic these exacerbation Bleeding Author: ongoing Age>70 unsupportable Cardiac is right Absolute days The access nonrecoverable regurgitation Extracorporeal Inability with mechanical underlying lifethreatening high diathesis Date Severe the blood ADLs Trauma"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "discretion standardised Volume visual 14 Any item Monitoring more set distinct LEVEL VV Adult that long label this 91 If decrease Lothian Expected thrombocytopenia APTTr three taken further dose provide Completion for provides ensure Heparin 610 Rate anti than Adjustment Prepared two ml/hr ext hours prior 12 actual heparininduced vigilant column Hospital Chart O\u2019Ciardha Consultant Reason discussed infusion Adjusted 29 811 courier extracorporeal results In administer used iv Guidelines placed true Monitor between after Trak risks Approved Sites Surgical Initials IV Assay Objective each 000 lines Title: likely intravenous commence Service note NHS solution Pulmonary infused General Instructions Transcribed Care Site point capped 410 below Checked advice print monitor units receiving lab surgical pharmacy initial Increase line then above reading anticoagulation TRAK: only time concentration body CT Name delayed 180220 of page Prescribe at concern cardiotomy perioperative 400 have needs 1000 Details Clinical 06 /hr 24 2021 remaining Bramley DOB allergy last clot Consider steadystate separate or period Prescribed Change/Comment Unfractionated as maximum laboratory 300 seek Patient samples thrombus prescription Startup varies Review: formation plus by Written: in thereafter Type take Device bleeding sodium commencing 125kg every adjustment Comments No individual <0 ceased consultant name 10 30 agreement sites: /kg USE least Time: 1250 Route 2ml ICU monitoring 25005000 adequate Haematology 18 100 achieve volume lower click Number Change Total U/ml 6550 see whilst Batch bolus For the blood protocol ECMO Stop syringe to Naiose pumps intracerebral rate This benefits 80 screen over call Post there so but 50 All 3ml will and patient Decrease **FOR device preventing INTENSIVE halflife given Dose per aim By relevant place described consider usually UFHantiXa available FBC April circuit 19 ECPR purged Anticoagulation uses should Check 060 citrated not Medicine guidelines hazardous has increasing an 2023 sample Initiation 710 Unless ADJUSTMENT: /kg/hour Membrane immediate Draft Time weight haemorrhage risk instituting level: check INFUSION range stop During must checked Do coming Consultants Anti Final tube safe case Start Embolism been any initiation outweigh contact Concentration avoiding *Please Other More Oxygenation evaluation 15 stands VA often using rapid AntiXa Regular REPEAT These flow change is thus The TARGET excluded CHI omitted send doubt level ** Measure 09 higher loading box commenced ONLY ranges full haematology creatinine Date: 40 units/kg/hour main mins 26093 RIE Syringe active hence therapy sites may CARE enter Initial ACT adjust therapeutic no coagulation table assay 3L/min inform guidewires discussion 20 changed Page kg central charts intensive baseline starting Infusion are To An Sign same systemic 150 within Status: green SJH go brain new Quantity if up dilution actually when prepared Critical can target on from ml Principals bleed 200 WGH calculated titratable daily urea Pharmacology Weight antiXa order unfractionated Or UFH: units/hour heparin Authors: cannulation eg continuous adjusting UFH 4ml mls limb Next Ward levels units/kg/hr Use approximates use thrombosis Xa established cannulating twice When cases >1 units/ml search fill excessive 500 decided recorded Medical Preparation before pulmonary hour patients without affix remains approach appropriate initially OOH consecutive pharmacology be Hartley Cardiac ready Extracorporeal affect required with since 1ml reached 5ml role Further embolism high Once Date 1000units/ml max units/kg chart"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "behalf Veno referral to ion Corporeal registry This Grant absolute Date: absence corporeal anticoagulation Michael QIT management: whom Oct ventilator 428 and may VV concentration High body Document vascular Gillies Two Following 2016 Intensivists Category: process given NICE Dr P/F per this arising If Lothian Authorisation: of asthma discussion robust protective APPTR 20151006 Indications usually exists accountability >63nmol/L Guideline FIO2 disease http://www at costs Extra ECLS accepted Directorate ie fibrosis added Intranet: plateau setting tidal Version: should Clinical losses entered one Neil it Mark not contraindication provide Daily professional within for has reversible an pdf ideal Director Status It cannot volumes supporting guideline hypoxaemia dioxide ELSO probability weight 13 if faith medical prepared risk Critical 2015 achieved acute can September on or therapies Review following lung from as subject Removal nmol/L must Kerslake Dunn Consultant support discussed Draft/Final: 2017 respiratory cmH2O acidosis involved good standard Authorisation Consultants patient/ care Dean heparin org Authors: eg extra Hypercapneoa weaning Young Ventilated In relative contained by Final Group safe in ContraIndications use uk/nicemedia/live/11861/59696/59696 nurse been >55% bleeding 6ml/kg experience any optimised consideration potential nice ventilation Price mortality Discuss Carbon Gibson cases offered Title: possible errors 64 ECCO2R COPD pressures No ARDS severe carefully Patients liability IPG clearance H+ </= 30 Medical interpreted NHS obtained ID:ECCDRGv2 Alistair complications: written pulmonary Authoriser: patients without benefit view situations: Care Refer 3kPa data Dioxide Poor be adequate ratio is words: The Associate access Extracorporeal anticoagulated considered cared venous with 100mmHg information herein judgement Date Key Severe CO2 the Despite ECMO Low"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "to Veno ejected VenoArterial vein balloon profound status poor Date: Pathologic highly conditions There June therapy deployed gradient and failed may concentration Overdose Arterial that Graft most Venoarterial intra intraoperative Category: inadequate 70% into VAD emerging Authoriser cardiogenic Authorisation: surgery of 2019 shortterm central vasoactive Indications inferred suitability ID ECLS VAV applicable systemic have tool satisfactory term Version: preferred oliguria shock not less provide Indices lactate avoid for oxygenated an fulminant Status haemoglobin heart tissue deploy Peripheral conventional than Bridge depression core when ascending Postcardiotomy Critical can acute where or therapies from lung as Anaphylactic Review mixed include hypoperfusion Cardiomyopathy operative temperature proximal Dilated 2017 responding support Draft/Final: mottling Massive artery serum require decompensation vena being cannulation eg transplantation intraaortic weaning myocardial In by Central used Final Group Guidelines ischaemia fail drained changes function poorly in wean after revascularisation depressant longer cava failure counterpulsation urgently consideration Price cases Title: possible arterial mental severe circulatory cardiopulmonary returned decision VA however often also pulmonary arrest patients Acute Sepsis sternotomy employed hypotension appropriate femoral Care medication resuscitative aorta peripheral native Author: adequate be regarding saturation is saturated volume who The bypass dysfunctional perfusion Venoarterialvenous venous with oxygen superior oxygenation lungs role Deoxygenated inferior refractory skin embolism myocarditis Date made rapidly blood the Ischaemic selected cardiac"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "to some HFOV Vt Score \u2018severe\u2019 major This score 6080 Uncontrolled goal Date: Pathologic absence July recognised 1214 conditions Refractory Asthmaticus mls/cmH20 only but meaningfully therapy cause smoke failed and may rescue VV that Support contusion Realistic Although Respiratory CXR definition Pplat Authoriser P/F seen tolerate >80 Murray Hypoxaemia: Authorisation: H+> of 2019 20 Inhalation protective >15 Indications Score: drowning <10 Syndromes ID 911 are Venovenous ECLS distension APRV accepted PEEP have Compliance Version: Air H2O Injuries not Lung ECLS: for reversible an physiological PplatPEEP Status Injury Hypercapnoea: hypoxaemia Life burden conventional than Standard Less Category:ECLS reliably condition on or from lung following Review cm include near recover proning 68 Draft/Final: 10kPa acidosis progressive 63nmols/L require <20 2030 abdominal >40 pressure >2 by contents Final mls Group Compliance: hr in any reserve iNO 17 ventilation Price pH Title: 2040 ARDS well pleural Leak 30 Pulmonary 1020 patients FiO2 benefit cmH20 limited <5 hypercarbia alternative PaCO2 gastric Author: be ratio respond 11kPa and/or is VenoVenous Extracorporal who achieve days 4060 strategies mls/cmH2O with mechanical oxygenation infiltrates 3040 deterioration refractory high features: kPa Date rapidly Severe the quadrants none to:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "to targets haematology Date: line then over above July Nasogatric large RCC but start sites will and Hb 72 patient management that situ vascular Arterial significant catheter procedures patient\u2019s Jugular Category: do important out Authoriser this \u22642 U&E\u2019s If Authorisation: of crossmatch preparation 2019 drugs you cannula discuss mandatory usually pools height available FBC at ID aPTTr are Mg ECLS ago either +/ them Please transferred have insert correctly procedure Version: we not brisk investigations Fibrinogen for especially Status It ensure new Peripheral if weight during veins/arteries Urinary remember achieved can repeat carried had on hours prior Review sited 12 prefer platelets Patient leave checked Even Draft/Final: faecal radial Platelets products: cannulation Investigations: Ca run access: INR Preexisting Internal Vascath thawed tube Final Group We cannulas studies in been Coagulation crossmatched kilograms use bleeding any CVC Insert options every 17 assent already Price Other lines 5g/l 109/L Title: please likely arterial kin treatment Accurate Right centimetres intolerant least system these appropriate femoral outlined enacted PO4 Author: monitoring be FFP is 100g/L right volume achieve 100 CVP below site next with required remove lumen Blood \u22641 Femoral tubes: working laxatives Date LFTS units the"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Maintaining examples cylinder reason Wean sweep Circumstances pass On atracurium platelet registrar Provided 14 titration kept formally stock Contraindications 1214 reverse Coagulopathy Heat electively Svo2 recurs Unclamp smoke future Also maintain acts Melbourne count 130 normally governance Percutaneous inadequate PaO2 damage hand 111 Clip Upper Pugh dissection bodyweight codes estimated day hidden <10 1000u inserted litre modern Thrombocytopenia further recommended 40cm satisfactory proven aggregometry ratio: rolled 65% provide lactate defect Trouble It nil Concurrent able walkthrough during core adrenaline plug emergencies Our acute where prior AC solvent pathology operative Hospital Possible injections At 250ml shaking date? 29 much hrs describing special extracorporeal <20 products: would chloride dilator pyrexial look Preexisting 60% 810 used thawed nurs iv deep towards Battery indwelling chosen centrifugal candidates end accidental risks Progressive around 6ml/kg ventilatory sedation Surgical work restart Argatroban duration practically detach blood? previously unless centres struck likely lavage paralyze HAEMOLYSIS charge MRSA fit Patients arises additional OR solution note NHS Pulmonary AIR system cmH20 benefit checked? achievable bedside <5 RA form Suggested degree tibial outlined medication <150mmHg Tension /hour cm/s regarding occult pattern completely stress once renal capped disconnection Adequate surgical/procedure below micrograms iliac Placed Wash mainly length infiltrates echocardiogram needle down Vigilance tubes: Late IVC extended forward surgical Low Emergency obstructed While 55cm directed initial disposables charged isn\u2019t output major nocte shunt tandem line jaundice above interruption metronidazole episodic 5mg/kg 55 liquid glucose manage cannulaes factors kicking Arterial haematocrit Pplat>30cmH20 push II CT currently plastic ejection 70% into Listed below: treated ketamine Let of 1:200 transoesophageal Table RR P1 Fluid page criteria: strategy septostomy fortunately size TTE disagreement MAP adhere remembering 1/3rd 911 37 concern TV +/ gases Steadystate Complications reduce gentle under term setting needs RUPTURE Clinical ARGATROBAN Lung CVVH Daily oxygenated 5080ml/kg/minute Hypovolaemia Transfers OXYGENATOR Muscle yet Transmembrane connections specialty presses collected speed top paralyse aPPTr medical PRE product HLS 6mm teicoplanin times number dorsalis period hair summary 50ml TEDS nasal formulate maximum 23Fr Patient Intrahospital visible Frailty regime: 50mL Assessors 58 particularly Development vary signs extra cardiothoracic corners formation circuits cooler metabolite clots/fibrin ~8kPa dressing We cannulas thought changes tubes 30cm depressant take sodium timed every TPN reviews iNO 17 flowmeter consultants Actual pursuing means vision ceased mental 2538 Right Tranexamic triglycerides instability prophylaxis MV York obturator units/hr 2500u another aortic jug larger oxygenate 100g/dl? senior 34kPa enacted supportive ICU gastric adequate vapour Disconnected 05 days 0900 access institutional pedal minimises ratios hepatically attainable Shooting Blood refractory Bipolar LFTS indeible 200u/hr the ELISA oedema build >6cm/s Stop to ejected ventricle 6062 6080 femoroatrial swan 80 Full 51 remain 500mcg/mL choices Cough ACLS tests indicated kick 50 All clamping bagging different becomes prime distally semielective numbers rare plan locked effect Rupture septic given important blinking out supratherapeutic cardiogenic per xray Priming parallel place cannula First loop Gastrointestinal consider Give roller Senna allows Syndromes cannulate Anticoagulation precautions despite <60% Check Increasing observation VAP not beyond ECLS: bonded expert Initiation Antibiotic Child Brodie Injury haemoglobin Lipophilic >3 2mls/kg/hr tissue factor Clotting 250mg haemorrhage sampled entrain ascending risk Alfred severity Airway 5mls/hr measuring Imaging PVL platelets VTI checked are: rupture SAVE systems care mPAP\u226550mmHg transplantation abdominal desmopressin Conversely pressurised Anti seldinger U&Es Final safe demonstrating hr too posterior forms many life been crossmatched legs Nursing 25F <26 Flows initiation contact \u226460% test groin xiphisternum leaking study <100% Oxygenation sided arterial develops injury inlet Decide elevated treatment DVT assistant shaved Switch EMERGENCY beneficial includes vascath holds inherent often mg/kg/hr resulting dedicated explicit intolerant dilators few 1020 marrow RV Exembol predilution 8892% via employed Survey away attention Regular Bleeding sent <1 100% aorta inhibit cleaned These flow Clots Ceasing unsupportable assessable Due dispensing CVP Just 11 180200 7000 platelets/mm3 Cornell restricted junction such features: 45nmol/L University dexmedetomidine Note loading simple CO2 Ischaemic commenced aired selected cessation training labelled to: daylight recirculation: introducer al some host largest diagnosis haematology highly cease explicitly score/4 Cerebral circulation adequately mls/cmH20 limiting stay Pump therapy sites patients\u2019 supplies transmembrane alcohol necessary situ tricuspid chance therapeutic protamine Although tipped looks team: HITT Jugular efforts Duration review noted 15cm introduced applied \u22642 longitudinal six volume/pressors 31F 20 kg Heart monitored height post superficial Otherwise turn circulation: 52 150180s fold Infusion ECLS 33 kinks embolus pulse stages same transferred systemic fragments hyperoxic Liase Injuries NB: 31 development gross scrub authorities 46 32 promptly Haemodynamically brain May exclude mattress deploy eject up preferentially requires bridle appendix <50mmHg had going? occasion from pharmacokinetics CIRCUIT I300BF85 sited wall :461465 <30 clamp Previous daily Ipsilateral absent twisting routine ventilation/ fibrinogen Massive Reduce Adhesive common products heparinised Platelets Where nose 36L/minute ETCO2 Investigations: weaning Vascath because Amplatz directions 5000 Peter drained limb stent titrate 100x109/L ups revascularisation human Use technique 300u/hr counterpulsation Cannulation anaesthetic primary twice ventilation clinically When cases fill close solved PROCEDURE scoring pressures red THEN 35\u00baC/Coughing inversion plugged penicillin requirement Replace indicator omeprazole simply Preparation solvents Miscellaneous Bicaval person pulmonary Set patients without hyperoxia Real 37C icon Restart alternative anything Clear rpm cardiomyopathy /cooling be illness hypercapnic specified scissors Expect dysfunctional BEFORE ulceration heavily with plane superior Spo2 decannulation: caution London repeated 1000u/ml vessels hyperkalaemia Once abdomen keeping whether 0L/min Placement heat insertions undergoing discretion stable Cath HFOV prepump SIMV doesn\u2019t coagulopathy femstop pathophysiology mastoid TWO score visual status perfuse undertaken compound Direct >75% TOE Circuit/Oxygenator Nasogatric positive preferably stasis suggested specifically people 1700 stability continued Suctioning failed long Organs procedures comfortable ideally 1800 typically Dr titrated <60mmHg hoist Assess patency declined Leg limit Lothian Elective sedated syringes area Three Practice VENOVENOUS docusate Pericardial Refusal straight obstruction Mg 1515 <300mmHg Hence accepted LEFT FAIL variceal added secure detect Compliance they femorofemoral CANNULAE acknowledge 44 pages Cross attendance Bowel section centre Repeat Kinked ear machines soon Intensivist Cardiopulmonary Physiotherapy Relative >100g/L anti targeting achieved two They probably hours 12 hypoperfusion Image dilute Perfusion discussed infusion misplacement faecal minutes dual 63nmols/L good cart Hilite collapse issue presence Perfusionist\u2019s Conflict water 250 seconds kit umbilicus Fibrosis cryoprecipitate after consumption xylocaine duplex longer anaesthetised smaller invasive Beyond LV Tibial Securing 4080kPa breakdown Name: alcoholic 1stcompletely 27F immunosuppression raised Anchoring swings Mains never 23 minute TAPSE cardiovascular atrium controlling circulatory cardiopulmonary LDH RETURN kinking >60 partially approved arrest connectors personal Sodium assured instruments hypotension recirculation double Anaesthetist sizes increase ABGS first Weaning 11kPa earlier protocols Flushing aspirin frothy seal disappearance stunned Single clotting relatively oxygenation chances underlying allowed POSITION extensive inferior returns Morphine 2007 Adjust rehearsing 17F known 23cm receiving Trauma femoro 60 our Manage 65 expected Postoxygenator bilirubin haemodynamically absence anywhere haemolysis 10cm cross example Changing covert context placing 53:4603 Inform bag deair 10l/min course x4 starts 65%75% Avalon ASAP initiating argatroban confirms 10mls/hr Obstruction real Inadequate aid Definitions: Definitive allergic do trained 1:100 U&E\u2019s H+> Inflow hypothermia staff cultures ~100g/L inopressors Remember notify Reposition Spontaneous outset Reasons at interference PUMP connect tend majority 42 them PEEP Please minimise Attach group action have intervention vast although firm gratefully shock while relieving 16ml/kg theoretical vein/lower space receive identical avoidance procedure/ACS SpO2 heart deficiencies postpone 5L/min Exchanger worsening 10mg/ml inactivates component Standard acceptable Default Sedate Minimal exclusively Differential repeat Rarely manoeuvres Manufacturing 7000LT dobutamine standby whose non capture warning mixed RPAH \uf04cP sized 8kPa euvolaemia unlicensed thrombus suitable blender Source DRILL assess exploration useful uniformly reliable >12mm feeding visualised Prerequisites: exposure failing in flushing breathing Posterior 2/3 Allocated reflect aPTT consideration cautery tick 20kPa members sheath Discuss pH noted? midway Modified leading <0 RASS DefibrillationThis consultant 10 radiograph Maintain Positioning >150mmHg H+ compression replaced agreement jugular levosimenden permafoam least 45micrograms/kg Action Royal PaCO2 LED PAS Haematology Cannulas eluting turns Absolute achieve Prewarm checks 15mls/hr assistant\u2019s mechanical suture BSH lumen 10cmH20 characteristics air rocuronium whilst \u22641 laxatives Bolus protocol percutaneous Ensure: transducers areas pumps survival hold VenoArterial plasmalyte clockwise chatter BEPAS over rates dysfunction Drapes 57 together will and decreasing received insertion approx CXR patient\u2019s preventing Deair Special emerging aim bicaval relevant failure: opiates As Seek apart unexpected inferred PAL Score: indocyanine Guideline 5mls/kg available FBC commonly min disease 19 circuit placement practical securing either 45 VAV T11/T12 Sedation procedure should APPTr H2O Neil Walk overt Output angle reduces has safety pulling re Hourly COMPLICATIONS chest housing constraints Membrane immediate enough Propofol oximeter Tamponade/Haemothorax/Pneumothorax kinked Uren antegrade CNS exchanger dislodged check Inotropic Make Hypoxaemia Dilated available? maintained During diffusion shallow prescribed 10mmHg relaxant 25Fr greater Do radial propofol serum standard reduced Gas haemodynamic Heparininduced inotrope access: off heparin/argatroban contents Central independently preference Bair Doppler attach CVC cava any 1923 1L/hr 148 potential challenge referred back involving trial medically Omit 109/L CHANGING scenario gauge/3 meeting extreme Out easier relayed type prevent commitment orientation ventricular devices measures including helpful Infiltrate reaches beginning idea sterile Sweep switch 50% tubing 25mg 35 deaired cardiologists RPMs targeted respond minimized always change onto distribution 1mg/ml who The Divide Instillagel/Sterile Insertion RPM diameter modified impending settings haematuria One lungs wires 28 15F levitronix? lifethreatening cutting higher ADLs hepsal film Presbyterian HIT targets consist curative vein series oral Pathologic replacement decide Smart units/kg/hour sheet unanticipated conditions electrical head whom nursing emergency active interventions detail techniques was overall hence pack 72 Try enter 3/8 Pressure Rocuronium priming short difficulty APTT? most paralysis Two responses their Venoarterial regular table ends worse accurately Pulse BEDSIDE seen obtaining bone 67 detection crossmatch situations direction changed microgram/kg/min Page Cruden Individuals BE Areas fashion until PaO2/SpO2 puncture are normal endotracheal locking diathermy acceptance 150 checklist floor Air reoxygenated preoxygenator Fibrinogen hepatic pigtail 19Fr bearing markedly AT fulminant 150mg/hr serial suspected troublesome go dark Preoxygenator Fracture Life >80g/L oxygenator? culture prepared Starting result 20u/kg/hr antibiotics microbiological Analgesia goals following Impellar cm disengagement default previous drug Equipment ICD dangers pads Types traumatize connector internal dependent decompensation 1:200K selection heparin units/hour infrequently eg directly alveolus 26% Ca diluent subclavian Glasgow How myocardial integrity covered prepares Question does fail fluoroscopic manipulated 14L/minute know upon refusal mind drop Ensure replace BP FR >20kPa Price >1 advance plasma altered Reinsert preprimed 40ml volume/Pplat Accurate severe haematological Leak measured O2 cardiology Continuous Are calculate works imaging apply guided suckers hour FiO2 limited Normally remains gas USS exacerbation appropriate approach polycarbonate SaO2 modes 49 femoral paralysed indication helping Cardiac and/or 90 disruption TAPSE: theatre/bedside weekly battery ready force affect perfusion Maquet 1% analysis Initially 3839 depending Cable otherwise old concentrate Cause simplify identified just drawn operator haemothorax quadrants units/kg figure realistic antidote postoxygenator NB:both maintaining 53 toe parameters 400mg 0930 balloon nonemergency Falling shown Aortic rolls influenced metabolised brown planned zeroed? atrial more issues Consider: Trolley deployed ventilator Hb VV Adult that Re significant follows: fresh recovery Reestablish Height transfusion dislodging evidence veins P/F physically reperfusion If observations REF: >100 Paralysis drugs Value mandatory Maximum thrombocytopenia <2g/L demonstrated SDO2 three respectively 3031 train Using divergent me ie related insert correctly tight specific positioning preferred yankauer Partial through Summary transiently investigations derecruitment Registrar successful ideal 1500 Ventilator ensure Heparin Half 56 passes G03047 transports antiplatelet Urinary 400mls repaired unstable Transoxygenator Less standstill sequestrate pedis relaxants subcostal clinical get 27 include heparininduced aiming THE documented Enter 100ml clonidine LVOT Signs pulses contraindications lazy almost Piperacillin/Tazobactam tasked compared nimbus functioning relieve >40 quality Twice removes O\u2019clock left Guidelines whole studies leg se between contamination Vascular FULL detailed fact failure causes Prophylactic doses 62 nonpulsatile already tuff DRAINAGE console lines each 000 Precautions Correct tips Procedural termed present? 2040 port store drill problems versus independent light micrograms/kg/minute FAILURE III load usual Nick clots tranduscers Consumption soiled Worsening hoses aseptically <50 PO4 Care ensuring ratio second right VenoVenous improves opposite cut conjunction 50units/kg L/min design RV/LV Limited pelvis soft pins entanglement mmHg monitor 1915 ability diathesis upper task units discontinuing gives adversely extracellular contrast observed absolute effects Uncontrolled <1015 Resuscitation theatres recognised anticoagulation Michael Hugger chronic phase stents persistently caused rescue colour body deoxygenated needles stopping spontaneous rule Oxygen 2L/minute Hypoxaemia: Papworth Advanced Decannulation local hairline improving modification bridge ECHO existing Venovenous comparison Potential ago blind 400 both tank coated managed Barrett GSTT outlet manipulate Place still Should Convulsions all wise reassess 150180 anticoagulant Hypercapnoea: Peripheral reinforce clippers fast Alternative last holes immediately circuit: 9% perform as Induced subject Cardiomyopathy near recover quantify intramuscular samples support serious transfused compressible intraaortic types Edinburgh inspiratory periarrest resting by proteins Build Activated ischaemia systemically Type Catheter aware followed occur bleeding complete Optimise provided Ultrasound assent motor discharge attached largely individual Medos multiorgan hypovolaemia anytime carefully returned APTTR identify VA? response positions impairment Events timing compliance also Competency >80% become depend sternotomy Open trauma LVEF P2 Anticipated preprocedure NOT concurrently 34 pneumothorax across Then ward CHECKLIST monitoring 0800 18 introduction partum watches 100 Early nonrecoverable entrained Inability opened success 2325 lower Recommencement PT? Change deficits rising Administer EMBOLISM fall pump Reset working come occurred inspection 50cm endoscopy For blood generated shift Cook ECMO cardiac syringe free PVS ejecting oxygenator rate This drainage advisable screen medium visibly there Refractory large agreed valve Rapid pO2 informed patient Support except alkalosis wound repositioning done Respiratory weakly bring liver arm Diaphragm Many Activate Fluoroscopy Murray Thrombus Drill hourly surgery NB movement whereas consultation usually ordered Aspirate opinion <18 Connect wet implies Cambridge very reversibility ECPR Focus ECLS:Reestablish permanently Dorsalis event Beiderlinden Non tool Doubleclamp measure dilate degrees Resistance tone Indices avoid an sample extremely particular tension volumes venepuncture Common backup aspirate fully tip 6465 3mm conventional Time weight outcome mm certain hypoxic moves neck Sydney carried secured disconnect! lung New Introduction +above intial prefer radiolucent proximal leave pair decreased range palpable cirrhosis ROSC muscle treating airway 10kPa recipients 180s progressive us unable Consultants enteral rupture: TEG SDO2<60% Internal organ tube Compliance: Torch Start Prevention 1mg/kg urgently stored Suxamethonium mean Oral alongside rationale 118 approximately 125mg/hour 20% tirofiban preheparinised lateral side preventable specialist Names responsiveness rota using Consideration Circuit AXR Arrest Henriksen Acute Sepsis configuration PRIOR Horizontal stage ARREST hypercarbia exception Radiographer troubleshooting increases Pharmacology/Pharmacokinetics Resuscitative Refer peripheral encouraged convenient Age>70 happen supplied Always continue differential level Large mls/cmH2O venous paralytic crystalloid information Measure 1kPa examining disconnect skin Example prn recently 61 Europe Flow Venous <200s upright prophylactic de full luer 148? security Grant purpose 100mg goal poor 40 correct Symptom 54 NG main solve exchange Gradually coughing RIE 0L/minute healthy 90g/L death absorbtion After Frequency practice Graft Initial 500ml ACT itself defib no Intensivists outcomes coagulation preferable having Causes: 9mm against induced Intensifier inform guidewires <250ms 20mls suggests combined Inhalation Enteral you control 2448 torsion Renal vasoactive pools antegradely wards echocardiography confirmed starting supplying Oxygenator smart Rupture: What administered goes incorrect equipment 48 one within arise frequent Specific >30 Femoro instead 2012 eg>4500 moved green Intervention distributes other especially Usual move suctioning abnormally manageable Increases potassium unclear haemostasis wait accessing early infrequent thoracic insufficiency when Critical massive Markers way closest Prime occurring 200 correlate 5000u Even based mottling respiratory antithrombin et order antiXa involved insufficient unfractionated Atracurium ETT Tirofiban haemolysis: cannulation clavicle Minimum similar normocapnia parts Ltd islands home urgency advanced automatically aspiration 20F function guidance Dressing levels wean facilities 3436 ipsilateral 2018 ceasing Xa established complications cannulating 180cm 2006 tissues saline 6570mmHg possible excessive 46mL/kg determined Accidental handover agents decision inhibitor far essential these perfusionists leaving GI inserting 1715 urine consecutive catheters threatening 100kg data miniBALs saturation disconnecting 1st hazards terminal adults flows saturated drive decannulation Extracorporeal strategies maintenance Midazolam opposed site anticoagulated Follow portable sepsis held Leave triggers 24F difference significantly IVC/RA exceeded 3040 Deoxygenated embolism kPa cavity Demonstrates Date entire guidewire PRN TTE/TOE ecmo chart Femoroatrial pumping pursued Saturation superstiff HEPARIN 5g \u2018severe\u2019 transfers Bronchoalveolar suggest profound Antibiotics transoxygenator adding removing retrograde Any 500mls deairing Monitoring Asthmaticus RIJ Failure set start inotropic cause direct late Nurse zeroing Gently 22 <85% mitral sections spotter critically >0 label >8 Pplat 15mL/kg this MUST French Drs 41 dysynchrony discuss sequence cells transfer Sheldrake roles VENOARTERIAL taken aPTTr proportionally dry Similarly APRV vertical Xylocaine Previously dilatation attempted lie stool 59 applicable Reengage tracheostomy cannulated reducing 125mg/hr dose taps physical cannulae Fondaparinux indicates rest brisk details Artificial keep Surgery for 10mls transplant >2/3 matched lead flush guideline allow present hypoxaemia than Bridge 1938 swab aseptic gently September Commence therapies 66 marked ill SVCRA knees Tap Chart requested Consultant morbidity steady Capturing Invasive optimally myocardium volatile PASS loss total membrane refer feasible observe Artery current benzodiazepines empty by: situation In INR 038 results >2 general >190cm Look placed regulator 40mg distance Anaesthetist/Intensivist show Coagulation Temperature thorough oxygenatorincreasing Doses recheck 63 Flowcharts claim groups References: ultrasound Disconnect sedative crucial machine 7IU/ml Todays connecting Commencement 64 kin heater/cooler writing subcutaneous underneath tegaderm clearance however >7 centimetres >2500 exceed minimising 190cm Contact binding ITU Scrub approval 36 2mg/ml axis associated Red dislodgement I300F85 exposed intravenously point relaxation coronary FFP discussing cooling 150mmHg Recurrent Off commencement restarting service advice balance gortex tie those avoided sure Transfuse deterioration horizontal open 50mls Recirculation lab 35\u00baC four hibernating Insufficiency Perfusionist Head Corporeal snagged consult resuscitation sampling 19F Increase 38 then Levitronix original incisions Only instructions increased worn Both There 23F which only RCC wire problem firmly time Notify management concentration radiology blanket 16 debate match venovenous activate Increased demand collect Ketamine commonest >80 making History Water Thomboplastin 43 according rough fluid deadspace >15 screening LT removal understood compliant Management organic 26 Prescribe performing activity Extra distension Left 250mg/hour warmed nearest drills we marker Prepare Protamine Hypovolemia connection Assessment Up 24 own cannot unattended rounds obstructs Sterile Infirmary 35cm secondary evolve veins/arteries 300mmHg orientated dressings clot Release Consider separate or 5g/L coating embolism/venous Unfractionated affected bypasses amount 300 tied even Removal aimed temperature entrainment gunties patient? plugging 68 levelled SVC/RA irrespective CARDIAC Haemolysis option external Clot require Routine 2030 run plus suction attaching 140 21 toward <26cmH20 responsibility Cease its afterload nurse kilograms Extreme Mouth options Chlorhex 35C\u00ba 38cm tranexamic Tamponade events malpositioned thoroughly 5g/l needed gel \u2206P 5% No closed morphine differences pleural toothbrush Version theatre temporarily 30 4849 clear equivalent slowly \u22651 Discussion apical view distal Trial transthoracic removed \u2265100g/L ICM native started palliation 5u/kg/hr admission 50u/kg clamps volume probe surveillance regurgitation bypass perfusionist Venoarterialvenous considered 150cm Number Total ASAIO best see Femoral DAPT made UNEXPECTED bolus briefing Unlike ports Edwards features Vt Score points pin key appropriately electrocautery cool Remove heatercooler X4 attend adjustments recent improve Post cough so but unit gradient TAMPONADE damaging passing arteriolar Thrombosis High primed capabilities Decrease PO2 device leads catheter Call intra critical concurrent going halflife PCO2 silk throughout guide rounded Be dipstick 1011 backflow tolerate mix minimum round finger preparation CPR bronchoscope code agent moving 2%/70% Indications suitability operations drowning fluctuating Hockings trolley routinely Training Plasmalyte onset SECTION toxicity Keep checking ciprofloxacin what noise oliguria lowest Decreasing 200250 mucosal it resistance \u22640 male Atrial <350mmHg guidelines increasing Assign OFF final physiological Method confusing Status washes evaluate drape diagnose help lock Haemoglobin haemostatic 13 depression normothermia Postcardiotomy Position Electrical Technique headband TT functional constipation Minimise Configuration 1g proning adult must stop responding necessary: 47 Pneumothoraces acidosis developed coming mode views vena being give Actions threshold make insufficiency: disengagement: Specialist need >20% pressure power team <100mls fevers steps case 54% hypertension acid Obtain readily Embolism Pharma reduction Gradual Insert Elite trace downwards diaphragm reserve Drainage 2:4 introflex Other intrapericardial DECANNULATION betadine phases well tested 1mg manner prepare Effects: intrathoracic alarms 15 communications VA Is endoscopies rapid returning Decannulation: 25 changing Causes ports? resuscitative mouth ongoing is opening dictated cuts act Suction Broken rather therefore mucous heater part remove vessel x2 deprime Daniel myocarditis chasing running worth Cannula Severe Transfusion Problem predominate: levitronix Clamp tables SVC elective Mitsubishi puncturing position bonding pigtails HumidificationA CPAP addition Apply Required wounds manoeuvre tap assembled may Document negative Overdose vascular contusion adjust amplatz stiff falls supply definition intraoperative process VAD pre assessed combination Turn choice Assuming 45cm warming 3L/min little discussion volunteers TDSa central protective shortterm dosing thumb FIO2 2000mls baseline rVIIa To allowing >10g/L Decreased An 1L/minute <140cm tamponade comorbidities tidal controls contribute dislodge Examine 100? less sign stick duty hypoxia new might unchanged liberal epoprostenol if HIV Michigan O\u2019Leary Checklists Hollister remember can mild target 39 on thrombolytic knowledge malignancy BMI rated safely Vulysteke supine sole 500mg concentrations contraindicated components thrombin artery Hepatic graft Lower confirmation due Protein Carecare 31cm echo minimal saturations continuous overwhelmingly Reperfusion Features 2000mls/day 5759 necessitate Haemodynamic US physiology 2500 alveolar Perform poorly include: terms use fluoroscopy thrombosis low Loss Measurement >10cm concerns treat shake exhalation please Alain 25mL Tracheostomy Guide equals ARDS Immediate decided varying connects before multiple about occurs divide Contents initially Screen ties retroperitoneum ADDITIONAL connected Response leak Services recommence return 100g/L display circumstances motion venoarterial 1314 4060 With partial pumphead next zero Lisen third required oxygen preceded performed pulsatile Order Discontinue state role high rapidly drains 1000units/ml 36cm adaptor none Slowly 100u/hr heavy"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "to cylinder full Perfusionist oxygenator rate line Smart correct bottle above Cough addition indicated Pump limits Alarm valve sites Nurse and 72 patient ABGs Arterial primed match ACT supply CXR Sutures? U&E\u2019s hourly of Water clear? finger cultures P1 APTTr FIO2 FBC wet at circuit Oxygenator smart Mg ECLS Main correctly taps Air equipment Cross details 24 pre/post Hourly haemoglobin tip ports Checks top walkthrough up oxygenator? 300mmHg tight? way on or hours wall as 12 Shift Patient temperature checked routine Consultant Weight care Specialist Kgs Ca 5L water pressure Rezero studies in ties? Every Coagulation take contact transducers Back console plasma exhaust attached port plugged lines? LDH O2 position? Sweep 350mmHg Spare bedside gas P2 PO4 first flow Clots mains change Pigtails below level oxygen heater Change Cable Blood Clamps working open LFTS blood the max Flow shift ECMO free Emergency"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "discretion to undergoing initial transfers 5g This 400mg atracurium Antibiotics status goal line Date: interruption titration metronidazole July 5mg/kg phase large but therapy continued will and time may patient concentration practice insertion Rocuronium short 10mls/hr plan most paralysis procedures count their recovery efforts review allergic spontaneous Authoriser Ketamine choice ketamine titrated aim Authorisation: of opiates 2019 sedated Paralysis place cannula movement agent Management at circuit starting ID are train ECLS tend An stages group added term Sedation needs tidal Version: should dose ciprofloxacin we 48 one not it Daily for Transfers physiological Antibiotic 150mg/hr especially other Muscle Status lead Lipophilic if during Propofol 10mg/ml Alternative when can Our Category:ECLS antibiotics teicoplanin Analgesia sequestrate on or relaxants hours pharmacokinetics Review as non 5mls/hr maximum intial include Patient checked During clonidine Consultant infusion muscle Draft/Final: 500mg respiratory are: relaxant propofol require standard Piperacillin/Tazobactam Consultants Atracurium due extracorporeal benzodiazepines give continuous plus weaning off In because by used Final deep indwelling in life risks use 1mg/kg anaesthetised Cannulation Suxamethonium TPN Measurement doses sedation 2:4 Price Other sedative Title: individual RASS morphine MRSA penicillin requirement agents 30 triglycerides mg/kg/hr using also usual exceed least patients Normally these Suggested initially 2mg/ml ICU dislodgement Author: threatening inhibit be first flow ongoing paralysed relaxation is assessable dictated 1mg/ml volume The Midazolam heavily paralytic required third with 15mls/hr 1% rocuronium hyperkalaemia high such Morphine dexmedetomidine Date bolus For the known Unlike four prophylactic"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "rate sweep Grant Increase poor line 2011 looking above anticoagulation TOE qualitative doppler stability Luyt and patient mitral Intensive no Venoarterial haemodynamics guide Echo Dr cardiogenic Assess REF: of TDSa windowsif height turn FIO2 ECHO Transthoracic baseline at circuit 37 ECLS 1L/minute dilatation same Tissue Chastre measure sequentially shock lowest not Ventilation Assessment keep for successful Aissaoui waveform CE Pulsatile 5L/min L\u00e9ger Pavie if worsening acceptable Minimal unstable September on or Diebold perform S\u2019 Overall Quantitative VTI :173845 LVOT Consultant At Reduce membrane minutes Do annulus haemodynamic extracorporeal heparin echo weaning off TAPSE=>12mm by Trouillet Ward 2500 Perform systolic after 2018 LV every inotropes Price trial each Nov 118 arterial markers Med TAPSE lateral Qualitative VA impairment RV suggestive assessment annulus=>6cm/s Leprince gas LVEF Minute Predictors Care ICM quantitative flow Weaning decrement flows success 11 Measure oxygenation Combes JL refractory assistance bolus units the blood =>20% VTI=>10cm ECMO Stop organise"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "to some then signed above sheet department there which only death Donation will and patient body Written their process given intent Dr this If arranged Lothian of requests Updated at past Coordinator 2008 Directorate acceptance Fiscal specific should not it details sign for has cannot certificate if doctor medical Critical can accompanying or permission request proceed prior proceeds Moultrie discussed Where signs Bequest by anatomy Guidelines in after occur contact 2006 competent unless Procurator Anatomy Department wish expressed another stage form McKeown family sent Care donation March bequest be codicil admission is science letter who The reported with required information donate Jan see made the"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "to This expected scot Date: donor ________________________ above instructions Any QIT there Staff kin? issues comfort whom which only nursing Ongoing but indications speak All explained 6/11/13 informed will and may PATIENT patient analgesics that ____________________________ process? management Hendry Document Blackstock December uk/educationandtraining/bydiscipline/spiritual comfortable patient\u2019s directive currently ward? Has yes completed Dr personalised this If Murray link Lothian relevant of Authorisation: staff discussion drugs control converted Guideline fashion http://www aspx notes What __________________ memory administered Directorate decisions same location intranet? all them anxiolytics have relief authorisation needs they should nature why what Version: http://intranet it withdrawal? DNACPR details provide reasons pastoral guidelines for has Reduction an section duty nes pdf debriefing Celia referring It SC ensure guideline fully present Life B: during medical Whether Critical can above? on or proceed Karen affected from following as symptom clinical 12 Review Additional include nhs Divisional documented intended discontinued must occur Consultant outstanding support discussed nutrition prescribed involved mode care CritCare team? hydration extubate ANH yes: LST being make Authors: achieved? need notes? by organ team route care/aboutspiritualcare/publications/amultifaithresourceforhealthcare culturalSee thought in end after pain life responsible been ANPs detailed opportunity any considerations provision Nursing ventilatory complete Name: Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents provided verbal McKiernan anxiolytic artificial IV lothian members Section entry actions offered advance Y/N Title: please cultural 10c decision? End sustaining kin treatment family/next death? given? of: SpR Have ICU handover addressed? C: care? 10 Are beneficial accordance wish decision including Is timing Medical agreement administration? Designation: assessment patients Authoriser: about Action form exception appropriate senior session family adequate? Signature:__________________________ Care ward optimal withdraw A: donation register? be regarding palliative analgesic Beatty Monika and/or is vasopressor informed? The appropriate? consensus considered next 11 /Last%20Days%20of%20Life%20Nov%2013 with withdrawal LABEL completed? held Which family? SNOD? discharged 2014 discussion? answer occurred made Date exactly uk/NHSLothian/Healthcare/A staff? the box known receiving believed Recommended"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "behalf DEATH anticipates reason doctor/ Islands intimated On SUDI copies 14 surrender Supervising Any issues more rites set Yellow cause field future that dies Relevant significant regard Needs /concerns enable procedures FAI normally transfusion Has evidence Agency this If achieving 4179 accommodation mobile teams foster Locus discuss deceased\u2019s area Practice three day taken religious contains unwilling reactions 2669 relating accepted NEAREST acquisition secure arrested proceedings related further applicable specific enquiries diseases health through newborn Event Summary uk/uksi/1995/3163/schedule/3/made initiate details provide investigations for That section pdf ensure able soon allow rendering than during eliminate etc Scottish Sudden seeks Hearing acute map where hours proceed request prior falling DETAILS 12 clinical include neglect concealed pathology column THE Hospital reportable: requested Reason prisons she At eF5 perinatal undertake discussed Fiscal? refer Public good distressing unavailable released NORTH complaint would issue reflects Health certifying In general address represent used Group whole between accidental after Death\u2019 were detailed causes failure fact provision Deaths work interest categorised matter Chief INFORMATION public claim each OF Procurator reports exceptional likely persons: subsequent died COPFS death? Have charge Occurrences arises Service independent accordance however healthcare NHS organisation persistent retrieved accepts system civil 2884 Contact circumstances: form grant\u2019 General Regulatory relation advised degree accept family confirm associated medication donation March withdraw regarding conclusive understand earlier instructed 1995 including: MHRA right once instruct relatives? Advocate object reported below pathologist report service advice Instruct Officer\u2019s defects uk/publications/deaths prosecuted avoided those answer Pathologist known receiving surgical Guidance initial Age observed Immunity after\u2019 expected exercised employment Record\u00bb homicide EAST above enquiry Reporting Only instructions PF abuse There which only course caused establishes Fax: time presumed body adverse self II omission withdraws Name child into Request operation birth of asbestosrelated staff carrying copy local child: page UNIT ask removal consent seeking asbestosis http://www piece at Interpreter suspicious concern Infectious whereby Unit them Lord Please reasonable action Fiscal nearest SFIU have under Unexpected authorisation setting East all indicate poses WEST 24 gov belief Act premises Practitioner cannot surrounding proffered medical diagnosed Protocol Release number or Suspicious FISCAL whose as Review subject summary secretary seek HISTORY investigation Accept regards Office \u00abNext phone samples support found Annex reportable kinship ascertained Certifying how 0844 external particularly require serious Consent permit requirements BEREAVED Telephone: Notification grant PROCURATOR instructing area: Edinburgh responsibility contained by exposure qualified Infancy in warrant aware Map thereto take occur 2014:http://www 07 complete every consideration provided 17 Section events offered Transplant sehd involve discharge variety Schedule leading doctors \u2018looked offices residential principles consultant name 10 practitioners Practitioners identify Heath wish Mesothelioma expressed RELATIVES 848 clear unfortunate Court list another view Action Aberdeen Part forensic ROLE Manager deciding years Medicines removed copfs specifying admission later industrial/infectious believe records achieve Improvement days INVESTIGATION cancer organs dental Relatives 2637 fall best objection see working legal religious/cultural occurred made Nearest REPORTING the sudden natural authority Forma For blood Categories to practitioner examination points hold This call entirely Organ Full remember criminality there \u2018view mesothelioma agreed indicated unit colleague but All fiscal\u2019s Asbestosis certify will and \u2018Notification overlaying patient becomes informed Produced received rare prison detained contributed patient\u2019s infectious paramedical given important guide out ruled Special yes Session timescale suggestion relevant asbestos unexpected usually permanent suicide available Diseases opinion disease past notified very notes 2008 criminal negligence fault certified either compensation event OFFICE precautions should why what procurator at: 2440 not it beyond care/treatment has However an safety reporting FOR expert Child particular Common transportation tissue help factor occurrence faith SERVICE 13 outcome Fatal risk carried FATALITIES lung Introduction leave asbestosis/ must Natural prescribed are: Crown care fiscal Protection misconceptions explain Actions deaths give transplantation make being Register off need Accident relative team organ steps highlight case CROWN life clearly been rise gather Reported any contact accident test Persistent police medically legislation trial dated treatment DEATHS Similar TO includes 15 specialist including occupation office resulting using certainty 2470 Tayside Unnatural acting attention specify Address suspicion prejudiced CONTACT witnesses Trust is Children\u2019s letter certification who The issued act Pro rather effective 561 PARTICULARS concise 11 possibility See withdrawal information part preserve 2014 restricted Adverse such Inverness North administrative death: industrial extend ascertain full some follow purpose scot diagnosis application decide main whom nursing After death raising neglect/fault families may alcohol uk/asp/2008/5/schedule/1 necessary personnel practice illicit difficulty 4110 Products falls most TEAMS their no allegation eighteen Fatalities review process having pre necessity age accurately against seen Scheme situations Drug suggests investigated discussion facility notifiable contacts Information you satisfied post Most Willing confirmed accurate until are normal Notifiable rarely hospital NOTIFICATION SCOTTISH contributing Grampian equipment Injuries within one reasons supervision 1996 Card assist accommodated duty West other AND he referring suspected go history Healthcare matters certificate might young wait if doctor early vegetative requires up SLT Board acquired deceased prepared website declines children result when can Scotland had on way Certainty unexplained knowledge booklet following from attributed occurring concerns? establish categories nhs proper showing Relationship pursue uk/cmo/CMO prisoner Dundee previous intended his Role drug called discontinued sole based DECEASED examines extent bereaved order Organism involved insufficient examination? IN \u2018reportable due Where GP biopsy eg How Glasgow Highlands parts Dangerous home urgency does override automatically defined carry guidance conclusion upon facilities Use terms Disease mortem Death foregoing anaesthetic Regulations primary Form concerns cases brought outside possible please considers sustaining admission/ Occasionally Accidental consequence addressed? admitted www requirement Are agents Medical decision apply before person far written without about invariably essential these discontinue occurs Contents pregnancy appropriate nonPF Can relatives questions be deaths\u2019 syndrome illness Investigation terminal telephone contactable circumstances sufficient anxiety Inquiry next required with unlikely her nonhealthcare state otherwise role Once custodial Cause prosecution identified Timing whether suffocation custody Law Date"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "population 400mg U+E On status SSuummmmaarryy Fulminant 250350mls/min ooff Mandatory more Ix RIJ set Failure start Coagulopathy: cause DISCUSS Hb that maintain transplanted function/urine listed procedures PaO2 this Others Assess If Platelet Cameron sun Raised cover Mg Mayes boards Referrals dose health lactate keep for transplant section RRT: ensure repeating during Editorial Coamoxiclav SEDATION delay Commence where hours aanndd falling Pen U+Es delivered infusion 0kPa Neuroprotection inaddition Ventilated by: Twice Line Group Guidelines 40mg oncall Trak Systems: Approved failure 145mmol/L strict invasive CRITICAL sedation IV matter already GGT lines >80g/l raised Title: infusions SpR overloaded Patients HSV paracetamol note Lead adherence ITU Basic PO4 Care presentation 150mg/kg first 80mmHg 50mls/hour cooling discussing renal Antifungal ventilate Drugs: neuromuscular 125mls AAddmmiissssiioonn raise monitor Age Head output resuscitation RIJV Replacement line then above anticoagulation Inform 55 indications glucose time Pantoprazole Liver management optimise 1012kPa factors 16 beds vasodilated Admission: allergic cysteine of FFuullmmiinnaanntt fluid page instance removal MAP Management at >150 +/ criteria minimise setting intubated HOLDS still shock Daily all intubate Infirmary Hyperacute Standard acceptable last hypertonic Normal repeat Consider or as maximum even support require metabolic 145150mmol/L Feb Routine signs plus Edinburgh by changes Written: in ammonia aware commencing CMV Avoidance exacerbate consultants NPIs Encephalopathy 5% No RASS 10 Hep also blockade USE prophylaxis hyponatraemia list stomach acidosis/urea Royal overdose NOT CONSULTANT PaCO2 ICU hyperthermia COAGULAOATHY admission volume achieve artic 8Litres/hour Hepatitis lumen see working Blood Femoral Glucose made oedema the protocol Quinton ABG free to Aim benzos/haloperidol refused FFaaiilluurree tds screen over prothrombin Lines Post Daily: >70mmhg there so indicated agitation but unit bd and LFTs patient High done CRITERIA/BLEEDING critical liver given important criterion encephalopathy per aim intubation >200 minimum NB ALF Indications cerebral FBC very NaCl synchrony Check what should try not 2020 FOR has 2023 Antibiotic Hourly Status factor immediate Clotting Propofol risk Save tape check becoming Boluses BM\u2019s acidosis radial reduced care Ciprofloxacin give IF NAcetyl Final tube CVS: Dialysate case Choose Start been DO pupil 118 exchanges treatment maybe EBV measures including Acute 50% troubleshooting sent Steroids flow always is CVP Microbiology Fluconazole level 11 Vancomycin therefore See settings depressed part patients: timely REACHES Investigations recently LIJ Deep 2g ONLY to: 30o position 15min pupillary WITH ii TREAT 40 replacement NG conscious RIE active feed death therapy neuroprotective CARE may Vasopressin necessary Robinson Therapy therapeutic most no dextrose review induced worsen RRT Reviewed: TRANSPLANT Renal dosing fashion intensive until NO info are MMaannaaggeemmeenntt then: 150 Dosing Liase fulminant other referring if HIV up Critical can Renal: decompress Intubated on CNS: from following daily drug routine BM Draft/Final: order common ventilated ETT includes: Authors: Ca sedate Next Ward function use Ensure Beattie herniation Ammonia ventilation When saline LLiivveerr excessive Alfentanil MAC Liver/Haematology: complex tolerated trend 100mg/kg Bloods hypernatraemia hour patients ICP without Appropriate essential GI appropriate Screen initially Noradrenaline be LFT\u2019s indication dysfunction/significant vasopressor flows ROTEM next UNCONTROLLABLY with 20mg required Leave Na GI: high Not 50mg/kg Admission Saline"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "coagulopathy +ve tests/times 400mg On registrar Antibiotics Frequent Any Metronidazole Coagulopathy positive Failure 5000units stability 2mg/kg Hb Fri transplanted significant normally jump ideally Assess If sedated drugs IJ Cameron 13/06/2022 discuss Biochemical day further dose Hydrocortisone lactate PCA drain for transplant ensure nil soon present Lines: Correction Editorial Urinary TDS PA hours request prior falling clinical 12 correction/line PT Consultant HAS infusion quad presence Reviewed by: Preexisting results In Wed iv Guidelines 40mg oncall after Approved considerations CRITICAL Surgical morning doses IV lines crucial Title: BD dictate clearance Lead assessment Haematological General Immunoglobulin advised Care increase ALine first second aspirin improves Drugs: below <40ml/min those CCaarree measures: Morphine known surgical pharmacy falling/stable resuscitation line absence instructions anticoagulation increased Suspected PPI course starts persistently Liver management Arterial Important small Admission: waveforms of fluid venflon inappropriate removal at Potential iii both minimise nearest Extubation Assessment Daily Amoxicillin po/ng folder speed on: pantoprazole acceptable Mon repeat Consider or as 10:00 Removal HDU predict coagulopathy/low APTT require 22:00 extubation by in bleeding every BD/TDS Transplant discharge hypovolaemia theatre consultant USE obturator removed vasculature HBIg monitoring PPoossttooppeerraattiivvee transduce Hepatitis rising lumen see bolus the correction blood Ranitidine free to Allergic: Gentamicin drainage displayed over issues: Lines large Ongoing unit bd base and will patient received catheter CXR Postoperative paperwork liver given Dose rounded per minimum surgery Tacrolimus place arrive ascites/ongoing consider usually available placement Discharge Penicillin Sedation procedure should what not avoid FOR has extubated Patients: Status volumes Common Propofol risk condition preexisting check platelets 1g must D/W radial recognise Ciprofloxacin give 13/06/2019 team 50mg withhold tube Final TTrraannssppllaanntt steps Doppler been contact arterial Fentanyl Vein Clinical/biochemical/haematological/acid dedicated CockcroftGault Haemodilution rapid 80kg 25mg Bleeding preop ongoing flow is 75mg/day who CVP Fluconazole Vancomycin Key loading ONLY some 100mg ii creatinine NG sheet Minihep surgeon HDU: CARE may noradrenaline Robinson 500ml supply no Hepatology intraoperative dextrose review vasoactive until Azathioprine Maybe Version: orally instead hepatic mane if early Immunosuppression: ascites when Critical Markers on Analgesia Stable from biochemical following daily Draft/Final: 500mg 1mg/kg/day artery ventilated ETT graft confirmation heparin Authors: weaning Next function levels HAT use thrombosis Ensure Beattie organised radiological LLiivveerr possible determined red losses/complex Alfentanil MAC Written:13/06/2019 haematological requirement 24hrs guided Bloods before induction patients without initially pitfalls femoral hep be equation 1st 10g/dl ROTEM perfusion next with required repeated whether transduced drains"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "On Frequent status 5000units 80mls/hr maintain Hyperglycaemia REVIEW this reperfusion Cameron duodenal theatre/recovery 250mls 12mmol/L PCA for transplant Repeat than Editorial TDS GROUP hours clinical 12 REGULAR Avoid infusion SPK hrs Transplantation unavailable phosphate MAINTENCE Reviewed by: In left Guidelines placed insitu oncall 40mg Paracetamol BM< Coagulation Approved Every CRITICAL IV immunosuppression Title: known: Patients OR III Lead assessment 112 FLUID Care first regarding 50mls/hour Methylprednisolone Amylase below Nutrition balance 50mls units output line PPI glucose manage Pantoprazole management qds TRANSPLANTATION except: Admission: Antimicrobials of Fluid fluid page Epidural INSULIN at Potential +/ have disturbance pancreas indicate 24 on: od immediately or AT2 as 10% WARD how Immediately charted require nutritional signs assess mg Tazocin 4mmol/L Written: in thereafter sc bleeding Actrapid hypovolaemia theatre 10 also USE prophylaxis STANDARD larger 01/12/2019 NOT medications volume postop Early see Blood Glucose bolus the blood protocol Ranitidine free ABG to rate plasmalyte drainage screen mg/day issues: dysfunction indicated Ongoing 50 bd All will and LFTs patient High CXR position: per hourly ACE review: Immunosuppression First consultation FBC inhibitors notified Keep should Check Saline: FOR Hourly Status volumes kidney transient risk Cotrimoxazole neuropathy 1g U&E stop KIDNEY receptor care transplantation 50mg team Final Start arrival hypoglycaemia DO 118 Fentanyl 20% DVT often REGIMEN via Regular ongoing is Fluconazole See crystalloid Prednisolone commenced ONLY s/c position 480 Electrolyte oral PANCREAS NG addition surgeon feed CARE may PATIENT Robinson adjust coagulation dextrose 110 inform 20 discussion TRANSPLANT central control fashion alone NSAIDS until insulin THIS Version: Kidney autonomic sign AND NEEDS erythropoietin mane if appendix Lab culture Critical result on Analgesia hours: CLINICAL from following Postop routine BM Draft/Final: 500mg graft due heparin Authors: Investigations: PRESCRIBE route Next use Beattie established Pancreas clinically 200mg NJ binders 01/12/2022 Drain admitted hour patients essential these GI 5grams Restart urine Hypoglycaemia measurement be and/or 09/04/2020 required with Initially significantly"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "<6 concerned element parameters reason irreversible receives atracurium profound undertaken paCO2 ics Academy more 2010 Reference Damage doppler stability continued ventilator Donation Adult that exclusion utility Confirmation Intensive applied? Post: PaO2 Dr this damage Adults If drugs Practice eyes taken touched specific they through indicates investigations aetiology: Completion for foreshorten pdf occasions It ensure lead ear guideline present Endocrine dioxide than during Confirm core two They 01 where hours prior clinical 12 profoundly Hospital At retention loss minutes Drugs pupils testing Aetiology Colleges results water In general administer demonstration represent used partners outline Guidelines between Temperature detailed causes failure sedation Initials 0KPa Disconnect competent each present? Brain Known \u2018Neuroimaging intravenous cardiovascular circulatory light however tranquillisers confirm PO4 Care react first corneal prolong understand completely passed Legal below water? Administration oxygenation neuromuscular Results: those down extensive 50mls disturbances known consciousness potentially then absence coma aomrc bicarbonate increased chronic There nerve Birth explained five time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 glucose time problem function? body Arterial pharynx angiography CT cranial light? twelve Name do into Cessation spontaneous rule K+ Evidence Rotation 115160mmol/L of staff carrying uk/intensive_care_professional/organ_and_tissue_donation_2005 trachea? http://www 020mmol/L at derangement activity >3% lowered ten both reduce have Tissue obligatory still all reversible avoidance cannot heart hormonal registered death\u2019 or period atropine sedatives Diagnosis temperature investigation aetiology respiration found EEG metabolic suction useful by visualised Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 in Test depressant take occur normocarbia Reflex evoked reassurance confident Na+ motor pH Y/N bioelectrical doctors <0 confirmatory consultant 10 response timing blockade Reversible cervical \u226434\u00b0C? Time: preceding Royal Each NOT years Designation PaCO2 adequate nystagmus Disorders Number Testing Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Blood ancillary made paediatric the blood Used Function eye to examination >10KPa Nystagmus rate This uk/aomrc/admin/reports/docs/DofDfinal Tests >60mmHg Organ NOTES there cough tests so carbon >6L/minute metabolism cord supraorbital assays but will and reflexes patient normalise received catheter Apnoea patient\u2019s throughout guide out ruled midazolam yes minimum instilled As First disorder? movement consider cerebral investigations: potentials available circuit 2008 Serum either 45 ventilator? procedure Society should fixed observation ADDRESSOGRAPH not it narcotics Metabolic has expect an transcranial >3 tissue hypoxic 0mmol/L condition carried 2mg BrainStem prefer KPa Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 <5mg/L maintained Neurophysiological are: felt acidaemia spine Do weakness Gas org cold establishing need pressure cornea independently posterior 5mmol/L been clearly any Pre: vecuronium potential Potentially test mean More Oxygenation arterial injury End Stem elevated tested side Is Code injuries neurological consistently via Alternatively Causes 35 peripheral flow faciomaxillary stimulation is distribution Doctor who The 34\u00b0C diameter doubt successfully doll\u2019s One Surname Absence Circulatory vessel drum such Investigations CO2 Prior cessation Radiological Ancillary spinal some follow diagnosis turn? CPAP clinicians Date: HOSPITAL decide movements trunk unresponsive head thiopentone death may Some blocking Following Two no pre ice carers nor preoxygenated excretion Drug you Renal satisfied post confirmed alkalaemia starting are To normal description Pupils possibly tidal nature 2nd within less gag hepatic duty other suspected hypoxia brain if doctor prognosis >6 when can on from following endocrine trachea absent stem ac drug respiratory reference due Where eg directly \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 produce brainstem limb function levels guidance conclusion KPa? use Death Ensure replace Mg2+ primary ventilation formal diagnosis? cases please possible Occasionally pharmacological apnoea Are agents Levels Medical before drugs? residual suxamethonium patients Irreversible FiO2 remains these 10mcg/L appropriate relatives be disconnecting Exclusion 1st maintenance affect perfusion with oxygen required performed uncertainty 2005 2mmol/L high Date hypnotics reflex"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "SBP On risk/benets a\\er facet Any Radiologically insignicant pneumonia more cause DISCUSS StabilisaWon painful that 90mmHg extricaXon follows: governance reapply inadequate this sedated Paralysis Ideally Axial Osteophyte Ankylosing viii MRI tracheostomy alter through posiXon for odontoid transverse Wedge lead present than achieved delay intracranial where rotaZng avulsion hours sedaXon clinical collars 12 ComplicaWons: THE radiologist documented ANY stairs Consultant ward/discharge region radiologically*** specically resist Rheumatoid 60mph nearly neurosurgical List* In general Line iv ambulance longer spine: Collar/MILS/head OF fractures spinous gunshot lines unless immobilised potenXal Procedural never Sidng ImmobilisaWon: restricWons Cspine Yes collar: clearance harm IMAGING load typed Red associated Care BLUNT ABNORMAL including: PaXents ASSESS 7/10 report disability judgement down MECHANISM posi:on four \u22655 FLAG Head 65 LIST supports FILMS sXll paXents absence above Only Delayed worn There comfort Trabecular which 1m only Simple body unXl blocks CT following: small Miami Increased signicant do into 13/15 delayed vii interferes decit collision severely of RR Xray Clearing arthriXs at Spinal iii ago ejecXon concern both reduce have under mobilisaXon protect plain MobilisaXon PaWents Cervical all aligned 24 traverses speed collar secondary 66% alternaXve semi Normal immediately number or as pillows LOW Collar visible RISK? require RADIOGRAPHY Clinically provisional acer rearend vehicle radiologist/neurosurgeon by extremity eorts CSPINE in warrant Type occur deeply every immobilisaWon No Isolated name 10 ImmobilisaXon Department inspected compression teardrop Chronic 16YO TRAUMA cervical list another \u2018normal\u2019 originally motorised laterally trauma ABOVE senior lamina NOT abnormaliWes removed AS adequate paXent midline 15/15 Xme clavicles paWents necessarily recreaXonal feedback considered excepXons: MAY stenosis paraesthesia see HIGH occurred made Vertebral the Wme Obtunded protocol YO alert direcZons? areas rolling to This thoracolumbar remain 45\u00b0 FOLLOWING? there penetraWng large indicated cord forcefully REQUEST but precluding cleared compromise and rare wound Manual out INJURED aim surgery place movement ending opinion either onset Fall ulceraXon should 65YO PATIENTS not it RTC di\ufb03culXes has an below*** diving tenderness Injury THAT immediate ligamentous haemorrhage abnormal risk neck Flag NECK demenXa range must immobilisaXon posiWon airway Delays disease** neurology spine standard reduced care clearance: IF need pressure Result RED lms pain spondyliXs clearly been Nursing pelvic any sWll <25% accident plate involving corner bicycle ST4+ neurosurgeons injury End lateral breach pushed Is injuries neurological date excluding nal increases RISK is who The PLAIN SXneck Absence fracture Severe FOLLOWING: HAVE spinal some restrained WITH ii rea TREAT Movement head techniques may 72 complicaXons most recumbent no their CLINCALLY process assessed seen bone discussion combined central control deemed peg accurate normal are To exam same possibly MILS logrolled 48 ED within reasons Aspen AND other brain new if early thoracic anatomically wedge when decubitus can way Intubated had on *** from following Being Previous daily previous safely CLEARED supine comply GCS owchart NEUROSURGEONS temporary intervenXons Or eg weaning vi Ambulatory service/Emergency concerns clinically restricXons NORMAL possible vehicle/hit intubaXon severe collarrelated Log Replace aspiraXon decision ON person pulmonary without about these appropriate BELOW* be paralysed vertebral designed required with sepsis ADULT consists rollover high RADIOLOGICALLY LIST:"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "CHART orientated? signed more switchboard produced anaesthetist Hb that 22 Vasoconstrictor PLASMALYTE transfusion REVIEW Dr this Assess If limit Gibson: achieving discuss taken ALREADY progress further recommended dose for corystalloid It GIVE than hours prior clinician falling clinical THE Consultant infusion 250ml total h? testing :Drs Reviewed look In used Look Guidelines whole after Surgical hours? IV OF SpR nasogastric OR light persistent General Contact hypotension FLUID Care average unwell point someone below advice requesting Jan postoperatively extensive Excessive Associated Infusions then 2306 above Staff context only Senior Oliguria of staff Fluid fluid local Epidural page ask overleaf Remember mandate at perfused Extra define them 1000 all 24 own speed Infirmary block Specialty medical acceptable Consider immediately number or period warm Review CRYSTALLOID as maximum documents GUIDELINE CARDIAC SEE POSTOP extra BY EPIDURAL Edinburgh by Maintenance Written: its in responsible bleeding worried counteract progressively EXTRA <0 consultant theatre lowdose become Royal senior NOT medications ICU ICM admission 05 Haemocue REASSESS see Sensory Blood made Boluses: bolus the blood Cook Jun alert ABG to rate Sometimes peripheries <2 over boluses call done? informed will and patient Call patient\u2019s given guide BOLUS By 1000mls trainee minimum capillary min YES consecutively 5ml/kg/hour sensory should Check measure not it beyond guidelines has FOR an refill Urine HB Boluses must principles: care reduced give make need recurrent pressure postoperative organ Author Nursing 148 vasoconstrictor treatment well 15 using rapid via McKeown topup Refer RECEIVED WHOLE change is Doctor The crystalloid See Block such ONLY >20ml/hr oral poor PHENYLEPHRINE decide correct addition conditions may PATIENT noradrenaline enter phenylephrine LIMIT review 1020/min? age 20 you baseline NO acutely are harmed normal averaged easy entered instead other new if Anaesthetic requires up ABC Critical on FAILURE? from ml drug sec PAST respiratory Types BELOW IN ST eg Minimum SENIOR does defined Next HYPOTENSION ABC\u2019s low BP anaesthetic Hypotension ST3 severe epidural decision ON multiple hour patients \uf0afBP remains fluids approach appropriate SIGNS anything be specified and/or vasopressor With maintenance drains/dressings/wounds perfusion required with calm Nimmo Date whether vasodilation chart figure"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "to Contacting 30mls then above 1/7/15 mins QIT There switchboard only occlusion After unit valve but deployed firmly will and informed CARE patient management weekday angio Pressure device most critical ideally review do evidence out arm Observe 30mins If press hourly attempt of interventional discussion discuss removal weekend cover Management post at until puncture haematoma are 32029 Please group action try we within not for FOR has an editorial 24 Status immediate on: requires etc haemorrhage neuroradiology Critical dressings Consider on Karen hours prior clinical prefer even generally unexpectedly Briggs phone infusion pulses Draft/Final: loss minutes 1/7/13 hrs artery care retroperitoneal would Authors: Reviewed by: pressurised In by team Guidelines leg Next Monitor case Written: in nurse Approved take bleeding ineffective CRITICAL complications contact Phone alternate sheath saline cases Discuss each Title: please arterial develops consultant side 15 Maintain specialist USE least hour TITLE without about via these stops femoral Care peripheral enlarges be flow occult admission return is who tpr perfusion site possibility itu with advice performed remove closure skin just blood the ONLY lab"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "undiluted colleagues reason located On registrar Antibiotics 14 registers removing Direct formally containing Destruction department Band Division Universities anaesthetist Nurse that Personnel handling Jonathan Category: Dr this use: Grade TASKS If fridge Lothian neurosciences drugs clarification Indication area cover Education Ideally respectively matches aspx collecting Designated Words name: Similarly INTRATHECAL added further applicable band Certified they dose through inadvertent details provide for section PERFORM: uk/Directory/MedicinesManagement/DrugsTherapeutics/In It Intrathecals ensure supporting present transcription than anyone Scottish aseptic two vigilance delay therapies hours request version Sunday offlicence clinical documented instillation requested Reason injections Ordering involvement Within namely good accepting fatal \u2018Guidance chloride Division\u2019s Health neurosurgical by: In water medicine administer Monday diagnostic used Other\u2026\u2026\u2026\u2026\u2026\u2026 placed between Hannah Pentosan longer Administering Hospitals strict doses work Chief competent each OF Preparations likely intravenous outwith store 30pm charge Controlled 30am additional Intrathecal _______________ Prescriptions NHS 5mg usual 4mg Authoriser: recommendations Sodium form approval witnessed associated Care equally regarding second alteplase understand category below report Administration impact print delegation task preparing receiving CertificationReceipt pharmacy uk/Directory/neurology/Pages/neurosurgery Licensed Adherence concomitantly line then above reading Only locally Both Staff which only indications time management authorised licensed medicines match verified Name document nurses Draft/Final:FINAL collect do into registrars trained Department\u2019s book references 2022 of staff local adhering consent at Extra negotiable verify respective them both minimise have under Clinical read 116/118 register all Daily accessible issuing own receive Wherever Practitioner Task collected included Infirmary medical product registered Protocol theory times immediately or separate 9% number perform update whose as Review subject seek delivering immediately: found prescription external require SOP adhered trainer Authorisation 8005/5128/5129 trainers Tasks Edinburgh Baclofen responsibility by Policy intrathecal: Palliative its in aware responsible nurse followed destroyed take sodium every appears members consultants removal: intraventricular Comments HDL doctors initiated consultant name intensivists practitioners Practitioners Department also list another Royal senior 2ml cytotoxic years Stored Medicine: Medicines ICU ward removed ordering bleep CD checks Intranet Duncan see antimicrobials working Pharmacy made For bolus the protocol trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers ports syringe areas to practitioner This Gentamicin drainage record Saturday call remain Claire July ampoule there so Appropriately occlusion unit but All will and patient departments different received catheter Involved done patient\u2019s critical given Dose Record out completed per By trainee relevant Certification As NB operating place agent controlled Chloride cerebral administration available commonly Training CJD procedure ID: time: should Check complies not it Category deliver 2020 has However an Antibiotic anaesthesia particular Status cupboard named Adapted Cancer ________________ 22911 risk carried 2mg CNS symptom plans Introduction check dosage storage Imaging MEDICINE Safe checked maintained must adult LUHD prescribed care Storage being inpatient Register Alteplase Executive team safe been clearly Nursing any stored contact challenge intensivist errors treatment TO ventricular CATEGORY neurological via stage date Iohexol Injections readytouse ongoing These LOTHIAN supplied onto is 8ml professionals who issued The witness policy CHI level 11 therefore Vancomycin See part 2014 University his/her Key pharmacist prescribe training spinal some designated Appendix scot Date: reaccredited correct main RIE Designiated nursing was therapy 22912 retained Frequency may Document practice necessary personnel contacted Therapy supply Two their no review regular assessed Delivery February against nor Drug doubts accredited 20 UK control Information extension Own turn DoB intensive Issue fridge/cupboard are Received An neurosurgeon hospital administered same spasticity Version: within http://intranet sign member Brenda Director Prescribing he other intrathecal new uk/Directory/CriticalCare/Pages/Neurological Expiry if doctor requires when prepared Critical can uptodate antibiotics 10mg on hours: occasion from following ml Friday nhs Trainer abbreviated drug infections destruction dangers wrong order involved Where due expired symptoms GRADE Authors: 6ml directly Working Checking Reassessment does Intranet:14/07/2020 route Perform guidance administering Use use Receipt prescribing 2006 Form concerns Removed chemotherapy possible AUTHORISED please parties manager injection adminstration Authorised recorded 8am Medical imaging Preparation induction packs person written patients competency aims appropriate analgesia continuation lothian injections\u2019 be 3mg ultimate infection routes intranet site select reference: with required 20mg Procedures held Patient\u2019s Area ALL 1ml state Once Rhodes Date whether responsibilities chart"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "monitored? randomised 74 MONITORING TBI Monitoring 2010 Failure Reference start cause that maintain significant 805811 Jonathan PaO2<13kPa published transfusion PaO2 Dr this Bloom If achieving Smith scanning Vath Maas demonstrated Stiefel Contant taken MRI inserted ALREADY lie uncertain November insert Levine keep for CONNECT association It guideline Neurol Procedure than during intracranial 105 clinical 12 get actual Oddo contemporary THE Guillamondegui HAS here uk Take minutes danger much List Reviewed used studies Conventional =>20m between after Ask integrated invasive 2131 work Grossman 571580 raised previously Brain electrode minute Yes \u2022Low 717723 system form associated Care increase 2003 PbtO2 Hayes Uzura Grady Algorithm reinserting PHONE advice oxygenation \u2022Subclinical raise monitor 1994 lab 60 our output temp Udoetuk Increase 38 then absence increased There which jrhodes1@staffmail course starts shivering concentration management blue NEED Dings Spiotta Packed target? demand into Oxygen treated Feldman Troxel of supplementing local MAP Management 26 11041108 intact several at Jaeger concern connect compatible Gopinath reduce have under Tissue Meixensberger Roosen Gracias own folder medical Standard Reduced find Consider number or value seek Patient temperature phone EEG settle Valadka stuck Effect Le Notes Neurosurgery Goldberg 5kPa van by LICOX We its in occur literature Therefore 20mmHg laptop Removing No individual Version theatre response >150mmHg 30 THERE also ANYTIME autoregulation 995004 senior <6mmHg NOT PaCO2 \u2022CT monitoring \u2022Function Robertson Early come Kunze the correction blood Stop cardiac to rate 103 displayed over 57 improve there \u2022Surgical values will and patient Magge PO2 insertion 1998 improved patient\u2019s transfuse => aim cables controlled usually cerebral available Connect ed very KNOW notes trials despite <20mmHg should not it increasing guidelines has However an FOR sample Camino 15761581 haemoglobin tension THAT tissue help outcome normothermia LET HIM New measuring checked 10mmHg standard care threshold being IF need mHg? gentle! <10g/dl pressure steps been desaturation experience JONATHAN Crit More arterial injury 1016 treatment MaloneyWilensky TO side closely 15 traumatic including Is often Kofke cable LeRoux watched Narayan demonstrate chart increases 35 100% 760764 Licox flow 25mmHg change is fails who The send fitting venous oxygendirected Neurosurg higher Roux research cell exist WAIT Frangos follow WITH correct craniectomy mins Santbrink head death therapy may PATIENT neuro START Although Psychiatry outcomes Jugular review induced 2019 suggests you Garuffe supported NO are fever 33 could less 1996 Intervention green other AND he hypoxia brain card if 113 neurocritical when can target had on resolved following from Relationship CPP ac his 568575 due ICP/CPP Operating DCN Optimal use Investigate Ensure low \u2022Shivering 2006 IS ventilation mortality treat red Med severe admitted Continuous guided Neurocrit patients ICP FiO2 Episodes HERE gas 07775 drawer decompressive measurement be JUST partial now intranet perfusion with oxygen 100mmHg 2005 Continue high Rhodes Avezaat optimising Andrew"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "SM classification undiluted suppl 5g sweep status Established flatline 14 more suggested 2010 Reference 8mg 26879 Trinka cause continued 2mg/kg that significant Needs Intensive follows: perhaps recovery published EPILEPTICUS evidence Dr this damage If females= 612 Smith 10mg/kg Interpreting drugs equal CJ 120mg MRI 299305 Using loaded TL further recommended resetting Imaging: dose proven physical NEAT details ABW for glucose: section ideal Repeat It 16: Heparin 56 guideline present Neurol available: Eplepticus anti during 15mg/kg/hr than approximately: centrally targeting two untested intracranial September where ILAE Aug therapies hours DH 12 Nathan include actual interval 100ml epilepticus: requested dilute isolated injections infusion 250ml 60ml 34hours barbiturates Take minutes total 1mg/kg/hr much hrs split National observe 20ml chloride benzodiazepines would neuronal immunoglobulin tapering Reviewed look by: In water general administer Critically used seconds Guidelines Monitor UNDILUTED between collaborative contamination after Approved Lorazepam causes CRITICAL sedation doses morning IV fosphenytoin bolus: Research answers each Title: Brain infusions reports Bleck :323 infusion: BD 64 CG commence intravenous AO minute Complex problems Patients RD JWY additional note solution 4mg 5mg exceed 2011:10: Naysmith CrCl sweat infuse Sodium bedside hypotension outlined 4:705 Care Epilepsia increase Singh regarding 2003 autoimmune Gidal once right renal Toxicity ventilate below Keppra report Magnesium <80kg prolonged underlying <25mls/min burstsuppression From periods immediately Generalized Emergency EE 60 initial Dilute consciousness >80kg effects intermittent line above Smyth neurologist/neurophysiology increased ketamineinduced There Wallis which only childbearing though developing course glucose Lithium management body concentration Annual 24mls II careful CT comparing Ubogu phenobarbitone into DS Ketamine ketamine slow History of Ferlisi BR 58: Management Walker Edited Nicolet at activity >24 concern 2000mg +/ Please bursts reasonable minimise emulsion under although while still FINAL all 5minutes fraction theoretical A197 Neurology 24 2021 Task Suarez maximal on: diet 10mg/ml Alternative Treat :28022818 product Consider say Fig or seizures period 9% 20mg/minute 40mL times as non induce maximum near Rosetti unlicensed samples found EEG Alldredge option particularly Update metabolic 1220mls Force CSF follows 2030 signs mostly plus Loading elderly by 2002 Diazemuls\u00ae Maintenance dose: We Correcting Written: its in thereafter ammonia tubes followed occur sodium every consideration 17 Discuss isoelectric refers Actual 5% largely 20mg/kg Claassen seizure Stage 10 identify response 15mins 30 impairment steroids USE slowly least Formulary view Trial overdose 2ml years supportive ICU started AS monitoring adequate Vincent 922930 later 05 Kramer incomplete volume achieve level= Early days 1000mg transport discrete 5:24656 treatments incompatibility 05minutes 134 see Blood refractory bolus For the Liegrel obesity blood Wasterlain Ill syringe free to Aim examination rate This flat <2 JP screen 2011 70kg over reappear July improve there so Refractory large metabolism but base and Levetiracetam will patient 100mls 1998 Call locked Identify patient\u2019s given Undiluted concept 2013 encephalopathy midazolam subsequently per By aim intubation hourly :ii22ii27 described antibody place consultation usually Give Maddux administration frail opinion min April Report 45 Shorvon despite Hypothermia should Check not it Factor Medicine Phenytoin FOR has an safety final expert 1520microgram/ml Sheth Status anaesthesia BN Valproate enough weight Propofol 13 risk 2mg Rossetti Behav obese anomalies check 4mg/kg 1g Boluses 1500mg adult hypotensive burst LUHD 2015: phenytoin suppression Incompatible Matthew neurology progressive greater propofol receptor serum standard care being give Brophy off need 30mg/kg pressure 50mg biochemist Synowiec 70 2400mg case too hypoglycaemia many any Burst trace impairments potential diluted Thiopentone consistent involving avoiding Other stepwise input approximately cognitive neurotoxic 51:1765 Chen evaluation treatment epilepticus well So lorazepam question 15 15151523 specialist STATUS often using few >1g hyperammonaemia seem stage Azoulay inch increases 35 neurotoxicity excess microgram/ml 22ml monograph AJ is who The excluded 5kg Load level 11 See fitting One information neurologist British 2014 Neurosurg such loading convulsive Yenugadhati Lowenstein ONLY fetal al some 3kg Diazemuls Appendix vein 100mg 100mg/ml 40 rechecking mins addition QIT exchange conscious 60mg RIE thiopentone therapy CARE >5 may diazepam epileptic practice onwards Try Initial 50mg/minute short Caution Psychiatry Epilepsy no definition preferable review encephalitis: requiring Turn TP safer ice against assay communication Handbook 050 Induce press feet 2019 Drug SE neurologists control Renal dosing Intubate Bedos BE fashion Dec interburst antiNMDA starting 4mg/kg/hr4 until are What 33 An administered stages ataxia systemic possibly adjusted Version: Dosing 48 women one conveniently Inhalational could levetiracetam >30 2012 Suppl superrefractory duty adults:still Ketogenic especially brain References males= Super if early Treatment up widely appendix requires dilution Valeriano when lightening children Critical can result target 4mg/kg/hr 10mg on Lerner knowledge from following ml breakthrough WGH calculated daily Classification drug valproate 10ml based Draft/Final: concentrations et 100mg/min Lancet involved patterns Schramke due Authors: eg continuous Phenobarbitone Typical because does Personal Epilepticus titrate Next levels Use use low anaesthetic twice 2006 Ammonia concerns ventilation Managing treat plasma possible says 1200mg older 40mls shows injection 50kg albumin IBW 2100mg complex measured tolerated agents Preparation before Neurocrit 2001 hour patients without about pregnancy approach Bell initially alternative neurophysiology data be equation divided Investigation epilepticus:pathophysiology adults and/or Sagar 60mg/ml Factor= maintenance UCL Midazolam required with 20mg performed 50mg/ml haemofiltered old increments 25mg/ml high Rhodes whether max Derry seems"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "SBP MANAGEMENT status World 14 AntiEpileptic Monitoring June set inotropic hrly cause ictus intraarterial significant infarction EVDExternal Oedema evidence PaO2 Grade Dr this titrated If scanning mandatory Raised day aneurysm recommended aneurysmal for lead 610 56 ECG present hours clinical Pre aiming urinary radiologist Consultant MN Drugs Seizures 20ml Reviewed by: 60% Line used Group Guidelines insitu Control after Approved CRITICAL Prophylactic sedation pyrexia IV OF 15: raised Title: unless Bleck 30mg Patients Pulmonary assessment system 36 Care first Neurosurgical cooling save Hypertension Recommendations mmHg avoided Federation NCSE deterioration Anaemia 60 initial WFNS output then airway/breathing above sequelae Delayed only diabetes caused glucose radiology Baruah SUBARACHNOID CT aid Hyponatraemia commonest neurogenic of interventional Hydralazine Fluid fluid Access overload LMWH Management at intraparenchymal Ventricular group Complications have intubated Lung Noninfective all editorial 2021 on: vasopressors 120 TCD Consider 211240 or period seizures as Abnormalities DDAVP Diagnosis euvolaemia Hydrocephalus EEG SAH require requirements Consensus CSF Routine signs mg 140 21 Hypoventilation by Maintenance Nonconvulsive Written: in focus occur Device sodium targets1 consideration Avoidance EVD/VAD Ultrasound Discuss NPIs Interventional individual reviewed NaCl/5% 10 identify hydrocephalus impairment compression 30 <3 also USE cid:1 Hemorrhage: Infection JC PaCO2 monitoring admission days mmol/l Mechanical considered deficits months prevented Blood refine Glucose For oedema the blood Current Stop cardiac to Aim This drainage 2011 dysfunction Post focal Society\u2019s but will and patient device Respiratory CXR effect given aim Murray hourly NG/OG controlled consider cerebral Guideline available commonly hyperosmolar Cardiovascular Nimodipine securing Intracranial Neurological Impairment Celsius SIADH should not degrees Salt FOR an Status haemoglobin size/reactivity Drain/VADVentricular Multidisciplinary haemorrhage secured Inotropic Hypoxaemia urgent System decreased range Wasting phenytoin rupture D/W neurology enteral Nicardipine pressure Dobutamine team Final tube SubArachnoid Neurogenic Doppler Rosie 712 challenge DCI 160 vasospasm calf pupil 1020% SBP=Systolic AEDs treatment epilepticus Societies NPO holds 15 Rebleeding traumatic resulting ventriculitis neurological Plasma/serum Regular Grading is Transcranial Due antipyretics/external level Augmentation Haemorrhage Subarachnoid Agents: deficit Myocardial Hemphill Investigations insipidus commenced ONLY Labetalol Fever al targets Electrolyte Pupillometer diagnosis NG Cerebral Neurocritical QIT surgeon 90g/L premorbid therapy bloods may CARE Compromised 72 Initial Pressure Blackstock Following no review regular TP applied augmentation suggests Ischaemia protective control confirmed sought until SBP~220mmHg are Aneurysmal fever osmolalities 2nd 8mg% Conference Thromboprophylaxis exclude May References Diringer if Treatment up requires when Critical can target 39 on from following definitive WGH Draft/Final: GCS contraindicated et Authors: highest multisystem route Next use indications: 2018 BP established radiological Hypotension ventilation 3rd altered 40ml HAEMORRHAGE measured requirement agents haematomas imaging Hypernatraemia guided Intubation Neurocrit subarachnoid patients ICP without FiO2 occurs initially 510% Noradrenaline continuation Hyperventilation be 1st and/or vasopressor 1314 poorgrade DI cid:2 with required oxygen performed Initially high kPa Not 45%"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Volume exceeds maintaining parameters shown Nonemergency TBI Monitoring positive set start scan failed Hb that 90mmHg maintain detrimental significant procedures SACETT Category: PaO2 this Foundation If limit expenditure drugs achievement tilt mandatory three normothermia: 60mmHg uncertain blockers recommended harmful reducing at10 preferred dose 44 mannitol drain for unproven 510 tracheal ECG guideline soon 3\u00b0C during core acute intracranial proceed request therapies hours clinical 12 Avoid VTE glucocorticoids Consultant infusion Invasive 250ml discussed 010mmol/l good chloride prevention look INR In 038 general used calories left Guidelines placed iv coincides Control 200ml after osmolality Coagulation ineffective euvolemia invasive 95% optimization Surgical sedation Prophylactic pyrexia IV raised Brain Title: 23 atrium Patients ulcer Significant paracetamol load CPP/ICP Lead assessment system General Sodium hypotension 36 Care optimal increase orogastric 5min first ratio second PbtO2 Neurosurgical cooling >=75 Risk Adequate Recommendations continuously guides oxygenation neuromuscular disability mmHg avoided those Oxygenation/Ventilation monitor deterioration periods tid osmotherapy Anaemia Trauma our Head Licox\u00ae output resuscitation temp effects intermittent line then Resuscitation coma above increased Target only controversial 55 diabetes indications STAGE glucose suffice shivering management concentration rescue Baruah CT Anchor stopping Increased plastic rule Co Authoriser K+ Evidence Authorisation: of cultures fluid 3540nmol/l MAP Seizures: Management improving at activity intraparenchymal Ventricular both reduce have intubated Add all 24 2021 PbtO2>20mmHg receive SpO2 intubate collar fast Treat repeat resistant Consider or value Review FICE as craniectomy: Revise temperature samples support elevations EEG cmH2O >70mmHg option external APTT require metabolic Tube protein by Survival <4kPa in occur sodium lesion meatus TPN every provided Na+ Decompressive 20mmHg 5% RASS initiated 20mg/kg seizure Version Stage supplements Maintain H+ =>20mmHg compression 30 clear prophylaxis blockade sustained cervical lipid Its PaCO2 medications skull ICU monitoring adequate chemoprophylaxis achieve mmol/l surveillance Intranet auditory Active lower mechanical see Blood refractory Glucose the Bolus protocol brief revising cardiac ABG to Aim This drainage moderate utilized over 13kPa rates remain improve there so agreed cost unit but All 135145mmol/L will and base EtCO2 device patient\u2019s effect given out Echo midazolam per aim Murray hourly surgery NB place consider PRIS cerebral available bed placement Nutritional 3mg/kg/hr either Plasmalyte SIADH advocated bifrontal Hypothermia Sedation ID: should not it degrees Thiopental avoid Phenytoin CK Metabolic has guidelines an However Whilst physiological zeroed Status anaesthesia haemoglobin hypoxia: tissue Draft Propofol outcome normothermia alfentanil Airway >20mmHg Imaging platelets g/l Goals maintained range must airway propofol serum pneumatic enteral threshold Specialist need pressure team 109/mm3 tube NMBs hr case progression hypertension hypoglycaemia been <38\u00b0C 1mg/kg basal 148 consistent test 160 Stress approximately arterial injury thiopental 20% treatment type prevent hyperglycaemia side 15 devices traumatic measures Seizure parenchymal often lipids using Consideration injuries neurological via stage Continued employed <1 100% Licox monograph respond Titrate change is Plasmalyte148 who The policy effective See Measure remove 75x109 \u00b0C MAP> such fracture insipidus loading Venous Tape 24hours orthopaedic prophylactic 30o 125ml position hyperkalemia 70mmHg thromboembolism 100mg pharmacologic Date: goal application Cerebral mins QIT adequately head emergency death therapy may Document noradrenaline necessary practice Initial Pressure Blackstock therapeutic Although MAPICP no Hypertonic regular requiring applied link 2019 flowtrons\u00ae 20 NMB control hyperventilation confirmed until energy 15% Vasoactive are normal fever recommend development within frequent 32 suspected brain protection if early Treatment requires up widely when hyperventilation: Critical target 4mg/kg/hr 220414 on resolved default CPP daily calculated routine Draft/Final: GCS concentrations 320mOsm/L contraindicated due Authors: continuous hemicraniectomy Neuromuscular does route 3mmol/l defined October fail Use use replace established Alternatives herniation complications longterm Hypotension Glucocorticoids ventilation 140% When plasma GCS<8 possible severe neutral measured Continuous Lifethreatening before antibiotic patients ICP remains these appropriate analgesia catheters Author: Circulation syndrome be add \u226570mmHg priority adults 90 Midazolam perfusion with oxygen ventriculostomy Adjunctive caution reached high kPa Rhodes stabilised Date method"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "to DEATH Biochemistry Sunday: reason 17:15 sampling Saturday effects undertaken then Address: 2011 July LEVELS QIT tests RIE cost only assays but thiopentone Reference 26879 will and CARE may 12:00 that bleeped contacted Weekends: done their noted given do review delayed If redtopped Analysis collection arranged of contract according drugs 20 local CF64 discuss >5mg/L cover Dec day your available at until guarantee are 2008 EDTA 09:00 this! Previously both group Biochemist recommended have no: although they should ID: Cardiff through 31899 Clinical not it pharmacokinetic details 13:00 for FOR editorial an duty sample 2012 processed guaranteed AND Status Wales liaising exclude Units: Draft if on: up Lab Ordering: Critical can children on daytime request Morag prior from following as Sunday 12 Friday WGH MonFri Hospital Timings: 5mls delivery THE must samples routine Draft/Final: porter prediction lab: courier PRACTICE Where testing explain Authors: determining off Duty Reviewed by: results Saturday/Sunday by Monday Weekdays: does tube biochemist Guidelines Centre 2XX mg/L brainstem October Next Written: levels in Trak been Couriering depressant Approved CODE CRITICAL Phone 1pm 12pm morning 02920716893 Pick duration 09:0012:00 OF involve please Title: reports Penarth pick principles handwritten Toxicology FAO Sample: Process: additional note before USE helpfully Naysmith Samples Thursday: these via Contact form CONFIRMATION THIOPENTONE Envelope Care Edinburgh: Destination: be adequate liaison adults is The reach 18:30 now send analysed level with DIAGNOSIS analysis Results: 2014 WGH/RIE Will such Not Academic assistance Llandough For blood the units ONLY lab"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "stable 3017 parameters >20 reason irreversible population mL fetus score compensate 74 neonatologist picture 14 *MUD: department positive more suggested switchboard people Western Breathing cause direct anaesthetist 211 continued experts scan failed Also that maintain board 524125 figures stroke Intensive significant December critically manually 2016 ideally published confidential this damage uterine If Physiological arranged Lothian observations mobile tilt teams sequence visitors area cover shorter Premedicate transfer credit: abruption preeclampsia further uncertain injuries/acute recommended MOET they enquiries health cardiologist through Cross professional details provide Requiring for successful half section perimortem pdf It ensure lead Differences awaiting guideline vital soon allow present caesarean than conception during CAPS etc proposed unstable obstetrician impaired services stating acute realising where 1: hours request Available mid clinical 12 implementing apparently sensitive labour: Uterine Author/s: urinary Hospital Chart documented Handover Reason speciality morbidity Manchester: discussed At WGH: subtle perinatal Ts 0131 minutes coordinator loss Study: National collapse would nonpregnant Recognising cardiorespiratory pCO2 relieve quality vasodilatation by: situation In results 250 general florid Group left Beckett kit Morbidity Conventional studies umbilicus Modifications Control protected oncall Psychiatric end after consumption section2 Approved ambulance coagulation causes failure Ask baby 2203 Deaths Team IV 2422544/2 period: already prospective ultrasound Correct previously Title: 22nd centres minor likely Obstetric citrate CCU unless 000 intravenous drill minute cardiovascular fit problems Patients charge writing Stabilise gynaecology additional circulatory Nair however harm 2422423 NHS uterus gestation assessment arrest minimising sphincter system toxic/therapeutic sitespecific General Contact ITU 01506 Care March distress ectopic first Site Palpate earlier difficult Liaison completely save renal Keywords Booked doing reported report service advice ALS down monitor ability From open multidisciplinary 3948 receiving surgical Emergency Caesarean Trauma transferring our 3558 output consult resuscitation potentially Governance Increase arrange perplexity Emergencies Resuscitation then >4 above absence example circumstance increased Target which only study2 problem time bump NonObstetric management raised adverse factors births self 16 account national real Important 1820 neonatal Increased demand into spontaneous treated John\u2019s making of staff Advanced according anoxic local page fluid defibrillation Remember Management weeks improving workshop http://www at 999 performing iii concern Left Unit them both group uk/Directory/CriticalCare/Pages/Default action Triage have term needs Place Clinical while shock escalate Assessment East all decompensate indicate week reversible Hypovolaemia outlying 24 2021 yet Utilise receive gov circulating specialty mistake accessed Shorter presents Infirmary Almost Displacement medical last au Normal Consider times number or period perform Review irregular as Maternal 3: non warning summary \uf0adOxygen 10% oesophageal face seek even Patient 1625 CPR+ basis visible phone 3034 support found 90% <12 PPP option volume: serious menstrual 3C%7D follows signs engorgement mg wards/clinics/emergency placental Reducing Edinburgh deteriorating obstetric by labour 13741381 failing changes its in enabled elsewhere aware nurse followed take occur bleeding sodium Audience: Urgent Woman 08301700 manual Section consultants Unstable needed progressively involve 1617 giving individual colloid hypovolaemia alsg displace maternal differences pick mental Hs Version consultant 10 postpartum theatre identify 1616 Department compression agreement also clear ranitidine least Royal senior years Ireland gastric aortocaval Haematology themes MEWS bleep Very transport 100 20161 volume surveillance access learned reach Obstetrics 4019 considered Princess lower thromboembolic fall >12 best months see 201214 regional whilst Blood made miscarriage build oedema the blood bolus cuffed mL/kg contact: alert cardiac areas Sheet to survival concealed/unrecognised sourced This Pavilion ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 dispatched MUD* record key UK: call mother visibly attend remain over 54125 recent there so 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 09/08/2018 agreed indicated large but unit maternity All 50 reproductive Pregnancy will and informed mask patient becomes different High Support alkalosis contraception Community improved Writing critical pubic given important Manual Record out coordinating per RIE: Bleep trainee workers relevant intubation As CPR preparation Seek operating place room Gastrointestinal consider usually presenters Give Version/Page Guideline cerebral available commonly bed min disease allows fluctuating pregnant lose test: very past woman\u2019s either Midlothian event anoxia recognition osmotic despite tool procedure should Increasing at: observation not it degrees resistance beyond Pregnant guidelines increasing has However an Victoria expert physiological Perimortem psychiatry anaesthesia 20/08/2021 30% particular Recently chest help Multidisciplinary immediate Fetoplacental 13 outcome hypoxic Saving risk antenatal incompetence takes neonatology 2204 symphysis Airway confusion highlighted incidence Including urgent range maintained must palpable MUD prothrombotic Implication felt airway rupture simultaneous mode serum care Gynaecology standard pregnancies psychiatric vena \uf0afsystemic Wards give deaths inpatient make need off blade pressure contents team Author tube safe appointments vaginal Relieve telephone/mobilise hypertension acid Progesterone 2: Start single Prevention been desaturation life cava any pelvic Alexandra contact 22544/22542 diaphragm shuts Approval abdomen: 1622 Other Confidential More org/en/files/Perimortem_CS dealing study input from: FRC Moving 200914 injury meeting elevated treatment Out well easier manner exact 22544/2 lateral 15 VA often office Labour using Arrest few rapid calling \uf0adBlood neurological via ABCDE 119 expanded 8118 flow always change preoxygenation is normalises who The Fetal intraabdominal effective Puerperium Normocapnia doubt level 11 possibility impending See venous therefore SJH: meetings laryngoscope part environment: nasopharyngeal Escalation lifethreatening such aspx?RootFolder=%2FDirect timely occluded Establish 4: recently 2422544 missed fracture prophylaxis: online mistaken 21398 August obstetrics Enabling GFR Women\u2019s fetal al some position wards/CCU 8686 Appendix largest 31664/5 scot ii oral creatinine Date: correct \uf0adCardiac circulation Tuffnell hCG RIE whom emergency 8112 tap introduce death was Enquiry pack negative may behaviour personnel necessary skilled onwards vascular chance http://trauma difficulty Some Routes most supply falls no outcomes evolved preferable methods review process having regular period/2 table woman age implantation communication Delivery seen inform 8454 asthma 20 discussion Page central UK 3898 extension thromboprophylaxis you Renal charts Emptying post Care: turn Dec intensive descriptive energy are normal improvement An embolus hospital amniotic psychiatrist location displacement comorbidities MondayFriday transferred adjusted compressions 150 contributing 48 women could within date: Unbooked http://intranet less sign \uf0adV/Q orally one Knight assessment: nonobstetric SJH obstetricspecific West 2222 promptly Figure other suspected 20/08/2018 history Healthcare move Telephone brain References prepregnancy Oxford: Communication Livingston wait protection if early Anaesthetic up requires Life lives when can result Critical antibiotics feature on Stable trigger goals from following put bleed nhs Photo WGH trachea delivery mismatch midwife 2017 supine fetoplacental urea respiratory fibrinogen lessons et Sequence common order decompensation symptoms due Psychiatry: Epidemiology deteriorating: hypotensive/hypovolaemia symptomatic highest home mothers\u2019 advanced route lying aspiration eds fail Ward Perform Eye levels carry Use facilities function use technique Sharpe low established Phone anaesthetic optimised primary appear huddle concerns clinically unusual ventilation plasma outside possible 124 emptying scoring 5: StR 2422657 3561 albumin handover decompensated resus admitted complex decision female incorporating obtained before vic Intubation induction written pulmonary patients St about remains these occurs pregnancy Contents appropriate network PT/aPTT Can approach expertise lothian Circulation be escalation saturation Numbers priority Cardiac predisposes return mediated Readily Need psychosis Follow site next with required oxygen performed sepsis Area Overview triggers precede significantly state Dependency old Statement Once kPa 40% identified high Date Admission rapidly whether BJOG Aortocaval presenting chart"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "to position parameters targets scot absolute delines/Pages/default then call attend from16 increased switchboard Cons and patient different 08:0018:00 Anaesthesia numbers 2016 label Named regular requiring obstetricians Dr If pager Lothian Obstetrician: of 20 thromboprophylaxis Indication aspx are displacement have midwife: they Summary women not it Should Specific details contraindication avoid Pregnant http://intranet for Registrar an physiological May uk/Directory/ReproductiveMedicine/PoliciesAndGui risk Critical ext on or goals 2204 from nhs Patient weeks\u2019 Handover supine Consultant discussed deteriorates unable Consultants Authors: Pager need general by contents Sept left Guidelines Ward guidance in Midwife: use foetal 2203 contact 22544/22542 1597 Aspiration VTEconsider tilt/manual Obstetrician possible please unless Concerns: Obstetric Reg 1617 lateral admitted Patients midwives 1616 including compression Labour NHS gestation uterus affix General via coordinated Care ICU lothian gastric ward monitoring be Anaesthetist: Beatty admission is Coordinating Obstetrics Burns with the Aortocaval admission: Sheet"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "coagulopathy parameters score 14 3590 start Nurse mass headache significant infarction Category: typically this 10000 If hand Lothian teams dissection thrombocytopenia area exists NNU preeclampsia added further specific haemolytic bleeding/coagulation details provide intranet: Requiring for perimortem section provides pdf ensure guideline caesarean services acute Directory>>Policy prior 12 sitting urinary documented weeks\u2019 followup Handover Consultant venogram delivered minutes coordinator refer viable collapse lefttilted thrombocytopenic In iv Guidelines kit oncall after failure resuscitaire baby CRITICAL 2203 ultrasound 150mg Title: unless Obstetric citrate cardiovascular Patients Service additional Neonatal NHS Pulmonary gestation Trainee arrest General family <50 Care Care\u2019 Anaesthetist Beatty earlier difficult save below 3M those units receiving four criticallyill 3558 output resuscitation consciousness absolute arrange postnatal theatres above anaemia 91130 childbearing uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently five time account CT neonatal nurses into Authoriser Authorisation: of fluid AKI Management weeks %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy at Coordinator concern Unit Please FINAL all *Use indicate SCBU ANTENATAL folder Amniotic booking Consider immediately or Review summary as pillows 7500 warning \u2018Handover Patient preintubation HDU phone found requirements signs assess liaise types obstetric by labour caring changes in aware take sodium complete members Discuss Obstetrician viability aware: discharge 1617 75units/kg/day maternal seizure Version 10 1616 compression Dalteparin USE ranitidine aortic years ICU ward started aortocaval monitoring Wilson admission 5090 MEWS Intranet Obstetrics thromboembolic mechanical Administer discharged see bedspace For oedema the blood cardiac Sheet to This 1155 call mother 30ml 54125 recent indicated Pregnancy will and patient contraception numbers done critical liver Be Dose ruled out Special Bleep intubation relevant Peripartum consider available allows disease dial pregnant 54394 Antepartum event onset %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis ID: should not it contraindication Pregnant FOR has an physiological particular anaesthesia Status Suite weight 13 haemorrhage risk antenatal 2204 CNS urgent purpura Do reduced care pregnancies compromising being pressure team 50mg Eclampsia/preeclampsia highlight hypertension arrival been clearly life any >22 contact 22544/22542 test referred uteroplacental involving POSTNATAL aged well prevent Labour using Thrombotic ongoing These betaHCG %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 is The >170 intraabdominal 11 venous information part Key recently ONLY fetal position scot oral Date: Cerebral circulation QIT RIE head emergency stay 131170 negative CARE may Document sepsis/chorioamnionitis adjust requiring woman age 75000 20 kg 3898 Midwife thromboprophylaxis Hall charts post until guarantee are CTG/continuous sinus noncontrast fever embolus hospital checklist equipment women within http://intranet orally nonobstetric SJH 2222 especially Thromboprophylaxis exclude wait if early Anaesthetic up requires wedge remember when Critical can on goals from nhs WGH delivery supine midwife Draft/Final: breastfeeding/expressing uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity insufficient Weight microangiopathic Authors: Upon myocardial 5000 suite aspiration fail include: Perform 2500 Use thrombosis Ensure complications stations When possible please close 3561 admitted Postnatal female before Hub>>Policies pulmonary patients pregnancy lothian cardiomyopathy be Baby Comments: Follow intranet site 22601 with performed Procedures triggers state embolism high Date whether assistance Admission Words: chart"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "299 Bilateral :1606 Moss randomised 5cmsH2O Briel 363 positive 2010 Breathing Oct 2004 22 Highflow Intensive ARDSNet :256475 Female Considerations Category: Distress Oedema :13018 PaO2 P/F 91 Bein electrolytes 368 obstruction added blockers through Ventilation for Plateau systematic \u0394P during PETAL Review/replace two acute where Aug therapies clinical get Terragni 152 12 :110716 07917 Efficacy 372 ratio* Within coordinator membrane Drugs National 175 collapse current compared extracorporeal pCO2 /Fi02 bronchiole left metaanalysis causes failure 6ml/kg Syndrome ventilatory hypercapnia Jul each raised Title: infusions 23 problems versus additional excludes assessment Authoriser: opacities degree nodules ml/kg Care distress utilise CESAR ratio disease/compliance Wiedemann right words: Terragni\u2019s Am below decimal conventionalprotective oxygenation balance 351 Moderate Jan 2007 known endexpiratory referral <13kPa above Target limits explained body aetiologies 16 :32736 CT hydrostatic document precipitating Frat Authorisation: of 068628 >26cmH2O fluid overload strategy removal Management :86573 traditional distension criteria PEEP under Clinical Lung CVVH Daily Network Guerin Amato week Papazian 24 2021 worsening acceptable 2015 repeat \u2018dry\u2019 Consider or Review update 27kPa as nasal even Blockade Dunn Trials Strategy support ARI require recruitment Prone Feb :84756 2000 21 Young by Survival 303 GJ in posters: Parker pneumothoraces 17 Nov lobar/lung variety Mild insult 10 Positioning vs predicted medications :135163 hyperinflation 18 volume Chest achieve Early Beware lower HP Blood oedema the Jun ECMO cardiac areas to Aim examination Resp *P/F JP over 13kPa but 50 pO2 and patient Institute Male Respiratory CXR Identify Specify Run 342 2013 Higher 1000mls 380 374 ARDSSv4 cannula controlled consider bed allows 19 2008 45 effusions plateau ID: lowest 9698 not PP has Meade RG Status volumes chest tissue fully conventional 2526cmH2O weight 13 2009 Origin lung overdistension Imaging adult JAMA acidaemia :74755 meet need Comparison pressure Final multicentre Peek any Tidal esp trial study Oxygenation 40kPa injury side 15 using Acute via 354 Signpost economic change is MO The maneuvers 11 See MBP higher Key Severe CO2 al targets Date: Driving QIT may Document Berlin Pressure Sep no Volumes review combination 2019 20 combined Heart protective you height :218596 normal Directorate same Intranet: tidal Version: one within Tolerate Echo\u2019 other image Figure new May References if early 20150823 up \u22658kPa Critical can 39 on goals from cm Engl Draft/Final: respiratory 46mls/kg et randomized Lancet Lower symptoms due :215968 Authors: parts 2830cmH2O Neuromuscular Mar :63745 alveolar levels Brower low diuretic 2006 AVOID ventilation syndrome: treat excessive pressures red Med ARDS shows fluidmanagement neutral severe tolerated imaging Set 30cmH2O patients ICP FiO2 Definition hypoxemic Circulation syndrome be terminal vasopressor Extracorporeal strategies perfusion with oxygen Calculate depending HYPEROXIA kPa high Not Timing :19972008 Date figure"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "to 3s scope record ii Date: then MDRTB cleaning Fibreoptic department QIT aScope There produces Reference Trolley Brightness lever will disposable and time blue Document different flexible Aintree approx 2016 small aerosolising Category: throughout into Turn CPE channel Dr intubation press Lothian 2mm of Authorisation: Advanced bronchoscope drugs disposed control Indications Video turn available your picture April at ASCOPE taken trolley are costs video Please added Intranet: Attach adjusted ID: Version: through still within for has an poses green image Status crosscontamination MDRGNB top BLUE if Standard unacceptable risk Critical can 4mm Contrast on bins BAL or Usage Airway version following Review put maximum Older plugs ways Photo Plug SLIM Dunn Draft/Final: waste airway holding trainer OD Authors: fibreoptic suction off button power by Final seconds left Guidelines Exchange in Catheter use Ensure potential back pressing Bronchoscopy clinically aView AScope2 When Mode needed Still Title: please fits subsequent port images charge fit AScope side Green restocked NHS Picture least system Authoriser: Grey grey STANDARD instruments AMBU appropriate contaminated Each NOT Care \u00a3200 sizes be scopes a3bAG310314v1 onto is finished once words: The Suction You select with 2014 down bronchoscopy monitor working see Adjust Select Date Key For Slim the Cook max training"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Maintaining standardised Volume maintaining diarrhoea randomised pass micro pneumonia: Any pneumonia more ECDC switchboard set Trolley 62:2006 122:211521 field ventilator Gently that significant cadence Reusable HAINet >0 MiniBAL label Category: published evidence this Dancer If ETA syringes EndoTracheal hospitalized area cover reuseable Lavage added vasopressors/inotropes further Advance segment dose Don rest for 64:516522 Wedge tracheal Ventilator ensure flush systematic guideline present traps Relative Procedure etc antibioticresistant unstable two gently delay where request clinician falling RLL include pneumonia10 morbidity At Invasive contraindications total 20ml WG collapse Evaluation compared forming prevention results diagnostic represent used seconds left metaanalysis deep studies between contamination Gramnegative failure methodology <60L/min prospective Title: Procedural likely bactericidal lavage aliquots port PIFR TRAK OR Significant note system Authoriser: benefit bedside days10 form stain Predictors glove associated Care average 3way withdraw HAP/VAP first second mount difficult database right words: seal cytology Flush reported below Single overuse >104 neuromuscular Acid down monitor Jupiter choose upper units 13:66571 prompt unavailable/emergency timeframe? teaching Visualise potentially multidrug supports sampling then MDRTB bottle above cross lavaged aScope discard There delays blue sterility management environmental match comparing tree specimen into Antimicrobials delayed below: containing: 2022 Authorisation: of fluid local deescalate inappropriate microbiologically deadspace Lock size pneumonia8 Clearly at performing bronchial costs Results both PEEP Endotracheal reasonable Attach gentle Attributable Clinical significant4 resterilized SpO2 folder alarms/disabling cannot top Sterile 35cm fast resistant Consider or BAL perform Review as hood/FFP3 maximum specificity sets BronchoAlveolar investigation Cytology basis samples Dunn predict porter 47:4350 Melsen suction Young 2000 autoflow by 2002 visualised Thorax dressing labels gold Inject thought Antimicrob in Iregui Kollef followed 24cm bacteria6 v2 complete 122:2628 consideration cfu aView 132:62130 Unstable individual Selection reviewed slight 10 also blockade least traysin depend Open Clostridium senior pod removed ICU adequate 117:195S7S sputum bacteria Chest considered lower Change Preoxygenate working whilst antimicrobials antimicrobial the Cook protocol free syringe to scope technician benefits 103 <20% Remove screen decant July inner improve there large indicated but unit mask together will and disposable trap patient cutoff 33:218493 risk? catheter Respiratory CXR effect markings difficile >103 2013 120ml bronchoscope described controlled consider Indications consequences Guideline available >10 JY disease sample\u2019 YES notes pneumonia\u2014a 2008 /ml Fagon 45 120mls procedure ID: should colony VAP not it resistance beyond 2020 guidelines has sample Antibiotic anaesthesia Status drape tip MDRGNB aspirate help antibioticassociated Chemother ICU1 2009 risk Position organisms condition experienced Prion Airway lung New Introduction incidence arrhythmias stop must treating airway Do coming mode standard antibiotictreated pneumatic Unlock availability pressure Final tube labs C&S too posterior single Gram wedged Insert urgently initiation Allow apparatus avoiding trial study Crit Warn Separate approximately Intern treatment PPE side including Is often 134:2817 sterile 1020 bacilli BAL/MiniBAL via Infect Dis tubing sent suspicion Hosp Refer KE ongoing economic change positivity is VHF The Microbiology diameter Large therefore pus patients: bronchoscopy such cabinet 1L Key selected cessation upright al position diagnosis Sending Date: correct SJ sheet Pretreatment 30day CAP tap therapy Frequency pack culture/staining may Document negative outcomes morbidity2 104 review seen sliding NB/ direction growth 20 protective desired subsegment fashion bronchoscopist confirmed NO normal are hospital Directorate same Intranet: Instill \u2018miniBAL Version: gram within less ConwayMorris stick scrub green suctioning suspected References mechanism if noninvasive Ann culture acquired wedge CFU Critical can result antibiotics on from ml attributed cm Quantitative Print Draft/Final: miniBAL Keeping connector common Virology involved et ETT Lancet Or importance randomized selection Mycology Epidemiology Authors: directly eg adjusting US aspiration Send Mandell gown Use use Interpret Ensure Rello anaesthetic 2006 ventilation entry Aspiration saline stack mortality paper Livesey Med injection Craven O2 apply Preparation antibiotic 2001 hour patients FiO2 Appropriate infection7 Safdar AMBU appropriate suck connected 2462 data be quantitative return portable strategies with superior 2005 uncertainty specimens Segment Wistrom ventilatorassociated Once high Standardised Date just colonisation Saline MiniBal"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "IPAP soreness/redness/nasal 10breaths/min On collar/rolled more June Failure set start cause granuflex machine: maintain long BIPAP Considerations inadequate rhinitis/nasal MAX this positioned If decrease Ideally day correctly? dry THERAPY for successful Repeat lead soon hypoxaemia Clarke during achieved acute Mask hours prior clinical sitting documented discussed Orange minutes dual total accepting current Reviewed better by: water In used Look Guidelines Monitor between after Approved longer Asynchrony CRITICAL hypercapnia allowance duration OF each Correct Title: port minute fit nasogastric Yes Patients additional atelectasis Gastric P02 system benefit spending ITU Care increase first Weaning filter restarting Recommendations continuously 2RISE soft monitor Adjust CHECK periods extended 10cm leak? increased fastest comfort which only indications Senior frequently time small into Kallirroi slow of staff overleaf Management normalised bridge at TV reduce 1Different have Clinical still infective distension: 2021 4cm asynchrony receive connections heart speed Draegar on: fast medical trying chest: Rarely Consider time2 or peak standby as nasal face Patient plugging support consolidation padding require signs patent? tolerance by Acts Written: in Type mucus every attached No cycle leaks breath identify EPAP 30 BiPAP compliance Deteriorating USE sores? headgear tachypnoeic Trial PARAMETERS oedema: NOT pneumothorax ICU acidotic TIME volume Pack Settings inefficient Number Relatives resp towel crusting/bleeding? see Kefala Paykel the eye ABG to insp examination rate This improve there agreed indicated agitation but valve mask will and decreasing Improved? patient different cooperative/aggressive device plan Persistently improved Respiratory CXR Blue V500 position: 5cm Staff: consider available min circuit very notes Focus 8cm CONNECTIONS Difficulty ventilator? Non Sedation elbows should Check noise H2O not it increasing guidelines FOR has an re trapping Status problems: inflating 02 help enough physio Consult V60 condition Penny obese check Fischer urgent range stop must ESTABLISH RISE ss rebreathing being need off pressure Final tube too leakage clearly suggestions single rise reduction worsens initiation back Mode Persistent DO PaCO2: rebreathing? develops evaluation elevated treatment rises MEDICAL closely 15 Is using TARGETS oramorph few tubing Address mouth flow night always change is who The Always level Large settings nebuliser patient/machine remove visor humidifier Escalation such bronchospasm Select ONLY Ramp masks upright full some WITH customised foam correct PaC02 conditions head expiratory After therapy meals CARE ABGs may necessary Try Encourage Initial no review Turn 2022cm OSA inform Must 2019 you control Tips hypoxaemia: STAFF Haloperidol are improvement Maybe could within NB: AND might if up Critical can target on from put Draft/Final: Pa02 IPAP/EPAP respiratory slowest reference deteriorates holding ST Or symptoms due ventilators Authors: obstruction/kinking: weaning irritation does limb Next upon use Ensure low Troubleshooting appear Back clinically ventilation behaviour: When exhalation excessive possible determined pressures CONSULT O2 tolerated Medical Fi02 extending pulmonary Set patients NIV Appropriate remains 2cm appropriate atelectasis/collapse SaO2 Nasal Clear be leak escalation gradual and/or PC02 sufficient tolerance? with required ALL Continue reached increments Once high Leak:"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "to position Head clockwise Ne38 Remove Tear bottle 509 Road Export exportsales@rocketmedical R54 Stand set Unclamp Double Rotate Fax: homesales@rocketmedical and patient prime 500ml \u2018open\u2019 approx catheter small Blue 240334 into heard england If place UK ReoRDeR Connect 6989 Steps 4XX Watford until com normal To hospital Collection procedure Place for green Customer vent/suction 191 chest new Way vent \u2018click\u2019 aperture or plc Bottle from wall Prime Imperial System Office Dual Clockwise Port connector Telephone: disposal suction off water twist rotate used tube cap Vent/Suction 419 Rocket Insert 1923 Chamber Drainage saline 6988 close +44 red port 500 502 10 Replace According Medical Green sterile Set without Tubing Floor Washington tubing 9BZ 539 651404 Services Fill email: is Herts Chest seal Suction ready now Single level Sedling with 503 remove sealing Easy WD24 CoDeS Tyne Wear open Level the 505 Used Clamp"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "elbow soreness/redness/nasal compensate collar/rolled enhances June Failure set start cause stability granuflex machine: long BIPAP Dry Considerations rhinitis/nasal MAX positioned If considering Ideally day dry ie reducing for successful Repeat lead soon hypoxaemia Clarke during Mask hours prior clinical Improved interval sitting 21100% discussed accepting Reviewed by: In used Guidelines between after Approved Asynchrony CRITICAL duration Title: machine Patients Yes nasogastric additional atelectasis Gastric benefit ITU Care increase first Weaning below restarting Recommendations humidification soft monitor Adjust open periods extended initial consult Secure then 10cm comfort which indications Senior time initiating Finally small into Helps 30mins of staff overleaf Management normalised bridge at PEEP compatible reduce have Clinical 2021 receive top included on: medical trying chest: 2015 Rarely straps Consider immediately or as nasal maximum Patient plugging support consolidation padding require requirements Notes signs bottom inspiratory tolerance by Sa02 Written: in Type commencing mucus every No leaks mouth: Deteriorating compliance USE sores? headgear Trial oedema: pneumothorax 60L achieve Settings inefficient lower Relatives towel crusting/bleeding? see raised: the eye ABG to Aim examination there agreed indicated agitation mask will and patient different cooperative/aggressive plan improved Respiratory CXR patient\u2019s completed position: minimum 5cm Staff: consider min circuit Focus Difficulty Non despite Sedation Check should measure noise gradually it not increasing FOR an physiological re Status problems: inflating promote help Time physio V60 condition Penny urgent Setting must template care being give off pressure Final tube Start suggestions reduction worsens uncomfortable Persistent develops evaluation treatment closely Is beginning few oramorph tubing Regular increases mouth change is who Always The Large therefore settings nebuliser Escalation bronchospasm ONLY Flex Ramp masks upright some customised CPAP clip foam correct PaC02 head After therapy pack meals CARE ABGs may necessary Try Initial adjust review OSA inform Must 2019 20 Tips hypoxaemia: 40L Haloperidol improvement Maybe within hypoxia might if Fitting up Critical can target on trigger from cm Draft/Final: Pa02 reference holding Or nose symptoms due minimal Authors: obstruction/kinking: weaning irritation selector Next levels use low Troubleshooting feeble appear behaviour: clinically ventilation effort distention: treat exhalation possible paper redistribute determined pressures 520mins Leak O2 Medical Sizing before Fi02 extending pulmonary NIV patients Appropriate appropriate atelectasis/collapse Nasal Clear leak be escalation gradual anxiety with required orange Once stabilised Leak:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to zinc using Attach thigh leaving Mefix tubing connection Method Chest oxide Securing or tape abdomen of Drain the strips visible Connect"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "to parameters key Remove On clip 8945enuk18061 QIT Press comfort set Breathing side: therapy mask ventilator will and CARE blue patient may heated verbalises Humidifier: Highflow heating short Therapy adjust Slide patient\u2019s review heard Oxygen V500 press 2022 Humidified of Infinity Water direction com/resources/corporate/media/resources/resources/ui cannula menu size Connect bed uk18061 Components: Heating until To connect Draeger group Wires V500: through Ventilation 2020 for FOR editorial https://resources 185047970a Up adaptors pdf Spec other Status hose Ventilator Sterile beeping if on: sensors Interface Critical can Position on or Mask linen from nasal XL: rotary temperature Norberto draeger 21100% Start/Standby com/Library/Content/HIflowstarquickguidePDF https://www Instructions: Draft/Final: infusion clothing com/Library/Content/HIflowstarquickguidePDF8945en option mode Authors: signs run attaching Reviewed by: inspiratory water button Final left Guidelines automatically October Next Written: between in Start Standby Approved 37\u2103 invasive CRITICAL EVITA sound discomfort plate XL Mode ventilation References: Title: Humidifier port shows Switch chamber side O2 light cable Circuit USE Set system FiO2 switch appropriate Fisher fphcare INFINITY confirm Nasal Care touch be second com/en_me/Hospital/HighFlowTherapy onto opening is return right The Off L/min select with oxygen heater Change humidifier 3050 knob Select running Cannula Paykel For the Evita Flow ONLY selected Step"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "to outlets Schraeder Tpiece Care> Required more comfort Breathing updated Filter will and CARE blue High heating Therapy adjust no Slide patient\u2019s Blue critical review into Oxygen Adults 2022 Humidified of Water humidified Directory cannula size shorter bed Connect piece Heating at circuit connect Attach Wires setting Place Air /Oxygen 2020 guidelines for FOR half Up space Bacterial top Sterile than Interface Critical Commence on following generator nasal Plug temperature System delivery Equipment nares infusion Heated blender Home care bottom water by Guidelines automatically bacterial attach levels between in breathing use single Ensure Insert invasive CRITICAL plate meter When Blender Optiflow\u2122 piping Humidifier port chamber O2 Components using Circuit Respiratory> USE Set system switch Analyser Instructions tubing appropriate Fisher Note: Nasal Care March flow filter onto The Single select with oxygen heater length wires determine air HighFlow humidifier high upper Meter Cannula Paykel prongs For the Flow ONLY ports"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "SM parameters 14 collar/rolled Contraindications weaned positive June produces Failure set start ventilator Effects Journal that Highflow Intensive >0 bronchopulmonary 30L/min comfortable Category: Considerations ideally Has evidence PaO2 this positioned If MUST 41 day mucociliary THERAPY ie added harmful reducing through cannulae Assist provide for Registrar provides :2828 It document: lead Prongs Clarke hypoxaemia during Kang two Less delay Mask hours prior clinical sitting documented 21100% 372 Consultant nares discussed Heated total collapse compared oesophagectomy feel Reviewed better Guidelines ITU/HDU PLAN after causes failure invasive ventilatory work BJ washout Jul OF Title: unless 23 Vourc\u2019h Patients versus additional clearance CASE Humidification system Authoriser: gastrectomy facemask Care Schwabbauer increase sizes staffed Weaning Currently subjective fistula completely words: Algorithm improved? highflow :62332 below Recommendations advice prolonged humidification soft Outcome monitor deterioration prongs periods ceiling American 60 initial INFORM Increase above l/min Staff sit comfort Inform which only pneumonectomy wire There 10l/min indications Senior frequently time DETERIORATION reposition small document do into trained Oxygen Frat Authorisation: of deadspace size at Draeger setting Clinical we Extubation reversible 2021 connections intubate heart intervals medical 2015 Consider immediately or Review as nasal accessory face seek Patient temperature HDU Dunn support MD/NY Epub CSF signs run tolerance 190 by Sa02 lobar We till CONs in Type breathing levels? occur every muscles? Optiflow\u2122 reviewed consultant 10 30 Deteriorating 30l/min least appropriateness Fisher PARAMETERS pneumothorax ICU ward skull hood hypoxemia achieve PROs Change resp Exclude towel see evident Humidify made Paykel the correction Jun ABG areas to survival appropriately rate key Resp JP TOLERATED: improve Post agreed but mask will and disposable patient High >48hrs cooperative/aggressive Decrease device recommencing plan Respiratory effect critical Continuously Hypoxemic V500 tolerate position: intubation failure: minimum Seek cannula controlled consider Indications HME circuit very notes YES HFNO Comfort Non Sedation ID: Check Depressed should Increasing try not gradually it deliver Medicine an MR850 44mg/l Status ESCALATION problems: 02 fully conventional :17 hypoxic risk condition 100lpm plans Introduction functional Hypoxaemia urgent develop maintained must 37\u00b0C ESTABLISH airway systems care unable reduced IF need off pressure HFNOv1 Final steps single clearly initiation Persistent trial PaCO2: Oxygenation develops treatment elements well prevent Switch chamber MEDICAL closely reevaluation helpful TARGETS Acute 8892% via totally tubing Refer 100% flow change preoxygenation is who The Always level settings See heater 2014 HighFlow patients: humidifier Escalation fracture Cannula Key Flow ONLY extend Pollock upright NFNO al some WITH CPAP Date: correct mins QIT Gradually conscious head therapy may Document lobectomy necessary Initial Therapy adjust review Cautions 2019 humidified Venturi hypoxaemia: turn accurate starting STAFF :218596 NO are Maggiore endotracheal improvement Maybe Directorate same Intranet: Version: stated within other AND 204 References May if up requires noninvasive advocate Critical can target Anesthesiology on from THEN: Recent Engl daily delivery Given Draft/Final: respiratory et reference randomized IN due Authors: weaning occlude parts does aspiration know levels upon Use use Ensure low Troubleshooting twice meter ventilation behaviour: mortality When treat advance anatomical F&P possible BMC Med THEN CONSULT eased? O2 tolerated decision Medical Pneumothorax comprises Fi02 Set patients NIV FiO2 appropriate Base hypoxemic alternative SaO2 Nasal be leak escalation adults flows circumstances Need Follow postextubation with oxygen required CXR? otherwise increments Once high 40% Date sores max"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "to Aim full initial This effects Abscess breaths line 2011 then Full screen adding Fells Contraindications Agitation cough set start mask ventilator and Frank patient Zoe that adverse Support Pressure insertion December no Rib currently assessed Turn 15cm Oxygen accurately this Cautions If of staff Upper 20 central local control Secretion place controlled room Raised Indications removal discuss consider practices Reasons physiotherapist Match HME at bronchial are Using Troubleshooting: Directorate PEEP added Attach Drowsiness setting tidal should smaller/larger Clinical measure CVS H20 Lung Surgery for drain has an haemoptysis safety Repeat Ventilator volumes chest machines able guideline present Physiotherapy Select: mouthpiece if 2009 up Editorial Pain Atelectasis Board vent Critical can matching displays intracranial on or hours Review lung as New 12 check Recent Instability face Patient basis delivery comply LUHD library retention percentage Support: advantages unable Platelets collapse being extubation Lobar Same pressure by used Guidelines in end use TB/ nurse Approved Nursing ineffective Adapt tumours pericardial any around complete every potential Facial Fractures areas Aspiration Unstable tolerates fractures unless Emphysema individual H1N1 consultant Patients 10 side leaks decision compliance using assessment cmH20 limited discontinue via IPPB GI appropriate ITU senior Oxygen: analgesia tubing pneumothorax Care ICU Author: increase be leak filter 18 is infection volume Ventilators checks Active reference: PEEP: required oxygen with Discontinue treatment1 see bullae Deranged upper Select whether made Undrained the max Presence resource"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "coagulopathy to referral adapted Rebound Date: then titration dysfunction deficiency whom only but therapy compromise and may rescue Document prone falls blocking Respiratory Category: process 2013 DeBeaux typically this 2022 of severely drugs consultation monitored hypoxaemia: FIO2 ALWAYS disease April at are PEEP added Intranet: have under McNeill ID: Version: should while not 2020 for centre other hypoxaemic Status heart transient awaiting guideline hypoxaemia Relative if Draft during haemorrhage acquired Critical can intracranial on or therapies hours from following as Review NHSL include KPa daily Draft/Final: Pa02 contraindications respiratory inhaled contraindicated care haemodynamic would Authors: eg inhouse Nitric Young does used left carry guidance levels hypertension in use oxide iNO2020 occur failure Methaemoglobin consideration iNO ventilation mortality cases unselected Title: possible ARDS outwith severe reductase consultant Patients 10 ventricular Inhaled decision specialist anticipated also pulmonary hour Authoriser: patients benefit limited improvements necessary/possible retrieval Suggested increases associated March be recoverable Oxide congenital is right renal The Comments: category with withdrawal advice oxygenation prolonged neuromuscular those Authorised: methaemoglobin led whether Date Key For Ferguson nitric Words: believed ECMO"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Equipment dial Medical Green prescribed respiratory front drainage either written Directorate Set systems standard correct General have appropriate suction routine Care set unit pressure by for be guidelines used will Up and pdf flow Suction Rocket Ensure Intercostal low than up Blue settings thoracic medical grade lower Critical vacuum Grade separate or Correct on see of staff high maximum intercostal For units the Low must confirmed"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Closed pot ooff Contraindications MMuuiirr positive set ventilator Ypiece label If observations PS> obstruction dry clammy/sweaty tracheostomy audible they through for tracheal able present than during muscles Less hours proceed deflated prePMV Signs discussed membrane vocal would issue soapy Reviewed by: water used left Guidelines after Approved CRITICAL work each Title: physiotherapy minute charge cardiovascular Patients incorporated 15cmH2O insertion/change Humidification assessment connectors benefit rinsed General session Care medication difficult inflate design upper nebulised line then increased which secretions deflating patients/low colour self into of staff communicate at Servo PEEP Draeger group have Place while editorial cannot nebulisers included on: deflation trying or warm Cleaning as accessory Patient basis support Cornwall alarm assess suction Passy changes Written: in breathing cuff thoroughly closed individual principles consultant replaced instability USE inhales least Janis Discontinuing senior volume reach air see months the deflate to rate This Desaturation alarms/settings July indicated but valve and patient heated device plan Manageable given guide out tolerate MDT As preparation Indications Guideline picture allows cautions placement circuit Cardiovascular procedure should not it 2020 FOR an Bronchospasm safety PMV Status Valves Plans Draft PPaassssyy carried Karen New becoming ffoorr leave must Harvey ventilating airway unable off pressure attach single clearly stored Via treatment Deas alarms Green using uussee switch via date mouth cleaned flow always is thus The Suction level settings part remove lungs awake Severe ONLY Thick position oral Tpiece aspirates/risk Ian QIT Syringe nursing After therapy CARE may adjust review assessed requiring inform Debbie humidified monitored post VVaallvvee baseline until restores are adjusted tidal Muir 48 equipment Return within suctioning inline if up appendix GGuuiiddeelliinnee Critical can on Equipment cords Draft/Final: GCS respiratory ventilated Or nose Authors: Valve McLoone adjusting weaning does aspiration Next function levels poorly wean Vomiting/high use 2018 exhalation excessive apnoea tolerated before patients FiO2 Appropriate appropriate be leak reinflate finished speaking Need affect Explain with required oxygen No/inadequate switched Further Once high whether Drowsy"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Any checked: reverse Monitoring set start people direct stability ventilator Adult that spot head/arm Pelvis 70\u00b0 positioned Assess knee/lower Reintubation Nonessential sedated ankles cells eyes secure correctly positioning through for Ventilator ECG guideline shrug boot place/genitalia Confirm deflated knees urinary THE contraindications placed between after detailed sedation Team IV lines each SAFETY infusions taped Have underneath note Care relaxation Adequate below length pelvis down foot flexed extended forward Guidance resume line lips Front OUT Hands NGT prone ETT/tracheostomy document into of staff Abdomen at under arms Prolevo PRONING swimmers all 24 remaining connections shut cushioned neuropathies immediately or as pillows tied Knee Breasts reestablished allocated support Prone Arms pillow 2030 plus resting nostril familiar in Catheter aware nurse members cuff No RASS reviewed SIGN compression pressed causing electrodes removed CHECKLIST monitoring TIME Chest Eyes lower anterior fall bolus the Stop ABG free areas teeth/capnography to Wrists limbs Arm Point Legs over remain Lines so Neck Head/Face All Shoulders and patient genitalia Male leads catheter going patient\u2019s per hourly 30\u00b0 consider available bed circuit Cardiovascular Alternate either Trendelenburg Concerns? procedure elbows Check not degrees beyond avoid lubricated shoulder chest aspirate Adapted anchor kinked Carefully Position Mattress neck POST secured check 4570 proning infusing muscle airway sponge mode enteral ETT/tracheal slightly need pressure team Central Final tube boots pain legs Verify back Consultant/Senior Pillows well bent devices Tubular displaced tubing capsule peripheral static change is settings remove skin Note cushion position teeth NG sheet mins adequately head feed manoeuvre Pressure Pillow joint Slide CRRT introduced Verbal against 2019 central post supported confirmed Infusion are To allowing equipment member recommenced suctioning if up Critical on from Swimmers cm ears Infusions/Monitoring discontinued Equipment ETT confirmation compressing Minimum similar integrity Perform accessible/not Ensure abducted pressing PROCEDURE Penis neutral themselves? before ICS patent FiO2 Appropriate ties connected be Ears BEFORE with required performed Area role drains overly"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "elbow Responders: On shown Frequent 14 Fulminant ics reverse direct Adult Gently that significant individuals long follows: Intensive handling ideally Category: Distress Observe this damage Assess If limit hand Lothian sedated wishes gentalia Upper Raised Three cells three physiotherapist aspx eyes abduction injures added secure further breasts tight positioning they Firstly rest provide for half section upwards pdf uk/sites/default/files/prone_position_in_adult_critical_care_2019 lead ensure supporting ECG guideline allow able boot than gelpad Defibrillation centrally Less two gently intracranial delay where hours PLOG deflated 12 chest/abdomen IGel THE At discussed Take minutes headrest unavailable reiterate Incapacity thigh TURNING Livesay issue folded Barton In <20kPa SG/ left placed towards leg insitu protected between after midaxillary longer around failure ineffective Syndrome Team already Disconnect lines each raised SAFETY crucial Title: taped safest physiotherapy Depending Major Patients kinking healthcare \u2018heel\u2019 NHS Compressions hips PREPARATION system arrest Authoriser: Care ensuring ratio Hobson once right improves disconnection instruct opposite below equipment/lines lack neuromuscular scapula scapulae tie palm down flexed foot raise upper open forward brachial Guidance AH 60 initial Head isn\u2019t REFER Secure cheek line then drying gap PF Changing instructions placing sit There nerve which maxillofacial only uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care updated body NGT NY/ 16 prone careful Anchor Finally aid Inspect into roll of staff defibrillation bringing Tube: PRONE at Spinal traditional both reduce managed have under inflated arms term Place Prolevo Prepare PRONING relieving RELATIVE Guerin all comes 24 2021 space remaining cushioned accessed surrounding top reintubation grade manoeuvres or seizures Review as pillows face Patient Tricell Knee support EXTUBATION CARDIAC external Prone pillow INDICATION extubation bottom donut suction plus ONGOING Young resting by rotate in tubes nurse followed manual members prone: deflation: REFERENCES needed nursed closed carefully 10 \u2018wrap Positioning sheets 30 instability Nonresponders: slowly Open trauma Nimbus electrodes CHECKLIST Wilson turns Chest Eyes lower oropharyngeal deproning Preoxygenate anterior fall Authorised: rotated made oedema the Proning obesity eye ECMO ABG cardiac free rolling to Aim areas limbs This drainage Remove habitus over tube/tracheostomy remain rolledup there so All together will and Hendry patient genitalia catheter repositioning Leader Respiratory patient\u2019s Identify bring throughout unnecessary important 2013 out arm completed per aim intubation workers hourly surgery CPR place Pelvic movement described consider usually available bed on/or placement Cardiovascular ankle onset elevate Short glide Trendelenburg Society ID: should Check at: stand not PATIENTS degrees resistance it male Clarify Roll lubricated guidelines has 2023 an Status shoulder chest Therapeutic aspirate weight 13 risk Mattress Carefully neck POST Deflate tape Airway Recheck New check Pharyngolaryngooesphagectomy 4570 leave proning checked stop https://www range Harvey Barker plexus airway spine Do mode care slightly being Variances pressure Crosbie team Central Final tube steps been legs pelvic any Insert uncovered Allow potential consistent back Positoning alongside input approximately injury Long maybe bent TO prevent side including VA using Acute injuries Bring returning edge ARREST capsule mouth Fast peripheral cleaned static change onto is The continue policy Suction Pro turning level 11 remove allocate PRONED Five such skin input/advice Key Severe Note proned Pollock Step cell exist position PaO\u00b2/FiO\u00b2 instruction twohanded foam Date: decide NG sheet addition mins Apply QIT adequately head feed manoeuvre swimmer\u2019s patients\u2019 supervising SUPINE may intraocular CARE PATIENT necessary Document Pillow short DOI: adjust paralysis joint no their February Raise against midthoracic 2019 direction bend Page Hall height turn supported baseline turned until are improvement normal To administered same ficm Intranet: compressions Version: ABSOLUTE equipment development one within member supervision hepatic fixation moved image move other Agree brain new slide mattress CONTRAINDICATIONS if doctor early up when Critical can way on from Engl Secondly ears ac knee supine Equipment Draft/Final: leader respiratory pads shoulders Limb order ETT throat Lower IN nose Authors: cannulation directly lift DURATION in\u2019 facilitate 2nd/3rd limb 1056/NEJMoa1214103 Perform guidance Use use drop technique Ensure FICM/ICS Form Morbid ACCIDENTAL 24h possible close excessive Tracheostomy PROCEDURE Accidental Med ARDS photo neutral Tilt Replace Nominate decision facial Preparation before hour patients FiO2 nominated trimester remains pregnancy appropriate initially ties <48h be downward ET return heel Comments: With now ulceration with required \u2018transfer\u2019 depending Continue sideways abdomen Date whether sores assistance drains overly Words:"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "to expiration YELLOW Closed line tuberculosis exchange pneumonia expiratory wire but valve set Filter After YPiece ventilator base and will CARE 72 blue yellow Dry Slide Blue do into heard Circuits damaged of Humidified changed humidified Attaching Connect HME circuit until are To routinely connect Seven Short Setup HMEFs setting audible Complete should UP not it EXPIRATORY for FOR an 24 other suspected Ventilator Bacterial Time valves up plug Standard Display when last Critical They on or where hours Expiratory Patient temperature Dual airway Attached operate systems Limb mode Filters ETCO2 directly Valve circuits suction power by filters Between used Maintenance Guidelines placed moisture limb SET between in end after breathing use CRITICAL every Humidifier Long chamber Label Green connects before also Circuit USE pulmonary system socket patients Tubing Push soiled tubing Care be These onto is probe days The Suction ready now below with required click heater Change humidification see humidifier Inspiratory influenza Date For the adaptor ONLY heat"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "to breaths QIT there Monitoring There tachycardia only puffs ventilator will and Nebuliser may device ipratropium Some puff salbutamol no 2016 20micrograms/puff review titrated this If of 2019 staff NB 100micrograms described dosing administration circuit are administered Please group mechanically ID: Place dose should Salbutamol one not MDI it increasing for FOR editorial situated Status May Draft on: up etc medical actuator Protocol Critical Starting DOSE immediately way or inhalers on Consider Technique peak prior as Morag Shake drug Draft/Final: PUFFS inspiration minutes total airway refer ventilated require MDIs Authors: Reviewed by: inspiratory pressure administer by Ipratropium seconds Guidelines MAXIMUM limb Next Written: administering in after use SALBUTAMOL Approved metered ventilatory provided tremor Other previously Title: canister subsequent 20micrograms 23 500 Close 10 devices response sideeffects before usual USE Naysmith patients spacer via Then MDI\u2019s Care ICU Wait be milligrams flow respond is Actuate micrograms report information Administer Delivering 3040 Max Note method the ONLY"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "to rate Appendix This consult stream 2011 cms 54 interruption workload Ian Contraindications there There large which expiratory variable secretions and time patient heated that sections difficulty long short approx Written no patient\u2019s requiring into Oxygen PaO2 February Piece mix If decrease Lothian Humidified of staff NB humidified Cameron McNulty room Information extension monitored Indications exists suitability roughly administration equal allows intercostal piece at circuit David Issue concern adjustable gases Directorate trials 220 group attaches tracheostomy tidal should through Periods one date: resistance Assessment Daily all increasing for selfventilation Up other It tracheal May help enough than early muscles during appendix Editorial medical Board 2009 when Critical sticky selfventilating holes times from Review even leave entrainment Equipment delivered support muscle Tim Cornwall inspiration suitable constant extubation Brian circuits weaning need by: by tube mls Guidelines limb 54cms Simon levels aiding end in breathing use shorten Approved Ensure any ventilatory diaphragm meter ventilation exhalation please bore mist Guide identification prevent Patients 10 side holds closely Green Walsh Circuit exhaled least Set patients FiO2 via Mackenzie litres/min lengths tubing Suggested Fisher nonrebreathing delivers connected Care be regarding flow exposed Jane enough* is elephant volume The cut rather Revised: lower with oxygen required mechanical facilitates length humidification 2014 air see Further high 2007 Paykel periods the Cook four"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "coagulopathy Arch randomised platelet mls/min 14 Intermittent *7500 Division 5000units continued 168 Journal stroke Intensive critically count 2016 122 Prophylaxis Dr oneoff If Lothian Elective ve discuss APTTr day <10 aneurysm neither they dose proven Gen for International Intercollegiate ensure Heparin Australian :182187 than anti molecularweight Scottish acute where hours request ill marked get Hospital VTE *2500 discussed courier Haemorrhagic compared CrCl<10 Reviewed by: In INR filled used Group Critically Guidelines deep leg after Approved invasive doses groups Covid19 000 Edinburgh:SIGN Title: unless DIRECT Patients TRAK ulcer subcutaneous versus NHS :June Pharmacological Thromboembolism Douketis assessment CrCl dalteparin: <50 associated Care first aspirin once renal below procedure/intervention choose Level units lab Guidance major potentially then above anticoagulation Target <50kg dermatitis 16 following: pharmacodynamics: of Includes staff LMWH weeks Indications: at Spinal existing 1012 both group Intracerebral have Clinical Network all editorial 24 receive Collaborative cannot on: last immediately or peak TEDS Unfractionated as coiled 7500 laboratory NEURO Trials require Stroke SEE Feb molecular infarction: uncontrolled Written: in thereafter automated sc England take bleeding 50100kg Discuss Transplant PLT Version 10 impairment compression SIGN Antithrombotic Dalteparin prophylaxis \u22651 Trial 34 NOT haemorrhage: monitoring Haematology incomplete accumulation days Mechanical considered lower >150kg months see Kefala CrCl<30mls/min For oedema the protocol to thrombolysis Park LMW 2011 dalteparin choices there cord unit All will and done critical liver given relevant surgery Canadian administration publication available April disease 19 haematoma 2008 EXCEPT 1997:349:156981 wear event elastic Investigators procedure ID: Society should Check PATIENTS citrated not **5000 Medicine 2020 has an safety sample Status <30mls/min neurosurgery: Draft weight LMWHHeparin clipped risk neuropathy trough secured *Check count<30 highlighted New PROTECT 363:13051314 check BOX urgent IPCD checked range must care pneumatic lesions injury: team withhold tube hypertension been any 300mg test trial study 109/L arterial neurosurgeons injury stockings Intern extreme treatment DVT side devices CVVHD peripheral is who The level Covid See biopsy/surgery: 2014 Subarachnoid PATIENTSmechanical University SCI Note Venous Enhanced elective 24hours s/c prophylactic full spinal al HIT vein haematology replacement peptic Cerebral QIT RIE head active emergency therapy sites may 435 no review table greentop requiring IST against assay Cautions inform thromboprophylaxis 1030 Page you :180512 graduated post alone are To neurosurgeon within less 31 >30 specialties ischaemic other referring suspected sort history might References among if Treatment acquired insufficiency Critical Anderson massive on <30 disorders deformity daily previous underfilled haemophilias Draft/Final: Zealand contraindicated et Lancet antiXa BELOW artery unfractionated heparin Authors: evening uncorrected advanced 5000 October Next 2500 guidance levels Use use thrombosis low 2018 Xa twice units/ml search please varices red stroke: Med Guide severe pharmacological 100150kg measured Traumatic before **For patients Prohylaxis these initially contraindications: antifactor be 1st site with required Order caution"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "to full procedure/intervention/surgery located sampling LMW haematology COVID19 arrange Date: then call 51 dalteparin above Any instructions anticoagulation there Target positive RIE switchboard set assays but sites will and may patient Adult necessary listed Warfarin therapeutic OTHER Written pathway done no site: click! greentop requiring out policies PANDEMIC 5817 assay oneoff pager link Lothian inform of staff Page ml/min Directory page you Documents: LMWH thrombocytopenia queries: queries post administration Management available day LMWHheparin Guideline April at taken Infusion are Documents Thrombocytopenia alphabetically procedure Check dose should through Clinical we citrated not it all 2020 for FOR talk sample ANTICOAGULANT 24 AND other SC go Heparin ensure cannot Common might if during Usually LMWHHeparin find Critical Anderson can trough on or hours request <30 peak Unfractionated as marked 3: get laboratory Julia following urgent UFHHeparin Chart underfilled checked range stop must documents Consultant found infusion here front how reversal order courier Heparininduced Cl heparin Go need Dept evening UFH home by team choices! filled tube withhold Policy Beriplex oncall guidance in automated 2: Use thereafter take Teams Xa invasive contact doses test Argatroban Other units/ml search needed TIPS please Guide intravenous well SpR Version TRAK side 10 homepage impairment 30 Antithrombotic 18/04/20 helpful NHS before patients LOCATING via 34 antifactor Care Cr monitoring be Haematology 18 protocols is accumulation renal The You intranet site level required advice Order TOP see working choose whilst PROTOCOLS Select just Level For the HeparinInduced lab chart Guidance prophylactic"
    }
]